practice_3_JupiterLab/data/gm_feature_engineered_fda.csv

report_id,country,occur_country,report_type,serious,death,life_threatening,hospitalization,disabling,receive_date,age,age_unit,gender,weight,drug,reaction,is_serious,severity_score,severity_norm,age_group,country_group,drug_risk,drug_freq,high_risk_drug,reaction_length,reaction_pain,reaction_infection,reaction_death,reaction_cancer,reaction_failure,reaction_pneumonia,reaction_bleeding,reaction_complexity,year,month,day,weekday,report_type_risk,age_drug_risk,gender_drug_risk
26016170,US,US,1,2.0,0,0,0,0,2025-11-10,42.0,801.0,Male,75.0,DUPIXENT,abdominal pain,0,0,0.0,Adult,US,0.015513897866839042,221,0,14,1,0,0,0,0,0,0,2,2025,11,10,0,0.08073634859349145,0.6515837104072397,0.0
26017452,NP,NP,1,1.0,1,0,1,0,2025-11-10,51.0,801.0,Male,75.0,METHOTREXATE,toxicity to various agents,1,8,0.5714285714285714,MidAge,Other,0.17346938775510204,7,1,26,0,0,0,0,0,0,0,4,2025,11,10,0,0.08073634859349145,8.846938775510203,0.0
26017586,US,US,1,2.0,0,0,0,0,2025-11-10,57.0,801.0,Female,75.0,PEPCID COMPLETE,exposure during pregnancy,0,0,0.0,MidAge,US,0.0,1,0,25,0,0,0,0,0,0,0,3,2025,11,10,0,0.08073634859349145,0.0,0.0
26018910,SG,SG,1,1.0,0,0,0,0,2025-11-10,62.0,801.0,Female,75.0,PACLITAXEL,drug ineffective,1,0,0.0,MidAge,Other,0.07142857142857142,3,0,16,0,0,0,0,0,0,0,2,2025,11,10,0,0.08073634859349145,4.428571428571428,0.07142857142857142
26018949,EU,EU,3,1.0,0,0,0,0,2025-11-10,57.0,801.0,Female,75.0,DULOXETINE,drug interaction,1,0,0.0,MidAge,EU,0.0,2,0,16,0,0,0,0,0,0,0,2,2025,11,10,0,0.17857142857142855,0.0,0.0
26019625,US,US,1,1.0,0,0,0,0,2025-11-10,67.0,801.0,Male,75.0,DOCETAXEL,osteoporosis,1,0,0.0,Senior,US,0.061224489795918366,7,0,12,0,0,0,0,0,0,0,1,2025,11,10,0,0.08073634859349145,4.1020408163265305,0.0
26019988,US,US,1,2.0,0,0,0,0,2025-11-10,57.0,801.0,Female,75.0,POLYETHYLENE GLYCOL 3350,incorrect product administration duration,0,0,0.0,MidAge,US,0.0,4,0,41,0,0,0,0,0,0,0,4,2025,11,10,0,0.08073634859349145,0.0,0.0
25942883,CA,CA,2,1.0,0,0,0,0,2025-10-21,46.0,801.0,Male,75.0,VEDOLIZUMAB,colitis ulcerative,1,0,0.0,Adult,CA,0.057692307692307696,26,0,18,0,0,0,0,0,0,0,2,2025,10,21,1,0.08936301793444651,2.653846153846154,0.0
25942964,JP,JP,1,1.0,1,0,0,0,2025-10-21,78.0,801.0,Male,75.0,BEVACIZUMAB,vascular stent thrombosis,1,5,0.35714285714285715,Senior,JP,0.17857142857142858,2,1,25,0,0,0,0,0,0,0,3,2025,10,21,1,0.08073634859349145,13.928571428571429,0.0
25943989,US,US,1,2.0,0,0,0,0,2025-10-21,57.0,801.0,Female,75.0,SKYRIZI,swelling of eyelid,0,0,0.0,MidAge,US,0.051587301587301584,36,0,18,0,0,0,0,0,0,0,3,2025,10,21,1,0.08073634859349145,2.9404761904761902,0.051587301587301584
25944665,US,US,1,2.0,0,0,0,0,2025-10-21,68.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Senior,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,10,21,1,0.08073634859349145,1.0549450549450547,0.015513897866839042
25945112,US,Unknown,1,1.0,0,0,1,0,2025-10-21,93.0,801.0,Male,75.0,ABIRATERONE ACETATE,blood potassium decreased,1,3,0.21428571428571427,Senior,US,0.21428571428571427,1,1,25,0,0,0,0,0,0,0,3,2025,10,21,1,0.08073634859349145,19.928571428571427,0.0
25945394,US,US,2,1.0,0,0,0,0,2025-10-21,57.0,801.0,Female,83.46,SKYRIZI,loss of consciousness,1,0,0.0,MidAge,US,0.051587301587301584,36,0,21,0,0,0,0,0,0,0,3,2025,10,21,1,0.08936301793444651,2.9404761904761902,0.051587301587301584
25945732,US,US,1,1.0,0,0,1,0,2025-10-21,16.0,801.0,Female,75.0,WEGOVY,asthma,1,3,0.21428571428571427,Child,US,0.14285714285714285,4,1,6,0,0,0,0,0,0,0,1,2025,10,21,1,0.08073634859349145,2.2857142857142856,0.14285714285714285
25946070,US,US,1,2.0,0,0,0,0,2025-10-21,64.0,801.0,Female,96.16,NEULASTA,needle issue,0,0,0.0,MidAge,US,0.0,5,0,12,0,0,0,0,0,0,0,2,2025,10,21,1,0.08073634859349145,0.0,0.0
25946757,US,US,1,2.0,0,0,0,0,2025-10-22,77.0,801.0,Female,98.866,REMODULIN,peripheral swelling,0,0,0.0,Senior,US,0.0,4,0,19,0,0,0,0,0,0,0,2,2025,10,22,2,0.08073634859349145,0.0,0.0
26022111,US,US,1,2.0,0,0,0,0,2025-11-10,57.0,801.0,Female,75.0,DUPIXENT,rash macular,0,0,0.0,MidAge,US,0.015513897866839042,221,0,12,0,0,0,0,0,0,0,2,2025,11,10,0,0.08073634859349145,0.8842921784098254,0.015513897866839042
26023703,CA,CA,1,1.0,0,0,0,0,2025-11-11,65.0,801.0,Female,75.0,LETROZOLE,drug intolerance,1,0,0.0,MidAge,CA,0.07142857142857142,3,0,16,0,0,0,0,0,0,0,2,2025,11,11,1,0.08073634859349145,4.642857142857142,0.07142857142857142
26024027,US,US,1,1.0,0,0,0,0,2025-11-11,82.0,801.0,Male,75.0,DUPIXENT,cataract,1,0,0.0,Senior,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,11,11,1,0.08073634859349145,1.2721396250808015,0.0
26073427,JP,JP,1,2.0,0,0,0,0,2025-11-21,4.0,800.0,Male,75.0,MINOCYCLINE,therapy partial responder,0,0,0.0,Child,JP,0.0,1,0,25,0,0,0,0,0,0,0,3,2025,11,21,4,0.08073634859349145,0.0,0.0
26073603,CA,CA,1,1.0,0,1,0,0,2025-11-21,57.0,801.0,Male,75.0,DEXAMETHASONE,ventricular hypertrophy,1,4,0.2857142857142857,MidAge,CA,0.1857142857142857,5,1,23,0,0,0,0,0,0,0,2,2025,11,21,4,0.08073634859349145,10.585714285714284,0.0
26074251,CA,CA,2,1.0,0,0,0,0,2025-11-21,57.0,801.0,Female,75.0,RITUXIMAB,blood pressure increased,1,0,0.0,MidAge,CA,0.12406015037593986,19,0,24,0,0,0,0,0,0,0,3,2025,11,21,4,0.08936301793444651,7.071428571428572,0.12406015037593986
26075829,US,US,1,2.0,0,0,0,0,2025-11-21,27.0,801.0,Female,75.0,DUPIXENT,condition aggravated,0,0,0.0,Young,US,0.015513897866839042,221,0,20,0,0,0,0,0,0,0,2,2025,11,21,4,0.08073634859349145,0.4188752424046541,0.015513897866839042
26076396,US,US,2,1.0,0,0,0,0,2025-11-21,71.0,801.0,Female,75.0,AXICABTAGENE CILOLEUCEL,squamous cell carcinoma of skin,1,0,0.0,Senior,US,0.0,1,0,31,0,0,0,0,0,0,0,5,2025,11,21,4,0.08936301793444651,0.0,0.0
25946933,US,US,1,1.0,0,0,0,0,2025-10-22,68.0,801.0,Female,80.726,FIRDAPSE,carpal tunnel syndrome,1,0,0.0,Senior,US,0.0,3,0,22,0,0,0,0,0,0,0,3,2025,10,22,2,0.08073634859349145,0.0,0.0
25947729,US,US,1,2.0,0,0,0,0,2025-10-22,57.0,801.0,Female,52.608,REMODULIN,device maintenance issue,0,0,0.0,MidAge,US,0.0,4,0,24,0,0,0,0,0,0,0,3,2025,10,22,2,0.08073634859349145,0.0,0.0
25948863,US,US,1,2.0,0,0,0,0,2025-10-22,57.0,801.0,Male,75.0,DUPIXENT,illness,0,0,0.0,MidAge,US,0.015513897866839042,221,0,7,0,0,0,0,0,0,0,1,2025,10,22,2,0.08073634859349145,0.8842921784098254,0.0
25949525,US,US,1,1.0,0,0,0,0,2025-10-22,53.0,801.0,Male,75.0,TRULICITY,hepatobiliary cancer,1,0,0.0,MidAge,US,0.04285714285714286,5,0,20,0,0,0,1,0,0,0,2,2025,10,22,2,0.08073634859349145,2.2714285714285714,0.0
25949592,EU,EU,2,1.0,0,0,1,0,2025-10-22,57.0,801.0,Female,75.0,METHOTREXATE SODIUM,chest pain,1,3,0.21428571428571427,MidAge,EU,0.125,4,1,10,1,0,0,0,0,0,0,2,2025,10,22,2,0.08936301793444651,7.125,0.125
25950497,US,US,1,2.0,0,0,0,0,2025-10-23,57.0,801.0,Female,75.0,DUPIXENT,weight increased,0,0,0.0,MidAge,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,2,2025,10,23,3,0.08073634859349145,0.8842921784098254,0.015513897866839042
26024809,EU,EU,3,1.0,0,0,1,0,2025-11-11,57.0,801.0,Female,75.0,ACETAMINOPHEN,cholestasis,1,3,0.21428571428571427,MidAge,EU,0.10267857142857142,16,0,11,0,0,0,0,0,0,0,1,2025,11,11,1,0.17857142857142855,5.852678571428571,0.10267857142857142
26025781,US,US,2,2.0,0,0,0,0,2025-11-11,72.0,801.0,Male,75.0,VONJO,off label use,0,0,0.0,Senior,US,0.0,3,0,13,0,0,0,0,0,0,0,3,2025,11,11,1,0.08936301793444651,0.0,0.0
26025862,EU,EU,1,1.0,0,0,1,0,2025-11-11,57.0,801.0,Female,75.0,RIVAROXABAN,cerebellar ischaemia,1,3,0.21428571428571427,MidAge,EU,0.21428571428571427,2,1,20,0,0,0,0,0,0,0,2,2025,11,11,1,0.08073634859349145,12.214285714285714,0.21428571428571427
26026281,US,US,1,2.0,0,0,0,0,2025-11-11,9.0,801.0,Female,75.0,DUPIXENT,breast mass,0,0,0.0,Child,US,0.015513897866839042,221,0,11,0,0,0,0,0,0,0,2,2025,11,11,1,0.08073634859349145,0.13962508080155137,0.015513897866839042
26027334,CA,CA,1,1.0,0,0,0,0,2025-11-11,56.0,801.0,Female,75.0,VOLTAREN,blindness unilateral,1,0,0.0,MidAge,CA,0.0,1,0,20,0,0,0,0,0,0,0,2,2025,11,11,1,0.08073634859349145,0.0,0.0
26027792,US,US,1,2.0,0,0,0,0,2025-11-11,57.0,801.0,Male,75.0,PLUVICTO,general physical health deterioration,0,0,0.0,MidAge,US,0.0,8,0,37,0,0,0,0,0,0,0,4,2025,11,11,1,0.08073634859349145,0.0,0.0
26027806,US,US,2,1.0,0,0,0,0,2025-11-11,57.0,801.0,Female,75.0,NUPLAZID,hallucination,1,0,0.0,MidAge,US,0.09523809523809523,6,0,13,0,0,0,0,0,0,0,1,2025,11,11,1,0.08936301793444651,5.428571428571428,0.09523809523809523
26079555,US,US,1,2.0,0,0,0,0,2025-11-23,64.0,801.0,Female,75.0,DUPIXENT,drug ineffective,0,0,0.0,MidAge,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,2,2025,11,23,6,0.08073634859349145,0.9928894634776987,0.015513897866839042
26079812,CN,CN,1,1.0,0,0,0,0,2025-11-23,74.0,801.0,Male,76.0,TISLELIZUMAB,myelosuppression,1,0,0.0,Senior,CN,0.0,3,0,16,0,0,0,0,0,0,0,1,2025,11,23,6,0.08073634859349145,0.0,0.0
26080164,KR,KR,1,1.0,0,0,0,0,2025-11-24,80.0,801.0,Female,75.0,ISONIAZID,thrombocytopenia,1,0,0.0,Senior,Other,0.0,1,0,16,0,0,0,0,0,0,0,1,2025,11,24,0,0.08073634859349145,0.0,0.0
26028683,US,US,1,1.0,0,0,1,0,2025-11-11,57.0,801.0,Female,75.0,LENALIDOMIDE,infusion related hypersensitivity reaction,1,3,0.21428571428571427,MidAge,US,0.15413533834586465,19,1,42,0,0,0,0,0,0,0,4,2025,11,11,1,0.08073634859349145,8.785714285714285,0.15413533834586465
26028764,US,US,1,1.0,0,0,0,0,2025-11-11,14.0,801.0,Male,75.0,DUPIXENT,neuropathy peripheral,1,0,0.0,Child,US,0.015513897866839042,221,0,21,0,0,0,0,0,0,0,2,2025,11,11,1,0.08073634859349145,0.21719457013574658,0.0
26030831,GB,GB,1,1.0,0,0,0,0,2025-11-12,57.0,801.0,Female,75.0,CARBOPLATIN,contusion,1,0,0.0,MidAge,GB,0.12244897959183673,7,0,9,0,0,0,0,0,0,0,1,2025,11,12,2,0.08073634859349145,6.979591836734694,0.12244897959183673
26032761,US,US,2,1.0,0,0,0,0,2025-11-12,58.0,801.0,Male,75.0,CREON,pancreatic carcinoma,1,0,0.0,MidAge,US,0.03296703296703297,13,0,20,0,0,0,0,0,0,0,2,2025,11,12,2,0.08936301793444651,1.9120879120879122,0.0
26033409,US,US,1,2.0,0,0,0,0,2025-11-12,57.0,801.0,Female,75.0,CYCLOSPORINE,burning sensation,0,0,0.0,MidAge,US,0.0,5,0,17,0,0,0,0,0,0,0,2,2025,11,12,2,0.08073634859349145,0.0,0.0
26081541,US,US,2,1.0,0,0,1,0,2025-11-24,80.0,801.0,Female,58.0,HUMAN IMMUNOGLOBULIN G,hip fracture,1,3,0.21428571428571427,Senior,US,0.10714285714285714,8,0,12,0,0,0,0,0,0,0,2,2025,11,24,0,0.08936301793444651,8.571428571428571,0.10714285714285714
26082823,US,Unknown,1,1.0,0,1,0,1,2025-11-23,55.0,801.0,Male,96.75,LOSARTAN,therapy interrupted,1,6,0.42857142857142855,MidAge,US,0.2857142857142857,2,1,19,0,0,0,0,0,0,0,2,2025,11,23,6,0.08073634859349145,15.714285714285714,0.0
25956114,US,US,1,2.0,0,0,0,0,2025-10-24,57.0,801.0,Female,75.0,SIROLIMUS,mouth ulceration,0,0,0.0,MidAge,US,0.0,1,0,16,0,0,0,0,0,0,0,2,2025,10,24,4,0.08073634859349145,0.0,0.0
25956734,US,US,1,2.0,0,0,0,0,2025-10-24,85.0,801.0,Female,75.0,AYVAKIT,peripheral swelling,0,0,0.0,Senior,US,0.0,2,0,19,0,0,0,0,0,0,0,2,2025,10,24,4,0.08073634859349145,0.0,0.0
25957410,PR,PR,1,2.0,0,0,0,0,2025-10-24,69.0,801.0,Female,75.0,LENALIDOMIDE,asthenia,0,0,0.0,Senior,Other,0.15413533834586465,19,1,8,0,0,0,0,0,0,0,1,2025,10,24,4,0.08073634859349145,10.63533834586466,0.15413533834586465
26037054,US,US,2,2.0,0,0,0,0,2025-11-12,57.0,801.0,Female,75.0,CORTICOTROPIN,arthralgia,0,0,0.0,MidAge,US,0.0,3,0,10,0,0,0,0,0,0,0,1,2025,11,12,2,0.08936301793444651,0.0,0.0
26037579,US,US,2,1.0,0,0,1,0,2025-11-12,31.0,801.0,Female,75.0,SPRAVATO,hyperventilation,1,3,0.21428571428571427,Young,US,0.026785714285714284,8,0,16,0,0,0,0,0,0,0,1,2025,11,12,2,0.08936301793444651,0.8303571428571428,0.026785714285714284
26037984,US,US,2,1.0,1,0,1,0,2025-11-12,80.0,801.0,Female,75.0,SKYRIZI,pneumonia aspiration,1,8,0.5714285714285714,Senior,US,0.051587301587301584,36,0,20,0,0,0,0,0,1,0,2,2025,11,12,2,0.08936301793444651,4.1269841269841265,0.051587301587301584
26038660,US,US,1,2.0,0,0,0,0,2025-11-13,57.0,801.0,Female,75.0,TRELEGY ELLIPTA,nausea,0,0,0.0,MidAge,US,0.0,4,0,6,0,0,0,0,0,0,0,1,2025,11,13,3,0.08073634859349145,0.0,0.0
26039780,US,US,1,2.0,0,0,0,0,2025-11-13,57.0,801.0,Female,75.0,ACETAMINOPHEN,toxicity to various agents,0,0,0.0,MidAge,US,0.10267857142857142,16,0,26,0,0,0,0,0,0,0,4,2025,11,13,3,0.08073634859349145,5.852678571428571,0.10267857142857142
25960555,US,US,1,2.0,0,0,0,0,2025-10-27,69.0,801.0,Male,129.25,GEMTESA,glycosylated haemoglobin increased,0,0,0.0,Senior,US,0.0,1,0,34,0,0,0,0,0,0,0,3,2025,10,27,0,0.08073634859349145,0.0,0.0
25960784,US,US,1,2.0,0,0,0,0,2025-10-27,57.0,801.0,Male,79.55,DUPIXENT,cough,0,0,0.0,MidAge,US,0.015513897866839042,221,0,5,0,0,0,0,0,0,0,1,2025,10,27,0,0.08073634859349145,0.8842921784098254,0.0
25960865,US,US,1,2.0,0,0,0,0,2025-10-27,71.0,801.0,Male,75.0,ORGOVYX,pollakiuria,0,0,0.0,Senior,US,0.0,4,0,11,0,0,0,0,0,0,0,1,2025,10,27,0,0.08073634859349145,0.0,0.0
25961851,US,IL,1,1.0,0,0,0,0,2025-10-27,67.0,801.0,Male,75.0,OPDIVO,hepatitis,1,0,0.0,Senior,US,0.08928571428571429,4,0,9,0,0,0,0,0,0,0,1,2025,10,27,0,0.08073634859349145,5.982142857142858,0.0
25962337,MX,MX,1,1.0,0,0,0,0,2025-10-27,41.0,801.0,Male,76.0,OCREVUS,multiple sclerosis,1,0,0.0,Adult,Other,0.0,3,0,18,0,0,0,0,0,0,0,2,2025,10,27,0,0.08073634859349145,0.0,0.0
25962418,EU,EU,1,1.0,1,0,0,0,2025-10-27,51.0,801.0,Male,75.0,BUPRENORPHINE,asphyxia,1,5,0.35714285714285715,MidAge,EU,0.2857142857142857,2,1,8,0,0,0,0,0,0,0,1,2025,10,27,0,0.08073634859349145,14.571428571428571,0.0
26040942,US,Unknown,1,2.0,0,0,0,0,2025-11-12,57.0,801.0,Female,75.0,DUPIXENT,conjunctivitis,0,0,0.0,MidAge,US,0.015513897866839042,221,0,14,0,0,0,0,0,0,0,1,2025,11,12,2,0.08073634859349145,0.8842921784098254,0.015513897866839042
26041752,US,US,1,2.0,0,0,0,0,2025-11-13,57.0,801.0,Female,59.09,DUPIXENT,oropharyngeal discomfort,0,0,0.0,MidAge,US,0.015513897866839042,221,0,24,0,0,0,0,0,0,0,2,2025,11,13,3,0.08073634859349145,0.8842921784098254,0.015513897866839042
26041819,US,US,1,2.0,0,0,0,0,2025-11-13,64.0,801.0,Male,75.0,DUPIXENT,sensitive skin,0,0,0.0,MidAge,US,0.015513897866839042,221,0,14,0,0,0,0,0,0,0,2,2025,11,13,3,0.08073634859349145,0.9928894634776987,0.0
26042023,CN,CN,1,1.0,0,0,1,0,2025-11-13,57.0,801.0,Female,75.0,TORIPALIMAB,myelosuppression,1,3,0.21428571428571427,MidAge,CN,0.21428571428571427,1,1,16,0,0,0,0,0,0,0,1,2025,11,13,3,0.08073634859349145,12.214285714285714,0.21428571428571427
26086588,EU,EU,1,1.0,0,0,1,0,2025-11-25,63.0,801.0,Male,75.0,MIRTAZAPINE,hepatotoxicity,1,3,0.21428571428571427,MidAge,EU,0.19047619047619047,3,1,14,0,0,0,0,0,0,0,1,2025,11,25,1,0.08073634859349145,12.0,0.0
26087035,EU,EU,1,1.0,0,0,0,0,2025-11-25,29.0,801.0,Female,75.0,ESOMEPRAZOLE,rash maculo-papular,1,0,0.0,Young,EU,0.0,1,0,19,0,0,0,0,0,0,0,2,2025,11,25,1,0.08073634859349145,0.0,0.0
26087817,US,US,2,1.0,0,0,0,0,2025-11-25,57.0,801.0,Female,75.0,VENCLEXTA,pancytopenia,1,0,0.0,MidAge,US,0.18571428571428572,5,1,12,0,0,0,0,0,0,0,1,2025,11,25,1,0.08936301793444651,10.585714285714285,0.18571428571428572
26088412,US,US,1,1.0,0,0,1,0,2025-11-25,80.0,801.0,Male,75.0,XGEVA,compression fracture,1,3,0.21428571428571427,Senior,US,0.10714285714285714,2,0,20,0,0,0,0,0,0,0,2,2025,11,25,1,0.08073634859349145,8.571428571428571,0.0
25964429,CA,CA,2,1.0,0,0,0,0,2025-10-27,57.0,801.0,Female,75.0,BENRALIZUMAB,chest discomfort,1,0,0.0,MidAge,CA,0.0,1,0,16,0,0,0,0,0,0,0,2,2025,10,27,0,0.08936301793444651,0.0,0.0
25965077,GB,GB,1,1.0,0,0,0,0,2025-10-27,57.0,801.0,Female,57.0,CITALOPRAM,muscle twitching,1,0,0.0,MidAge,GB,0.42857142857142855,2,1,16,0,0,0,0,0,0,0,2,2025,10,27,0,0.08073634859349145,24.428571428571427,0.42857142857142855
25965105,US,US,2,1.0,0,0,0,0,2025-10-27,35.0,801.0,Female,75.0,SPRAVATO,sedation,1,0,0.0,Young,US,0.026785714285714284,8,0,8,0,0,0,0,0,0,0,1,2025,10,27,0,0.08936301793444651,0.9375,0.026785714285714284
25965415,US,US,1,2.0,0,0,0,0,2025-10-27,91.0,801.0,Female,75.0,DUPIXENT,injection site pain,0,0,0.0,Senior,US,0.015513897866839042,221,0,19,1,0,0,0,0,0,0,3,2025,10,27,0,0.08073634859349145,1.4117647058823528,0.015513897866839042
25965482,US,US,1,2.0,0,0,0,0,2025-10-27,40.0,801.0,Male,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Adult,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,10,27,0,0.08073634859349145,0.6205559146735616,0.0
25966454,US,US,1,2.0,0,0,0,0,2025-10-28,74.0,801.0,Female,75.0,ORENCIA,pain,0,0,0.0,Senior,US,0.10204081632653061,14,0,4,1,0,0,0,0,0,0,1,2025,10,28,1,0.08073634859349145,7.551020408163265,0.10204081632653061
26044249,US,US,1,2.0,0,0,0,0,2025-11-14,71.0,801.0,Male,75.0,TIGECYCLINE,diarrhoea,0,0,0.0,Senior,US,0.0,1,0,9,0,0,0,0,0,0,0,1,2025,11,14,4,0.08073634859349145,0.0,0.0
26044397,GB,GB,1,1.0,0,0,0,0,2025-11-14,67.0,801.0,Male,75.0,FINASTERIDE,disorder of sex development,1,0,0.0,Senior,GB,0.0,2,0,27,0,0,0,0,0,0,0,4,2025,11,14,4,0.08073634859349145,0.0,0.0
26045369,US,US,2,1.0,0,0,0,0,2025-11-14,78.0,801.0,Male,75.0,IXAZOMIB,compression fracture,1,0,0.0,Senior,US,0.0,2,0,20,0,0,0,0,0,0,0,2,2025,11,14,4,0.08936301793444651,0.0,0.0
26045950,AU,AU,1,1.0,0,0,1,0,2025-11-14,65.0,801.0,Male,91.9,LENALIDOMIDE,pyrexia,1,3,0.21428571428571427,MidAge,AU,0.15413533834586465,19,1,7,0,0,0,0,0,0,0,1,2025,11,14,4,0.08073634859349145,10.018796992481203,0.0
26089046,US,US,1,2.0,0,0,0,0,2025-11-25,71.0,801.0,Female,75.0,DUPIXENT,injury associated with device,0,0,0.0,Senior,US,0.015513897866839042,221,0,29,0,0,0,0,0,0,0,4,2025,11,25,1,0.08073634859349145,1.101486748545572,0.015513897866839042
26089451,US,US,1,2.0,0,0,0,0,2025-11-25,70.0,801.0,Male,75.0,DUPIXENT,drug effect less than expected,0,0,0.0,Senior,US,0.015513897866839042,221,0,30,0,0,0,0,0,0,0,5,2025,11,25,1,0.08073634859349145,1.085972850678733,0.0
26092152,US,US,1,1.0,0,1,1,0,2025-11-26,17.0,801.0,Male,75.0,IBUPROFEN,hypotension,1,7,0.5,Child,US,0.11607142857142858,8,0,11,0,0,0,0,0,0,0,1,2025,11,26,2,0.08073634859349145,1.9732142857142858,0.0
26092624,CN,CN,1,2.0,0,0,0,0,2025-11-26,63.0,801.0,Male,75.0,MYCOPHENOLATE MOFETIL,aspartate aminotransferase increased,0,0,0.0,MidAge,CN,0.10150375939849625,19,0,36,0,0,0,0,0,0,0,3,2025,11,26,2,0.08073634859349145,6.394736842105264,0.0
26051768,US,US,2,1.0,0,0,0,0,2025-11-17,57.0,801.0,Female,75.0,RISPERIDONE,adverse drug reaction,1,0,0.0,MidAge,US,0.125,4,1,21,0,0,0,0,0,0,0,3,2025,11,17,0,0.08936301793444651,7.125,0.125
26052620,EU,EU,2,1.0,0,0,0,0,2025-11-17,44.0,801.0,Male,75.0,SKYRIZI,chronic lymphocytic leukaemia,1,0,0.0,Adult,EU,0.051587301587301584,36,0,29,0,0,0,0,0,0,0,3,2025,11,17,0,0.08936301793444651,2.2698412698412698,0.0
26053807,US,US,1,2.0,0,0,0,0,2025-11-17,53.0,801.0,Female,75.0,DUPIXENT,nasopharyngitis,0,0,0.0,MidAge,US,0.015513897866839042,221,0,15,0,0,0,0,0,0,0,1,2025,11,17,0,0.08073634859349145,0.8222365869424693,0.015513897866839042
26053821,US,US,1,2.0,0,0,0,0,2025-11-17,38.0,801.0,Male,75.0,DUPIXENT,idiopathic urticaria,0,0,0.0,Adult,US,0.015513897866839042,221,0,20,0,0,0,0,0,0,0,2,2025,11,17,0,0.08073634859349145,0.5895281189398835,0.0
26054011,EU,EU,1,1.0,0,0,0,0,2025-11-17,47.0,801.0,Female,75.0,AZATHIOPRINE,toxicity to various agents,1,0,0.0,Adult,EU,0.0,2,0,26,0,0,0,0,0,0,0,4,2025,11,17,0,0.08073634859349145,0.0,0.0
25973973,US,Unknown,1,1.0,0,0,0,0,2025-10-28,37.0,801.0,Female,87.75,TALTZ,migraine,1,0,0.0,Adult,US,0.0,1,0,8,0,0,0,0,0,0,0,1,2025,10,28,1,0.08073634859349145,0.0,0.0
25974378,US,Unknown,1,1.0,0,0,1,0,2025-10-29,79.0,801.0,Female,52.71,DARATUMUMAB\HYALURONIDASE-FIHJ,renal failure,1,3,0.21428571428571427,Senior,US,0.21428571428571427,2,1,13,0,0,0,0,1,0,0,2,2025,10,29,2,0.08073634859349145,16.928571428571427,0.21428571428571427
25974459,EU,EU,1,1.0,0,0,1,0,2025-10-29,57.0,804.0,Female,1.88,METOPROLOL,bradycardia neonatal,1,3,0.21428571428571427,MidAge,EU,0.21428571428571427,1,1,20,0,0,0,0,0,0,0,2,2025,10,29,2,0.08073634859349145,12.214285714285714,0.21428571428571427
25974554,US,US,2,1.0,0,0,0,0,2025-10-29,76.0,801.0,Female,75.0,CREON,hip arthroplasty,1,0,0.0,Senior,US,0.03296703296703297,13,0,16,0,0,0,0,0,0,0,2,2025,10,29,2,0.08936301793444651,2.5054945054945055,0.03296703296703297
25975621,US,US,1,2.0,0,0,0,0,2025-10-29,30.0,801.0,Male,75.0,XELJANZ XR,therapeutic product effect incomplete,0,0,0.0,Young,US,0.0,9,0,37,0,0,0,0,0,0,0,4,2025,10,29,2,0.08073634859349145,0.0,0.0
26056547,US,US,1,2.0,0,0,0,0,2025-11-18,57.0,801.0,Female,75.0,ISOTRETINOIN,adverse drug reaction,0,0,0.0,MidAge,US,0.023809523809523808,9,0,21,0,0,0,0,0,0,0,3,2025,11,18,1,0.08073634859349145,1.357142857142857,0.023809523809523808
26056790,US,US,1,2.0,0,0,0,0,2025-11-18,57.0,801.0,Female,75.0,ISOTRETINOIN,alopecia,0,0,0.0,MidAge,US,0.023809523809523808,9,0,8,0,0,0,0,0,0,0,1,2025,11,18,1,0.08073634859349145,1.357142857142857,0.023809523809523808
26056938,US,US,1,2.0,0,0,0,0,2025-11-18,57.0,801.0,Female,75.0,ISOTRETINOIN,adverse event,0,0,0.0,MidAge,US,0.023809523809523808,9,0,13,0,0,0,0,0,0,0,2,2025,11,18,1,0.08073634859349145,1.357142857142857,0.023809523809523808
26057223,US,US,1,2.0,0,0,0,0,2025-11-18,17.0,801.0,Female,75.0,ISOTRETINOIN,oropharyngeal pain,0,0,0.0,Child,US,0.023809523809523808,9,0,18,1,0,0,0,0,0,0,2,2025,11,18,1,0.08073634859349145,0.40476190476190477,0.023809523809523808
26057276,US,US,1,2.0,0,0,0,0,2025-11-18,16.0,801.0,Female,75.0,ISOTRETINOIN,intentional dose omission,0,0,0.0,Child,US,0.023809523809523808,9,0,25,0,0,0,0,0,0,0,3,2025,11,18,1,0.08073634859349145,0.38095238095238093,0.023809523809523808
26059368,CN,CN,1,1.0,0,0,1,0,2025-11-18,73.0,801.0,Male,59.0,DICLOFENAC SODIUM,upper gastrointestinal haemorrhage,1,3,0.21428571428571427,Senior,CN,0.4047619047619048,3,1,34,0,0,0,0,0,0,0,3,2025,11,18,1,0.08073634859349145,29.54761904761905,0.0
26059692,US,US,1,1.0,1,0,0,0,2025-11-18,57.0,801.0,Female,75.0,XEOMIN,death,1,5,0.35714285714285715,MidAge,US,0.08928571428571429,4,0,5,0,0,1,0,0,0,0,1,2025,11,18,1,0.08073634859349145,5.089285714285714,0.08928571428571429
26093258,US,US,1,2.0,0,0,0,0,2025-11-26,49.0,801.0,Female,75.0,DUPIXENT,dyspnoea,0,0,0.0,Adult,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,11,26,2,0.08073634859349145,0.7601809954751131,0.015513897866839042
26094244,US,US,2,1.0,0,0,0,0,2025-11-26,41.0,801.0,Male,75.0,XYWAV,impaired gastric emptying,1,0,0.0,Adult,US,0.04285714285714286,5,0,25,0,0,0,0,0,0,0,3,2025,11,26,2,0.08936301793444651,1.7571428571428571,0.0
26094325,US,US,1,1.0,0,0,0,0,2025-11-26,65.0,801.0,Female,75.0,BENLYSTA,osteoarthritis,1,0,0.0,MidAge,US,0.0,1,0,14,0,0,0,0,0,0,0,1,2025,11,26,2,0.08073634859349145,0.0,0.0
26094998,US,US,2,1.0,0,0,0,0,2025-11-26,57.0,801.0,Female,100.0,HUMAN IMMUNOGLOBULIN G,lower respiratory tract infection,1,0,0.0,MidAge,US,0.10714285714285714,8,0,33,0,1,0,0,0,0,0,4,2025,11,26,2,0.08936301793444651,6.107142857142857,0.10714285714285714
26095702,US,US,1,2.0,0,0,0,0,2025-11-27,70.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Senior,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,11,27,3,0.08073634859349145,1.085972850678733,0.015513897866839042
26096699,US,US,1,1.0,0,0,0,0,2025-11-27,76.0,801.0,Female,99.787,ALBUTEROL SULFATE,wrong technique in product usage process,1,0,0.0,Senior,US,0.0,8,0,40,0,0,0,0,0,0,0,6,2025,11,27,3,0.08073634859349145,0.0,0.0
26096903,EU,EU,1,1.0,0,0,0,0,2025-11-27,77.0,801.0,Male,88.0,DAPTOMYCIN,interstitial lung disease,1,0,0.0,Senior,EU,0.16666666666666666,3,1,25,0,0,0,0,0,0,0,3,2025,11,27,3,0.08073634859349145,12.833333333333332,0.0
26059706,CA,CA,2,1.0,0,0,0,0,2025-11-18,31.0,801.0,Male,75.0,VEDOLIZUMAB,colitis ulcerative,1,0,0.0,Young,CA,0.057692307692307696,26,0,18,0,0,0,0,0,0,0,2,2025,11,18,1,0.08936301793444651,1.7884615384615385,0.0
26059854,EU,EU,1,1.0,0,0,1,0,2025-11-18,59.0,801.0,Male,60.0,LOVENOX,deep vein thrombosis,1,3,0.21428571428571427,MidAge,EU,0.21428571428571427,1,1,20,0,0,0,0,0,0,0,3,2025,11,18,1,0.08073634859349145,12.642857142857142,0.0
26060854,US,US,1,2.0,0,0,0,0,2025-11-18,57.0,801.0,Female,75.0,PLUVICTO,general physical health deterioration,0,0,0.0,MidAge,US,0.0,8,0,37,0,0,0,0,0,0,0,4,2025,11,18,1,0.08073634859349145,0.0,0.0
26097227,US,US,1,2.0,0,0,0,0,2025-11-27,71.0,801.0,Male,75.0,ORGOVYX,pollakiuria,0,0,0.0,Senior,US,0.0,4,0,11,0,0,0,0,0,0,0,1,2025,11,27,3,0.08073634859349145,0.0,0.0
26097766,EU,EU,1,1.0,0,0,0,0,2025-11-27,34.0,801.0,Female,75.0,SPINRAZA,caesarean section,1,0,0.0,Young,EU,0.0,1,0,17,0,0,0,0,0,0,0,2,2025,11,27,3,0.08073634859349145,0.0,0.0
26097861,US,US,1,2.0,0,0,0,0,2025-11-27,35.0,801.0,Male,75.0,OXYCODONE HYDROCHLORIDE,drug diversion,0,0,0.0,Young,US,0.0,1,0,14,0,0,0,0,0,0,0,2,2025,11,27,3,0.08073634859349145,0.0,0.0
26098037,US,US,1,2.0,0,0,0,0,2025-11-27,66.0,801.0,Male,75.0,RITUXIMAB,treatment failure,0,0,0.0,Senior,US,0.12406015037593986,19,0,17,0,0,0,0,1,0,0,2,2025,11,27,3,0.08073634859349145,8.18796992481203,0.0
26098509,CA,CA,1,1.0,0,0,1,0,2025-11-27,96.0,801.0,Female,53.0,JANUMET,atrial fibrillation,1,3,0.21428571428571427,Senior,CA,0.21428571428571427,1,1,19,0,0,0,0,0,0,0,2,2025,11,27,3,0.08073634859349145,20.57142857142857,0.21428571428571427
26098657,EU,EU,1,1.0,0,0,0,0,2025-11-27,8.0,801.0,Female,75.0,MYCOPHENOLATE MOFETIL,lymphadenitis,1,0,0.0,Child,EU,0.10150375939849625,19,0,13,0,0,0,0,0,0,0,1,2025,11,27,3,0.08073634859349145,0.81203007518797,0.10150375939849625
26099858,EU,EU,1,1.0,0,0,0,0,2025-11-28,13.0,801.0,Female,75.0,QUETIAPINE FUMARATE,pericardial effusion,1,0,0.0,Child,EU,0.0,1,0,20,0,0,0,0,0,0,0,2,2025,11,28,4,0.08073634859349145,0.0,0.0
26064337,US,US,1,2.0,0,0,0,0,2025-11-19,57.0,801.0,Female,75.0,DUPIXENT,condition aggravated,0,0,0.0,MidAge,US,0.015513897866839042,221,0,20,0,0,0,0,0,0,0,2,2025,11,19,2,0.08073634859349145,0.8842921784098254,0.015513897866839042
26065147,GB,GB,1,1.0,0,0,1,0,2025-11-19,57.0,801.0,Male,75.0,ELEXACAFTOR\IVACAFTOR\TEZACAFTOR,lower respiratory tract infection,1,3,0.21428571428571427,MidAge,GB,0.21428571428571427,2,1,33,0,1,0,0,0,0,0,4,2025,11,19,2,0.08073634859349145,12.214285714285714,0.0
26066186,BR,BR,1,1.0,0,0,1,0,2025-11-19,57.0,801.0,Female,76.0,TYSABRI,seizure,1,3,0.21428571428571427,MidAge,BR,0.21428571428571427,1,1,7,0,0,0,0,0,0,0,1,2025,11,19,2,0.08073634859349145,12.214285714285714,0.21428571428571427
25982210,US,Unknown,1,1.0,0,0,0,0,2025-10-31,76.0,801.0,Female,112.0,ZILBRYSQ,influenza like illness,1,0,0.0,Senior,US,0.10714285714285714,2,0,22,0,0,0,0,0,0,0,3,2025,10,31,4,0.08073634859349145,8.142857142857142,0.10714285714285714
25982964,US,US,1,1.0,0,0,0,0,2025-10-31,57.0,801.0,Male,129.25,ORENITRAM,skin laceration,1,0,0.0,MidAge,US,0.0,2,0,15,0,0,0,0,0,0,0,2,2025,10,31,4,0.08073634859349145,0.0,0.0
25983464,EU,EU,1,1.0,0,0,0,0,2025-10-31,72.0,801.0,Female,75.0,OLANZAPINE,urinary retention,1,0,0.0,Senior,EU,0.11904761904761905,6,0,17,0,0,0,0,0,0,0,2,2025,10,31,4,0.08073634859349145,8.571428571428571,0.11904761904761905
25984489,EU,EU,1,1.0,1,0,0,0,2025-10-31,34.0,801.0,Male,75.0,FENTANYL,toxicity to various agents,1,5,0.35714285714285715,Young,EU,0.35714285714285715,1,1,26,0,0,0,0,0,0,0,4,2025,10,31,4,0.08073634859349145,12.142857142857142,0.0
25984612,US,US,1,2.0,0,0,0,0,2025-10-31,66.0,801.0,Female,75.0,BIVIGAM,urticaria,0,0,0.0,Senior,US,0.0,1,0,9,0,0,0,0,0,0,0,1,2025,10,31,4,0.08073634859349145,0.0,0.0
26104154,US,US,1,2.0,0,0,0,0,2025-11-29,57.0,801.0,Female,75.0,DUPIXENT,accidental exposure to product,0,0,0.0,MidAge,US,0.015513897866839042,221,0,30,0,0,0,0,0,0,0,4,2025,11,29,5,0.08073634859349145,0.8842921784098254,0.015513897866839042
26104774,JP,JP,1,2.0,0,0,0,0,2025-11-30,37.0,801.0,Female,49.0,MYCOPHENOLATE MOFETIL,therapy partial responder,0,0,0.0,Adult,JP,0.10150375939849625,19,0,25,0,0,0,0,0,0,0,3,2025,11,30,6,0.08073634859349145,3.755639097744361,0.10150375939849625
26104989,US,US,1,2.0,0,0,0,0,2025-11-30,47.0,801.0,Male,75.0,MYCOPHENOLATE MOFETIL,treatment failure,0,0,0.0,Adult,US,0.10150375939849625,19,0,17,0,0,0,0,1,0,0,2,2025,11,30,6,0.08073634859349145,4.7706766917293235,0.0
26105126,US,US,1,2.0,0,0,0,0,2025-12-01,4.0,801.0,Male,75.0,DUPIXENT,dry skin,0,0,0.0,Child,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,2,2025,12,1,0,0.08073634859349145,0.06205559146735617,0.0
26067778,US,US,1,1.0,0,0,0,0,2025-11-20,57.0,801.0,Female,75.0,SKYRIZI,renal cancer stage iv,1,0,0.0,MidAge,US,0.051587301587301584,36,0,21,0,0,0,1,0,0,0,4,2025,11,20,3,0.08073634859349145,2.9404761904761902,0.051587301587301584
26067859,CA,CA,2,1.0,0,0,0,0,2025-11-20,57.0,801.0,Female,75.0,VEDOLIZUMAB,oral herpes,1,0,0.0,MidAge,CA,0.057692307692307696,26,0,11,0,0,0,0,0,0,0,2,2025,11,20,3,0.08936301793444651,3.2884615384615388,0.057692307692307696
26068197,US,US,2,1.0,0,0,0,0,2025-11-20,57.0,801.0,Male,75.0,DUPILUMAB,pleurisy,1,0,0.0,MidAge,US,0.04285714285714286,5,0,8,0,0,0,0,0,0,0,1,2025,11,20,3,0.08936301793444651,2.442857142857143,0.0
26068993,CA,CA,1,1.0,1,1,1,1,2025-11-20,43.0,801.0,Female,96.0,DICLOFENAC SODIUM,type 2 diabetes mellitus,1,14,1.0,Adult,CA,0.4047619047619048,3,1,24,0,0,0,0,0,0,0,4,2025,11,20,3,0.08073634859349145,17.40476190476191,0.4047619047619048
26069507,EU,EU,1,1.0,0,1,0,0,2025-11-20,65.0,801.0,Male,65.0,AMLODIPINE,intentional overdose,1,4,0.2857142857142857,MidAge,EU,0.16964285714285715,8,1,20,0,0,0,0,0,0,0,2,2025,11,20,3,0.08073634859349145,11.026785714285715,0.0
26070088,CA,CA,1,1.0,0,0,1,0,2025-11-20,88.0,801.0,Male,75.0,SEMAGLUTIDE,balance disorder,1,3,0.21428571428571427,Senior,CA,0.14285714285714285,3,1,16,0,0,0,0,0,0,0,2,2025,11,20,3,0.08073634859349145,12.571428571428571,0.0
26070426,US,US,1,2.0,0,0,0,0,2025-11-20,57.0,801.0,Female,75.0,XEOMIN,blister,0,0,0.0,MidAge,US,0.08928571428571429,4,0,7,0,0,0,0,0,0,0,1,2025,11,20,3,0.08073634859349145,5.089285714285714,0.08928571428571429
25985260,US,US,1,2.0,0,0,0,0,2025-10-31,57.0,801.0,Female,75.0,XDEMVY,therapeutic product effect variable,0,0,0.0,MidAge,US,0.0,1,0,35,0,0,0,0,0,0,0,4,2025,10,31,4,0.08073634859349145,0.0,0.0
25985880,EU,EU,1,1.0,0,0,1,0,2025-11-01,32.0,801.0,Male,75.0,PRAZEPAM,coma,1,3,0.21428571428571427,Young,EU,0.21428571428571427,1,1,4,0,0,0,0,0,0,0,1,2025,11,1,5,0.08073634859349145,6.857142857142857,0.0
25987176,EU,EU,1,1.0,0,0,0,0,2025-11-03,57.0,801.0,Female,75.0,IBUPROFEN,meningitis aseptic,1,0,0.0,MidAge,EU,0.11607142857142858,8,0,18,0,0,0,0,0,0,0,2,2025,11,3,0,0.08073634859349145,6.616071428571429,0.11607142857142858
25988472,US,US,2,1.0,1,0,0,0,2025-11-03,75.0,801.0,Male,75.0,NUPLAZID,death,1,5,0.35714285714285715,Senior,US,0.09523809523809523,6,0,5,0,0,1,0,0,0,0,1,2025,11,3,0,0.08936301793444651,7.142857142857142,0.0
26105665,US,US,2,1.0,1,0,0,0,2025-12-01,93.0,801.0,Female,75.0,VABYSMO,death,1,5,0.35714285714285715,Senior,US,0.35714285714285715,1,1,5,0,0,1,0,0,0,0,1,2025,12,1,0,0.08936301793444651,33.214285714285715,0.35714285714285715
26106570,US,US,1,2.0,0,0,0,0,2025-12-01,28.0,801.0,Male,75.0,DUPIXENT,nasal congestion,0,0,0.0,Young,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,2,2025,12,1,0,0.08073634859349145,0.43438914027149317,0.0
26072356,EU,EU,2,1.0,0,0,1,0,2025-11-20,8.0,800.0,Male,75.0,DARATUMUMAB,infection,1,3,0.21428571428571427,Child,EU,0.14285714285714285,3,1,9,0,1,0,0,0,0,0,1,2025,11,20,3,0.08936301793444651,1.1428571428571428,0.0
26072518,US,US,1,2.0,0,0,0,0,2025-11-20,68.0,801.0,Female,75.0,DUPIXENT,psoriasis,0,0,0.0,Senior,US,0.015513897866839042,221,0,9,0,0,0,0,0,0,0,1,2025,11,20,3,0.08073634859349145,1.0549450549450547,0.015513897866839042
26072923,US,US,1,2.0,0,0,0,0,2025-11-21,57.0,801.0,Female,75.0,TRIAMCINOLONE ACETONIDE,product closure issue,0,0,0.0,MidAge,US,0.19047619047619047,3,1,21,0,0,0,0,0,0,0,3,2025,11,21,4,0.08073634859349145,10.857142857142856,0.19047619047619047
26073814,CA,CA,1,1.0,0,0,1,0,2025-11-21,59.0,801.0,Female,75.0,IBUPROFEN,arthralgia,1,3,0.21428571428571427,MidAge,CA,0.11607142857142858,8,0,10,0,0,0,0,0,0,0,1,2025,11,21,4,0.08073634859349145,6.848214285714286,0.11607142857142858
26075043,US,US,1,2.0,0,0,0,0,2025-11-21,77.0,801.0,Female,75.0,TYLENOL,drug ineffective,0,0,0.0,Senior,US,0.0,1,0,16,0,0,0,0,0,0,0,2,2025,11,21,4,0.08073634859349145,0.0,0.0
25988634,US,US,2,2.0,0,0,0,0,2025-11-03,14.0,801.0,Male,75.0,OMNITROPE,injection site pain,0,0,0.0,Child,US,0.0,5,0,19,1,0,0,0,0,0,0,3,2025,11,3,0,0.08936301793444651,0.0,0.0
25990620,EU,EU,2,1.0,0,0,1,0,2025-11-03,77.0,801.0,Male,168.0,POMALIDOMIDE,deep vein thrombosis,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,20,0,0,0,0,0,0,0,3,2025,11,3,0,0.08936301793444651,16.5,0.0
25991469,US,US,1,2.0,0,0,0,0,2025-11-03,57.0,801.0,Female,75.0,DUPIXENT,accidental exposure to product,0,0,0.0,MidAge,US,0.015513897866839042,221,0,30,0,0,0,0,0,0,0,4,2025,11,3,0,0.08073634859349145,0.8842921784098254,0.015513897866839042
25991645,US,US,1,2.0,0,0,0,0,2025-11-03,19.0,801.0,Female,75.0,DUPIXENT,off label use,0,0,0.0,Young,US,0.015513897866839042,221,0,13,0,0,0,0,0,0,0,3,2025,11,3,0,0.08073634859349145,0.2947640594699418,0.015513897866839042
26110377,US,US,1,2.0,0,0,0,0,2025-12-02,59.0,801.0,Female,56.961,REMODULIN,dyspnoea,0,0,0.0,MidAge,US,0.0,4,0,8,0,0,0,0,0,0,0,1,2025,12,2,1,0.08073634859349145,0.0,0.0
26110391,JP,JP,1,1.0,0,0,1,0,2025-12-02,57.0,801.0,Female,75.0,METHOTREXATE,hepatic cancer metastatic,1,3,0.21428571428571427,MidAge,JP,0.17346938775510204,7,1,25,0,0,0,1,0,0,0,3,2025,12,2,1,0.08073634859349145,9.887755102040817,0.17346938775510204
26076082,ZA,ZA,2,1.0,0,0,0,0,2025-11-21,71.0,801.0,Female,75.0,BUDESONIDE\FORMOTEROL,fall,1,0,0.0,Senior,ZA,0.10714285714285714,2,0,4,0,0,0,0,0,0,0,1,2025,11,21,4,0.08936301793444651,7.607142857142857,0.10714285714285714
26077579,JP,JP,1,1.0,1,0,0,0,2025-11-21,70.0,801.0,Male,75.0,TREPROSTINIL,interstitial lung disease,1,5,0.35714285714285715,Senior,JP,0.2857142857142857,2,1,25,0,0,0,0,0,0,0,3,2025,11,21,4,0.08073634859349145,20.0,0.0
26078107,US,US,1,2.0,0,0,0,0,2025-11-22,57.0,801.0,Female,75.0,LENALIDOMIDE,fatigue,0,0,0.0,MidAge,US,0.15413533834586465,19,1,7,0,0,0,0,0,0,0,1,2025,11,22,5,0.08073634859349145,8.785714285714285,0.15413533834586465
26078174,US,US,1,2.0,0,0,0,0,2025-11-22,57.0,801.0,Female,80.726,REMODULIN,contusion,0,0,0.0,MidAge,US,0.0,4,0,9,0,0,0,0,0,0,0,1,2025,11,22,5,0.08073634859349145,0.0,0.0
26114265,EU,EU,1,1.0,0,0,0,0,2025-12-02,53.0,801.0,Male,75.0,DOCETAXEL,prostate cancer metastatic,1,0,0.0,MidAge,EU,0.061224489795918366,7,0,26,0,0,0,1,0,0,0,3,2025,12,2,1,0.08073634859349145,3.2448979591836733,0.0
26114751,US,US,1,2.0,0,0,0,0,2025-12-02,37.0,801.0,Female,75.0,NEULASTA,device adhesion issue,0,0,0.0,Adult,US,0.0,5,0,21,0,0,0,0,0,0,0,3,2025,12,2,1,0.08073634859349145,0.0,0.0
26116452,US,US,1,2.0,0,0,0,0,2025-12-03,57.0,801.0,Male,75.0,DUPIXENT,sleep disorder due to a general medical condition,0,0,0.0,MidAge,US,0.015513897866839042,221,0,49,0,0,0,0,0,0,0,8,2025,12,3,2,0.08073634859349145,0.8842921784098254,0.0
26117033,US,US,1,2.0,0,0,0,0,2025-12-03,64.0,801.0,Male,75.0,LENALIDOMIDE,product dose omission in error,0,0,0.0,MidAge,US,0.15413533834586465,19,1,30,0,0,0,0,0,0,0,5,2025,12,3,2,0.08073634859349145,9.864661654135338,0.0
26080012,US,US,1,2.0,0,0,0,0,2025-11-24,57.0,801.0,Male,75.0,DUPIXENT,nasal congestion,0,0,0.0,MidAge,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,2,2025,11,24,0,0.08073634859349145,0.8842921784098254,0.0
26080928,US,US,1,2.0,0,0,0,0,2025-11-24,57.0,801.0,Female,75.0,DUPIXENT,nasopharyngitis,0,0,0.0,MidAge,US,0.015513897866839042,221,0,15,0,0,0,0,0,0,0,1,2025,11,24,0,0.08073634859349145,0.8842921784098254,0.015513897866839042
26080942,US,US,1,2.0,0,0,0,0,2025-11-24,82.0,801.0,Male,72.7,POMALYST,fatigue,0,0,0.0,Senior,US,0.11428571428571428,5,0,7,0,0,0,0,0,0,0,1,2025,11,24,0,0.08073634859349145,9.371428571428572,0.0
26081495,US,Unknown,2,2.0,0,0,0,0,2025-11-24,57.0,801.0,Female,75.0,ACETAMINOPHEN,toxicity to various agents,0,0,0.0,MidAge,US,0.10267857142857142,16,0,26,0,0,0,0,0,0,0,4,2025,11,24,0,0.08936301793444651,5.852678571428571,0.10267857142857142
26081576,GB,GB,3,1.0,0,0,0,0,2025-11-24,36.0,801.0,Female,75.0,GABAPENTIN,diarrhoea,1,0,0.0,Adult,GB,0.061224489795918366,7,0,9,0,0,0,0,0,0,0,1,2025,11,24,0,0.17857142857142855,2.204081632653061,0.061224489795918366
26083048,JP,JP,1,1.0,0,0,0,1,2025-11-24,88.0,801.0,Male,46.9,CUBICIN,suspected drug-induced liver injury,1,2,0.14285714285714285,Senior,JP,0.14285714285714285,1,1,35,0,0,0,0,0,0,0,4,2025,11,24,0,0.08073634859349145,12.571428571428571,0.0
25992846,US,US,1,2.0,0,0,0,0,2025-11-03,56.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,MidAge,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,11,3,0,0.08073634859349145,0.8687782805429863,0.015513897866839042
25994642,CA,CA,2,1.0,0,0,1,0,2025-11-04,58.0,801.0,Male,75.0,DUPILUMAB,pneumonia,1,3,0.21428571428571427,MidAge,CA,0.04285714285714286,5,0,9,0,0,0,0,0,1,0,1,2025,11,4,1,0.08936301793444651,2.4857142857142858,0.0
25995128,EU,EU,1,1.0,0,0,0,0,2025-11-04,39.0,801.0,Female,75.0,RITUXIMAB,epstein-barr virus infection,1,0,0.0,Adult,EU,0.12406015037593986,19,0,28,0,1,0,0,0,0,0,3,2025,11,4,1,0.08073634859349145,4.838345864661655,0.12406015037593986
25995896,US,US,1,1.0,0,0,0,0,2025-11-04,73.0,801.0,Female,79.95,KEVZARA,atrial fibrillation,1,0,0.0,Senior,US,0.14285714285714285,4,1,19,0,0,0,0,0,0,0,2,2025,11,4,1,0.08073634859349145,10.428571428571429,0.14285714285714285
26117600,US,Unknown,1,1.0,0,0,0,0,2025-12-03,74.0,801.0,Male,99.79,ATORVASTATIN CALCIUM,vitreous floaters,1,0,0.0,Senior,US,0.0,1,0,17,0,0,0,0,0,0,0,2,2025,12,3,2,0.08073634859349145,0.0,0.0
26118801,US,US,2,1.0,0,0,1,0,2025-12-03,66.0,801.0,Female,75.0,SKYRIZI,vertigo,1,3,0.21428571428571427,Senior,US,0.051587301587301584,36,0,7,0,0,0,0,0,0,0,1,2025,12,3,2,0.08936301793444651,3.4047619047619047,0.051587301587301584
26119273,US,US,1,1.0,0,0,1,0,2025-12-04,63.0,801.0,Female,75.0,ACETAMINOPHEN,upper gastrointestinal haemorrhage,1,3,0.21428571428571427,MidAge,US,0.10267857142857142,16,0,34,0,0,0,0,0,0,0,3,2025,12,4,3,0.08073634859349145,6.46875,0.10267857142857142
26119583,US,US,2,1.0,0,0,0,0,2025-12-04,75.0,801.0,Male,75.0,CREON,pancreatectomy,1,0,0.0,Senior,US,0.03296703296703297,13,0,14,0,0,0,0,0,0,0,1,2025,12,4,3,0.08936301793444651,2.4725274725274726,0.0
26119798,US,US,1,2.0,0,0,0,0,2025-12-04,69.0,801.0,Male,75.0,DUPIXENT,dry eye,0,0,0.0,Senior,US,0.015513897866839042,221,0,7,0,0,0,0,0,0,0,2,2025,12,4,3,0.08073634859349145,1.070458952811894,0.0
26121393,US,Unknown,1,1.0,1,0,0,0,2025-12-03,82.0,801.0,Male,75.0,QUTENZA,death,1,5,0.35714285714285715,Senior,US,0.35714285714285715,1,1,5,0,0,1,0,0,0,0,1,2025,12,3,2,0.08073634859349145,29.285714285714285,0.0
25998921,CA,CA,2,1.0,0,0,1,0,2025-11-05,82.0,801.0,Female,75.0,VEDOLIZUMAB,alcohol withdrawal syndrome,1,3,0.21428571428571427,Senior,CA,0.057692307692307696,26,0,27,0,0,0,0,0,0,0,3,2025,11,5,2,0.08936301793444651,4.730769230769231,0.057692307692307696
25999421,US,US,1,1.0,0,0,1,0,2025-11-05,57.0,801.0,Female,75.0,LENALIDOMIDE,adverse event,1,3,0.21428571428571427,MidAge,US,0.15413533834586465,19,1,13,0,0,0,0,0,0,0,2,2025,11,5,2,0.08073634859349145,8.785714285714285,0.15413533834586465
25999502,JP,JP,1,1.0,1,0,1,0,2025-11-05,8.0,800.0,Male,51.5,TRIAMCINOLONE ACETONIDE,ascites,1,8,0.5714285714285714,Child,JP,0.19047619047619047,3,1,7,0,0,0,0,0,0,0,1,2025,11,5,2,0.08073634859349145,1.5238095238095237,0.0
25999960,US,US,1,1.0,0,0,0,0,2025-11-05,68.0,801.0,Female,75.0,MELOXICAM,renal impairment,1,0,0.0,Senior,US,0.0,1,0,16,0,0,0,0,0,0,0,2,2025,11,5,2,0.08073634859349145,0.0,0.0
26088137,US,US,1,1.0,0,0,0,0,2025-11-25,73.0,801.0,Female,87.09,KEYTRUDA,hallucination,1,0,0.0,Senior,US,0.11904761904761905,3,0,13,0,0,0,0,0,0,0,1,2025,11,25,1,0.08073634859349145,8.690476190476192,0.11904761904761905
26095980,EU,EU,1,1.0,0,0,0,0,2025-11-27,57.0,801.0,Female,75.0,OMEPRAZOLE,spinal fracture,1,0,0.0,MidAge,EU,0.07142857142857142,3,0,15,0,0,0,0,0,0,0,2,2025,11,27,3,0.08073634859349145,4.071428571428571,0.07142857142857142
26097142,US,US,1,2.0,0,0,0,0,2025-11-27,57.0,801.0,Female,75.0,DUPIXENT,rash,0,0,0.0,MidAge,US,0.015513897866839042,221,0,4,0,0,0,0,0,0,0,1,2025,11,27,3,0.08073634859349145,0.8842921784098254,0.015513897866839042
26097519,GB,GB,1,1.0,0,0,0,0,2025-11-27,57.0,801.0,Female,75.0,EPIRUBICIN,neuropathy peripheral,1,0,0.0,MidAge,GB,0.10714285714285714,2,0,21,0,0,0,0,0,0,0,2,2025,11,27,3,0.08073634859349145,6.107142857142857,0.10714285714285714
26097843,CA,CA,2,1.0,0,0,1,0,2025-11-27,57.0,801.0,Female,75.0,OMALIZUMAB,asthenia,1,3,0.21428571428571427,MidAge,CA,0.21428571428571427,1,1,8,0,0,0,0,0,0,0,1,2025,11,27,3,0.08936301793444651,12.214285714285714,0.21428571428571427
26098734,EU,EU,1,1.0,0,0,1,0,2025-11-27,94.0,801.0,Female,56.0,LANSOPRAZOLE,subacute cutaneous lupus erythematosus,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,38,0,0,0,0,0,0,0,4,2025,11,27,3,0.08073634859349145,20.142857142857142,0.21428571428571427
26099139,US,Unknown,1,1.0,0,0,1,0,2025-11-28,42.0,801.0,Female,76.385,MYALEPT,illness,1,3,0.21428571428571427,Adult,US,0.21428571428571427,1,1,7,0,0,0,0,0,0,0,1,2025,11,28,4,0.08073634859349145,9.0,0.21428571428571427
26099410,AU,AU,1,1.0,0,0,0,0,2025-11-28,52.0,801.0,Female,75.0,METHOTREXATE,aplastic anaemia,1,0,0.0,MidAge,AU,0.17346938775510204,7,1,16,0,0,0,0,0,0,0,2,2025,11,28,4,0.08073634859349145,9.020408163265307,0.17346938775510204
26099625,EU,EU,1,1.0,0,0,1,0,2025-11-28,54.0,801.0,Male,88.0,CLOZAPINE,respiratory distress,1,3,0.21428571428571427,MidAge,EU,0.23214285714285715,4,1,20,0,0,0,0,0,0,0,2,2025,11,28,4,0.08073634859349145,12.535714285714286,0.0
26135149,US,US,1,2.0,0,0,0,0,2025-12-09,57.0,801.0,Female,75.0,ESTRADIOL,product dose omission in error,0,0,0.0,MidAge,US,0.0,8,0,30,0,0,0,0,0,0,0,5,2025,12,9,1,0.08073634859349145,0.0,0.0
26135730,IN,IN,1,1.0,0,0,0,0,2025-12-09,68.0,801.0,Female,75.0,PALBOCICLIB,cataract,1,0,0.0,Senior,IN,0.0,1,0,8,0,0,0,0,0,0,0,1,2025,12,9,1,0.08073634859349145,0.0,0.0
26135945,ID,ID,1,1.0,0,0,1,0,2025-12-09,45.0,801.0,Female,75.0,METHYLPREDNISOLONE,pulmonary tuberculosis,1,3,0.21428571428571427,Adult,Other,0.14285714285714285,3,1,22,0,0,0,0,0,0,0,2,2025,12,9,1,0.08073634859349145,6.428571428571428,0.14285714285714285
26012842,US,US,1,1.0,0,0,0,0,2025-11-07,52.0,801.0,Female,75.0,ORENCIA,adverse event,1,0,0.0,MidAge,US,0.10204081632653061,14,0,13,0,0,0,0,0,0,0,2,2025,11,7,4,0.08073634859349145,5.3061224489795915,0.10204081632653061
26014448,US,US,1,2.0,0,0,0,0,2025-11-08,57.0,801.0,Female,75.0,ALBUTEROL SULFATE,wrong technique in device usage process,0,0,0.0,MidAge,US,0.0,8,0,39,0,0,0,0,0,0,0,6,2025,11,8,5,0.08073634859349145,0.0,0.0
26014758,US,US,1,2.0,0,0,0,0,2025-11-08,49.0,801.0,Female,75.0,ZEPBOUND,drug ineffective,0,0,0.0,Adult,US,0.0,2,0,16,0,0,0,0,0,0,0,2,2025,11,8,5,0.08073634859349145,0.0,0.0
26015582,US,US,1,2.0,0,0,0,0,2025-11-09,57.0,801.0,Male,109.31,DUPIXENT,injection site pain,0,0,0.0,MidAge,US,0.015513897866839042,221,0,19,1,0,0,0,0,0,0,3,2025,11,9,6,0.08073634859349145,0.8842921784098254,0.0
26099759,CH,CH,1,1.0,0,0,0,0,2025-11-28,59.0,801.0,Male,75.0,OLANZAPINE,arrhythmia,1,0,0.0,MidAge,Other,0.11904761904761905,6,0,10,0,0,0,0,0,0,0,1,2025,11,28,4,0.08073634859349145,7.023809523809525,0.0
26100181,EU,EU,1,1.0,0,0,0,0,2025-11-28,60.0,801.0,Male,75.0,BORTEZOMIB,plasma cell myeloma,1,0,0.0,MidAge,EU,0.0,3,0,19,0,0,0,0,0,0,0,3,2025,11,28,4,0.08073634859349145,0.0,0.0
26102301,EU,EU,1,1.0,0,0,1,0,2025-11-28,63.0,801.0,Male,75.0,ATORVASTATIN,clostridium difficile colitis,1,3,0.21428571428571427,MidAge,EU,0.10714285714285714,2,0,29,0,0,0,0,0,0,0,3,2025,11,28,4,0.08073634859349145,6.75,0.0
26140266,EU,EU,1,1.0,0,0,0,0,2025-12-10,66.0,801.0,Female,75.0,DOXYCYCLINE,symptom recurrence,1,0,0.0,Senior,EU,0.19642857142857142,4,1,18,0,0,0,0,0,0,0,2,2025,12,10,2,0.08073634859349145,12.964285714285714,0.19642857142857142
26140738,US,US,1,2.0,0,0,0,0,2025-12-10,15.0,801.0,Male,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Child,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,12,10,2,0.08073634859349145,0.23270846800258563,0.0
26104918,US,US,1,1.0,0,0,0,0,2025-11-30,69.0,801.0,Male,75.0,MYCOPHENOLATE MOFETIL,lung transplant rejection,1,0,0.0,Senior,US,0.10150375939849625,19,0,25,0,0,0,0,0,0,0,3,2025,11,30,6,0.08073634859349145,7.003759398496241,0.0
26104932,US,US,1,2.0,0,0,0,0,2025-11-30,50.0,801.0,Male,75.0,MYCOPHENOLATE MOFETIL,treatment failure,0,0,0.0,Adult,US,0.10150375939849625,19,0,17,0,0,0,0,1,0,0,2,2025,11,30,6,0.08073634859349145,5.075187969924812,0.0
26105175,GB,GB,1,1.0,0,0,1,0,2025-12-01,57.0,801.0,Female,75.0,BISOPROLOL,brash syndrome,1,3,0.21428571428571427,MidAge,GB,0.21428571428571427,1,1,14,0,0,0,0,0,0,0,2,2025,12,1,0,0.08073634859349145,12.214285714285714,0.21428571428571427
26107429,EU,EU,1,1.0,0,1,0,0,2025-12-01,57.0,801.0,Male,75.0,MIDAZOLAM,loss of consciousness,1,4,0.2857142857142857,MidAge,EU,0.2857142857142857,1,1,21,0,0,0,0,0,0,0,3,2025,12,1,0,0.08073634859349145,16.285714285714285,0.0
26107658,US,Unknown,1,1.0,1,0,0,0,2025-11-26,100.0,801.0,Female,75.0,VELTASSA,death,1,5,0.35714285714285715,Senior,US,0.2619047619047619,3,1,5,0,0,1,0,0,0,0,1,2025,11,26,2,0.08073634859349145,26.190476190476193,0.2619047619047619
26016688,US,US,1,2.0,0,0,0,0,2025-11-10,50.0,801.0,Female,75.0,ORENCIA,arthralgia,0,0,0.0,Adult,US,0.10204081632653061,14,0,10,0,0,0,0,0,0,0,1,2025,11,10,0,0.08073634859349145,5.1020408163265305,0.10204081632653061
26017593,CA,CA,1,1.0,0,0,0,0,2025-11-10,57.0,801.0,Female,75.0,INFLIXIMAB,blood pressure systolic increased,1,0,0.0,MidAge,CA,0.07142857142857142,9,0,33,0,0,0,0,0,0,0,4,2025,11,10,0,0.08073634859349145,4.071428571428571,0.07142857142857142
26018808,US,US,2,1.0,0,0,0,0,2025-11-10,57.0,801.0,Female,75.0,SKYRIZI,breast cyst,1,0,0.0,MidAge,US,0.051587301587301584,36,0,11,0,0,0,0,0,0,0,2,2025,11,10,0,0.08936301793444651,2.9404761904761902,0.051587301587301584
26020294,US,US,1,2.0,0,0,0,0,2025-11-10,76.0,801.0,Male,90.703,POLYETHYLENE GLYCOL 3350,incorrect product administration duration,0,0,0.0,Senior,US,0.0,4,0,41,0,0,0,0,0,0,0,4,2025,11,10,0,0.08073634859349145,0.0,0.0
26021051,US,US,1,2.0,0,0,0,0,2025-11-10,57.0,801.0,Female,75.0,ACETAMINOPHEN,toxicity to various agents,0,0,0.0,MidAge,US,0.10267857142857142,16,0,26,0,0,0,0,0,0,0,4,2025,11,10,0,0.08073634859349145,5.852678571428571,0.10267857142857142
26141953,EU,EU,1,1.0,0,0,0,0,2025-12-10,51.0,801.0,Male,75.0,OZEMPIC,optic ischaemic neuropathy,1,0,0.0,MidAge,EU,0.0,1,0,26,0,0,0,0,0,0,0,3,2025,12,10,2,0.08073634859349145,0.0,0.0
26142277,US,US,1,1.0,0,0,0,0,2025-12-10,57.0,801.0,Female,75.0,SEMAGLUTIDE,arteriosclerosis coronary artery,1,0,0.0,MidAge,US,0.14285714285714285,3,1,32,0,0,0,0,0,0,0,3,2025,12,10,2,0.08073634859349145,8.142857142857142,0.14285714285714285
26143168,US,US,1,1.0,0,0,0,0,2025-12-11,60.0,801.0,Female,75.0,SPRAVATO,dizziness,1,0,0.0,MidAge,US,0.026785714285714284,8,0,9,0,0,0,0,0,0,0,1,2025,12,11,3,0.08073634859349145,1.607142857142857,0.026785714285714284
26143506,JP,JP,1,1.0,0,0,0,0,2025-12-11,9.0,800.0,Male,75.0,CABOMETYX,immune-mediated hepatic disorder,1,0,0.0,Child,JP,0.10714285714285714,4,0,32,0,0,0,0,0,0,0,3,2025,12,11,3,0.08073634859349145,0.9642857142857142,0.0
26145894,US,US,1,2.0,0,0,0,0,2025-12-11,2.0,801.0,Male,75.0,DUPIXENT,rash macular,0,0,0.0,Child,US,0.015513897866839042,221,0,12,0,0,0,0,0,0,0,2,2025,12,11,3,0.08073634859349145,0.031027795733678084,0.0
26145908,US,US,1,2.0,0,0,0,0,2025-12-11,74.0,801.0,Female,75.0,DUPIXENT,asthma,0,0,0.0,Senior,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,12,11,3,0.08073634859349145,1.1480284421460891,0.015513897866839042
26145975,US,US,1,2.0,0,0,0,0,2025-12-11,17.0,801.0,Male,75.0,DUPIXENT,keratitis,0,0,0.0,Child,US,0.015513897866839042,221,0,9,0,0,0,0,0,0,0,1,2025,12,11,3,0.08073634859349145,0.2637362637362637,0.0
26022548,EU,EU,1,1.0,0,0,0,0,2025-11-10,61.0,801.0,Male,75.0,VENLAFAXINE,drug withdrawal syndrome,1,0,0.0,MidAge,EU,0.25,2,1,24,0,0,0,0,0,0,0,3,2025,11,10,0,0.08073634859349145,15.25,0.0
26022791,EU,EU,1,1.0,0,0,1,0,2025-11-10,44.0,801.0,Female,75.0,MOUNJARO,blood iron decreased,1,3,0.21428571428571427,Adult,EU,0.2142857142857143,4,1,20,0,0,0,0,0,0,0,3,2025,11,10,0,0.08073634859349145,9.428571428571429,0.2142857142857143
26023143,JP,JP,1,1.0,0,0,0,0,2025-11-10,57.0,801.0,Male,75.0,MOMELOTINIB,renal impairment,1,0,0.0,MidAge,JP,0.0,3,0,16,0,0,0,0,0,0,0,2,2025,11,10,0,0.08073634859349145,0.0,0.0
26023763,AU,AU,1,1.0,0,0,0,0,2025-11-11,86.0,801.0,Female,75.0,PREDNISOLONE SODIUM PHOSPHATE,staphylococcal bacteraemia,1,0,0.0,Senior,AU,0.0,2,0,26,0,0,0,0,0,0,0,2,2025,11,11,1,0.08073634859349145,0.0,0.0
26024478,US,US,1,2.0,0,0,0,0,2025-11-11,57.0,801.0,Female,75.0,ACETAMINOPHEN,toxicity to various agents,0,0,0.0,MidAge,US,0.10267857142857142,16,0,26,0,0,0,0,0,0,0,4,2025,11,11,1,0.08073634859349145,5.852678571428571,0.10267857142857142
26024788,US,US,1,2.0,0,0,0,0,2025-11-11,57.0,801.0,Female,75.0,TRULICITY,blood glucose abnormal,0,0,0.0,MidAge,US,0.04285714285714286,5,0,22,0,0,0,0,0,0,0,3,2025,11,11,1,0.08073634859349145,2.442857142857143,0.04285714285714286
26025369,US,US,1,1.0,0,0,1,0,2025-11-11,51.0,801.0,Female,75.0,ACCRUFER,pneumonia,1,3,0.21428571428571427,MidAge,US,0.07142857142857142,3,0,9,0,0,0,0,0,1,0,1,2025,11,11,1,0.08073634859349145,3.642857142857143,0.07142857142857142
26108172,US,US,1,1.0,0,0,1,0,2025-12-01,30.0,801.0,Female,90.0,TAZVERIK,hospitalisation,1,3,0.21428571428571427,Young,US,0.21428571428571427,1,1,15,0,0,0,0,0,0,0,1,2025,12,1,0,0.08073634859349145,6.428571428571428,0.21428571428571427
26109630,US,US,1,2.0,0,0,0,0,2025-12-01,70.0,801.0,Female,75.0,CYTOMEL,hypersensitivity,0,0,0.0,Senior,US,0.0,1,0,16,0,0,0,0,0,0,0,1,2025,12,1,0,0.08073634859349145,0.0,0.0
26109993,US,US,1,2.0,0,0,0,0,2025-12-01,57.0,801.0,Male,75.0,DUPIXENT,pruritus,0,0,0.0,MidAge,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,12,1,0,0.08073634859349145,0.8842921784098254,0.0
26110588,US,US,1,2.0,0,0,0,0,2025-12-02,57.0,801.0,Female,75.0,LITHIUM,mobility decreased,0,0,0.0,MidAge,US,0.0,1,0,18,0,0,0,0,0,0,0,2,2025,12,2,1,0.08073634859349145,0.0,0.0
26111602,US,US,1,1.0,0,0,1,0,2025-12-02,55.0,801.0,Female,75.0,ETOPOSIDE,respiratory failure,1,3,0.21428571428571427,MidAge,US,0.21428571428571427,2,1,19,0,0,0,0,1,0,0,2,2025,12,2,1,0.08073634859349145,11.785714285714285,0.21428571428571427
26146947,US,US,1,1.0,0,1,0,0,2025-12-11,48.0,801.0,Male,75.0,DAPTOMYCIN,drug resistance,1,4,0.2857142857142857,Adult,US,0.16666666666666666,3,1,15,0,0,0,0,0,0,0,2,2025,12,11,3,0.08073634859349145,8.0,0.0
26147218,GB,GB,1,1.0,0,1,1,1,2025-12-11,33.0,801.0,Male,83.0,MOUNJARO,palpitations,1,9,0.6428571428571429,Young,GB,0.2142857142857143,4,1,12,0,0,0,0,0,0,0,1,2025,12,11,3,0.08073634859349145,7.071428571428572,0.0
26147757,CA,CA,1,1.0,1,0,0,0,2025-12-11,58.0,801.0,Female,75.0,FLUTICASONE PROPIONATE,thrombocytopenia,1,5,0.35714285714285715,MidAge,CA,0.35714285714285715,1,1,16,0,0,0,0,0,0,0,1,2025,12,11,3,0.08073634859349145,20.714285714285715,0.35714285714285715
26027947,US,US,2,1.0,0,0,0,0,2025-11-11,87.0,801.0,Female,75.0,NUPLAZID,hallucination,1,0,0.0,Senior,US,0.09523809523809523,6,0,13,0,0,0,0,0,0,0,1,2025,11,11,1,0.08936301793444651,8.285714285714285,0.09523809523809523
26028285,US,US,1,1.0,0,0,0,0,2025-11-11,0.0,801.0,Female,3.4,ABILIFY MAINTENA,tremor neonatal,1,0,0.0,,US,0.0,1,0,15,0,0,0,0,0,0,0,2,2025,11,11,1,0.08073634859349145,0.0,0.0
26028919,US,US,1,2.0,0,0,0,0,2025-11-12,15.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Child,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,11,12,2,0.08073634859349145,0.23270846800258563,0.015513897866839042
26030877,US,US,1,2.0,0,0,0,0,2025-11-12,57.0,801.0,Female,163.26,BESREMI,nausea,0,0,0.0,MidAge,US,0.0,1,0,6,0,0,0,0,0,0,0,1,2025,11,12,2,0.08073634859349145,0.0,0.0
26112331,US,Unknown,1,1.0,0,0,1,0,2025-12-01,57.0,801.0,Female,75.0,AMBRISENTAN,sinus disorder,1,3,0.21428571428571427,MidAge,US,0.21428571428571427,1,1,14,0,0,0,0,0,0,0,2,2025,12,1,0,0.08073634859349145,12.214285714285714,0.21428571428571427
26112775,US,US,1,2.0,0,0,0,0,2025-12-02,57.0,801.0,Male,75.0,DUPIXENT,poor quality product administered,0,0,0.0,MidAge,US,0.015513897866839042,221,0,33,0,0,0,0,0,0,0,4,2025,12,2,1,0.08073634859349145,0.8842921784098254,0.0
26113451,EU,EU,1,1.0,0,0,1,0,2025-12-02,53.0,801.0,Male,77.0,EVEROLIMUS,abdominal pain,1,3,0.21428571428571427,MidAge,EU,0.21428571428571427,1,1,14,1,0,0,0,0,0,0,2,2025,12,2,1,0.08073634859349145,11.357142857142856,0.0
26114557,JP,JP,1,1.0,0,0,0,0,2025-12-02,57.0,801.0,Male,75.0,MOMELOTINIB,leukaemia,1,0,0.0,MidAge,JP,0.0,3,0,9,0,0,0,0,0,0,0,1,2025,12,2,1,0.08073634859349145,0.0,0.0
26150391,US,US,1,2.0,0,0,0,0,2025-12-12,47.0,801.0,Male,75.0,DUPIXENT,hyperkeratosis,0,0,0.0,Adult,US,0.015513897866839042,221,0,14,0,0,0,0,0,0,0,1,2025,12,12,4,0.08073634859349145,0.729153199741435,0.0
26150553,US,Unknown,1,2.0,0,0,0,0,2025-12-12,59.0,801.0,Female,84.354,JAKAFI,product dose omission issue,0,0,0.0,MidAge,US,0.0,3,0,27,0,0,0,0,0,0,0,4,2025,12,12,4,0.08073634859349145,0.0,0.0
26034279,US,US,1,2.0,0,0,0,0,2025-11-12,57.0,801.0,Female,75.0,ACETAMINOPHEN,toxicity to various agents,0,0,0.0,MidAge,US,0.10267857142857142,16,0,26,0,0,0,0,0,0,0,4,2025,11,12,2,0.08073634859349145,5.852678571428571,0.10267857142857142
26034589,US,US,1,1.0,0,0,0,0,2025-11-12,65.0,801.0,Female,75.0,DUPIXENT,thyroid cancer,1,0,0.0,MidAge,US,0.015513897866839042,221,0,14,0,0,0,1,0,0,0,2,2025,11,12,2,0.08073634859349145,1.0084033613445378,0.015513897866839042
26036251,US,US,1,1.0,0,0,1,0,2025-11-12,57.0,801.0,Female,75.0,HYDROCORTISONE,adverse event,1,3,0.21428571428571427,MidAge,US,0.21428571428571427,1,1,13,0,0,0,0,0,0,0,2,2025,11,12,2,0.08073634859349145,12.214285714285714,0.21428571428571427
26117244,US,US,1,2.0,0,0,0,0,2025-12-03,77.0,801.0,Female,75.0,DUPIXENT,night sweats,0,0,0.0,Senior,US,0.015513897866839042,221,0,12,0,0,0,0,0,0,0,2,2025,12,3,2,0.08073634859349145,1.1945701357466063,0.015513897866839042
26119040,US,US,1,2.0,0,0,0,0,2025-12-04,33.0,801.0,Female,75.0,CLINDAMYCIN PHOSPHATE,drug ineffective,0,0,0.0,Young,US,0.0,1,0,16,0,0,0,0,0,0,0,2,2025,12,4,3,0.08073634859349145,0.0,0.0
26156223,US,US,1,2.0,0,0,0,0,2025-12-15,57.0,801.0,Female,75.0,ACOLTREMON,abnormal sensation in eye,0,0,0.0,MidAge,US,0.0,1,0,25,0,0,0,0,0,0,0,4,2025,12,15,0,0.08073634859349145,0.0,0.0
26156667,CA,CA,1,1.0,0,0,0,0,2025-12-15,57.0,801.0,Female,75.0,DULOXETINE HYDROCHLORIDE,pulmonary malformation,1,0,0.0,MidAge,CA,0.0,1,0,22,0,0,0,0,0,0,0,2,2025,12,15,0,0.08073634859349145,0.0,0.0
26157639,US,Unknown,1,2.0,0,0,0,0,2025-12-12,79.0,801.0,Male,75.0,LENALIDOMIDE,rash maculo-papular,0,0,0.0,Senior,US,0.15413533834586465,19,1,19,0,0,0,0,0,0,0,2,2025,12,12,4,0.08073634859349145,12.176691729323307,0.0
26057650,CA,CA,3,1.0,1,1,1,1,2025-11-18,57.0,801.0,Female,96.0,APREMILAST,arthropathy,1,14,1.0,MidAge,CA,1.0,1,1,11,0,0,0,0,0,0,0,1,2025,11,18,1,0.17857142857142855,57.0,1.0
26058231,US,US,1,2.0,0,0,0,0,2025-11-18,67.0,801.0,Male,81.6,CLONAZEPAM,drug ineffective,0,0,0.0,Senior,US,0.07142857142857142,3,0,16,0,0,0,0,0,0,0,2,2025,11,18,1,0.08073634859349145,4.785714285714286,0.0
26059566,US,Unknown,1,1.0,0,0,1,0,2025-11-18,76.0,801.0,Male,220.0,DARATUMUMAB\HYALURONIDASE-FIHJ,speech disorder,1,3,0.21428571428571427,Senior,US,0.21428571428571427,2,1,15,0,0,0,0,0,0,0,2,2025,11,18,1,0.08073634859349145,16.285714285714285,0.0
26060122,US,US,1,2.0,0,0,0,0,2025-11-18,52.0,801.0,Female,75.0,XELJANZ XR,conjunctivitis,0,0,0.0,MidAge,US,0.0,9,0,14,0,0,0,0,0,0,0,1,2025,11,18,1,0.08073634859349145,0.0,0.0
26060661,US,US,1,2.0,0,0,0,0,2025-11-18,87.0,801.0,Male,75.0,DUPIXENT,incorrect dose administered,0,0,0.0,Senior,US,0.015513897866839042,221,0,27,0,0,0,0,0,0,0,3,2025,11,18,1,0.08073634859349145,1.3497091144149966,0.0
26158139,CA,US,2,1.0,0,0,0,0,2025-12-15,63.0,801.0,Male,75.0,VEDOLIZUMAB,hypoaesthesia,1,0,0.0,MidAge,CA,0.057692307692307696,26,0,13,0,0,0,0,0,0,0,1,2025,12,15,0,0.08936301793444651,3.634615384615385,0.0
26158706,US,US,1,2.0,0,0,0,0,2025-12-15,57.0,801.0,Female,103.0,DUPIXENT,feeling abnormal,0,0,0.0,MidAge,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,2,2025,12,15,0,0.08073634859349145,0.8842921784098254,0.015513897866839042
26159125,US,US,1,2.0,0,0,0,0,2025-12-16,57.0,801.0,Male,75.0,DUPIXENT,confusional state,0,0,0.0,MidAge,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,12,16,1,0.08073634859349145,0.8842921784098254,0.0
26160125,US,US,1,2.0,0,0,0,0,2025-12-16,57.0,801.0,Female,75.0,DOCIVYX,off label use,0,0,0.0,MidAge,US,0.0,1,0,13,0,0,0,0,0,0,0,3,2025,12,16,1,0.08073634859349145,0.0,0.0
26160206,BR,BR,2,1.0,0,0,0,0,2025-12-16,57.0,801.0,Female,75.0,RISPERIDONE,suicide attempt,1,0,0.0,MidAge,BR,0.125,4,1,15,0,0,0,0,0,0,0,2,2025,12,16,1,0.08936301793444651,7.125,0.125
26160907,CN,CN,1,1.0,0,0,0,0,2025-12-16,23.0,801.0,Female,70.0,DACTINOMYCIN,urticaria,1,0,0.0,Young,CN,0.0,1,0,9,0,0,0,0,0,0,0,1,2025,12,16,1,0.08073634859349145,0.0,0.0
26120970,EU,EU,1,1.0,0,0,1,0,2025-12-04,24.0,801.0,Male,97.0,OLANZAPINE PAMOATE,pulmonary embolism,1,3,0.21428571428571427,Young,EU,0.21428571428571427,1,1,18,0,0,0,0,0,0,0,2,2025,12,4,3,0.08073634859349145,5.142857142857142,0.0
26122132,CN,CN,1,1.0,0,0,1,0,2025-12-04,74.0,801.0,Male,60.0,EPIRUBICIN,chemical cystitis,1,3,0.21428571428571427,Senior,CN,0.10714285714285714,2,0,17,0,0,0,0,0,0,0,2,2025,12,4,3,0.08073634859349145,7.928571428571428,0.0
26122819,US,US,1,2.0,0,0,0,0,2025-12-04,61.0,801.0,Female,89.36,REVLIMID,blister,0,0,0.0,MidAge,US,0.05357142857142857,4,0,7,0,0,0,0,0,0,0,1,2025,12,4,3,0.08073634859349145,3.267857142857143,0.05357142857142857
26123548,EU,EU,1,1.0,0,1,1,0,2025-12-04,58.0,801.0,Female,75.0,ARIPIPRAZOLE,coma,1,7,0.5,MidAge,EU,0.5,1,1,4,0,0,0,0,0,0,0,1,2025,12,4,3,0.08073634859349145,29.0,0.5
26123805,US,US,1,1.0,0,0,0,0,2025-12-05,57.0,801.0,Female,75.0,NOURIANZ,hallucination,1,0,0.0,MidAge,US,0.0,1,0,13,0,0,0,0,0,0,0,1,2025,12,5,4,0.08073634859349145,0.0,0.0
26037452,US,US,1,2.0,0,0,0,0,2025-11-12,57.0,801.0,Male,75.0,MOUNJARO,injection site mass,0,0,0.0,MidAge,US,0.2142857142857143,4,1,19,0,0,0,0,0,0,0,3,2025,11,12,2,0.08073634859349145,12.214285714285715,0.0
26038639,US,US,1,2.0,0,0,0,0,2025-11-13,57.0,801.0,Female,75.0,ACETAMINOPHEN,toxicity to various agents,0,0,0.0,MidAge,US,0.10267857142857142,16,0,26,0,0,0,0,0,0,0,4,2025,11,13,3,0.08073634859349145,5.852678571428571,0.10267857142857142
26039720,US,US,1,2.0,0,0,0,0,2025-11-13,57.0,801.0,Female,75.0,ACETAMINOPHEN,toxicity to various agents,0,0,0.0,MidAge,US,0.10267857142857142,16,0,26,0,0,0,0,0,0,0,4,2025,11,13,3,0.08073634859349145,5.852678571428571,0.10267857142857142
26040625,US,Unknown,1,2.0,0,0,0,0,2025-11-12,60.0,801.0,Male,75.0,LENALIDOMIDE,petechiae,0,0,0.0,MidAge,US,0.15413533834586465,19,1,9,0,0,0,0,0,0,0,1,2025,11,12,2,0.08073634859349145,9.248120300751879,0.0
26040854,EU,EU,1,1.0,0,0,0,0,2025-11-13,47.0,801.0,Male,75.0,MORPHINE,drug dependence,1,0,0.0,Adult,EU,0.0,1,0,15,0,0,0,0,0,0,0,2,2025,11,13,3,0.08073634859349145,0.0,0.0
26041192,US,US,1,2.0,0,0,0,0,2025-11-13,57.0,801.0,Female,75.0,ACETAMINOPHEN,toxicity to various agents,0,0,0.0,MidAge,US,0.10267857142857142,16,0,26,0,0,0,0,0,0,0,4,2025,11,13,3,0.08073634859349145,5.852678571428571,0.10267857142857142
26041273,US,US,1,2.0,0,0,0,0,2025-11-13,69.0,801.0,Male,75.0,CLARITIN,illness,0,0,0.0,Senior,US,0.0,1,0,7,0,0,0,0,0,0,0,1,2025,11,13,3,0.08073634859349145,0.0,0.0
26064144,GB,GB,1,1.0,0,0,0,0,2025-11-19,54.0,801.0,Female,88.0,ROSUVASTATIN,joint swelling,1,0,0.0,MidAge,GB,0.0,2,0,14,0,0,0,0,0,0,0,2,2025,11,19,2,0.08073634859349145,0.0,0.0
26064926,GB,GB,1,1.0,0,0,0,0,2025-11-19,33.0,801.0,Female,75.0,VARENICLINE TARTRATE,muscle spasms,1,0,0.0,Young,GB,0.0,1,0,13,0,0,0,0,0,0,0,2,2025,11,19,2,0.08073634859349145,0.0,0.0
26064993,EU,EU,3,1.0,0,0,0,0,2025-11-19,57.0,801.0,Female,75.0,PITAVASTATIN CALCIUM,mobility decreased,1,0,0.0,MidAge,EU,0.0,1,0,18,0,0,0,0,0,0,0,2,2025,11,19,2,0.17857142857142855,0.0,0.0
26124897,US,US,1,2.0,0,0,0,0,2025-12-05,57.0,801.0,Male,75.0,DUPIXENT,eye swelling,0,0,0.0,MidAge,US,0.015513897866839042,221,0,12,0,0,0,0,0,0,0,2,2025,12,5,4,0.08073634859349145,0.8842921784098254,0.0
26125344,EU,EU,1,1.0,0,0,1,0,2025-12-05,63.0,801.0,Male,75.0,CAPECITABINE,infusion site infection,1,3,0.21428571428571427,MidAge,EU,0.10714285714285714,2,0,23,0,1,0,0,0,0,0,3,2025,12,5,4,0.08073634859349145,6.75,0.0
26125425,US,US,1,2.0,0,0,0,0,2025-12-05,68.0,801.0,Female,50.91,DUPIXENT,injection site pain,0,0,0.0,Senior,US,0.015513897866839042,221,0,19,1,0,0,0,0,0,0,3,2025,12,5,4,0.08073634859349145,1.0549450549450547,0.015513897866839042
26126369,US,US,1,2.0,0,0,0,0,2025-12-05,32.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Young,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,12,5,4,0.08073634859349145,0.49644473173884934,0.015513897866839042
26127436,US,US,1,2.0,0,0,0,0,2025-12-05,57.0,801.0,Male,75.0,SKYRIZI,injection site papule,0,0,0.0,MidAge,US,0.051587301587301584,36,0,21,0,0,0,0,0,0,0,3,2025,12,5,4,0.08073634859349145,2.9404761904761902,0.0
26128031,US,US,1,2.0,0,0,0,0,2025-12-06,35.0,801.0,Female,75.0,DUPIXENT,asthma,0,0,0.0,Young,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,12,6,5,0.08073634859349145,0.5429864253393665,0.015513897866839042
26162284,EU,EU,1,1.0,1,0,0,0,2025-12-16,75.0,801.0,Male,89.5,VALSARTAN,cardiogenic shock,1,5,0.35714285714285715,Senior,EU,0.35714285714285715,1,1,17,0,0,0,0,0,0,0,2,2025,12,16,1,0.08073634859349145,26.785714285714285,0.0
26164147,US,US,1,2.0,0,0,0,0,2025-12-16,28.0,801.0,Female,75.0,DUPIXENT,maternal exposure during pregnancy,0,0,0.0,Young,US,0.015513897866839042,221,0,34,0,0,0,0,0,0,0,4,2025,12,16,1,0.08073634859349145,0.43438914027149317,0.015513897866839042
26164633,US,US,1,2.0,0,0,0,0,2025-12-16,85.0,801.0,Male,75.0,DUPIXENT,accidental exposure to product,0,0,0.0,Senior,US,0.015513897866839042,221,0,30,0,0,0,0,0,0,0,4,2025,12,16,1,0.08073634859349145,1.3186813186813187,0.0
26165658,EU,EU,1,1.0,0,0,1,0,2025-12-16,57.0,801.0,Male,75.0,ALPRAZOLAM,drug use disorder,1,3,0.21428571428571427,MidAge,EU,0.14285714285714285,3,1,17,0,0,0,0,0,0,0,3,2025,12,16,1,0.08073634859349145,8.142857142857142,0.0
26165834,GB,GB,1,1.0,0,0,0,0,2025-12-16,56.0,801.0,Female,68.0,IBUPROFEN,angioedema,1,0,0.0,MidAge,GB,0.11607142857142858,8,0,10,0,0,0,0,0,0,0,1,2025,12,16,1,0.08073634859349145,6.5,0.11607142857142858
26065655,US,US,1,1.0,0,0,1,1,2025-11-19,32.0,801.0,Female,75.0,SUMATRIPTAN,susac^s syndrome,1,5,0.35714285714285715,Young,US,0.35714285714285715,1,1,16,0,0,0,0,0,0,0,2,2025,11,19,2,0.08073634859349145,11.428571428571429,0.35714285714285715
26066331,US,US,1,2.0,0,0,0,0,2025-11-19,59.0,801.0,Female,95.0,LINZESS,discomfort,0,0,0.0,MidAge,US,0.0,1,0,10,0,0,0,0,0,0,0,1,2025,11,19,2,0.08073634859349145,0.0,0.0
26067451,CA,CA,2,1.0,0,0,1,0,2025-11-20,43.0,801.0,Female,85.0,BELIMUMAB,loss of consciousness,1,3,0.21428571428571427,Adult,CA,0.21428571428571427,1,1,21,0,0,0,0,0,0,0,3,2025,11,20,3,0.08936301793444651,9.214285714285714,0.21428571428571427
26067585,US,US,1,1.0,0,0,1,0,2025-11-20,9.0,801.0,Female,75.0,DUPIXENT,suicidal ideation,1,3,0.21428571428571427,Child,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,11,20,3,0.08073634859349145,0.13962508080155137,0.015513897866839042
26069057,PH,PH,1,1.0,0,1,1,0,2025-11-20,48.0,801.0,Female,92.0,XIGDUO XR,septic shock,1,7,0.5,Adult,Other,0.5,1,1,12,0,0,0,0,0,0,0,2,2025,11,20,3,0.08073634859349145,24.0,0.5
26128341,US,US,1,2.0,0,0,0,0,2025-12-07,66.0,801.0,Female,75.0,DUPIXENT,dry skin,0,0,0.0,Senior,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,2,2025,12,7,6,0.08073634859349145,1.0239172592113768,0.015513897866839042
26128475,US,US,2,1.0,0,0,0,0,2025-12-07,62.0,801.0,Female,75.0,CREON,pancreatic carcinoma,1,0,0.0,MidAge,US,0.03296703296703297,13,0,20,0,0,0,0,0,0,0,2,2025,12,7,6,0.08936301793444651,2.043956043956044,0.03296703296703297
26131514,EU,EU,1,1.0,0,0,0,0,2025-12-08,72.0,801.0,Female,75.0,OXALIPLATIN,anaphylactic reaction,1,0,0.0,Senior,EU,0.08571428571428572,5,0,21,0,0,0,0,0,0,0,2,2025,12,8,0,0.08073634859349145,6.171428571428572,0.08571428571428572
26131581,US,US,1,2.0,0,0,0,0,2025-12-08,57.0,801.0,Male,85.36,DUPIXENT,neurodermatitis,0,0,0.0,MidAge,US,0.015513897866839042,221,0,15,0,0,0,0,0,0,0,1,2025,12,8,0,0.08073634859349145,0.8842921784098254,0.0
26069772,GB,GB,1,1.0,0,0,0,0,2025-11-20,57.0,801.0,Female,75.0,RISPERIDONE,tearfulness,1,0,0.0,MidAge,GB,0.125,4,1,11,0,0,0,0,0,0,0,1,2025,11,20,3,0.08073634859349145,7.125,0.125
26071649,CH,CH,1,1.0,0,0,1,0,2025-11-20,75.0,801.0,Male,91.0,ZOLPIDEM TARTRATE,chest pain,1,3,0.21428571428571427,Senior,Other,0.21428571428571427,1,1,10,1,0,0,0,0,0,0,2,2025,11,20,3,0.08073634859349145,16.07142857142857,0.0
26071825,US,US,2,1.0,0,0,0,0,2025-11-20,62.0,801.0,Male,75.0,SKYRIZI,skin cancer,1,0,0.0,MidAge,US,0.051587301587301584,36,0,11,0,0,0,1,0,0,0,2,2025,11,20,3,0.08936301793444651,3.198412698412698,0.0
26072635,US,US,1,2.0,0,0,0,0,2025-11-20,63.0,801.0,Female,83.007,VYALEV,catheter site cellulitis,0,0,0.0,MidAge,US,0.0,1,0,24,0,0,0,0,0,0,0,3,2025,11,20,3,0.08073634859349145,0.0,0.0
26166091,US,US,1,2.0,0,0,0,0,2025-12-16,57.0,801.0,Female,75.0,SKYRIZI,feeling abnormal,0,0,0.0,MidAge,US,0.051587301587301584,36,0,16,0,0,0,0,0,0,0,2,2025,12,16,1,0.08073634859349145,2.9404761904761902,0.051587301587301584
26166387,US,US,1,2.0,0,0,0,0,2025-12-17,55.0,801.0,Female,75.0,DUPIXENT,sinusitis,0,0,0.0,MidAge,US,0.015513897866839042,221,0,9,0,0,0,0,0,0,0,1,2025,12,17,2,0.08073634859349145,0.8532643826761473,0.015513897866839042
26166873,EU,EU,1,1.0,0,0,1,0,2025-12-17,74.0,801.0,Female,75.0,OBINUTUZUMAB,septic shock,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,12,0,0,0,0,0,0,0,2,2025,12,17,2,0.08073634859349145,15.857142857142856,0.21428571428571427
26168426,US,US,1,1.0,0,0,0,0,2025-12-17,57.0,801.0,Female,75.0,XOLAIR,underdose,1,0,0.0,MidAge,US,0.14285714285714285,4,1,9,0,0,0,0,0,0,0,1,2025,12,17,2,0.08073634859349145,8.142857142857142,0.14285714285714285
26168440,CA,CA,2,1.0,0,0,1,0,2025-12-17,57.0,801.0,Female,75.0,TEZEPELUMAB,musculoskeletal discomfort,1,3,0.21428571428571427,MidAge,CA,0.10714285714285714,2,0,26,0,0,0,0,0,0,0,2,2025,12,17,2,0.08936301793444651,6.107142857142857,0.10714285714285714
26169007,EU,EU,1,1.0,0,0,0,0,2025-12-17,73.0,801.0,Male,56.0,OXALIPLATIN,hyperkalaemia,1,0,0.0,Senior,EU,0.08571428571428572,5,0,13,0,0,0,0,0,0,0,1,2025,12,17,2,0.08073634859349145,6.257142857142857,0.0
26169951,US,US,2,1.0,0,0,0,0,2025-12-17,57.0,801.0,Female,75.0,BRINSUPRI,angina pectoris,1,0,0.0,MidAge,US,0.0,1,0,15,0,0,0,0,0,0,0,2,2025,12,17,2,0.08936301793444651,0.0,0.0
26134740,US,US,1,1.0,0,0,0,0,2025-12-09,17.0,801.0,Male,75.0,DUPIXENT,loss of consciousness,1,0,0.0,Child,US,0.015513897866839042,221,0,21,0,0,0,0,0,0,0,3,2025,12,9,1,0.08073634859349145,0.2637362637362637,0.0
26135455,US,US,1,2.0,0,0,0,0,2025-12-09,57.0,801.0,Female,75.0,ESTRADIOL,product adhesion issue,0,0,0.0,MidAge,US,0.0,8,0,22,0,0,0,0,0,0,0,3,2025,12,9,1,0.08073634859349145,0.0,0.0
26135927,BR,BR,1,1.0,0,0,0,0,2025-12-09,57.0,801.0,Male,75.0,CABOMETYX,intestinal obstruction,1,0,0.0,MidAge,BR,0.10714285714285714,4,0,22,0,0,0,0,0,0,0,2,2025,12,9,1,0.08073634859349145,6.107142857142857,0.0
26136184,US,US,1,2.0,0,0,0,0,2025-12-09,57.0,801.0,Male,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,MidAge,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,12,9,1,0.08073634859349145,0.8842921784098254,0.0
26136346,US,US,1,2.0,0,0,0,0,2025-12-09,57.0,801.0,Female,75.0,PLUVICTO,general physical health deterioration,0,0,0.0,MidAge,US,0.0,8,0,37,0,0,0,0,0,0,0,4,2025,12,9,1,0.08073634859349145,0.0,0.0
26074646,US,Unknown,1,1.0,0,0,0,1,2025-11-20,86.0,801.0,Female,45.36,DESVENLAFAXINE SUCCINATE,vision blurred,1,2,0.14285714285714285,Senior,US,0.14285714285714285,1,1,14,0,0,0,0,0,0,0,2,2025,11,20,3,0.08073634859349145,12.285714285714285,0.14285714285714285
26076185,AU,AU,1,1.0,0,0,0,1,2025-11-21,57.0,801.0,Female,75.0,WEGOVY,blindness,1,2,0.14285714285714285,MidAge,AU,0.14285714285714285,4,1,9,0,0,0,0,0,0,0,1,2025,11,21,4,0.08073634859349145,8.142857142857142,0.14285714285714285
26076752,EU,EU,1,1.0,1,0,1,1,2025-11-21,64.0,801.0,Male,75.0,LENALIDOMIDE,plasma cell myeloma,1,10,0.7142857142857143,MidAge,EU,0.15413533834586465,19,1,19,0,0,0,0,0,0,0,3,2025,11,21,4,0.08073634859349145,9.864661654135338,0.0
26137413,US,US,1,2.0,0,0,0,0,2025-12-09,57.0,801.0,Female,75.0,COMBIGAN,product temperature excursion issue,0,0,0.0,MidAge,US,0.0,1,0,35,0,0,0,0,0,0,0,4,2025,12,9,1,0.08073634859349145,0.0,0.0
26138290,US,US,1,2.0,0,0,0,0,2025-12-10,70.0,801.0,Female,55.338,FINASTERIDE,off label use,0,0,0.0,Senior,US,0.0,2,0,13,0,0,0,0,0,0,0,3,2025,12,10,2,0.08073634859349145,0.0,0.0
26140248,US,US,2,1.0,0,0,0,0,2025-12-10,29.0,801.0,Male,75.0,PREDNISONE,drug ineffective,1,0,0.0,Young,US,0.1607142857142857,8,1,16,0,0,0,0,0,0,0,2,2025,12,10,2,0.08936301793444651,4.660714285714286,0.0
26140600,US,US,1,2.0,0,0,0,0,2025-12-10,66.0,801.0,Female,75.0,DUPIXENT,product use in unapproved indication,0,0,0.0,Senior,US,0.015513897866839042,221,0,36,0,0,0,0,0,0,0,5,2025,12,10,2,0.08073634859349145,1.0239172592113768,0.015513897866839042
26077953,US,US,1,2.0,0,0,0,0,2025-11-22,65.0,801.0,Male,90.7,ONAPGO,balance disorder,0,0,0.0,MidAge,US,0.0,1,0,16,0,0,0,0,0,0,0,2,2025,11,22,5,0.08073634859349145,0.0,0.0
26079830,US,US,1,2.0,0,0,0,0,2025-11-23,49.0,801.0,Female,75.0,SKYRIZI,covid-19,0,0,0.0,Adult,US,0.051587301587301584,36,0,8,0,0,0,0,0,0,0,1,2025,11,23,6,0.08073634859349145,2.5277777777777777,0.051587301587301584
26080182,US,US,1,2.0,0,0,0,0,2025-11-24,57.0,801.0,Male,75.0,DUPIXENT,anxiety,0,0,0.0,MidAge,US,0.015513897866839042,221,0,7,0,0,0,0,0,0,0,1,2025,11,24,0,0.08073634859349145,0.8842921784098254,0.0
26171208,US,US,1,2.0,0,0,0,0,2025-12-17,57.0,801.0,Female,83.4,VIZAMYL,back pain,0,0,0.0,MidAge,US,0.0,1,0,9,1,0,0,0,0,0,0,2,2025,12,17,2,0.08073634859349145,0.0,0.0
26171370,CA,CA,1,1.0,0,1,1,1,2025-12-17,43.0,801.0,Female,70.0,ORENCIA,drug ineffective,1,9,0.6428571428571429,Adult,CA,0.10204081632653061,14,0,16,0,0,0,0,0,0,0,2,2025,12,17,2,0.08073634859349145,4.387755102040816,0.10204081632653061
26172652,CN,CN,1,1.0,0,0,0,0,2025-12-18,86.0,801.0,Male,43.0,ENOXAPARIN SODIUM,mucosal haemorrhage,1,0,0.0,Senior,CN,0.0,2,0,19,0,0,0,0,0,0,0,2,2025,12,18,3,0.08073634859349145,0.0,0.0
26185746,US,Unknown,1,2.0,0,0,0,0,2025-12-19,67.0,801.0,Male,121.5,VANCOMYCIN,arthralgia,0,0,0.0,Senior,US,0.0,1,0,10,0,0,0,0,0,0,0,1,2025,12,19,4,0.08073634859349145,0.0,0.0
26216688,CA,CA,2,1.0,0,0,0,0,2025-12-31,57.0,801.0,Female,75.0,OCREVUS,infusion related reaction,1,0,0.0,MidAge,CA,0.0,3,0,25,0,0,0,0,0,0,0,3,2025,12,31,2,0.08936301793444651,0.0,0.0
26150409,US,Unknown,1,1.0,0,0,0,0,2025-12-12,72.0,801.0,Male,75.0,BORTEZOMIB,hepatitis acute,1,0,0.0,Senior,US,0.0,3,0,15,0,0,0,0,0,0,0,2,2025,12,12,4,0.08073634859349145,0.0,0.0
26150557,US,US,1,1.0,0,0,1,0,2025-12-12,28.0,801.0,Female,75.0,DOXYCYCLINE,acute generalised exanthematous pustulosis,1,3,0.21428571428571427,Young,US,0.19642857142857142,4,1,42,0,0,0,0,0,0,0,4,2025,12,12,4,0.08073634859349145,5.5,0.19642857142857142
26150881,US,Unknown,2,1.0,0,0,1,0,2025-12-12,57.0,801.0,Female,75.0,ACETAMINOPHEN,overdose,1,3,0.21428571428571427,MidAge,US,0.10267857142857142,16,0,8,0,0,0,0,0,0,0,1,2025,12,12,4,0.08936301793444651,5.852678571428571,0.10267857142857142
26151286,US,US,1,1.0,0,0,0,0,2025-12-12,25.0,801.0,Female,75.0,PREDNISONE,renal failure,1,0,0.0,Young,US,0.1607142857142857,8,1,13,0,0,0,0,1,0,0,2,2025,12,12,4,0.08073634859349145,4.017857142857142,0.1607142857142857
26153297,US,US,1,2.0,0,0,0,0,2025-12-14,57.0,801.0,Female,75.0,VALIUM,drug hypersensitivity,0,0,0.0,MidAge,US,0.0,1,0,21,0,0,0,0,0,0,0,2,2025,12,14,6,0.08073634859349145,0.0,0.0
26198702,GB,GB,1,1.0,0,0,1,0,2025-12-25,36.0,801.0,Male,75.0,PREGABALIN,priapism,1,3,0.21428571428571427,Adult,GB,0.10714285714285714,6,0,8,0,0,0,0,0,0,0,1,2025,12,25,3,0.08073634859349145,3.8571428571428568,0.0
26205143,US,US,1,2.0,0,0,0,0,2025-12-28,43.0,801.0,Female,75.0,DUPIXENT,hiatus hernia,0,0,0.0,Adult,US,0.015513897866839042,221,0,13,0,0,0,0,0,0,0,2,2025,12,28,6,0.08073634859349145,0.6670976082740788,0.015513897866839042
26205615,CN,CN,1,1.0,0,0,0,0,2025-12-28,73.0,801.0,Male,87.5,TISLELIZUMAB,myelosuppression,1,0,0.0,Senior,CN,0.0,3,0,16,0,0,0,0,0,0,0,1,2025,12,28,6,0.08073634859349145,0.0,0.0
26205682,US,US,1,2.0,0,0,0,0,2025-12-29,57.0,801.0,Female,61.36,DUPIXENT,drug ineffective,0,0,0.0,MidAge,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,2,2025,12,29,0,0.08073634859349145,0.8842921784098254,0.015513897866839042
26155794,CN,CN,1,2.0,0,0,0,0,2025-12-15,57.0,801.0,Female,75.0,TACROLIMUS,upper respiratory tract infection,0,0,0.0,MidAge,CN,0.09183673469387754,7,0,33,0,1,0,0,0,0,0,4,2025,12,15,0,0.08073634859349145,5.23469387755102,0.09183673469387754
26157266,US,US,1,1.0,1,0,0,0,2025-12-15,57.0,801.0,Male,75.0,PREDNISONE,death,1,5,0.35714285714285715,MidAge,US,0.1607142857142857,8,1,5,0,0,1,0,0,0,0,1,2025,12,15,0,0.08073634859349145,9.160714285714285,0.0
26158076,US,US,1,1.0,0,0,0,0,2025-12-15,18.0,801.0,Female,75.0,ADVIL,nausea,1,0,0.0,Child,US,0.0,1,0,6,0,0,0,0,0,0,0,1,2025,12,15,0,0.08073634859349145,0.0,0.0
26158791,US,US,1,2.0,0,0,0,0,2025-12-15,57.0,801.0,Male,75.0,PLUVICTO,drug effect less than expected,0,0,0.0,MidAge,US,0.0,8,0,30,0,0,0,0,0,0,0,5,2025,12,15,0,0.08073634859349145,0.0,0.0
26159048,US,US,1,1.0,0,0,1,0,2025-12-16,77.0,801.0,Female,59.42,POMALYST,pneumonia,1,3,0.21428571428571427,Senior,US,0.11428571428571428,5,0,9,0,0,0,0,0,1,0,1,2025,12,16,1,0.08073634859349145,8.799999999999999,0.11428571428571428
26160992,CA,CA,1,1.0,0,0,0,1,2025-12-16,71.0,801.0,Female,75.0,DEXAMETHASONE,cough,1,2,0.14285714285714285,Senior,CA,0.1857142857142857,5,1,5,0,0,0,0,0,0,0,1,2025,12,16,1,0.08073634859349145,13.185714285714285,0.1857142857142857
26042999,US,US,1,2.0,0,0,0,0,2025-11-13,28.0,801.0,Female,75.0,CORTICOTROPIN,drug ineffective,0,0,0.0,Young,US,0.0,3,0,16,0,0,0,0,0,0,0,2,2025,11,13,3,0.08073634859349145,0.0,0.0
26043608,CA,CA,1,1.0,0,0,0,0,2025-11-13,41.0,801.0,Male,75.0,TETRABENAZINE,tardive dyskinesia,1,0,0.0,Adult,CA,0.0,1,0,18,0,0,0,0,0,0,0,2,2025,11,13,3,0.08073634859349145,0.0,0.0
26044580,US,US,2,2.0,0,0,0,0,2025-11-14,70.0,801.0,Female,46.719,SKYRIZI,insomnia,0,0,0.0,Senior,US,0.051587301587301584,36,0,8,0,0,0,0,0,0,0,1,2025,11,14,4,0.08936301793444651,3.6111111111111107,0.051587301587301584
26045147,RU,RU,1,1.0,0,0,0,0,2025-11-14,57.0,801.0,Female,75.0,NUVARING,pregnancy with contraceptive device,1,0,0.0,MidAge,Other,0.0,1,0,35,0,0,0,0,0,0,0,4,2025,11,14,4,0.08073634859349145,0.0,0.0
26207059,CA,Unknown,1,1.0,1,1,1,1,2025-12-29,40.0,801.0,Female,96.0,CIMZIA,abdominal discomfort,1,14,1.0,Adult,CA,0.5,2,1,20,0,0,0,0,0,0,0,2,2025,12,29,0,0.08073634859349145,20.0,0.5
26207369,GB,GB,1,1.0,0,0,0,0,2025-12-29,65.0,801.0,Female,63.0,METRONIDAZOLE,faeces discoloured,1,0,0.0,MidAge,GB,0.14285714285714285,2,1,18,0,0,0,0,0,0,0,2,2025,12,29,0,0.08073634859349145,9.285714285714285,0.14285714285714285
26207950,US,US,1,1.0,0,0,0,0,2025-12-29,57.0,801.0,Female,75.0,ORENCIA,omphalitis,1,0,0.0,MidAge,US,0.10204081632653061,14,0,10,0,0,0,0,0,0,0,1,2025,12,29,0,0.08073634859349145,5.816326530612245,0.10204081632653061
26208140,US,Unknown,1,1.0,1,0,1,0,2025-12-29,60.0,801.0,Male,75.0,DOXYCYCLINE,aspergillus infection,1,8,0.5714285714285714,MidAge,US,0.19642857142857142,4,1,21,0,1,0,0,0,0,0,2,2025,12,29,0,0.08073634859349145,11.785714285714285,0.0
26208612,US,US,1,2.0,0,0,0,0,2025-12-29,57.0,801.0,Female,75.0,TIOCONAZOLE,drug ineffective,0,0,0.0,MidAge,US,0.0,2,0,16,0,0,0,0,0,0,0,2,2025,12,29,0,0.08073634859349145,0.0,0.0
26208665,US,US,1,2.0,0,0,0,0,2025-12-29,57.0,801.0,Female,75.0,TIOCONAZOLE,application site papules,0,0,0.0,MidAge,US,0.0,2,0,24,0,0,0,0,0,0,0,3,2025,12,29,0,0.08073634859349145,0.0,0.0
26208975,US,Unknown,1,1.0,0,0,0,0,2025-12-26,67.0,801.0,Female,75.0,COSENTYX,condition aggravated,1,0,0.0,Senior,US,0.05714285714285714,10,0,20,0,0,0,0,0,0,0,2,2025,12,26,4,0.08073634859349145,3.8285714285714283,0.05714285714285714
26209556,US,US,1,1.0,0,1,1,0,2025-12-29,4.0,802.0,Male,75.0,NITROGLYCERIN,drug ineffective,1,7,0.5,Child,US,0.5,1,1,16,0,0,0,0,0,0,0,2,2025,12,29,0,0.08073634859349145,2.0,0.0
26209732,CN,CN,1,1.0,0,0,1,0,2025-12-29,29.0,801.0,Male,76.0,CYTARABINE,myelosuppression,1,3,0.21428571428571427,Young,CN,0.21428571428571427,1,1,16,0,0,0,0,0,0,0,1,2025,12,29,0,0.08073634859349145,6.2142857142857135,0.0
26210260,US,US,2,1.0,0,0,0,0,2025-12-29,67.0,801.0,Male,75.0,CILTACABTAGENE AUTOLEUCEL,rectal cancer,1,0,0.0,Senior,US,0.17857142857142858,2,1,13,0,0,0,1,0,0,0,2,2025,12,29,0,0.08936301793444651,11.964285714285715,0.0
18629916,US,US,1,1.0,0,0,0,0,2020-12-17,58.0,801.0,Female,71.61,XELJANZ XR,knee arthroplasty,1,0,0.0,MidAge,US,0.0,9,0,17,0,0,0,0,0,0,0,2,2020,12,17,3,0.08073634859349145,0.0,0.0
18711888,JP,JP,1,1.0,0,1,1,0,2021-01-07,79.0,801.0,Male,59.0,METHYLPREDNISOLONE SODIUM SUCCINATE,immunosuppression,1,7,0.5,Senior,JP,0.5,1,1,17,0,0,0,0,0,0,0,1,2021,1,7,3,0.08073634859349145,39.5,0.0
19072609,CA,CA,1,1.0,0,0,0,0,2021-03-30,10.0,802.0,Female,75.0,VALPROIC ACID,drug resistance,1,0,0.0,Child,CA,0.0,1,0,15,0,0,0,0,0,0,0,2,2021,3,30,1,0.08073634859349145,0.0,0.0
19084798,US,US,2,1.0,0,0,0,0,2021-04-01,69.0,801.0,Male,75.0,VEDOLIZUMAB,seizure,1,0,0.0,Senior,US,0.057692307692307696,26,0,7,0,0,0,0,0,0,0,1,2021,4,1,3,0.08936301793444651,3.980769230769231,0.0
19266523,US,US,1,1.0,0,0,1,0,2021-05-18,34.0,801.0,Male,75.0,NOVOLOG MIX 70/30,device failure,1,3,0.21428571428571427,Young,US,0.21428571428571427,1,1,14,0,0,0,0,1,0,0,2,2021,5,18,1,0.08073634859349145,7.285714285714286,0.0
19565561,EU,EU,1,1.0,1,0,0,0,2021-07-14,70.0,801.0,Female,75.0,YERVOY,bone marrow failure,1,5,0.35714285714285715,Senior,EU,0.35714285714285715,4,1,19,0,0,0,0,1,0,0,3,2021,7,14,2,0.08073634859349145,25.0,0.35714285714285715
19716626,CO,CO,2,1.0,0,0,1,0,2021-08-18,21.0,801.0,Female,47.0,VEDOLIZUMAB,intestinal stenosis,1,3,0.21428571428571427,Young,Other,0.057692307692307696,26,0,19,0,0,0,0,0,0,0,2,2021,8,18,2,0.08936301793444651,1.2115384615384617,0.057692307692307696
19806455,JP,JP,1,1.0,0,0,1,0,2021-09-09,12.0,802.0,Male,8.3,SABRIL,retinal degeneration,1,3,0.21428571428571427,Child,JP,0.21428571428571427,1,1,20,0,0,0,0,0,0,0,2,2021,9,9,3,0.08073634859349145,2.571428571428571,0.0
19929547,CA,CA,1,1.0,0,0,1,0,2021-10-07,58.0,801.0,Female,75.0,REVATIO,hospitalisation,1,3,0.21428571428571427,MidAge,CA,0.21428571428571427,1,1,15,0,0,0,0,0,0,0,1,2021,10,7,3,0.08073634859349145,12.428571428571427,0.21428571428571427
20054843,CA,CA,2,1.0,0,0,0,0,2021-11-10,57.0,801.0,Female,52.0,REMICADE,colitis ulcerative,1,0,0.0,MidAge,CA,0.0,3,0,18,0,0,0,0,0,0,0,2,2021,11,10,2,0.08936301793444651,0.0,0.0
20057826,US,US,2,1.0,0,0,1,0,2021-11-11,15.0,801.0,Female,99.79,LANADELUMAB,loss of consciousness,1,3,0.21428571428571427,Child,US,0.12857142857142856,5,1,21,0,0,0,0,0,0,0,3,2021,11,11,3,0.08936301793444651,1.9285714285714284,0.12857142857142856
20108870,EU,EU,2,1.0,0,0,1,0,2021-11-24,6.0,801.0,Male,75.0,TEDUGLUTIDE,gastrointestinal anastomotic stenosis,1,3,0.21428571428571427,Child,EU,0.14285714285714285,3,1,37,0,0,0,0,0,0,0,3,2021,11,24,2,0.08936301793444651,0.8571428571428571,0.0
20311546,US,US,1,2.0,0,0,0,0,2022-01-08,56.0,801.0,Female,75.0,OTEZLA,therapy non-responder,0,0,0.0,MidAge,US,0.0,4,0,21,0,0,0,0,0,0,0,2,2022,1,8,5,0.08073634859349145,0.0,0.0
20701332,US,US,2,1.0,0,0,1,0,2022-04-12,57.0,801.0,Female,61.0,HUMAN IMMUNOGLOBULIN G,white blood cell count increased,1,3,0.21428571428571427,MidAge,US,0.10714285714285714,8,0,32,0,0,0,0,0,0,0,5,2022,4,12,1,0.08936301793444651,6.107142857142857,0.10714285714285714
20715870,JP,JP,2,1.0,1,0,1,0,2022-04-15,76.0,801.0,Male,75.0,LEUPROLIDE ACETATE,pneumonia,1,8,0.5714285714285714,Senior,JP,0.38095238095238093,3,1,9,0,0,0,0,0,1,0,1,2022,4,15,4,0.08936301793444651,28.95238095238095,0.0
26212271,US,US,1,2.0,0,0,0,0,2025-12-30,34.0,801.0,Female,75.0,DUPIXENT,pruritus,0,0,0.0,Young,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,12,30,1,0.08073634859349145,0.5274725274725274,0.015513897866839042
26212419,US,US,1,2.0,0,0,0,0,2025-12-30,67.0,801.0,Male,77.11,DUPIXENT,accidental exposure to product,0,0,0.0,Senior,US,0.015513897866839042,221,0,30,0,0,0,0,0,0,0,4,2025,12,30,1,0.08073634859349145,1.0394311570782158,0.0
26212972,US,US,1,1.0,0,0,1,0,2025-12-30,53.0,801.0,Female,75.0,CEFADROXIL,drug ineffective,1,3,0.21428571428571427,MidAge,US,0.21428571428571427,1,1,16,0,0,0,0,0,0,0,2,2025,12,30,1,0.08073634859349145,11.357142857142856,0.21428571428571427
26213687,US,US,1,1.0,0,1,0,0,2025-12-30,67.0,801.0,Female,75.0,METHOTREXATE SODIUM,histoplasmosis disseminated,1,4,0.2857142857142857,Senior,US,0.125,4,1,27,0,0,0,0,0,0,0,2,2025,12,30,1,0.08073634859349145,8.375,0.125
26214053,US,US,1,2.0,0,0,0,0,2025-12-30,57.0,801.0,Male,75.0,SKYRIZI,product storage error,0,0,0.0,MidAge,US,0.051587301587301584,36,0,21,0,0,0,0,0,0,0,3,2025,12,30,1,0.08073634859349145,2.9404761904761902,0.0
26215335,US,US,1,2.0,0,0,0,0,2025-12-30,73.0,801.0,Male,75.0,DUPIXENT,rash pruritic,0,0,0.0,Senior,US,0.015513897866839042,221,0,13,0,0,0,0,0,0,0,2,2025,12,30,1,0.08073634859349145,1.1325145442792501,0.0
21035577,US,US,2,1.0,0,0,0,0,2022-07-01,57.0,801.0,Female,75.0,XYWAV,surgery,1,0,0.0,MidAge,US,0.04285714285714286,5,0,7,0,0,0,0,0,0,0,1,2022,7,1,4,0.08936301793444651,2.442857142857143,0.04285714285714286
21079021,US,US,1,1.0,0,0,0,0,2022-07-13,57.0,801.0,Female,75.0,ELMIRON,pigmentary maculopathy,1,0,0.0,MidAge,US,0.0,1,0,22,0,0,0,0,0,0,0,2,2022,7,13,2,0.08073634859349145,0.0,0.0
21134601,EU,EU,1,1.0,0,1,0,0,2022-07-27,3.0,801.0,Female,75.0,LEVETIRACETAM,apnoea,1,4,0.2857142857142857,Child,EU,0.05714285714285714,5,0,6,0,0,0,0,0,0,0,1,2022,7,27,2,0.08073634859349145,0.17142857142857143,0.05714285714285714
21237605,JP,JP,2,1.0,0,0,0,0,2022-08-22,74.0,801.0,Male,75.0,ATEZOLIZUMAB,ascites,1,0,0.0,Senior,JP,0.0,1,0,7,0,0,0,0,0,0,0,1,2022,8,22,0,0.08936301793444651,0.0,0.0
26216860,US,US,1,1.0,0,0,0,0,2025-12-31,57.0,801.0,Female,75.0,SPRAVATO,product administration error,1,0,0.0,MidAge,US,0.026785714285714284,8,0,28,0,0,0,0,0,0,0,3,2025,12,31,2,0.08073634859349145,1.5267857142857142,0.026785714285714284
26164299,US,US,1,2.0,0,0,0,0,2025-12-16,64.0,801.0,Female,75.0,DUPIXENT,sleep disorder due to a general medical condition,0,0,0.0,MidAge,US,0.015513897866839042,221,0,49,0,0,0,0,0,0,0,8,2025,12,16,1,0.08073634859349145,0.9928894634776987,0.015513897866839042
26164475,US,US,1,2.0,0,0,0,0,2025-12-16,57.0,801.0,Female,81.82,DUPIXENT,incorrect dose administered,0,0,0.0,MidAge,US,0.015513897866839042,221,0,27,0,0,0,0,0,0,0,3,2025,12,16,1,0.08073634859349145,0.8842921784098254,0.015513897866839042
26165003,US,US,1,2.0,0,0,0,0,2025-12-16,57.0,801.0,Female,75.0,NURTEC ODT,nausea,0,0,0.0,MidAge,US,0.0,2,0,6,0,0,0,0,0,0,0,1,2025,12,16,1,0.08073634859349145,0.0,0.0
26165285,GB,GB,1,1.0,0,0,1,0,2025-12-16,57.0,801.0,Male,75.0,CLOZARIL,white blood cell count increased,1,3,0.21428571428571427,MidAge,GB,0.10714285714285714,4,0,32,0,0,0,0,0,0,0,5,2025,12,16,1,0.08073634859349145,6.107142857142857,0.0
26165528,US,US,1,1.0,0,0,1,0,2025-12-16,63.0,801.0,Female,75.0,DUPIXENT,blood glucose decreased,1,3,0.21428571428571427,MidAge,US,0.015513897866839042,221,0,23,0,0,0,0,0,0,0,3,2025,12,16,1,0.08073634859349145,0.9773755656108597,0.015513897866839042
26165986,US,US,1,2.0,0,0,0,0,2025-12-16,68.0,801.0,Female,56.699,PAROXETINE,discomfort,0,0,0.0,Senior,US,0.0,2,0,10,0,0,0,0,0,0,0,1,2025,12,16,1,0.08073634859349145,0.0,0.0
26166271,US,US,1,2.0,0,0,0,0,2025-12-16,57.0,801.0,Female,75.0,DUPIXENT,eyelid margin crusting,0,0,0.0,MidAge,US,0.015513897866839042,221,0,22,0,0,0,0,0,0,0,3,2025,12,16,1,0.08073634859349145,0.8842921784098254,0.015513897866839042
26168039,US,US,1,2.0,0,0,0,0,2025-12-17,57.0,801.0,Female,75.0,EXPAREL,labelled drug-drug interaction medication error,0,0,0.0,MidAge,US,0.0,1,0,47,0,0,0,0,0,0,0,5,2025,12,17,2,0.08073634859349145,0.0,0.0
26168349,CN,CN,1,1.0,0,0,0,0,2025-12-17,38.0,801.0,Female,75.0,METHYLPREDNISOLONE,therapy partial responder,1,0,0.0,Adult,CN,0.14285714285714285,3,1,25,0,0,0,0,0,0,0,3,2025,12,17,2,0.08073634859349145,5.428571428571428,0.14285714285714285
26168497,US,US,1,1.0,0,0,1,0,2025-12-17,57.0,801.0,Female,75.0,LAMOTRIGINE,nausea,1,3,0.21428571428571427,MidAge,US,0.10714285714285714,2,0,6,0,0,0,0,0,0,0,1,2025,12,17,2,0.08073634859349145,6.107142857142857,0.10714285714285714
21326800,EU,EU,1,1.0,1,1,1,0,2022-09-13,32.0,801.0,Male,75.0,CITALOPRAM,acute hepatic failure,1,12,0.8571428571428571,Young,EU,0.42857142857142855,2,1,21,0,0,0,0,1,0,0,3,2022,9,13,1,0.08073634859349145,13.714285714285714,0.0
21477418,DZ,DZ,2,1.0,0,0,0,0,2022-10-19,34.0,801.0,Female,75.0,REBIF,abortion spontaneous,1,0,0.0,Young,Other,0.0,1,0,20,0,0,0,0,0,0,0,2,2022,10,19,2,0.08936301793444651,0.0,0.0
21482588,US,US,2,1.0,0,0,1,0,2022-10-20,46.0,801.0,Female,75.0,LANADELUMAB,covid-19,1,3,0.21428571428571427,Adult,US,0.12857142857142856,5,1,8,0,0,0,0,0,0,0,1,2022,10,20,3,0.08936301793444651,5.914285714285714,0.12857142857142856
21627444,US,US,2,1.0,0,0,0,0,2022-11-22,58.0,801.0,Female,79.0,LANADELUMAB,vascular device infection,1,0,0.0,MidAge,US,0.12857142857142856,5,1,25,0,1,0,0,0,0,0,3,2022,11,22,1,0.08936301793444651,7.457142857142856,0.12857142857142856
22523709,EU,EU,1,1.0,0,0,0,0,2023-06-06,32.0,801.0,Female,75.0,DUPILUMAB,myopericarditis,1,0,0.0,Young,EU,0.04285714285714286,5,0,15,0,0,0,0,0,0,0,1,2023,6,6,1,0.08073634859349145,1.3714285714285714,0.04285714285714286
22760014,CA,CA,2,1.0,0,0,0,0,2023-07-28,57.0,801.0,Female,75.0,RITUXIMAB,productive cough,1,0,0.0,MidAge,CA,0.12406015037593986,19,0,16,0,0,0,0,0,0,0,2,2023,7,28,4,0.08936301793444651,7.071428571428572,0.12406015037593986
26169335,EU,EU,1,1.0,0,0,0,0,2025-12-17,20.0,801.0,Male,75.0,CLOZAPINE,visual impairment,1,0,0.0,Young,EU,0.23214285714285715,4,1,17,0,0,0,0,0,0,0,2,2025,12,17,2,0.08073634859349145,4.642857142857143,0.0
26170201,CA,CA,1,1.0,0,0,1,0,2025-12-17,57.0,801.0,Female,75.0,ORENCIA,arthritis,1,3,0.21428571428571427,MidAge,CA,0.10204081632653061,14,0,9,0,0,0,0,0,0,0,1,2025,12,17,2,0.08073634859349145,5.816326530612245,0.10204081632653061
26170955,US,US,1,2.0,0,0,0,0,2025-12-17,66.0,801.0,Male,75.0,DUPIXENT,inappropriate schedule of product administration,0,0,0.0,Senior,US,0.015513897866839042,221,0,48,0,0,0,0,0,0,0,5,2025,12,17,2,0.08073634859349145,1.0239172592113768,0.0
26171307,US,US,1,1.0,0,1,1,0,2025-12-17,75.0,801.0,Female,75.0,CARBOPLATIN,hyperglycaemia,1,7,0.5,Senior,US,0.12244897959183673,7,0,14,0,0,0,0,0,0,0,1,2025,12,17,2,0.08073634859349145,9.183673469387754,0.12244897959183673
26171684,US,US,1,1.0,0,0,0,0,2025-12-17,57.0,801.0,Female,75.0,HUMALOG,thyroid cancer,1,0,0.0,MidAge,US,0.05357142857142857,4,0,14,0,0,0,1,0,0,0,2,2025,12,17,2,0.08073634859349145,3.0535714285714284,0.05357142857142857
26171899,AU,AU,1,1.0,0,0,0,0,2025-12-17,57.0,801.0,Female,75.0,PREDNISOLONE SODIUM PHOSPHATE,adrenocortical insufficiency acute,1,0,0.0,MidAge,AU,0.0,2,0,34,0,0,0,0,0,0,0,3,2025,12,17,2,0.08073634859349145,0.0,0.0
26172360,EU,EU,1,1.0,0,0,1,0,2025-12-18,55.0,801.0,Male,75.0,PEMETREXED,immune-mediated encephalitis,1,3,0.21428571428571427,MidAge,EU,0.21428571428571427,3,1,28,0,0,0,0,0,0,0,2,2025,12,18,3,0.08073634859349145,11.785714285714285,0.0
26172427,JP,JP,1,1.0,0,0,0,0,2025-12-18,85.0,801.0,Male,75.0,MOMELOTINIB,interstitial lung disease,1,0,0.0,Senior,JP,0.0,3,0,25,0,0,0,0,0,0,0,3,2025,12,18,3,0.08073634859349145,0.0,0.0
22864705,CA,CA,1,1.0,0,0,0,0,2023-08-25,58.0,801.0,Female,75.0,ABACAVIR SULFATE\LAMIVUDINE,asthma,1,0,0.0,MidAge,CA,0.0,1,0,6,0,0,0,0,0,0,0,1,2023,8,25,4,0.08073634859349145,0.0,0.0
22869618,CA,CA,1,1.0,0,1,1,0,2023-08-26,26.0,801.0,Female,75.0,ONDANSETRON,febrile neutropenia,1,7,0.5,Young,CA,0.5,1,1,19,0,0,0,0,0,0,0,2,2023,8,26,5,0.08073634859349145,13.0,0.5
22915601,CA,CA,2,1.0,0,0,0,0,2023-09-07,70.0,801.0,Female,75.0,VEDOLIZUMAB,haematochezia,1,0,0.0,Senior,CA,0.057692307692307696,26,0,13,0,0,0,0,0,0,0,1,2023,9,7,3,0.08936301793444651,4.038461538461538,0.057692307692307696
22927008,EU,EU,1,1.0,0,0,1,0,2023-09-11,61.0,801.0,Male,85.0,GLIMEPIRIDE,necrotising oesophagitis,1,3,0.21428571428571427,MidAge,EU,0.21428571428571427,1,1,24,0,0,0,0,0,0,0,2,2023,9,11,0,0.08073634859349145,13.071428571428571,0.0
23021253,US,US,2,1.0,0,0,1,0,2023-10-03,56.0,801.0,Female,112.0,ICATIBANT,atrial fibrillation,1,3,0.21428571428571427,MidAge,US,0.21428571428571427,1,1,19,0,0,0,0,0,0,0,2,2023,10,3,1,0.08936301793444651,12.0,0.21428571428571427
23067004,US,US,1,1.0,0,0,1,0,2023-10-16,63.0,801.0,Male,79.0,DUPIXENT,vertigo,1,3,0.21428571428571427,MidAge,US,0.015513897866839042,221,0,7,0,0,0,0,0,0,0,1,2023,10,16,0,0.08073634859349145,0.9773755656108597,0.0
23133086,CA,CA,2,1.0,0,0,0,0,2023-11-01,68.0,801.0,Male,75.0,VEDOLIZUMAB,colitis ulcerative,1,0,0.0,Senior,CA,0.057692307692307696,26,0,18,0,0,0,0,0,0,0,2,2023,11,1,2,0.08936301793444651,3.9230769230769234,0.0
23248120,US,US,2,1.0,0,0,0,0,2023-11-30,61.0,801.0,Female,72.575,RINVOQ,femur fracture,1,0,0.0,MidAge,US,0.0,3,0,14,0,0,0,0,0,0,0,2,2023,11,30,3,0.08936301793444651,0.0,0.0
23251346,US,US,1,1.0,0,0,0,0,2023-12-01,57.0,801.0,Male,75.0,ILUVIEN,glaucoma,1,0,0.0,MidAge,US,0.0,3,0,8,0,0,0,0,0,0,0,1,2023,12,1,4,0.08073634859349145,0.0,0.0
23279263,US,US,1,2.0,0,0,0,0,2023-12-09,37.0,801.0,Female,75.0,DUPIXENT,dry skin,0,0,0.0,Adult,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,2,2023,12,9,5,0.08073634859349145,0.5740142210730446,0.015513897866839042
15255440,GB,GB,1,1.0,0,0,1,1,2018-08-08,60.0,801.0,Female,97.0,HUMIRA,platelet count increased,1,5,0.35714285714285715,MidAge,GB,0.17857142857142858,2,1,24,0,0,0,0,0,0,0,3,2018,8,8,2,0.08073634859349145,10.714285714285715,0.17857142857142858
16386549,CA,CA,2,1.0,0,0,0,0,2019-06-04,44.0,801.0,Female,75.0,VEDOLIZUMAB,crohn^s disease,1,0,0.0,Adult,CA,0.057692307692307696,26,0,15,0,0,0,0,0,0,0,2,2019,6,4,1,0.08936301793444651,2.5384615384615388,0.057692307692307696
16643132,US,US,1,1.0,0,0,0,0,2019-07-29,80.0,801.0,Female,75.0,XELJANZ XR,hip arthroplasty,1,0,0.0,Senior,US,0.0,9,0,16,0,0,0,0,0,0,0,2,2019,7,29,0,0.08073634859349145,0.0,0.0
17472287,CA,Unknown,1,1.0,0,0,0,0,2020-02-28,39.0,801.0,Female,75.0,LEFLUNOMIDE,rheumatoid arthritis,1,0,0.0,Adult,CA,0.0,1,0,20,0,0,0,0,0,0,0,2,2020,2,28,4,0.08073634859349145,0.0,0.0
18323100,US,US,1,1.0,1,0,0,0,2020-09-28,57.0,801.0,Female,75.0,OXYCONTIN,death,1,5,0.35714285714285715,MidAge,US,0.35714285714285715,1,1,5,0,0,1,0,0,0,0,1,2020,9,28,0,0.08073634859349145,20.357142857142858,0.35714285714285715
18330267,JP,JP,1,2.0,0,0,0,0,2020-09-30,57.0,801.0,Male,75.0,OPSUMIT,haemoptysis,0,0,0.0,MidAge,JP,0.10714285714285714,2,0,11,0,0,0,0,0,0,0,1,2020,9,30,2,0.08073634859349145,6.107142857142857,0.0
18354634,BR,BR,2,1.0,0,0,0,0,2020-10-07,57.0,801.0,Female,75.0,VEDOLIZUMAB,thermal burn,1,0,0.0,MidAge,BR,0.057692307692307696,26,0,12,0,0,0,0,0,0,0,2,2020,10,7,2,0.08936301793444651,3.2884615384615388,0.057692307692307696
18599765,US,US,1,2.0,0,0,0,0,2020-12-10,56.0,801.0,Male,75.0,XELJANZ XR,drug effect less than expected,0,0,0.0,MidAge,US,0.0,9,0,30,0,0,0,0,0,0,0,5,2020,12,10,3,0.08073634859349145,0.0,0.0
18669615,TH,TH,1,1.0,0,0,1,0,2020-12-28,63.0,801.0,Male,75.0,MYCOPHENOLATE MOFETIL,burkholderia pseudomallei infection,1,3,0.21428571428571427,MidAge,Other,0.10150375939849625,19,0,35,0,1,0,0,0,0,0,3,2020,12,28,0,0.08073634859349145,6.394736842105264,0.0
26173413,TW,TW,1,1.0,0,0,0,0,2025-12-18,27.0,801.0,Female,75.0,TECENTRIQ,off label use,1,0,0.0,Young,Other,0.14285714285714285,3,1,13,0,0,0,0,0,0,0,3,2025,12,18,3,0.08073634859349145,3.8571428571428568,0.14285714285714285
26173561,US,US,1,2.0,0,0,0,0,2025-12-18,57.0,801.0,Female,64.989,DUPIXENT,injection site pain,0,0,0.0,MidAge,US,0.015513897866839042,221,0,19,1,0,0,0,0,0,0,3,2025,12,18,3,0.08073634859349145,0.8842921784098254,0.015513897866839042
26173642,US,US,1,1.0,0,0,0,0,2025-12-18,57.0,801.0,Female,75.0,SPRAVATO,heart rate decreased,1,0,0.0,MidAge,US,0.026785714285714284,8,0,20,0,0,0,0,0,0,0,3,2025,12,18,3,0.08073634859349145,1.5267857142857142,0.026785714285714284
26173938,US,US,1,2.0,0,0,0,0,2025-12-18,23.0,801.0,Male,75.0,DUPIXENT,injection site pruritus,0,0,0.0,Young,US,0.015513897866839042,221,0,23,0,0,0,0,0,0,0,3,2025,12,18,3,0.08073634859349145,0.35681965093729795,0.0
26175343,GB,GB,1,1.0,0,0,1,0,2025-12-18,57.0,801.0,Male,75.0,ELEXACAFTOR\IVACAFTOR\TEZACAFTOR,hospitalisation,1,3,0.21428571428571427,MidAge,GB,0.21428571428571427,2,1,15,0,0,0,0,0,0,0,1,2025,12,18,3,0.08073634859349145,12.214285714285714,0.0
26175600,CA,CA,1,1.0,0,0,0,0,2025-12-18,43.0,801.0,Female,96.0,ORENCIA,abdominal pain upper,1,0,0.0,Adult,CA,0.10204081632653061,14,0,20,1,0,0,0,0,0,0,3,2025,12,18,3,0.08073634859349145,4.387755102040816,0.10204081632653061
26175653,CA,CA,1,1.0,1,0,0,0,2025-12-18,43.0,801.0,Female,96.0,ORENCIA,death,1,5,0.35714285714285715,Adult,CA,0.10204081632653061,14,0,5,0,0,1,0,0,0,0,1,2025,12,18,3,0.08073634859349145,4.387755102040816,0.10204081632653061
26176005,CN,CN,1,1.0,0,0,0,0,2025-12-18,34.0,801.0,Female,75.0,CYCLOSPORINE,graft versus host disease,1,0,0.0,Young,CN,0.0,5,0,25,0,0,0,0,0,0,0,4,2025,12,18,3,0.08073634859349145,0.0,0.0
26176678,US,US,1,2.0,0,0,0,0,2025-12-18,57.0,801.0,Female,75.0,JOENJA,infection,0,0,0.0,MidAge,US,0.0,3,0,9,0,1,0,0,0,0,0,1,2025,12,18,3,0.08073634859349145,0.0,0.0
23590937,CA,CA,1,1.0,0,0,1,0,2024-03-04,68.0,801.0,Female,75.0,RITUXIMAB,drug ineffective,1,3,0.21428571428571427,Senior,CA,0.12406015037593986,19,0,16,0,0,0,0,0,0,0,2,2024,3,4,0,0.08073634859349145,8.43609022556391,0.12406015037593986
23597417,EU,EU,1,1.0,1,0,0,0,2024-03-05,57.0,801.0,Male,75.0,MYCOPHENOLATE MOFETIL,septic shock,1,5,0.35714285714285715,MidAge,EU,0.10150375939849625,19,0,12,0,0,0,0,0,0,0,2,2024,3,5,1,0.08073634859349145,5.7857142857142865,0.0
23629574,JP,JP,1,1.0,1,0,0,0,2024-03-14,57.0,801.0,Female,75.0,YERVOY,death,1,5,0.35714285714285715,MidAge,JP,0.35714285714285715,4,1,5,0,0,1,0,0,0,0,1,2024,3,14,3,0.08073634859349145,20.357142857142858,0.35714285714285715
23634057,EU,EU,1,1.0,0,0,1,0,2024-03-14,70.0,801.0,Female,63.0,PREDNISONE,confusional state,1,3,0.21428571428571427,Senior,EU,0.1607142857142857,8,1,17,0,0,0,0,0,0,0,2,2024,3,14,3,0.08073634859349145,11.249999999999998,0.1607142857142857
23653159,CA,CA,2,1.0,0,0,1,0,2024-03-20,57.0,801.0,Female,75.0,ADALIMUMAB-AATY,fatigue,1,3,0.21428571428571427,MidAge,CA,0.21428571428571427,1,1,7,0,0,0,0,0,0,0,1,2024,3,20,2,0.08936301793444651,12.214285714285714,0.21428571428571427
23713613,CA,CA,1,1.0,0,0,0,0,2024-04-05,52.0,801.0,Male,75.0,ESCITALOPRAM,neoplasm skin,1,0,0.0,MidAge,CA,0.25,2,1,13,0,0,0,0,0,0,0,2,2024,4,5,4,0.08073634859349145,13.0,0.0
23715529,US,US,2,1.0,0,0,1,0,2024-04-07,39.0,801.0,Female,88.45,SKYRIZI,nephrolithiasis,1,3,0.21428571428571427,Adult,US,0.051587301587301584,36,0,15,0,0,0,0,0,0,0,1,2024,4,7,6,0.08936301793444651,2.011904761904762,0.051587301587301584
23784594,US,US,1,2.0,0,0,0,0,2024-04-25,20.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Young,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2024,4,25,3,0.08073634859349145,0.3102779573367808,0.015513897866839042
23831144,CA,CA,3,1.0,0,0,0,0,2024-05-08,57.0,801.0,Female,75.0,GABAPENTIN,asthma,1,0,0.0,MidAge,CA,0.061224489795918366,7,0,6,0,0,0,0,0,0,0,1,2024,5,8,2,0.17857142857142855,3.489795918367347,0.061224489795918366
24007724,CA,CA,2,1.0,0,0,1,0,2024-06-25,31.0,801.0,Male,75.0,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,urinary bladder rupture,1,3,0.21428571428571427,Young,CA,0.07142857142857142,3,0,23,0,0,0,0,0,0,0,3,2024,6,25,1,0.08936301793444651,2.214285714285714,0.0
24096472,US,US,1,1.0,1,0,1,0,2024-07-16,76.0,801.0,Female,75.0,KEVZARA,death,1,8,0.5714285714285714,Senior,US,0.14285714285714285,4,1,5,0,0,1,0,0,0,0,1,2024,7,16,1,0.08073634859349145,10.857142857142856,0.14285714285714285
26178326,GB,GB,1,1.0,0,0,0,0,2025-12-19,69.0,801.0,Female,113.0,ALENDRONIC ACID,pain in jaw,1,0,0.0,Senior,GB,0.0,1,0,11,1,0,0,0,0,0,0,3,2025,12,19,4,0.08073634859349145,0.0,0.0
26178946,EU,EU,1,1.0,1,0,1,0,2025-12-19,57.0,801.0,Female,75.0,MELPHALAN,acute respiratory distress syndrome,1,8,0.5714285714285714,MidAge,EU,0.5714285714285714,1,1,35,0,0,0,0,0,0,0,4,2025,12,19,4,0.08073634859349145,32.57142857142857,0.5714285714285714
26179527,US,US,1,1.0,0,0,0,0,2025-12-19,32.0,801.0,Female,75.0,TACROLIMUS,drug ineffective for unapproved indication,1,0,0.0,Young,US,0.09183673469387754,7,0,42,0,0,0,0,0,0,0,5,2025,12,19,4,0.08073634859349145,2.9387755102040813,0.09183673469387754
26179851,US,US,1,2.0,0,0,0,0,2025-12-19,57.0,801.0,Female,38.77,DUPIXENT,injection site irritation,0,0,0.0,MidAge,US,0.015513897866839042,221,0,25,0,0,0,0,0,0,0,3,2025,12,19,4,0.08073634859349145,0.8842921784098254,0.015513897866839042
26181108,EU,EU,1,1.0,0,0,1,0,2025-12-21,57.0,801.0,Male,75.0,ALPRAZOLAM,drug use disorder,1,3,0.21428571428571427,MidAge,EU,0.14285714285714285,3,1,17,0,0,0,0,0,0,0,3,2025,12,21,6,0.08073634859349145,8.142857142857142,0.0
26181122,US,US,1,2.0,0,0,0,0,2025-12-21,75.0,801.0,Female,75.0,SUTAB,nausea,0,0,0.0,Senior,US,0.0,2,0,6,0,0,0,0,0,0,0,1,2025,12,21,6,0.08073634859349145,0.0,0.0
26183281,GB,GB,1,1.0,0,0,1,1,2025-12-21,18.0,801.0,Female,50.0,NAPROXEN,platelet dysfunction,1,5,0.35714285714285715,Child,GB,0.2857142857142857,2,1,20,0,0,0,0,0,0,0,2,2025,12,21,6,0.08073634859349145,5.142857142857142,0.2857142857142857
26183591,JP,JP,1,1.0,0,0,1,0,2025-12-21,47.0,801.0,Female,75.0,LENALIDOMIDE,condition aggravated,1,3,0.21428571428571427,Adult,JP,0.15413533834586465,19,1,20,0,0,0,0,0,0,0,2,2025,12,21,6,0.08073634859349145,7.244360902255639,0.15413533834586465
26048306,GB,GB,1,1.0,0,1,0,0,2025-11-14,21.0,801.0,Female,75.0,METRONIDAZOLE,haemolytic uraemic syndrome,1,4,0.2857142857142857,Young,GB,0.14285714285714285,2,1,27,0,0,0,0,0,0,0,3,2025,11,14,4,0.08073634859349145,3.0,0.14285714285714285
26049965,JP,JP,1,1.0,0,0,0,0,2025-11-15,5.0,802.0,Female,3.9,SUGAMMADEX SODIUM,anaphylactic reaction,1,0,0.0,Child,JP,0.0,1,0,21,0,0,0,0,0,0,0,2,2025,11,15,5,0.08073634859349145,0.0,0.0
26050264,US,US,1,2.0,0,0,0,0,2025-11-16,54.0,801.0,Female,75.0,TRULICITY,accidental overdose,0,0,0.0,MidAge,US,0.04285714285714286,5,0,19,0,0,0,0,0,0,0,2,2025,11,16,6,0.08073634859349145,2.3142857142857145,0.04285714285714286
26051384,US,US,2,2.0,0,0,0,0,2025-11-17,64.0,801.0,Female,75.0,OTEZLA,therapy interrupted,0,0,0.0,MidAge,US,0.0,4,0,19,0,0,0,0,0,0,0,2,2025,11,17,0,0.08936301793444651,0.0,0.0
26051465,EU,EU,1,1.0,0,0,1,0,2025-11-17,73.0,801.0,Female,75.0,OXALIPLATIN,neurotoxicity,1,3,0.21428571428571427,Senior,EU,0.08571428571428572,5,0,13,0,0,0,0,0,0,0,1,2025,11,17,0,0.08073634859349145,6.257142857142857,0.08571428571428572
26051599,US,US,1,2.0,0,0,0,0,2025-11-17,46.0,801.0,Male,75.0,DUPIXENT,nasal polyps,0,0,0.0,Adult,US,0.015513897866839042,221,0,12,0,0,0,0,0,0,0,2,2025,11,17,0,0.08073634859349145,0.7136393018745959,0.0
26052141,GB,GB,3,1.0,0,0,0,0,2025-11-17,49.0,801.0,Female,70.0,LEVETIRACETAM,dyspnoea,1,0,0.0,Adult,GB,0.05714285714285714,5,0,8,0,0,0,0,0,0,0,1,2025,11,17,0,0.17857142857142855,2.8,0.05714285714285714
26052437,US,US,1,1.0,0,1,1,0,2025-11-17,14.0,801.0,Male,75.0,AMLODIPINE,hypotension,1,7,0.5,Child,US,0.16964285714285715,8,1,11,0,0,0,0,0,0,0,1,2025,11,17,0,0.08073634859349145,2.375,0.0
26052532,EU,EU,1,1.0,0,0,1,0,2025-11-17,74.0,801.0,Male,82.0,PACLITAXEL,erythema,1,3,0.21428571428571427,Senior,EU,0.07142857142857142,3,0,8,0,0,0,0,0,0,0,1,2025,11,17,0,0.08073634859349145,5.285714285714286,0.0
26052585,GB,GB,1,1.0,0,0,0,1,2025-11-17,77.0,801.0,Male,75.0,AMLODIPINE,loose tooth,1,2,0.14285714285714285,Senior,GB,0.16964285714285715,8,1,11,0,0,0,0,0,0,0,2,2025,11,17,0,0.08073634859349145,13.0625,0.0
26052909,US,US,1,1.0,0,1,1,0,2025-11-17,71.0,801.0,Male,75.0,RISPERIDONE,rhabdomyolysis,1,7,0.5,Senior,US,0.125,4,1,14,0,0,0,0,0,0,0,1,2025,11,17,0,0.08073634859349145,8.875,0.0
24160409,CA,CA,2,1.0,0,0,1,0,2024-08-01,57.0,801.0,Female,75.0,RITUXIMAB-ABBS,rheumatoid arthritis,1,3,0.21428571428571427,MidAge,CA,0.10714285714285714,2,0,20,0,0,0,0,0,0,0,2,2024,8,1,3,0.08936301793444651,6.107142857142857,0.10714285714285714
24165026,JP,JP,2,1.0,1,0,1,0,2024-08-02,57.0,801.0,Male,74.2,HEMLIBRA,haemorrhage subcutaneous,1,8,0.5714285714285714,MidAge,JP,0.5714285714285714,1,1,24,0,0,0,0,0,0,0,2,2024,8,2,4,0.08936301793444651,32.57142857142857,0.0
24194792,US,US,1,1.0,0,0,0,0,2024-08-09,26.0,801.0,Female,75.0,XELJANZ,product dose omission in error,1,0,0.0,Young,US,0.0,3,0,30,0,0,0,0,0,0,0,5,2024,8,9,4,0.08073634859349145,0.0,0.0
24196736,CA,CA,1,1.0,0,0,0,0,2024-08-10,57.0,801.0,Female,75.0,INFLIXIMAB,large intestinal stenosis,1,0,0.0,MidAge,CA,0.07142857142857142,9,0,25,0,0,0,0,0,0,0,3,2024,8,10,5,0.08073634859349145,4.071428571428571,0.07142857142857142
24272890,CA,CA,2,1.0,0,0,1,0,2024-09-02,88.0,801.0,Male,75.0,SARILUMAB,pneumonia aspiration,1,3,0.21428571428571427,Senior,CA,0.21428571428571427,1,1,20,0,0,0,0,0,1,0,2,2024,9,2,0,0.08936301793444651,18.857142857142858,0.0
24403786,US,US,1,2.0,0,0,0,0,2024-10-07,57.0,801.0,Female,75.0,CEQUA,expired product administered,0,0,0.0,MidAge,US,0.0,1,0,28,0,0,0,0,0,0,0,3,2024,10,7,0,0.08073634859349145,0.0,0.0
24416841,EU,EU,2,1.0,0,1,1,0,2024-10-09,57.0,801.0,Female,75.0,VORASIDENIB,acute myocardial infarction,1,7,0.5,MidAge,EU,0.5,1,1,27,0,0,0,0,0,0,0,3,2024,10,9,2,0.08936301793444651,28.5,0.5
24468262,EU,EU,1,1.0,0,0,1,0,2024-10-18,77.0,801.0,Female,75.0,METFORMIN,lactic acidosis,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,2,1,15,0,0,0,0,0,0,0,2,2024,10,18,4,0.08073634859349145,16.5,0.21428571428571427
24580933,US,US,2,2.0,0,0,0,0,2024-11-05,34.0,801.0,Male,65.76,ADCETRIS,weight decreased,0,0,0.0,Young,US,0.0,2,0,16,0,0,0,0,0,0,0,2,2024,11,5,1,0.08936301793444651,0.0,0.0
24592435,US,US,1,1.0,0,1,0,0,2024-11-08,57.0,801.0,Female,75.0,PADCEV,stevens-johnson syndrome,1,4,0.2857142857142857,MidAge,US,0.2857142857142857,1,1,24,0,0,0,0,0,0,0,2,2024,11,8,4,0.08073634859349145,16.285714285714285,0.2857142857142857
24593717,US,US,2,1.0,0,0,0,0,2024-11-08,81.0,801.0,Male,99.773,VYNDAMAX,neuropathy peripheral,1,0,0.0,Senior,US,0.0,1,0,21,0,0,0,0,0,0,0,2,2024,11,8,4,0.08936301793444651,0.0,0.0
24653886,US,US,1,2.0,0,0,0,0,2024-11-22,57.0,801.0,Female,75.0,TRESIBA,cataract,0,0,0.0,MidAge,US,0.0,1,0,8,0,0,0,0,0,0,0,1,2024,11,22,4,0.08073634859349145,0.0,0.0
24680200,US,US,1,1.0,0,1,1,0,2024-11-29,69.0,801.0,Female,149.0,LUMASON,anaphylactic shock,1,7,0.5,Senior,US,0.25,2,1,18,0,0,0,0,0,0,0,2,2024,11,29,4,0.08073634859349145,17.25,0.25
24710857,JP,JP,1,1.0,0,0,1,0,2024-12-09,7.0,800.0,Male,75.0,TECENTRIQ,type 1 diabetes mellitus,1,3,0.21428571428571427,Child,JP,0.14285714285714285,3,1,24,0,0,0,0,0,0,0,4,2024,12,9,0,0.08073634859349145,1.0,0.0
24724775,US,US,1,2.0,0,0,0,0,2024-12-12,50.0,801.0,Male,75.0,DUPIXENT,pruritus,0,0,0.0,Adult,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2024,12,12,3,0.08073634859349145,0.7756948933419521,0.0
24741785,CA,CA,1,1.0,0,0,0,0,2024-12-17,57.0,801.0,Female,75.0,DICLOFENAC SODIUM,glossodynia,1,0,0.0,MidAge,CA,0.4047619047619048,3,1,11,0,0,0,0,0,0,0,1,2024,12,17,1,0.08073634859349145,23.071428571428577,0.4047619047619048
24750723,JP,JP,1,1.0,0,0,0,0,2024-12-18,80.0,801.0,Male,62.7,NUCALA,compression fracture,1,0,0.0,Senior,JP,0.0,2,0,20,0,0,0,0,0,0,0,2,2024,12,18,2,0.08073634859349145,0.0,0.0
24757647,US,Unknown,1,2.0,0,0,0,0,2024-12-20,64.0,801.0,Female,75.0,BIMZELX,abdominal pain upper,0,0,0.0,MidAge,US,0.0,22,0,20,1,0,0,0,0,0,0,3,2024,12,20,4,0.08073634859349145,0.0,0.0
24757661,US,Unknown,1,2.0,0,0,0,0,2024-12-20,34.0,801.0,Female,136.0,BIMZELX,arthralgia,0,0,0.0,Young,US,0.0,22,0,10,0,0,0,0,0,0,0,1,2024,12,20,4,0.08073634859349145,0.0,0.0
24757890,US,Unknown,1,2.0,0,0,0,0,2024-12-20,72.0,801.0,Female,63.492,BIMZELX,eating disorder,0,0,0.0,Senior,US,0.0,22,0,15,0,0,0,0,0,0,0,2,2024,12,20,4,0.08073634859349145,0.0,0.0
24758147,US,Unknown,1,2.0,0,0,0,0,2024-12-20,55.0,801.0,Female,75.0,BIMZELX,pain in extremity,0,0,0.0,MidAge,US,0.0,22,0,17,1,0,0,0,0,0,0,3,2024,12,20,4,0.08073634859349145,0.0,0.0
24758228,US,Unknown,1,2.0,0,0,0,0,2024-12-20,82.0,801.0,Female,75.0,BIMZELX,psoriasis,0,0,0.0,Senior,US,0.0,22,0,9,0,0,0,0,0,0,0,1,2024,12,20,4,0.08073634859349145,0.0,0.0
24758295,US,Unknown,1,2.0,0,0,0,0,2024-12-20,45.0,801.0,Female,75.0,BIMZELX,condition aggravated,0,0,0.0,Adult,US,0.0,22,0,20,0,0,0,0,0,0,0,2,2024,12,20,4,0.08073634859349145,0.0,0.0
24781880,CA,Unknown,2,1.0,0,0,0,0,2024-12-27,57.0,801.0,Female,75.0,CERTOLIZUMAB PEGOL,pneumonia,1,0,0.0,MidAge,CA,0.04285714285714286,5,0,9,0,0,0,0,0,1,0,1,2024,12,27,4,0.08936301793444651,2.442857142857143,0.04285714285714286
24790547,US,US,1,2.0,0,0,0,0,2024-12-30,69.0,801.0,Male,75.0,DUPIXENT,dyspnoea,0,0,0.0,Senior,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2024,12,30,0,0.08073634859349145,1.070458952811894,0.0
24808934,EU,EU,1,1.0,0,1,1,0,2025-01-06,80.0,801.0,Female,75.0,ESCITALOPRAM,anaphylactic reaction,1,7,0.5,Senior,EU,0.25,2,1,21,0,0,0,0,0,0,0,2,2025,1,6,0,0.08073634859349145,20.0,0.25
24821098,US,US,1,2.0,0,0,0,0,2025-01-08,14.0,801.0,Male,64.857,FABRAZYME,weight decreased,0,0,0.0,Child,US,0.0,1,0,16,0,0,0,0,0,0,0,2,2025,1,8,2,0.08073634859349145,0.0,0.0
24850205,GB,GB,2,1.0,0,0,0,0,2025-01-16,65.0,801.0,Male,75.0,VEDOLIZUMAB,lower respiratory tract infection,1,0,0.0,MidAge,GB,0.057692307692307696,26,0,33,0,1,0,0,0,0,0,4,2025,1,16,3,0.08936301793444651,3.75,0.0
24867025,CA,CA,2,1.0,0,0,1,0,2025-01-21,69.0,801.0,Female,75.0,VELTASSA,hospitalisation,1,3,0.21428571428571427,Senior,CA,0.2619047619047619,3,1,15,0,0,0,0,0,0,0,1,2025,1,21,1,0.08936301793444651,18.071428571428573,0.2619047619047619
24879228,US,US,1,2.0,0,0,0,0,2025-01-23,65.0,801.0,Female,75.0,DUPIXENT,asthma,0,0,0.0,MidAge,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,1,23,3,0.08073634859349145,1.0084033613445378,0.015513897866839042
24880376,EU,EU,2,1.0,0,0,0,0,2025-01-23,58.0,801.0,Male,75.0,FOSCARBIDOPA\FOSLEVODOPA,suicidal ideation,1,0,0.0,MidAge,EU,0.0,1,0,17,0,0,0,0,0,0,0,2,2025,1,23,3,0.08936301793444651,0.0,0.0
24891163,US,US,1,2.0,0,0,0,0,2025-01-27,27.0,801.0,Female,75.0,DUPIXENT,sleep disorder due to a general medical condition,0,0,0.0,Young,US,0.015513897866839042,221,0,49,0,0,0,0,0,0,0,8,2025,1,27,0,0.08073634859349145,0.4188752424046541,0.015513897866839042
24953586,CA,CA,1,1.0,1,0,0,0,2025-02-11,97.0,801.0,Female,97.0,RITUXIMAB,abdominal discomfort,1,5,0.35714285714285715,Senior,CA,0.12406015037593986,19,0,20,0,0,0,0,0,0,0,2,2025,2,11,1,0.08073634859349145,12.033834586466167,0.12406015037593986
24971610,US,US,2,1.0,0,0,1,0,2025-02-14,57.0,801.0,Female,75.0,MAVENCLAD,bladder mass,1,3,0.21428571428571427,MidAge,US,0.21428571428571427,1,1,12,0,0,0,0,0,0,0,2,2025,2,14,4,0.08936301793444651,12.214285714285714,0.21428571428571427
24983394,EU,EU,2,1.0,0,0,1,0,2025-02-19,75.0,801.0,Male,70.0,CARBIDOPA\LEVODOPA,influenza,1,3,0.21428571428571427,Senior,EU,0.3333333333333333,3,1,9,0,0,0,0,0,0,0,1,2025,2,19,2,0.08936301793444651,25.0,0.0
26185292,US,US,1,1.0,0,0,1,0,2025-12-22,35.0,801.0,Female,75.0,AMPICILLIN AND SULBACTAM,septic cardiomyopathy,1,3,0.21428571428571427,Young,US,0.21428571428571427,1,1,21,0,0,0,0,0,0,0,2,2025,12,22,0,0.08073634859349145,7.5,0.21428571428571427
26187627,CA,CA,2,1.0,0,0,0,0,2025-12-22,66.0,801.0,Female,75.0,ROSUVASTATIN,throat cancer,1,0,0.0,Senior,CA,0.0,2,0,13,0,0,0,1,0,0,0,2,2025,12,22,0,0.08936301793444651,0.0,0.0
26187775,US,US,1,1.0,0,0,0,0,2025-12-22,70.0,801.0,Female,75.0,WEGOVY,skin neoplasm excision,1,0,0.0,Senior,US,0.14285714285714285,4,1,22,0,0,0,0,0,0,0,3,2025,12,22,0,0.08073634859349145,10.0,0.14285714285714285
26188141,EU,EU,1,1.0,0,0,0,0,2025-12-22,45.0,801.0,Male,75.0,ADALIMUMAB,enterocolitis,1,0,0.0,Adult,EU,0.07142857142857142,3,0,13,0,0,0,0,0,0,0,1,2025,12,22,0,0.08073634859349145,3.214285714285714,0.0
26188747,US,US,1,1.0,0,0,1,0,2025-12-22,57.0,801.0,Female,75.0,RITUXIMAB,infection,1,3,0.21428571428571427,MidAge,US,0.12406015037593986,19,0,9,0,1,0,0,0,0,0,1,2025,12,22,0,0.08073634859349145,7.071428571428572,0.12406015037593986
21662498,US,US,2,1.0,0,0,0,0,2022-11-30,63.0,801.0,Male,149.69,BOSULIF,suicidal ideation,1,0,0.0,MidAge,US,0.0,1,0,17,0,0,0,0,0,0,0,2,2022,11,30,2,0.08936301793444651,0.0,0.0
21719011,CA,CA,2,1.0,0,0,0,0,2022-12-13,40.0,801.0,Female,75.0,HUMAN IMMUNOGLOBULIN G,haemorrhage,1,0,0.0,Adult,CA,0.10714285714285714,8,0,11,0,0,0,0,0,0,0,1,2022,12,13,1,0.08936301793444651,4.285714285714286,0.10714285714285714
21723304,JP,JP,1,1.0,0,0,1,1,2022-12-13,75.0,801.0,Female,75.0,YERVOY,coagulation factor deficiency,1,5,0.35714285714285715,Senior,JP,0.35714285714285715,4,1,29,0,0,0,0,0,0,0,3,2022,12,13,1,0.08073634859349145,26.785714285714285,0.35714285714285715
22056267,US,US,1,1.0,1,0,1,0,2023-03-02,67.0,801.0,Female,75.0,PRIVIGEN,death,1,8,0.5714285714285714,Senior,US,0.39285714285714285,2,1,5,0,0,1,0,0,0,0,1,2023,3,2,3,0.08073634859349145,26.32142857142857,0.39285714285714285
22314833,US,US,1,1.0,0,0,0,0,2023-05-12,57.0,801.0,Female,75.0,TRIKAFTA,hunger,1,0,0.0,MidAge,US,0.0,1,0,6,0,0,0,0,0,0,0,1,2023,5,12,4,0.08073634859349145,0.0,0.0
22667236,CA,CA,2,1.0,0,0,0,0,2023-07-04,57.0,801.0,Female,75.0,RITUXIMAB-ABBS,covid-19,1,0,0.0,MidAge,CA,0.10714285714285714,2,0,8,0,0,0,0,0,0,0,1,2023,7,4,1,0.08936301793444651,6.107142857142857,0.10714285714285714
22757375,US,US,2,2.0,0,0,0,0,2023-07-27,70.0,801.0,Female,75.0,XELJANZ XR,movement disorder,0,0,0.0,Senior,US,0.0,9,0,17,0,0,0,0,0,0,0,2,2023,7,27,3,0.08936301793444651,0.0,0.0
22812740,EU,EU,1,1.0,0,0,0,0,2023-08-11,55.0,801.0,Female,52.0,CIPROFLOXACIN,hallucination,1,0,0.0,MidAge,EU,0.07142857142857142,3,0,13,0,0,0,0,0,0,0,1,2023,8,11,4,0.08073634859349145,3.9285714285714284,0.07142857142857142
26054705,CO,CO,2,1.0,0,0,1,0,2025-11-17,35.0,801.0,Male,62.0,INVEGA SUSTENNA,rhabdomyolysis,1,3,0.21428571428571427,Young,Other,0.21428571428571427,1,1,14,0,0,0,0,0,0,0,1,2025,11,17,0,0.08936301793444651,7.5,0.0
26056244,US,US,2,1.0,0,0,0,0,2025-11-18,43.0,801.0,Male,75.0,SPRAVATO,hypertension,1,0,0.0,Adult,US,0.026785714285714284,8,0,12,0,0,0,0,0,0,0,1,2025,11,18,1,0.08936301793444651,1.1517857142857142,0.0
26056769,US,US,1,1.0,0,0,1,0,2025-11-18,17.0,801.0,Female,52.154,ISOTRETINOIN,suicide attempt,1,3,0.21428571428571427,Child,US,0.023809523809523808,9,0,15,0,0,0,0,0,0,0,2,2025,11,18,1,0.08073634859349145,0.40476190476190477,0.023809523809523808
26191705,EU,EU,1,1.0,0,0,1,0,2025-12-23,79.0,801.0,Female,75.0,DAPTOMYCIN,leukopenia,1,3,0.21428571428571427,Senior,EU,0.16666666666666666,3,1,10,0,0,0,0,0,0,0,1,2025,12,23,1,0.08073634859349145,13.166666666666666,0.16666666666666666
26192258,US,US,1,2.0,0,0,0,0,2025-12-23,85.0,801.0,Female,75.0,DUPIXENT,dermatitis,0,0,0.0,Senior,US,0.015513897866839042,221,0,10,0,0,0,0,0,0,0,1,2025,12,23,1,0.08073634859349145,1.3186813186813187,0.015513897866839042
26192568,US,US,1,2.0,0,0,0,0,2025-12-23,34.0,801.0,Female,75.0,DUPIXENT,allergy to animal,0,0,0.0,Young,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,3,2025,12,23,1,0.08073634859349145,0.5274725274725274,0.015513897866839042
26057889,EU,EU,1,1.0,0,0,1,0,2025-11-18,33.0,801.0,Female,75.0,PREDNISONE,salpingitis,1,3,0.21428571428571427,Young,EU,0.1607142857142857,8,1,11,0,0,0,0,0,0,0,1,2025,11,18,1,0.08073634859349145,5.303571428571428,0.1607142857142857
26058646,EU,EU,2,1.0,0,0,0,0,2025-11-18,68.0,801.0,Male,75.0,OXALIPLATIN,type ii hypersensitivity,1,0,0.0,Senior,EU,0.08571428571428572,5,0,24,0,0,0,0,0,0,0,3,2025,11,18,1,0.08936301793444651,5.828571428571428,0.0
26058699,GB,GB,1,1.0,0,0,0,0,2025-11-18,57.0,801.0,Female,75.0,CISPLATIN,lower limb fracture,1,0,0.0,MidAge,GB,0.10714285714285714,2,0,19,0,0,0,0,0,0,0,3,2025,11,18,1,0.08073634859349145,6.107142857142857,0.10714285714285714
26058727,US,US,1,2.0,0,0,0,0,2025-11-18,57.0,801.0,Female,75.0,SYNTHROID,muscular weakness,0,0,0.0,MidAge,US,0.17857142857142858,2,1,17,0,0,0,0,0,0,0,2,2025,11,18,1,0.08073634859349145,10.178571428571429,0.17857142857142858
26058875,EU,EU,1,1.0,0,0,1,0,2025-11-18,58.0,801.0,Female,75.0,LEVOFLOXACIN,gastrointestinal disorder,1,3,0.21428571428571427,MidAge,EU,0.25,4,1,25,0,0,0,0,0,0,0,2,2025,11,18,1,0.08073634859349145,14.5,0.25
26059146,US,US,1,2.0,0,0,0,0,2025-11-18,57.0,801.0,Female,75.0,BELBUCA,product solubility abnormal,0,0,0.0,MidAge,US,0.0,1,0,27,0,0,0,0,0,0,0,3,2025,11,18,1,0.08073634859349145,0.0,0.0
26060780,CN,CN,1,1.0,0,0,0,0,2025-11-18,11.0,801.0,Male,75.0,CYCLOSPORINE,skin graft rejection,1,0,0.0,Child,CN,0.0,5,0,20,0,0,0,0,0,0,0,3,2025,11,18,1,0.08073634859349145,0.0,0.0
25016202,US,US,2,1.0,0,0,0,0,2025-02-27,25.0,801.0,Male,75.0,SKYRIZI,ileectomy,1,0,0.0,Young,US,0.051587301587301584,36,0,9,0,0,0,0,0,0,0,1,2025,2,27,3,0.08936301793444651,1.2896825396825395,0.0
25044362,JP,JP,1,1.0,0,0,0,0,2025-03-06,6.0,800.0,Male,75.0,LUTATHERA,peptic ulcer,1,0,0.0,Child,JP,0.0,1,0,12,0,0,0,0,0,0,0,2,2025,3,6,3,0.08073634859349145,0.0,0.0
25052071,US,US,1,2.0,0,0,0,0,2025-03-07,57.0,801.0,Female,75.0,OPZELURA,intentional product use issue,0,0,0.0,MidAge,US,0.0,2,0,29,0,0,0,0,0,0,0,4,2025,3,7,4,0.08073634859349145,0.0,0.0
25056431,US,US,2,1.0,0,0,1,0,2025-03-10,40.0,801.0,Female,75.0,XYWAV,hospitalisation,1,3,0.21428571428571427,Adult,US,0.04285714285714286,5,0,15,0,0,0,0,0,0,0,1,2025,3,10,0,0.08936301793444651,1.7142857142857144,0.04285714285714286
25098428,US,US,1,2.0,0,0,0,0,2025-03-20,73.0,801.0,Female,59.42,POMALYST,eye irritation,0,0,0.0,Senior,US,0.11428571428571428,5,0,14,0,0,0,0,0,0,0,2,2025,3,20,3,0.08073634859349145,8.342857142857143,0.11428571428571428
25112740,US,Unknown,1,2.0,0,0,0,0,2025-03-24,57.0,801.0,Female,75.0,BIMZELX,fatigue,0,0,0.0,MidAge,US,0.0,22,0,7,0,0,0,0,0,0,0,1,2025,3,24,0,0.08073634859349145,0.0,0.0
25119921,US,US,1,1.0,0,0,1,0,2025-03-25,77.0,801.0,Female,75.0,DUPIXENT,hospitalisation,1,3,0.21428571428571427,Senior,US,0.015513897866839042,221,0,15,0,0,0,0,0,0,0,1,2025,3,25,1,0.08073634859349145,1.1945701357466063,0.015513897866839042
26061833,US,US,2,1.0,0,0,0,0,2025-11-18,51.0,801.0,Female,109.0,SKYRIZI,cholecystectomy,1,0,0.0,MidAge,US,0.051587301587301584,36,0,15,0,0,0,0,0,0,0,1,2025,11,18,1,0.08936301793444651,2.630952380952381,0.051587301587301584
26061886,US,US,2,1.0,0,0,1,0,2025-11-19,64.0,801.0,Male,83.0,SKYRIZI,knee operation,1,3,0.21428571428571427,MidAge,US,0.051587301587301584,36,0,14,0,0,0,0,0,0,0,2,2025,11,19,2,0.08936301793444651,3.3015873015873014,0.0
26061967,US,US,1,2.0,0,0,0,0,2025-11-19,27.0,801.0,Female,75.0,DUPIXENT,eczema,0,0,0.0,Young,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,11,19,2,0.08073634859349145,0.4188752424046541,0.015513897866839042
26064425,US,US,1,2.0,0,0,0,0,2025-11-19,20.0,801.0,Female,75.0,DUPIXENT,influenza,0,0,0.0,Young,US,0.015513897866839042,221,0,9,0,0,0,0,0,0,0,1,2025,11,19,2,0.08073634859349145,0.3102779573367808,0.015513897866839042
26065059,EU,EU,1,1.0,0,1,1,0,2025-11-19,63.0,801.0,Male,75.0,PREDNISOLONE,drug ineffective,1,7,0.5,MidAge,EU,0.35714285714285715,2,1,16,0,0,0,0,0,0,0,2,2025,11,19,2,0.08073634859349145,22.5,0.0
26194311,US,US,1,1.0,0,0,0,0,2025-12-24,62.0,801.0,Female,75.0,TEMOZOLOMIDE,neoplasm progression,1,0,0.0,MidAge,US,0.0,1,0,20,0,0,0,0,0,0,0,2,2025,12,24,2,0.08073634859349145,0.0,0.0
26195875,US,US,3,1.0,1,0,1,0,2025-12-24,57.0,801.0,Female,75.0,CLOZAPINE,toxicity to various agents,1,8,0.5714285714285714,MidAge,US,0.23214285714285715,4,1,26,0,0,0,0,0,0,0,4,2025,12,24,2,0.17857142857142855,13.232142857142858,0.23214285714285715
26196766,US,US,1,2.0,0,0,0,0,2025-12-24,57.0,801.0,Female,75.0,OMEPRAZOLE,product storage error,0,0,0.0,MidAge,US,0.07142857142857142,3,0,21,0,0,0,0,0,0,0,3,2025,12,24,2,0.08073634859349145,4.071428571428571,0.07142857142857142
26197185,JP,JP,1,1.0,0,0,0,0,2025-12-24,57.0,801.0,Male,75.0,VONOPRAZAN FUMARATE,gastric haemorrhage,1,0,0.0,MidAge,JP,0.0,1,0,19,0,0,0,0,0,0,0,2,2025,12,24,2,0.08073634859349145,0.0,0.0
26197590,US,US,1,2.0,0,0,0,0,2025-12-24,69.0,801.0,Male,75.0,DUPIXENT,incorrect dose administered,0,0,0.0,Senior,US,0.015513897866839042,221,0,27,0,0,0,0,0,0,0,3,2025,12,24,2,0.08073634859349145,1.070458952811894,0.0
26066179,NZ,NZ,1,1.0,0,0,0,0,2025-11-19,32.0,801.0,Female,75.0,CLOZARIL,faecaloma,1,0,0.0,Young,Other,0.10714285714285714,4,0,9,0,0,0,0,0,0,0,1,2025,11,19,2,0.08073634859349145,3.4285714285714284,0.10714285714285714
26067246,US,US,1,2.0,0,0,0,0,2025-11-20,22.0,801.0,Male,75.0,DUPIXENT,pruritus,0,0,0.0,Young,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,11,20,3,0.08073634859349145,0.3413057530704589,0.0
26067299,US,US,1,1.0,0,0,0,0,2025-11-20,9.0,801.0,Female,75.0,COSENTYX,crohn^s disease,1,0,0.0,Child,US,0.05714285714285714,10,0,15,0,0,0,0,0,0,0,2,2025,11,20,3,0.08073634859349145,0.5142857142857142,0.05714285714285714
26067718,US,US,2,1.0,0,0,0,0,2025-11-20,35.0,801.0,Male,75.0,CREON,pulmonary embolism,1,0,0.0,Young,US,0.03296703296703297,13,0,18,0,0,0,0,0,0,0,2,2025,11,20,3,0.08936301793444651,1.153846153846154,0.0
26069514,AU,AU,1,1.0,0,0,0,0,2025-11-20,16.0,801.0,Male,75.0,ISOTRETINOIN,granuloma skin,1,0,0.0,Child,AU,0.023809523809523808,9,0,14,0,0,0,0,0,0,0,2,2025,11,20,3,0.08073634859349145,0.38095238095238093,0.0
22985228,CA,CA,2,1.0,0,0,0,0,2023-09-26,28.0,801.0,Female,75.0,VEDOLIZUMAB,crohn^s disease,1,0,0.0,Young,CA,0.057692307692307696,26,0,15,0,0,0,0,0,0,0,2,2023,9,26,1,0.08936301793444651,1.6153846153846154,0.057692307692307696
23013810,US,US,1,1.0,0,1,1,0,2023-10-01,28.0,801.0,Male,75.0,OLANZAPINE,gastric hypomotility,1,7,0.5,Young,US,0.11904761904761905,6,0,20,0,0,0,0,0,0,0,2,2023,10,1,6,0.08073634859349145,3.3333333333333335,0.0
23086087,US,US,2,1.0,0,0,0,0,2023-10-19,57.0,801.0,Female,75.0,XYWAV,suicidal ideation,1,0,0.0,MidAge,US,0.04285714285714286,5,0,17,0,0,0,0,0,0,0,2,2023,10,19,3,0.08936301793444651,2.442857142857143,0.04285714285714286
23156733,EU,EU,1,1.0,0,0,0,0,2023-11-07,57.0,801.0,Female,75.0,LAMOTRIGINE,epilepsy,1,0,0.0,MidAge,EU,0.10714285714285714,2,0,8,0,0,0,0,0,0,0,1,2023,11,7,1,0.08073634859349145,6.107142857142857,0.10714285714285714
23202001,US,US,1,2.0,0,0,0,0,2023-11-20,59.0,801.0,Male,75.0,DUPIXENT,dry skin,0,0,0.0,MidAge,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,2,2023,11,20,0,0.08073634859349145,0.9153199741435035,0.0
23226999,US,US,2,1.0,0,0,0,0,2023-11-24,57.0,801.0,Female,91.0,HUMAN IMMUNOGLOBULIN G,pneumonia,1,0,0.0,MidAge,US,0.10714285714285714,8,0,9,0,0,0,0,0,1,0,1,2023,11,24,4,0.08936301793444651,6.107142857142857,0.10714285714285714
23258011,CA,CA,2,1.0,0,0,0,0,2023-12-04,68.0,801.0,Male,75.0,DUPILUMAB,dermatitis exfoliative generalised,1,0,0.0,Senior,CA,0.04285714285714286,5,0,34,0,0,0,0,0,0,0,3,2023,12,4,0,0.08936301793444651,2.914285714285714,0.0
23353482,US,US,1,2.0,0,0,0,0,2023-12-31,57.0,801.0,Female,75.0,DARZALEX FASPRO,product complaint,0,0,0.0,MidAge,US,0.0,1,0,17,0,0,0,0,0,0,0,2,2023,12,31,6,0.08073634859349145,0.0,0.0
23411869,US,US,1,1.0,0,0,0,0,2024-01-17,57.0,801.0,Female,75.0,XCOPRI,loss of consciousness,1,0,0.0,MidAge,US,0.0,1,0,21,0,0,0,0,0,0,0,3,2024,1,17,2,0.08073634859349145,0.0,0.0
23483149,US,US,1,2.0,0,0,0,0,2024-02-05,72.0,801.0,Female,51.71,IBRANCE,hypoacusis,0,0,0.0,Senior,US,0.07142857142857142,3,0,10,0,0,0,0,0,0,0,1,2024,2,5,0,0.08073634859349145,5.142857142857142,0.07142857142857142
23560046,CA,CA,2,1.0,0,0,0,0,2024-02-23,57.0,801.0,Female,75.0,KESIMPTA,colitis,1,0,0.0,MidAge,CA,0.0,2,0,7,0,0,0,0,0,0,0,1,2024,2,23,4,0.08936301793444651,0.0,0.0
23647903,US,US,1,1.0,0,0,1,0,2024-03-19,79.0,801.0,Female,75.0,DUPIXENT,hip fracture,1,3,0.21428571428571427,Senior,US,0.015513897866839042,221,0,12,0,0,0,0,0,0,0,2,2024,3,19,1,0.08073634859349145,1.2255979314802843,0.015513897866839042
23661525,US,US,1,1.0,0,0,0,0,2024-03-22,64.0,801.0,Male,75.0,XTANDI,malignant neoplasm progression,1,0,0.0,MidAge,US,0.0,1,0,30,0,0,0,0,0,0,0,3,2024,3,22,4,0.08073634859349145,0.0,0.0
23672594,CA,CA,1,1.0,0,0,1,0,2024-03-26,78.0,801.0,Female,93.0,ACETAMINOPHEN,abdominal pain upper,1,3,0.21428571428571427,Senior,CA,0.10267857142857142,16,0,20,1,0,0,0,0,0,0,3,2024,3,26,1,0.08073634859349145,8.008928571428571,0.10267857142857142
25151916,US,US,1,1.0,0,0,1,0,2025-04-02,57.0,801.0,Male,75.0,ACETAMINOPHEN,overdose,1,3,0.21428571428571427,MidAge,US,0.10267857142857142,16,0,8,0,0,0,0,0,0,0,1,2025,4,2,2,0.08073634859349145,5.852678571428571,0.0
25161731,US,US,2,1.0,0,0,0,0,2025-04-04,17.0,801.0,Female,54.43,COSENTYX,leukoplakia oral,1,0,0.0,Child,US,0.05714285714285714,10,0,16,0,0,0,0,0,0,0,2,2025,4,4,4,0.08936301793444651,0.9714285714285714,0.05714285714285714
25174177,US,US,1,2.0,0,0,0,0,2025-04-08,68.0,801.0,Male,75.0,DUPIXENT,dyspnoea,0,0,0.0,Senior,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,4,8,1,0.08073634859349145,1.0549450549450547,0.0
25179118,US,US,1,2.0,0,0,0,0,2025-04-09,23.0,801.0,Female,75.0,DUPIXENT,rash erythematous,0,0,0.0,Young,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,4,9,2,0.08073634859349145,0.35681965093729795,0.015513897866839042
25184693,US,US,1,2.0,0,0,0,0,2025-04-10,57.0,801.0,Male,75.0,DUPIXENT,abdominal pain,0,0,0.0,MidAge,US,0.015513897866839042,221,0,14,1,0,0,0,0,0,0,2,2025,4,10,3,0.08073634859349145,0.8842921784098254,0.0
25206524,US,US,1,1.0,0,0,0,0,2025-04-17,56.0,801.0,Male,75.0,REVLIMID,gait disturbance,1,0,0.0,MidAge,US,0.05357142857142857,4,0,16,0,0,0,0,0,0,0,2,2025,4,17,3,0.08073634859349145,3.0,0.0
25221495,US,US,1,1.0,0,0,1,0,2025-04-21,54.0,801.0,Female,50.794,DUPIXENT,pneumonia,1,3,0.21428571428571427,MidAge,US,0.015513897866839042,221,0,9,0,0,0,0,0,1,0,1,2025,4,21,0,0.08073634859349145,0.8377504848093082,0.015513897866839042
26198104,CN,CN,1,1.0,0,0,0,0,2025-12-24,30.0,801.0,Female,56.0,TOBRAMYCIN,conjunctival oedema,1,0,0.0,Young,CN,0.0,1,0,19,0,0,0,0,0,0,0,2,2025,12,24,2,0.08073634859349145,0.0,0.0
26198858,US,US,1,2.0,0,0,0,0,2025-12-25,57.0,801.0,Female,75.0,BUPROPION HYDROCHLORIDE,product odour abnormal,0,0,0.0,MidAge,US,0.0,1,0,22,0,0,0,0,0,0,0,3,2025,12,25,3,0.08073634859349145,0.0,0.0
26199048,US,US,1,1.0,0,0,1,0,2025-12-25,31.0,801.0,Female,75.0,MYCOPHENOLATE MOFETIL,toxicity to various agents,1,3,0.21428571428571427,Young,US,0.10150375939849625,19,0,26,0,0,0,0,0,0,0,4,2025,12,25,3,0.08073634859349145,3.1466165413533838,0.10150375939849625
26199224,GB,GB,1,1.0,0,0,1,0,2025-12-25,57.0,801.0,Male,75.0,GABAPENTIN,gastritis,1,3,0.21428571428571427,MidAge,GB,0.061224489795918366,7,0,9,0,0,0,0,0,0,0,1,2025,12,25,3,0.08073634859349145,3.489795918367347,0.0
26199305,US,US,1,1.0,0,0,1,0,2025-12-25,81.0,801.0,Male,79.55,DUPIXENT,respiration abnormal,1,3,0.21428571428571427,Senior,US,0.015513897866839042,221,0,20,0,0,0,0,0,0,0,2,2025,12,25,3,0.08073634859349145,1.2566257272139625,0.0
26199587,US,US,1,2.0,0,0,0,0,2025-12-25,54.0,801.0,Female,75.0,DUPIXENT,headache,0,0,0.0,MidAge,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,12,25,3,0.08073634859349145,0.8377504848093082,0.015513897866839042
26200009,CN,CN,1,1.0,0,0,0,0,2025-12-25,55.0,801.0,Female,75.0,XGEVA,white blood cell count decreased,1,0,0.0,MidAge,CN,0.10714285714285714,2,0,32,0,0,0,0,0,0,0,5,2025,12,25,3,0.08073634859349145,5.892857142857142,0.10714285714285714
26201048,EU,EU,1,1.0,0,0,0,0,2025-12-26,57.0,801.0,Female,75.0,ADALIMUMAB,enterocolitis,1,0,0.0,MidAge,EU,0.07142857142857142,3,0,13,0,0,0,0,0,0,0,1,2025,12,26,4,0.08073634859349145,4.071428571428571,0.07142857142857142
26201358,US,US,1,1.0,0,0,1,0,2025-12-26,57.0,801.0,Female,75.0,RITUXIMAB,upper respiratory tract infection,1,3,0.21428571428571427,MidAge,US,0.12406015037593986,19,0,33,0,1,0,0,0,0,0,4,2025,12,26,4,0.08073634859349145,7.071428571428572,0.12406015037593986
23936034,US,Unknown,2,1.0,0,0,0,0,2024-06-04,12.0,801.0,Female,114.0,FENFLURAMINE,seizure,1,0,0.0,Child,US,0.0,1,0,7,0,0,0,0,0,0,0,1,2024,6,4,1,0.08936301793444651,0.0,0.0
24010568,CA,CA,2,1.0,0,0,0,0,2024-06-25,49.0,801.0,Female,75.0,RITUXIMAB,bronchitis,1,0,0.0,Adult,CA,0.12406015037593986,19,0,10,0,0,0,0,0,0,0,1,2024,6,25,1,0.08936301793444651,6.078947368421053,0.12406015037593986
24090663,JP,JP,2,1.0,0,0,0,0,2024-07-15,4.0,801.0,Female,16.4,FENFLURAMINE HYDROCHLORIDE,epilepsy,1,0,0.0,Child,JP,0.0,1,0,8,0,0,0,0,0,0,0,1,2024,7,15,0,0.08936301793444651,0.0,0.0
24173931,US,US,1,1.0,0,0,1,0,2024-08-05,57.0,801.0,Male,75.0,IDELVION,wrist surgery,1,3,0.21428571428571427,MidAge,US,0.10714285714285714,2,0,13,0,0,0,0,0,0,0,2,2024,8,5,0,0.08073634859349145,6.107142857142857,0.0
24201351,US,US,1,2.0,0,0,0,0,2024-08-12,67.0,801.0,Male,75.0,KEVZARA,gait disturbance,0,0,0.0,Senior,US,0.14285714285714285,4,1,16,0,0,0,0,0,0,0,2,2024,8,12,0,0.08073634859349145,9.571428571428571,0.0
24249490,US,US,1,2.0,0,0,0,0,2024-08-26,71.0,801.0,Male,75.0,DUPIXENT,rash macular,0,0,0.0,Senior,US,0.015513897866839042,221,0,12,0,0,0,0,0,0,0,2,2024,8,26,0,0.08073634859349145,1.101486748545572,0.0
25249130,US,US,1,1.0,0,0,0,0,2025-04-29,57.0,801.0,Female,63.492,PARAGARD T 380A,surgery,1,0,0.0,MidAge,US,0.0,4,0,7,0,0,0,0,0,0,0,1,2025,4,29,1,0.08073634859349145,0.0,0.0
25254839,US,US,3,2.0,0,0,0,0,2025-04-30,57.0,801.0,Male,75.0,FILSPARI,influenza,0,0,0.0,MidAge,US,0.0,4,0,9,0,0,0,0,0,0,0,1,2025,4,30,2,0.17857142857142855,0.0,0.0
25261914,US,US,1,1.0,0,0,0,0,2025-05-02,28.0,801.0,Male,75.0,VIREAD,osteonecrosis,1,0,0.0,Young,US,0.0,1,0,13,0,0,0,0,0,0,0,1,2025,5,2,4,0.08073634859349145,0.0,0.0
25265288,US,US,2,1.0,0,0,0,0,2025-05-02,57.0,801.0,Female,75.0,XYWAV,surgery,1,0,0.0,MidAge,US,0.04285714285714286,5,0,7,0,0,0,0,0,0,0,1,2025,5,2,4,0.08936301793444651,2.442857142857143,0.04285714285714286
25265545,AU,AU,2,1.0,0,0,0,1,2025-05-02,66.0,801.0,Female,75.0,LENVIMA,palmar-plantar erythrodysaesthesia syndrome,1,2,0.14285714285714285,Senior,AU,0.07142857142857142,2,0,43,0,0,0,0,0,0,0,3,2025,5,2,4,0.08936301793444651,4.714285714285714,0.07142857142857142
25286267,CA,CA,2,1.0,0,0,0,0,2025-05-09,29.0,801.0,Female,75.0,SKYRIZI,obstruction,1,0,0.0,Young,CA,0.051587301587301584,36,0,11,0,0,0,0,0,0,0,1,2025,5,9,4,0.08936301793444651,1.496031746031746,0.051587301587301584
25303791,US,US,1,1.0,0,0,0,0,2025-05-13,43.0,801.0,Male,75.0,OCREVUS,headache,1,0,0.0,Adult,US,0.0,3,0,8,0,0,0,0,0,0,0,1,2025,5,13,1,0.08073634859349145,0.0,0.0
25306101,EU,EU,1,1.0,0,0,1,0,2025-05-13,17.0,801.0,Female,57.0,PRIVIGEN,"hallucination, visual",1,3,0.21428571428571427,Child,EU,0.39285714285714285,2,1,21,0,0,0,0,0,0,0,2,2025,5,13,1,0.08073634859349145,6.678571428571429,0.39285714285714285
26205112,US,US,1,1.0,0,0,0,0,2025-12-28,57.0,801.0,Female,75.0,ESTRADIOL,circumstance or information capable of leading to medication error,1,0,0.0,MidAge,US,0.0,8,0,66,0,0,0,0,0,0,0,9,2025,12,28,6,0.08073634859349145,0.0,0.0
26205165,CA,CA,2,1.0,0,0,0,0,2025-12-28,46.0,801.0,Female,75.0,REMICADE,breast conserving surgery,1,0,0.0,Adult,CA,0.0,3,0,25,0,0,0,0,0,0,0,3,2025,12,28,6,0.08936301793444651,0.0,0.0
25385478,JP,JP,1,1.0,1,0,0,0,2025-06-02,70.0,801.0,Male,75.0,KEYTRUDA,myocarditis,1,5,0.35714285714285715,Senior,JP,0.11904761904761905,3,0,11,0,0,0,0,0,0,0,1,2025,6,2,0,0.08073634859349145,8.333333333333334,0.0
25389056,US,US,1,2.0,0,0,0,0,2025-06-03,57.0,801.0,Female,75.0,LEVALBUTEROL TARTRATE,product ineffective,0,0,0.0,MidAge,US,0.0,1,0,19,0,0,0,0,0,0,0,2,2025,6,3,1,0.08073634859349145,0.0,0.0
25407295,US,US,2,1.0,1,0,0,0,2025-06-06,69.0,801.0,Male,75.0,CILTACABTAGENE AUTOLEUCEL,neoplasm malignant,1,5,0.35714285714285715,Senior,US,0.17857142857142858,2,1,18,0,0,0,0,0,0,0,2,2025,6,6,4,0.08936301793444651,12.321428571428571,0.0
25423495,US,Unknown,1,1.0,0,0,0,0,2025-06-11,51.0,801.0,Female,75.0,CIMZIA,rheumatoid arthritis,1,0,0.0,MidAge,US,0.5,2,1,20,0,0,0,0,0,0,0,2,2025,6,11,2,0.08073634859349145,25.5,0.5
25424319,US,US,1,2.0,0,0,0,0,2025-06-11,22.0,801.0,Female,75.0,DUPIXENT,mental status changes,0,0,0.0,Young,US,0.015513897866839042,221,0,21,0,0,0,0,0,0,0,3,2025,6,11,2,0.08073634859349145,0.3413057530704589,0.015513897866839042
25427330,JP,JP,1,1.0,0,0,1,0,2025-06-12,65.0,801.0,Female,75.0,TECENTRIQ,pneumothorax,1,3,0.21428571428571427,MidAge,JP,0.14285714285714285,3,1,12,0,0,0,0,0,0,0,1,2025,6,12,3,0.08073634859349145,9.285714285714285,0.14285714285714285
25431623,US,US,2,1.0,0,0,0,0,2025-06-13,57.0,801.0,Female,75.0,NUPLAZID,glaucoma,1,0,0.0,MidAge,US,0.09523809523809523,6,0,8,0,0,0,0,0,0,0,1,2025,6,13,4,0.08936301793444651,5.428571428571428,0.09523809523809523
25437737,US,US,1,1.0,0,0,0,0,2025-06-16,35.0,801.0,Female,75.0,MYCOPHENOLATE MOFETIL,abortion spontaneous,1,0,0.0,Young,US,0.10150375939849625,19,0,20,0,0,0,0,0,0,0,2,2025,6,16,0,0.08073634859349145,3.5526315789473686,0.10150375939849625
25440977,US,Unknown,1,2.0,0,0,0,0,2025-06-16,57.0,801.0,Female,75.0,BIMZELX,product leakage,0,0,0.0,MidAge,US,0.0,22,0,15,0,0,0,0,0,0,0,2,2025,6,16,0,0.08073634859349145,0.0,0.0
25444016,US,Unknown,1,1.0,0,0,0,0,2025-06-17,57.0,801.0,Female,75.0,BIMZELX,pruritus,1,0,0.0,MidAge,US,0.0,22,0,8,0,0,0,0,0,0,0,1,2025,6,17,1,0.08073634859349145,0.0,0.0
25444164,US,Unknown,1,2.0,0,0,0,0,2025-06-17,45.0,801.0,Female,75.0,BIMZELX,hidradenitis,0,0,0.0,Adult,US,0.0,22,0,12,0,0,0,0,0,0,0,1,2025,6,17,1,0.08073634859349145,0.0,0.0
19001201,CA,CA,1,1.0,1,0,0,0,2021-03-12,34.0,801.0,Female,81.0,DUAC,maternal exposure during pregnancy,1,5,0.35714285714285715,Young,CA,0.35714285714285715,1,1,34,0,0,0,0,0,0,0,4,2021,3,12,4,0.08073634859349145,12.142857142857142,0.35714285714285715
19042011,CA,CA,2,1.0,0,0,0,0,2021-03-22,74.0,801.0,Female,75.0,VEDOLIZUMAB,crohn^s disease,1,0,0.0,Senior,CA,0.057692307692307696,26,0,15,0,0,0,0,0,0,0,2,2021,3,22,0,0.08936301793444651,4.269230769230769,0.057692307692307696
19330477,JP,JP,2,1.0,1,0,1,0,2021-05-28,60.0,801.0,Male,75.0,LEUPROLIDE ACETATE,hepatic cirrhosis,1,8,0.5714285714285714,MidAge,JP,0.38095238095238093,3,1,17,0,0,0,0,0,0,0,2,2021,5,28,4,0.08936301793444651,22.857142857142854,0.0
19760478,EU,EU,1,1.0,1,0,0,0,2021-08-30,62.0,801.0,Male,75.0,IRINOTECAN,tumour lysis syndrome,1,5,0.35714285714285715,MidAge,EU,0.35714285714285715,1,1,21,0,0,0,0,0,0,0,3,2021,8,30,0,0.08073634859349145,22.142857142857142,0.0
19903309,EU,EU,1,1.0,1,0,1,0,2021-10-01,57.0,801.0,Female,75.0,RITUXIMAB,multiple organ dysfunction syndrome,1,8,0.5714285714285714,MidAge,EU,0.12406015037593986,19,0,35,0,0,0,0,0,0,0,4,2021,10,1,4,0.08073634859349145,7.071428571428572,0.12406015037593986
20372475,EU,EU,3,1.0,1,0,1,0,2022-01-25,57.0,801.0,Female,75.0,LEVOFLOXACIN,condition aggravated,1,8,0.5714285714285714,MidAge,EU,0.25,4,1,20,0,0,0,0,0,0,0,2,2022,1,25,1,0.17857142857142855,14.25,0.25
20595588,AU,AU,1,1.0,0,0,1,0,2022-03-15,37.0,801.0,Male,75.0,CLOZARIL,hospitalisation,1,3,0.21428571428571427,Adult,AU,0.10714285714285714,4,0,15,0,0,0,0,0,0,0,1,2022,3,15,1,0.08073634859349145,3.964285714285714,0.0
20687713,CA,CA,1,1.0,0,0,0,0,2022-04-08,57.0,801.0,Female,75.0,INFLIXIMAB,blood pressure systolic increased,1,0,0.0,MidAge,CA,0.07142857142857142,9,0,33,0,0,0,0,0,0,0,4,2022,4,8,4,0.08073634859349145,4.071428571428571,0.07142857142857142
20934992,US,US,1,2.0,0,0,0,0,2022-06-08,57.0,801.0,Female,75.0,ACTEMRA,arthralgia,0,0,0.0,MidAge,US,0.17857142857142858,6,1,10,0,0,0,0,0,0,0,1,2022,6,8,2,0.08073634859349145,10.178571428571429,0.17857142857142858
20957443,AU,AU,2,1.0,0,0,0,0,2022-06-14,55.0,801.0,Female,75.0,TEDUGLUTIDE,renal impairment,1,0,0.0,MidAge,AU,0.14285714285714285,3,1,16,0,0,0,0,0,0,0,2,2022,6,14,1,0.08936301793444651,7.857142857142857,0.14285714285714285
21290596,EU,EU,1,1.0,0,0,1,0,2022-09-03,72.0,801.0,Female,75.0,LEVOFLOXACIN,acinetobacter infection,1,3,0.21428571428571427,Senior,EU,0.25,4,1,23,0,1,0,0,0,0,0,2,2022,9,3,5,0.08073634859349145,18.0,0.25
26092923,EU,EU,1,1.0,0,0,1,0,2025-11-26,72.0,801.0,Female,75.0,TRASTUZUMAB,pneumonia,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,9,0,0,0,0,0,1,0,1,2025,11,26,2,0.08073634859349145,15.428571428571427,0.21428571428571427
25624102,US,US,1,2.0,0,0,0,0,2025-07-30,59.0,801.0,Female,75.0,DUPIXENT,asthma,0,0,0.0,MidAge,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,7,30,2,0.08073634859349145,0.9153199741435035,0.015513897866839042
25628487,JP,JP,1,1.0,1,0,1,0,2025-07-31,73.0,801.0,Male,75.0,DEFITELIO,sepsis,1,8,0.5714285714285714,Senior,JP,0.5714285714285714,1,1,6,0,0,0,0,0,0,0,1,2025,7,31,3,0.08073634859349145,41.714285714285715,0.0
26093652,US,US,1,1.0,0,0,1,0,2025-11-26,57.0,801.0,Female,75.0,CABOMETYX,encephalopathy,1,3,0.21428571428571427,MidAge,US,0.10714285714285714,4,0,14,0,0,0,0,0,0,0,1,2025,11,26,2,0.08073634859349145,6.107142857142857,0.10714285714285714
25869196,US,US,1,1.0,0,0,0,0,2025-10-01,69.0,801.0,Male,75.0,GABAPENTIN,adrenal insufficiency,1,0,0.0,Senior,US,0.061224489795918366,7,0,21,0,0,0,0,0,0,0,2,2025,10,1,2,0.08073634859349145,4.224489795918367,0.0
25869400,CN,CN,2,1.0,0,0,1,0,2025-10-01,73.0,801.0,Female,50.0,BRENTUXIMAB VEDOTIN,agranulocytosis,1,3,0.21428571428571427,Senior,CN,0.21428571428571427,1,1,15,0,0,0,0,0,0,0,1,2025,10,1,2,0.08936301793444651,15.642857142857142,0.21428571428571427
25869587,CN,CN,1,1.0,0,0,0,0,2025-10-01,48.0,801.0,Female,42.4,EPIRUBICIN HYDROCHLORIDE,alanine aminotransferase increased,1,0,0.0,Adult,CN,0.0,1,0,34,0,0,0,0,0,0,0,3,2025,10,1,2,0.08073634859349145,0.0,0.0
25870453,US,US,1,2.0,0,0,0,0,2025-10-01,14.0,801.0,Female,75.0,DUPIXENT,white blood cell count increased,0,0,0.0,Child,US,0.015513897866839042,221,0,32,0,0,0,0,0,0,0,5,2025,10,1,2,0.08073634859349145,0.21719457013574658,0.015513897866839042
25870534,US,US,1,2.0,0,0,0,0,2025-10-01,57.0,801.0,Male,99.09,DUPIXENT,dry eye,0,0,0.0,MidAge,US,0.015513897866839042,221,0,7,0,0,0,0,0,0,0,2,2025,10,1,2,0.08073634859349145,0.8842921784098254,0.0
25872020,US,US,1,2.0,0,0,0,0,2025-10-02,33.0,801.0,Female,75.0,EBGLYSS,food allergy,0,0,0.0,Young,US,0.0,1,0,12,0,0,0,0,0,0,0,2,2025,10,2,3,0.08073634859349145,0.0,0.0
25872059,AR,AR,1,1.0,0,0,1,1,2025-10-02,85.0,801.0,Male,75.0,XOLAIR,lower limb fracture,1,5,0.35714285714285715,Senior,Other,0.14285714285714285,4,1,19,0,0,0,0,0,0,0,3,2025,10,2,3,0.08073634859349145,12.142857142857142,0.0
25873207,JP,JP,1,1.0,0,0,0,0,2025-10-02,64.0,801.0,Female,75.0,DOCETAXEL,scleroderma,1,0,0.0,MidAge,JP,0.061224489795918366,7,0,11,0,0,0,0,0,0,0,1,2025,10,2,3,0.08073634859349145,3.9183673469387754,0.061224489795918366
25873355,EU,EU,1,1.0,0,0,0,0,2025-10-02,81.0,801.0,Male,75.0,PREGABALIN,hepatic cytolysis,1,0,0.0,Senior,EU,0.10714285714285714,6,0,17,0,0,0,0,0,0,0,2,2025,10,2,3,0.08073634859349145,8.678571428571429,0.0
25873436,US,US,1,1.0,0,0,0,0,2025-10-02,57.0,801.0,Female,75.0,CRESTOR,atrial fibrillation,1,0,0.0,MidAge,US,0.0,1,0,19,0,0,0,0,0,0,0,2,2025,10,2,3,0.08073634859349145,0.0,0.0
25873517,US,US,1,1.0,0,0,1,0,2025-10-02,59.0,801.0,Female,75.0,ENBREL,femur fracture,1,3,0.21428571428571427,MidAge,US,0.21428571428571427,1,1,14,0,0,0,0,0,0,0,2,2025,10,2,3,0.08073634859349145,12.642857142857142,0.21428571428571427
25874475,US,Unknown,1,1.0,0,0,0,0,2025-10-02,51.0,801.0,Female,75.0,CALQUENCE,myalgia,1,0,0.0,MidAge,US,0.0,1,0,7,0,0,0,0,0,0,0,1,2025,10,2,3,0.08073634859349145,0.0,0.0
25874637,US,US,1,1.0,0,0,1,0,2025-10-02,46.0,801.0,Female,98.0,GAMUNEX-C,dysphagia,1,3,0.21428571428571427,Adult,US,0.21428571428571427,1,1,9,0,0,0,0,0,0,0,1,2025,10,2,3,0.08073634859349145,9.857142857142856,0.21428571428571427
25875461,US,US,1,2.0,0,0,0,0,2025-10-03,2.0,801.0,Male,75.0,DUPIXENT,hypersensitivity,0,0,0.0,Child,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,1,2025,10,3,4,0.08073634859349145,0.031027795733678084,0.0
25875609,US,US,1,2.0,0,0,0,0,2025-10-03,63.0,801.0,Female,75.0,DUPIXENT,accidental exposure to product,0,0,0.0,MidAge,US,0.015513897866839042,221,0,30,0,0,0,0,0,0,0,4,2025,10,3,4,0.08073634859349145,0.9773755656108597,0.015513897866839042
25876095,US,US,2,1.0,0,0,0,0,2025-10-03,57.0,801.0,Female,75.0,CREON,hospice care,1,0,0.0,MidAge,US,0.03296703296703297,13,0,12,0,0,0,0,0,0,0,2,2025,10,3,4,0.08936301793444651,1.879120879120879,0.03296703296703297
25876204,CA,CA,2,1.0,0,0,0,0,2025-10-03,57.0,801.0,Male,75.0,SKYRIZI,lung neoplasm malignant,1,0,0.0,MidAge,CA,0.051587301587301584,36,0,23,0,0,0,0,0,0,0,3,2025,10,3,4,0.08936301793444651,2.9404761904761902,0.0
25877296,GB,GB,1,1.0,0,0,0,0,2025-10-03,67.0,801.0,Female,64.0,APIXABAN,diarrhoea,1,0,0.0,Senior,GB,0.07142857142857142,3,0,9,0,0,0,0,0,0,0,1,2025,10,3,4,0.08073634859349145,4.785714285714286,0.07142857142857142
25676749,GB,GB,1,1.0,0,0,0,0,2025-08-13,76.0,801.0,Female,75.0,RITUXIMAB,renal impairment,1,0,0.0,Senior,GB,0.12406015037593986,19,0,16,0,0,0,0,0,0,0,2,2025,8,13,2,0.08073634859349145,9.428571428571429,0.12406015037593986
25677397,US,US,1,1.0,0,0,0,0,2025-08-13,13.0,801.0,Female,75.0,DUPIXENT,loss of consciousness,1,0,0.0,Child,US,0.015513897866839042,221,0,21,0,0,0,0,0,0,0,3,2025,8,13,2,0.08073634859349145,0.20168067226890754,0.015513897866839042
25677478,US,US,1,1.0,0,0,0,0,2025-08-13,87.0,801.0,Male,75.0,LENALIDOMIDE,anxiety,1,0,0.0,Senior,US,0.15413533834586465,19,1,7,0,0,0,0,0,0,0,1,2025,8,13,2,0.08073634859349145,13.409774436090224,0.0
25689695,US,US,1,2.0,0,0,0,0,2025-08-18,77.0,801.0,Female,72.562,ALBUTEROL SULFATE,wrong technique in product usage process,0,0,0.0,Senior,US,0.0,8,0,40,0,0,0,0,0,0,0,6,2025,8,18,0,0.08073634859349145,0.0,0.0
25698066,US,US,1,1.0,0,0,1,0,2025-08-19,72.0,801.0,Female,75.0,INCLISIRAN,stevens-johnson syndrome,1,3,0.21428571428571427,Senior,US,0.21428571428571427,1,1,24,0,0,0,0,0,0,0,2,2025,8,19,1,0.08073634859349145,15.428571428571427,0.21428571428571427
25698242,US,US,1,2.0,0,0,0,0,2025-08-19,76.0,801.0,Female,75.0,AIMOVIG,injection site bruising,0,0,0.0,Senior,US,0.0,1,0,23,0,0,0,0,0,0,0,3,2025,8,19,1,0.08073634859349145,0.0,0.0
25700943,US,US,1,2.0,0,0,0,0,2025-08-19,10.0,801.0,Female,75.0,DUPIXENT,skin abrasion,0,0,0.0,Child,US,0.015513897866839042,221,0,13,0,0,0,0,0,0,0,2,2025,8,19,1,0.08073634859349145,0.1551389786683904,0.015513897866839042
25701577,US,US,1,1.0,0,0,0,0,2025-08-19,64.0,801.0,Female,75.0,BASAGLAR,cerebrovascular accident,1,0,0.0,MidAge,US,0.0,2,0,24,0,0,0,0,0,0,0,2,2025,8,19,1,0.08073634859349145,0.0,0.0
25703616,US,US,3,2.0,0,0,0,0,2025-08-20,57.0,801.0,Female,75.0,AVMAPKI FAKZYNJA CO-PACK,product dose omission issue,0,0,0.0,MidAge,US,0.0,2,0,27,0,0,0,0,0,0,0,4,2025,8,20,2,0.17857142857142855,0.0,0.0
25703630,US,US,1,2.0,0,0,0,0,2025-08-20,57.0,801.0,Female,75.0,AVMAPKI FAKZYNJA CO-PACK,ear discomfort,0,0,0.0,MidAge,US,0.0,2,0,14,0,0,0,0,0,0,0,2,2025,8,20,2,0.08073634859349145,0.0,0.0
25704493,US,US,1,2.0,0,0,0,0,2025-08-20,47.0,801.0,Male,75.0,COSENTYX,device malfunction,0,0,0.0,Adult,US,0.05714285714285714,10,0,18,0,0,0,0,0,0,0,2,2025,8,20,2,0.08073634859349145,2.6857142857142855,0.0
25709582,US,US,1,2.0,0,0,0,0,2025-08-21,57.0,801.0,Female,75.0,PLUVICTO,general physical health deterioration,0,0,0.0,MidAge,US,0.0,8,0,37,0,0,0,0,0,0,0,4,2025,8,21,3,0.08073634859349145,0.0,0.0
25710339,US,US,1,2.0,0,0,0,0,2025-08-21,57.0,801.0,Female,75.0,MIRENA,condition aggravated,0,0,0.0,MidAge,US,0.0,1,0,20,0,0,0,0,0,0,0,2,2025,8,21,3,0.08073634859349145,0.0,0.0
25712364,US,US,1,2.0,0,0,0,0,2025-08-21,10.0,801.0,Female,30.84,GENOTROPIN,product reconstitution quality issue,0,0,0.0,Child,US,0.0,1,0,36,0,0,0,0,0,0,0,4,2025,8,21,3,0.08073634859349145,0.0,0.0
22935544,CA,CA,1,1.0,0,0,0,0,2023-09-12,45.0,801.0,Male,75.0,ABRILADA,lumbar vertebral fracture,1,0,0.0,Adult,CA,0.0,1,0,25,0,0,0,0,0,0,0,3,2023,9,12,1,0.08073634859349145,0.0,0.0
23140921,US,US,2,1.0,0,0,0,0,2023-11-03,25.0,801.0,Female,68.0,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,autism spectrum disorder,1,0,0.0,Young,US,0.07142857142857142,3,0,24,0,0,0,0,0,0,0,3,2023,11,3,4,0.08936301793444651,1.7857142857142856,0.07142857142857142
23187306,US,US,1,1.0,0,0,1,0,2023-11-15,84.0,801.0,Female,75.0,DUPIXENT,dehydration,1,3,0.21428571428571427,Senior,US,0.015513897866839042,221,0,11,0,0,0,0,0,0,0,1,2023,11,15,2,0.08073634859349145,1.3031674208144794,0.015513897866839042
23187979,US,US,1,2.0,0,0,0,0,2023-11-15,78.0,801.0,Female,75.0,XELJANZ XR,respiratory disorder,0,0,0.0,Senior,US,0.0,9,0,20,0,0,0,0,0,0,0,2,2023,11,15,2,0.08073634859349145,0.0,0.0
23241361,IN,IN,1,1.0,0,0,0,0,2023-11-29,75.0,801.0,Female,60.2,LORLATINIB,cardiac failure congestive,1,0,0.0,Senior,IN,0.0,1,0,26,0,0,0,0,1,0,0,3,2023,11,29,2,0.08073634859349145,0.0,0.0
23252606,EU,EU,2,1.0,0,0,0,0,2023-12-01,39.0,801.0,Female,75.0,HIZENTRA,pericarditis,1,0,0.0,Adult,EU,0.0,1,0,12,0,0,0,0,0,0,0,1,2023,12,1,4,0.08936301793444651,0.0,0.0
23306538,US,US,1,1.0,0,0,0,0,2023-12-18,70.0,801.0,Male,75.0,BORTEZOMIB,autonomic neuropathy,1,0,0.0,Senior,US,0.0,3,0,20,0,0,0,0,0,0,0,2,2023,12,18,0,0.08073634859349145,0.0,0.0
23340329,US,US,1,2.0,0,0,0,0,2023-12-27,31.0,801.0,Female,61.678,DUPIXENT,rash,0,0,0.0,Young,US,0.015513897866839042,221,0,4,0,0,0,0,0,0,0,1,2023,12,27,2,0.08073634859349145,0.4809308338720103,0.015513897866839042
23360202,CA,CA,1,1.0,0,0,1,0,2024-01-03,45.0,801.0,Female,95.0,ASPIRIN,full blood count abnormal,1,3,0.21428571428571427,Adult,CA,0.21428571428571427,1,1,25,0,0,0,0,0,0,0,4,2024,1,3,2,0.08073634859349145,9.642857142857142,0.21428571428571427
23497508,US,US,1,2.0,0,0,0,0,2024-02-08,13.0,801.0,Male,56.0,DUPIXENT,off label use,0,0,0.0,Child,US,0.015513897866839042,221,0,13,0,0,0,0,0,0,0,3,2024,2,8,3,0.08073634859349145,0.20168067226890754,0.0
23638800,IN,IN,1,1.0,0,0,0,0,2024-03-15,59.0,801.0,Female,75.0,DACOMITINIB,skin disorder,1,0,0.0,MidAge,IN,0.0,1,0,13,0,0,0,0,0,0,0,2,2024,3,15,4,0.08073634859349145,0.0,0.0
23699494,JP,JP,1,1.0,1,0,0,0,2024-04-02,57.0,801.0,Male,75.0,YERVOY,acute myocardial infarction,1,5,0.35714285714285715,MidAge,JP,0.35714285714285715,4,1,27,0,0,0,0,0,0,0,3,2024,4,2,1,0.08073634859349145,20.357142857142858,0.0
26098808,EU,EU,1,1.0,0,0,0,0,2025-11-27,28.0,801.0,Female,75.0,MYCOPHENOLATE MOFETIL,transplant rejection,1,0,0.0,Young,EU,0.10150375939849625,19,0,20,0,0,0,0,0,0,0,2,2025,11,27,3,0.08073634859349145,2.842105263157895,0.10150375939849625
26098970,GB,GB,1,1.0,0,0,0,0,2025-11-27,70.0,801.0,Male,99.0,AMITRIPTYLINE,depression,1,0,0.0,Senior,GB,0.0,1,0,10,0,0,0,0,0,0,0,1,2025,11,27,3,0.08073634859349145,0.0,0.0
26099322,US,US,1,1.0,0,0,1,0,2025-11-28,77.0,801.0,Female,75.0,DUPIXENT,sciatica,1,3,0.21428571428571427,Senior,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,11,28,4,0.08073634859349145,1.1945701357466063,0.015513897866839042
26099780,AE,AE,1,1.0,0,0,0,0,2025-11-28,30.0,801.0,Male,75.0,OLANZAPINE,thrombocytopenia,1,0,0.0,Young,Other,0.11904761904761905,6,0,16,0,0,0,0,0,0,0,1,2025,11,28,4,0.08073634859349145,3.5714285714285716,0.0
26100121,US,US,1,2.0,0,0,0,0,2025-11-28,68.0,801.0,Male,86.7,ZYTIGA,aspartate aminotransferase increased,0,0,0.0,Senior,US,0.0,1,0,36,0,0,0,0,0,0,0,3,2025,11,28,4,0.08073634859349145,0.0,0.0
26100389,US,US,1,1.0,0,1,1,0,2025-11-28,60.0,801.0,Female,38.0,LIDOCAINE,generalised tonic-clonic seizure,1,7,0.5,MidAge,US,0.5,1,1,32,0,0,0,0,0,0,0,3,2025,11,28,4,0.08073634859349145,30.0,0.5
25878349,US,US,1,2.0,0,0,0,0,2025-10-03,25.0,801.0,Male,75.0,EPCLUSA,inappropriate schedule of product administration,0,0,0.0,Young,US,0.0,1,0,48,0,0,0,0,0,0,0,5,2025,10,3,4,0.08073634859349145,0.0,0.0
25879335,US,US,2,2.0,0,0,0,0,2025-10-03,57.0,801.0,Female,75.0,SKYRIZI,unevaluable event,0,0,0.0,MidAge,US,0.051587301587301584,36,0,17,0,0,0,0,0,0,0,2,2025,10,3,4,0.08936301793444651,2.9404761904761902,0.051587301587301584
25879483,US,US,1,2.0,0,0,0,0,2025-10-03,57.0,801.0,Female,75.0,ORENCIA,loss of therapeutic response,0,0,0.0,MidAge,US,0.10204081632653061,14,0,28,0,0,0,0,0,0,0,4,2025,10,3,4,0.08073634859349145,5.816326530612245,0.10204081632653061
26114902,EU,EU,1,1.0,0,0,1,0,2025-12-03,72.0,801.0,Female,94.0,AMLODIPINE,cough,1,3,0.21428571428571427,Senior,EU,0.16964285714285715,8,1,5,0,0,0,0,0,0,0,1,2025,12,3,2,0.08073634859349145,12.214285714285715,0.16964285714285715
26115941,EU,EU,1,1.0,1,0,0,0,2025-12-03,70.0,801.0,Male,73.0,OPDIVO,immune-mediated myocarditis,1,5,0.35714285714285715,Senior,EU,0.08928571428571429,4,0,27,0,0,0,0,0,0,0,2,2025,12,3,2,0.08073634859349145,6.25,0.0
25806715,US,US,1,2.0,0,0,0,0,2025-09-16,92.0,801.0,Male,73.923,TYVASO DPI,haemoglobin increased,0,0,0.0,Senior,US,0.0,4,0,21,0,0,0,0,0,0,0,2,2025,9,16,1,0.08073634859349145,0.0,0.0
25810145,US,US,1,2.0,0,0,0,0,2025-09-17,29.0,801.0,Male,75.0,DUPIXENT,dry skin,0,0,0.0,Young,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,2,2025,9,17,2,0.08073634859349145,0.4499030381383322,0.0
25811832,US,US,1,2.0,0,0,0,0,2025-09-17,43.0,801.0,Female,75.0,TOLVAPTAN,nausea,0,0,0.0,Adult,US,0.0,1,0,6,0,0,0,0,0,0,0,1,2025,9,17,2,0.08073634859349145,0.0,0.0
25812547,US,US,1,2.0,0,0,0,0,2025-09-17,41.0,801.0,Male,75.0,TRUVADA,tooth loss,0,0,0.0,Adult,US,0.0,1,0,10,0,0,0,0,0,0,0,2,2025,9,17,2,0.08073634859349145,0.0,0.0
25897870,US,US,1,2.0,0,0,0,0,2025-10-08,56.0,801.0,Male,75.0,XELJANZ,back pain,0,0,0.0,MidAge,US,0.0,3,0,9,1,0,0,0,0,0,0,2,2025,10,8,2,0.08073634859349145,0.0,0.0
25898451,EU,EU,1,1.0,0,0,0,0,2025-10-09,76.0,801.0,Female,70.0,CARBOPLATIN,diarrhoea,1,0,0.0,Senior,EU,0.12244897959183673,7,0,9,0,0,0,0,0,0,0,1,2025,10,9,3,0.08073634859349145,9.306122448979592,0.12244897959183673
25900222,AU,Unknown,1,1.0,1,0,0,0,2025-10-09,52.0,801.0,Female,75.0,MIRTAZAPINE,completed suicide,1,5,0.35714285714285715,MidAge,AU,0.19047619047619047,3,1,17,0,0,0,0,0,0,0,2,2025,10,9,3,0.08073634859349145,9.904761904761905,0.19047619047619047
25900437,EU,EU,1,1.0,0,0,1,0,2025-10-09,73.0,801.0,Female,75.0,ETOPOSIDE,condition aggravated,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,2,1,20,0,0,0,0,0,0,0,2,2025,10,9,3,0.08073634859349145,15.642857142857142,0.21428571428571427
25901409,US,Unknown,1,1.0,0,0,1,0,2025-10-09,75.0,801.0,Female,66.68,ZILBRYSQ,pneumonia fungal,1,3,0.21428571428571427,Senior,US,0.10714285714285714,2,0,16,0,0,0,0,0,1,0,2,2025,10,9,3,0.08073634859349145,8.035714285714285,0.10714285714285714
26119910,US,US,1,2.0,0,0,0,0,2025-12-04,7.0,801.0,Female,49.8,DUPIXENT,eczema,0,0,0.0,Child,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,12,4,3,0.08073634859349145,0.10859728506787329,0.015513897866839042
26120086,US,US,2,1.0,0,0,0,0,2025-12-04,72.0,801.0,Female,75.0,SKYRIZI,skin cancer,1,0,0.0,Senior,US,0.051587301587301584,36,0,11,0,0,0,1,0,0,0,2,2025,12,4,3,0.08936301793444651,3.714285714285714,0.051587301587301584
26120572,US,US,1,2.0,0,0,0,0,2025-12-04,44.0,801.0,Male,75.0,LEVETIRACETAM,drug ineffective for unapproved indication,0,0,0.0,Adult,US,0.05714285714285714,5,0,42,0,0,0,0,0,0,0,5,2025,12,4,3,0.08073634859349145,2.5142857142857142,0.0
26121692,EU,EU,1,1.0,0,0,0,0,2025-12-04,50.0,801.0,Female,80.0,CLINDAMYCIN,suicide attempt,1,0,0.0,Adult,EU,0.0,1,0,15,0,0,0,0,0,0,0,2,2025,12,4,3,0.08073634859349145,0.0,0.0
25819351,US,US,1,2.0,0,0,0,0,2025-09-18,60.0,801.0,Female,75.0,DUPIXENT,osteoporosis,0,0,0.0,MidAge,US,0.015513897866839042,221,0,12,0,0,0,0,0,0,0,1,2025,9,18,3,0.08073634859349145,0.9308338720103425,0.015513897866839042
25821848,US,US,2,2.0,0,0,0,0,2025-09-19,57.0,801.0,Female,75.0,DAYBUE,insomnia,0,0,0.0,MidAge,US,0.0,1,0,8,0,0,0,0,0,0,0,1,2025,9,19,4,0.08936301793444651,0.0,0.0
25827222,EU,EU,1,1.0,0,0,0,0,2025-09-20,57.0,801.0,Female,75.0,CYCLOSPORINE,inappropriate antidiuretic hormone secretion,1,0,0.0,MidAge,EU,0.0,5,0,44,0,0,0,0,0,0,0,4,2025,9,20,5,0.08073634859349145,0.0,0.0
25828032,US,US,1,1.0,0,0,0,0,2025-09-21,78.0,801.0,Female,75.0,ORENCIA,product storage error,1,0,0.0,Senior,US,0.10204081632653061,14,0,21,0,0,0,0,0,0,0,3,2025,9,21,6,0.08073634859349145,7.959183673469388,0.10204081632653061
25831797,EU,EU,2,1.0,0,0,1,0,2025-09-22,43.0,801.0,Male,75.0,COSENTYX,crohn^s disease,1,3,0.21428571428571427,Adult,EU,0.05714285714285714,10,0,15,0,0,0,0,0,0,0,2,2025,9,22,0,0.08936301793444651,2.457142857142857,0.0
25833498,NG,NG,1,1.0,1,0,1,0,2025-09-22,35.0,801.0,Male,75.0,GLIVEC,death,1,8,0.5714285714285714,Young,Other,0.5714285714285714,1,1,5,0,0,1,0,0,0,0,1,2025,9,22,0,0.08073634859349145,20.0,0.0
24232935,CA,CA,1,1.0,0,0,0,0,2024-08-21,36.0,801.0,Female,75.0,DICLOFENAC POTASSIUM,ankylosing spondylitis,1,0,0.0,Adult,CA,0.0,1,0,22,0,0,0,0,0,0,0,2,2024,8,21,2,0.08073634859349145,0.0,0.0
24238348,US,US,3,2.0,0,0,0,0,2024-08-22,57.0,801.0,Male,75.0,FILSPARI,blepharospasm,0,0,0.0,MidAge,US,0.0,4,0,13,0,0,0,0,0,0,0,1,2024,8,22,3,0.17857142857142855,0.0,0.0
24239253,US,US,3,2.0,0,0,0,0,2024-08-22,45.0,801.0,Female,75.0,FILSPARI,dizziness,0,0,0.0,Adult,US,0.0,4,0,9,0,0,0,0,0,0,0,1,2024,8,22,3,0.17857142857142855,0.0,0.0
24249540,US,US,1,2.0,0,0,0,0,2024-08-26,57.0,801.0,Male,113.38,DUPIXENT,dry skin,0,0,0.0,MidAge,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,2,2024,8,26,0,0.08073634859349145,0.8842921784098254,0.0
24319982,US,US,2,2.0,0,0,0,0,2024-09-14,44.0,801.0,Female,75.0,VEDOLIZUMAB,product dose omission issue,0,0,0.0,Adult,US,0.057692307692307696,26,0,27,0,0,0,0,0,0,0,4,2024,9,14,5,0.08936301793444651,2.5384615384615388,0.057692307692307696
24375157,EU,EU,1,1.0,0,0,0,0,2024-09-28,36.0,801.0,Male,75.0,PRAVASTATIN SODIUM,dizziness,1,0,0.0,Adult,EU,0.0,1,0,9,0,0,0,0,0,0,0,1,2024,9,28,5,0.08073634859349145,0.0,0.0
24393988,US,US,2,1.0,0,0,0,0,2024-10-03,70.0,801.0,Female,75.0,CREON,hip fracture,1,0,0.0,Senior,US,0.03296703296703297,13,0,12,0,0,0,0,0,0,0,2,2024,10,3,3,0.08936301793444651,2.307692307692308,0.03296703296703297
24427511,US,US,1,2.0,0,0,0,0,2024-10-11,2.0,801.0,Male,75.0,DUPIXENT,rhinorrhoea,0,0,0.0,Child,US,0.015513897866839042,221,0,11,0,0,0,0,0,0,0,1,2024,10,11,4,0.08073634859349145,0.031027795733678084,0.0
24432991,US,US,1,2.0,0,0,0,0,2024-10-14,57.0,801.0,Female,46.712,DUPIXENT,drug intolerance,0,0,0.0,MidAge,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,2,2024,10,14,0,0.08073634859349145,0.8842921784098254,0.015513897866839042
24448233,CA,Unknown,2,1.0,0,0,0,0,2024-10-16,57.0,801.0,Female,75.0,CERTOLIZUMAB PEGOL,ankylosing spondylitis,1,0,0.0,MidAge,CA,0.04285714285714286,5,0,22,0,0,0,0,0,0,0,2,2024,10,16,2,0.08936301793444651,2.442857142857143,0.04285714285714286
24461531,US,US,1,1.0,0,0,0,0,2024-10-18,37.0,801.0,Female,86.168,BIMZELX,psoriasis,1,0,0.0,Adult,US,0.0,22,0,9,0,0,0,0,0,0,0,1,2024,10,18,4,0.08073634859349145,0.0,0.0
24528490,US,US,2,1.0,0,0,0,0,2024-10-21,30.0,801.0,Female,118.37,NURTEC ODT,maternal exposure during pregnancy,1,0,0.0,Young,US,0.0,2,0,34,0,0,0,0,0,0,0,4,2024,10,21,0,0.08936301793444651,0.0,0.0
24547969,CA,CA,2,1.0,0,0,1,0,2024-10-25,57.0,801.0,Female,75.0,VEDOLIZUMAB,anal abscess,1,3,0.21428571428571427,MidAge,CA,0.057692307692307696,26,0,12,0,0,0,0,0,0,0,2,2024,10,25,4,0.08936301793444651,3.2884615384615388,0.057692307692307696
26122664,US,US,1,1.0,1,0,0,0,2025-12-04,58.0,801.0,Female,75.0,POMALYST,death,1,5,0.35714285714285715,MidAge,US,0.11428571428571428,5,0,5,0,0,1,0,0,0,0,1,2025,12,4,3,0.08073634859349145,6.628571428571428,0.11428571428571428
26124756,AU,AU,1,1.0,0,0,0,0,2025-12-05,63.0,801.0,Male,75.0,DARATUMUMAB,thrombocytopenia,1,0,0.0,MidAge,AU,0.14285714285714285,3,1,16,0,0,0,0,0,0,0,1,2025,12,5,4,0.08073634859349145,9.0,0.0
25902448,ZA,ZA,2,1.0,0,0,1,0,2025-10-09,53.0,801.0,Male,75.0,BUDESONIDE\FORMOTEROL,cardiac disorder,1,3,0.21428571428571427,MidAge,ZA,0.10714285714285714,2,0,16,0,0,0,0,0,0,0,2,2025,10,9,3,0.08936301793444651,5.678571428571428,0.0
25902839,US,US,2,1.0,0,0,0,0,2025-10-09,82.0,801.0,Male,62.0,VENCLEXTA,acute myeloid leukaemia,1,0,0.0,Senior,US,0.18571428571428572,5,1,23,0,0,0,0,0,0,0,3,2025,10,9,3,0.08936301793444651,15.22857142857143,0.0
25903878,JP,JP,1,1.0,0,0,1,0,2025-10-10,78.0,801.0,Male,75.0,TREPROSTINIL,dyspnoea,1,3,0.21428571428571427,Senior,JP,0.2857142857142857,2,1,8,0,0,0,0,0,0,0,1,2025,10,10,4,0.08073634859349145,22.285714285714285,0.0
25904325,US,US,1,1.0,0,0,0,0,2025-10-10,68.0,801.0,Female,74.83,ALBUTEROL SULFATE,wrong technique in product usage process,1,0,0.0,Senior,US,0.0,8,0,40,0,0,0,0,0,0,0,6,2025,10,10,4,0.08073634859349145,0.0,0.0
26127348,US,US,1,1.0,0,0,1,0,2025-12-05,60.0,801.0,Female,75.0,DUPIXENT,staphylococcal infection,1,3,0.21428571428571427,MidAge,US,0.015513897866839042,221,0,24,0,1,0,0,0,0,0,2,2025,12,5,4,0.08073634859349145,0.9308338720103425,0.015513897866839042
26127968,JP,JP,1,1.0,0,0,0,0,2025-12-06,4.0,801.0,Female,75.0,LEVETIRACETAM,drug ineffective,1,0,0.0,Child,JP,0.05714285714285714,5,0,16,0,0,0,0,0,0,0,2,2025,12,6,5,0.08073634859349145,0.22857142857142856,0.05714285714285714
26128105,US,US,1,2.0,0,0,0,0,2025-12-07,56.0,801.0,Female,75.0,DUPIXENT,vomiting,0,0,0.0,MidAge,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,12,7,6,0.08073634859349145,0.8687782805429863,0.015513897866839042
26128172,US,US,1,2.0,0,0,0,0,2025-12-07,21.0,801.0,Male,75.0,DUPIXENT,pruritus,0,0,0.0,Young,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,12,7,6,0.08073634859349145,0.32579185520361986,0.0
26128806,US,US,1,1.0,0,0,0,0,2025-12-08,19.0,801.0,Female,75.0,ISOTRETINOIN,abortion spontaneous,1,0,0.0,Young,US,0.023809523809523808,9,0,20,0,0,0,0,0,0,0,2,2025,12,8,0,0.08073634859349145,0.45238095238095233,0.023809523809523808
26129616,AU,AU,1,1.0,0,0,0,0,2025-12-08,57.0,801.0,Female,75.0,CABERGOLINE,blood prolactin increased,1,0,0.0,MidAge,AU,0.0,1,0,25,0,0,0,0,0,0,0,3,2025,12,8,0,0.08073634859349145,0.0,0.0
26130588,US,Unknown,1,1.0,0,0,1,0,2025-12-05,57.0,801.0,Female,75.0,VELTASSA,therapy interrupted,1,3,0.21428571428571427,MidAge,US,0.2619047619047619,3,1,19,0,0,0,0,0,0,0,2,2025,12,5,4,0.08073634859349145,14.928571428571429,0.2619047619047619
25909872,US,US,1,2.0,0,0,0,0,2025-10-12,57.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,MidAge,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,10,12,6,0.08073634859349145,0.8842921784098254,0.015513897866839042
24608222,US,US,1,1.0,0,0,1,0,2024-11-12,65.0,801.0,Female,75.0,IBRANCE,lower limb fracture,1,3,0.21428571428571427,MidAge,US,0.07142857142857142,3,0,19,0,0,0,0,0,0,0,3,2024,11,12,1,0.08073634859349145,4.642857142857142,0.07142857142857142
24615040,JP,JP,2,1.0,0,0,0,0,2024-11-13,74.0,801.0,Male,57.9,OPDIVO,immune-mediated enterocolitis,1,0,0.0,Senior,JP,0.08928571428571429,4,0,29,0,0,0,0,0,0,0,2,2024,11,13,2,0.08936301793444651,6.607142857142858,0.0
24617185,US,US,1,1.0,0,0,0,0,2024-11-14,29.0,801.0,Female,79.365,PARAGARD T 380A,reproductive complication associated with device,1,0,0.0,Young,US,0.0,4,0,48,0,0,0,0,0,0,0,5,2024,11,14,3,0.08073634859349145,0.0,0.0
24620277,US,US,1,2.0,0,0,0,0,2024-11-14,57.0,801.0,Female,75.0,CONTRAVE,headache,0,0,0.0,MidAge,US,0.0,1,0,8,0,0,0,0,0,0,0,1,2024,11,14,3,0.08073634859349145,0.0,0.0
24630201,EU,EU,1,1.0,0,0,0,0,2024-11-18,55.0,801.0,Female,75.0,DASATINIB,cytomegalovirus colitis,1,0,0.0,MidAge,EU,0.0,2,0,23,0,0,0,0,0,0,0,2,2024,11,18,0,0.08073634859349145,0.0,0.0
24650881,JP,JP,2,1.0,1,0,0,0,2024-11-22,47.0,801.0,Male,58.3,MARIBAVIR,infection,1,5,0.35714285714285715,Adult,JP,0.35714285714285715,1,1,9,0,1,0,0,0,0,0,1,2024,11,22,4,0.08936301793444651,16.785714285714285,0.0
24665528,US,US,1,1.0,0,0,0,0,2024-11-26,59.0,801.0,Female,75.0,VONJO,nephrolithiasis,1,0,0.0,MidAge,US,0.0,3,0,15,0,0,0,0,0,0,0,1,2024,11,26,1,0.08073634859349145,0.0,0.0
24674829,CA,CA,2,1.0,0,0,1,0,2024-11-28,64.0,801.0,Male,75.0,VEDOLIZUMAB,chronic obstructive pulmonary disease,1,3,0.21428571428571427,MidAge,CA,0.057692307692307696,26,0,37,0,0,0,0,0,0,0,4,2024,11,28,3,0.08936301793444651,3.6923076923076925,0.0
24677745,US,US,2,1.0,0,0,1,0,2024-11-29,58.0,801.0,Female,75.0,SKYRIZI,streptococcal infection,1,3,0.21428571428571427,MidAge,US,0.051587301587301584,36,0,23,0,1,0,0,0,0,0,2,2024,11,29,4,0.08936301793444651,2.992063492063492,0.051587301587301584
24686521,GB,GB,1,1.0,1,1,0,0,2024-12-02,57.0,801.0,Female,75.0,SILDENAFIL,death,1,9,0.6428571428571429,MidAge,GB,0.6428571428571429,1,1,5,0,0,1,0,0,0,0,1,2024,12,2,0,0.08073634859349145,36.642857142857146,0.6428571428571429
24723686,US,US,1,2.0,0,0,0,0,2024-12-11,12.0,801.0,Male,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Child,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2024,12,11,2,0.08073634859349145,0.1861667744020685,0.0
24757720,US,Unknown,1,2.0,0,0,0,0,2024-12-20,44.0,801.0,Female,126.98,BIMZELX,dry skin,0,0,0.0,Adult,US,0.0,22,0,8,0,0,0,0,0,0,0,2,2024,12,20,4,0.08073634859349145,0.0,0.0
24757801,US,Unknown,1,2.0,0,0,0,0,2024-12-20,57.0,801.0,Female,79.365,BIMZELX,joint swelling,0,0,0.0,MidAge,US,0.0,22,0,14,0,0,0,0,0,0,0,2,2024,12,20,4,0.08073634859349145,0.0,0.0
24757854,US,Unknown,1,2.0,0,0,0,0,2024-12-20,31.0,801.0,Female,75.0,BIMZELX,psoriasis,0,0,0.0,Young,US,0.0,22,0,9,0,0,0,0,0,0,0,1,2024,12,20,4,0.08073634859349145,0.0,0.0
24758125,US,US,1,2.0,0,0,0,0,2024-12-20,43.0,801.0,Female,75.0,BIMZELX,fatigue,0,0,0.0,Adult,US,0.0,22,0,7,0,0,0,0,0,0,0,1,2024,12,20,4,0.08073634859349145,0.0,0.0
26131493,US,US,2,1.0,1,0,0,0,2025-12-08,79.0,801.0,Male,75.0,VENCLEXTA,death,1,5,0.35714285714285715,Senior,US,0.18571428571428572,5,1,5,0,0,1,0,0,0,0,1,2025,12,8,0,0.08936301793444651,14.671428571428573,0.0
26132412,EU,EU,1,1.0,0,0,0,0,2025-12-08,49.0,801.0,Male,75.0,AMLODIPINE BESYLATE,depressed mood,1,0,0.0,Adult,EU,0.0,1,0,14,0,0,0,0,0,0,0,2,2025,12,8,0,0.08073634859349145,0.0,0.0
26133060,US,Unknown,2,1.0,0,0,0,0,2025-12-09,67.0,801.0,Female,75.0,LENALIDOMIDE,b-cell type acute leukaemia,1,0,0.0,Senior,US,0.15413533834586465,19,1,27,0,0,0,0,0,0,0,4,2025,12,9,1,0.08936301793444651,10.327067669172932,0.15413533834586465
26134409,EU,EU,1,1.0,0,0,1,0,2025-12-09,29.0,801.0,Female,75.0,PREDNISOLONE,blood corticotrophin decreased,1,3,0.21428571428571427,Young,EU,0.35714285714285715,2,1,30,0,0,0,0,0,0,0,3,2025,12,9,1,0.08073634859349145,10.357142857142858,0.35714285714285715
25840168,US,US,1,1.0,0,0,0,0,2025-09-24,57.0,801.0,Female,75.0,NUCALA,underdose,1,0,0.0,MidAge,US,0.0,2,0,9,0,0,0,0,0,0,0,1,2025,9,24,2,0.08073634859349145,0.0,0.0
25843408,US,US,1,2.0,0,0,0,0,2025-09-24,59.0,801.0,Female,75.0,DUPIXENT,fatigue,0,0,0.0,MidAge,US,0.015513897866839042,221,0,7,0,0,0,0,0,0,0,1,2025,9,24,2,0.08073634859349145,0.9153199741435035,0.015513897866839042
25845028,EU,EU,1,1.0,0,0,1,0,2025-09-25,57.0,801.0,Female,75.0,METOPROLOL SUCCINATE,upper respiratory tract infection,1,3,0.21428571428571427,MidAge,EU,0.21428571428571427,1,1,33,0,1,0,0,0,0,0,4,2025,9,25,3,0.08073634859349145,12.214285714285714,0.21428571428571427
25851737,IN,IN,2,1.0,0,0,1,0,2025-09-26,65.0,801.0,Female,75.0,PERJETA,off label use,1,3,0.21428571428571427,MidAge,IN,0.21428571428571427,2,1,13,0,0,0,0,0,0,0,3,2025,9,26,4,0.08936301793444651,13.928571428571427,0.21428571428571427
25852075,EU,EU,1,1.0,0,0,1,0,2025-09-26,57.0,801.0,Female,75.0,DIAZEPAM,drug ineffective,1,3,0.21428571428571427,MidAge,EU,0.2619047619047619,3,1,16,0,0,0,0,0,0,0,2,2025,9,26,4,0.08073634859349145,14.928571428571429,0.2619047619047619
25853519,US,US,1,2.0,0,0,0,0,2025-09-26,57.0,801.0,Female,75.0,JOENJA,ear infection,0,0,0.0,MidAge,US,0.0,3,0,13,0,1,0,0,0,0,0,2,2025,9,26,4,0.08073634859349145,0.0,0.0
25854787,US,US,1,2.0,0,0,0,0,2025-09-27,75.0,801.0,Female,62.142,CREON,paraesthesia,0,0,0.0,Senior,US,0.03296703296703297,13,0,12,0,0,0,0,0,0,0,1,2025,9,27,5,0.08073634859349145,2.4725274725274726,0.03296703296703297
26134733,EU,EU,1,1.0,0,0,1,0,2025-12-09,63.0,801.0,Male,75.0,CYCLOPHOSPHAMIDE,sars-cov-2 test positive,1,3,0.21428571428571427,MidAge,EU,0.21428571428571427,2,1,24,0,0,0,0,0,0,0,3,2025,12,9,1,0.08073634859349145,13.5,0.0
26135381,US,US,1,2.0,0,0,0,0,2025-12-09,57.0,801.0,Female,68.027,ESTRADIOL,product ineffective,0,0,0.0,MidAge,US,0.0,8,0,19,0,0,0,0,0,0,0,2,2025,12,9,1,0.08073634859349145,0.0,0.0
26136610,US,US,1,2.0,0,0,0,0,2025-12-09,57.0,801.0,Female,75.0,RYBREVANT,adverse event,0,0,0.0,MidAge,US,0.05357142857142857,4,0,13,0,0,0,0,0,0,0,2,2025,12,9,1,0.08073634859349145,3.0535714285714284,0.05357142857142857
26138311,US,Unknown,2,1.0,1,0,0,0,2025-12-10,57.0,801.0,Female,75.0,LENALIDOMIDE,death,1,5,0.35714285714285715,MidAge,US,0.15413533834586465,19,1,5,0,0,1,0,0,0,0,1,2025,12,10,2,0.08936301793444651,8.785714285714285,0.15413533834586465
25917123,CA,CA,1,1.0,0,0,1,0,2025-10-14,57.0,801.0,Female,75.0,INFLIXIMAB,faecal vomiting,1,3,0.21428571428571427,MidAge,CA,0.07142857142857142,9,0,15,0,0,0,0,0,0,0,2,2025,10,14,1,0.08073634859349145,4.071428571428571,0.07142857142857142
25918539,EU,EU,1,1.0,0,0,1,0,2025-10-14,17.0,801.0,Female,75.0,PREGABALIN,drug use disorder,1,3,0.21428571428571427,Child,EU,0.10714285714285714,6,0,17,0,0,0,0,0,0,0,3,2025,10,14,1,0.08073634859349145,1.8214285714285714,0.10714285714285714
25862591,EU,EU,1,1.0,0,0,1,0,2025-09-30,78.0,801.0,Male,170.0,RITONAVIR,confusional state,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,17,0,0,0,0,0,0,0,2,2025,9,30,1,0.08073634859349145,16.71428571428571,0.0
25866937,US,US,1,2.0,0,0,0,0,2025-10-01,72.0,801.0,Female,64.853,TYVASO,dyspnoea,0,0,0.0,Senior,US,0.0,2,0,8,0,0,0,0,0,0,0,1,2025,10,1,2,0.08073634859349145,0.0,0.0
25867895,US,US,1,1.0,0,0,0,1,2025-10-01,58.0,801.0,Female,75.0,CARBOPLATIN,deafness,1,2,0.14285714285714285,MidAge,US,0.12244897959183673,7,0,8,0,0,0,0,0,0,0,1,2025,10,1,2,0.08073634859349145,7.1020408163265305,0.12244897959183673
25868180,US,US,2,1.0,0,0,1,0,2025-10-01,72.0,801.0,Male,75.0,SKYRIZI,balance disorder,1,3,0.21428571428571427,Senior,US,0.051587301587301584,36,0,16,0,0,0,0,0,0,0,2,2025,10,1,2,0.08936301793444651,3.714285714285714,0.0
25868490,US,US,1,2.0,0,0,0,0,2025-10-01,57.0,801.0,Female,75.0,SYMBICORT,cough,0,0,0.0,MidAge,US,0.0,2,0,5,0,0,0,0,0,0,0,1,2025,10,1,2,0.08073634859349145,0.0,0.0
25918634,US,Unknown,1,2.0,0,0,0,0,2025-10-10,57.0,801.0,Female,75.0,ZYPREXA,treatment failure,0,0,0.0,MidAge,US,0.0,1,0,17,0,0,0,0,1,0,0,2,2025,10,10,4,0.08073634859349145,0.0,0.0
25918810,US,US,1,2.0,0,0,0,0,2025-10-14,57.0,801.0,Female,75.0,ESTRADIOL,device adhesion issue,0,0,0.0,MidAge,US,0.0,8,0,21,0,0,0,0,0,0,0,3,2025,10,14,1,0.08073634859349145,0.0,0.0
25919701,ZA,ZA,2,1.0,0,0,1,0,2025-10-14,54.0,801.0,Male,75.0,INSULIN GLARGINE,gangrene,1,3,0.21428571428571427,MidAge,ZA,0.21428571428571427,1,1,8,0,0,0,0,0,0,0,1,2025,10,14,1,0.08936301793444651,11.571428571428571,0.0
25920310,CA,CA,1,1.0,0,0,0,0,2025-10-14,8.0,801.0,Male,75.0,MYCOPHENOLATE MOFETIL,post transplant lymphoproliferative disorder,1,0,0.0,Child,CA,0.10150375939849625,19,0,44,0,0,0,0,0,0,0,4,2025,10,14,1,0.08073634859349145,0.81203007518797,0.0
25921335,US,US,1,2.0,0,0,0,0,2025-10-14,62.0,801.0,Female,98.41,KEVZARA,inflammation,0,0,0.0,MidAge,US,0.14285714285714285,4,1,12,0,0,0,0,0,0,0,1,2025,10,14,1,0.08073634859349145,8.857142857142856,0.14285714285714285
25921779,US,US,1,2.0,0,0,0,0,2025-10-14,57.0,801.0,Male,80.907,TYVASO DPI,inappropriate schedule of product administration,0,0,0.0,MidAge,US,0.0,4,0,48,0,0,0,0,0,0,0,5,2025,10,14,1,0.08073634859349145,0.0,0.0
25922536,US,US,1,2.0,0,0,0,0,2025-10-15,57.0,801.0,Female,75.0,IQIRVO,nausea,0,0,0.0,MidAge,US,0.0,2,0,6,0,0,0,0,0,0,0,1,2025,10,15,2,0.08073634859349145,0.0,0.0
25922927,US,US,1,2.0,0,0,0,0,2025-10-15,18.0,801.0,Male,75.0,DUPIXENT,rash erythematous,0,0,0.0,Child,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,10,15,2,0.08073634859349145,0.27925016160310273,0.0
25869772,US,US,1,2.0,0,0,0,0,2025-10-01,57.0,801.0,Female,75.0,XEOMIN,drug ineffective,0,0,0.0,MidAge,US,0.08928571428571429,4,0,16,0,0,0,0,0,0,0,2,2025,10,1,2,0.08073634859349145,5.089285714285714,0.08928571428571429
25871191,EU,EU,1,1.0,0,1,1,0,2025-10-01,71.0,801.0,Female,75.0,MYCOPHENOLATE MOFETIL,meningitis listeria,1,7,0.5,Senior,EU,0.10150375939849625,19,0,19,0,0,0,0,0,0,0,2,2025,10,1,2,0.08073634859349145,7.206766917293233,0.10150375939849625
25872244,US,US,1,2.0,0,0,0,0,2025-10-02,57.0,801.0,Female,75.0,DUPIXENT,injection site pain,0,0,0.0,MidAge,US,0.015513897866839042,221,0,19,1,0,0,0,0,0,0,3,2025,10,2,3,0.08073634859349145,0.8842921784098254,0.015513897866839042
25874565,IN,IN,1,1.0,0,0,0,0,2025-10-02,21.0,801.0,Male,75.0,ACETAMINOPHEN,acute generalised exanthematous pustulosis,1,0,0.0,Young,IN,0.10267857142857142,16,0,42,0,0,0,0,0,0,0,4,2025,10,2,3,0.08073634859349145,2.15625,0.0
25875012,US,US,1,1.0,0,0,0,0,2025-10-02,79.0,801.0,Female,75.3,REVLIMID,rash,1,0,0.0,Senior,US,0.05357142857142857,4,0,4,0,0,0,0,0,0,0,1,2025,10,2,3,0.08073634859349145,4.232142857142857,0.05357142857142857
25875713,US,US,1,2.0,0,0,0,0,2025-10-03,83.0,801.0,Female,75.0,DUPIXENT,dyspnoea,0,0,0.0,Senior,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,10,3,4,0.08073634859349145,1.2876535229476405,0.015513897866839042
25876361,US,US,2,1.0,0,0,1,0,2025-10-03,68.0,801.0,Female,75.0,TREMFYA,spinal stenosis,1,3,0.21428571428571427,Senior,US,0.10714285714285714,2,0,15,0,0,0,0,0,0,0,2,2025,10,3,4,0.08936301793444651,7.285714285714286,0.10714285714285714
25876914,US,US,1,2.0,0,0,0,0,2025-10-03,57.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,MidAge,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,10,3,4,0.08073634859349145,0.8842921784098254,0.015513897866839042
25876981,CN,CN,1,1.0,0,0,1,0,2025-10-03,57.0,801.0,Male,75.0,MYCOPHENOLATE MOFETIL,white blood cell count decreased,1,3,0.21428571428571427,MidAge,CN,0.10150375939849625,19,0,32,0,0,0,0,0,0,0,5,2025,10,3,4,0.08073634859349145,5.7857142857142865,0.0
25877076,US,US,1,2.0,0,0,0,0,2025-10-03,24.0,801.0,Male,75.0,DUPIXENT,eczema,0,0,0.0,Young,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,10,3,4,0.08073634859349145,0.372333548804137,0.0
25877238,VE,VE,2,1.0,0,0,0,0,2025-10-03,57.0,801.0,Female,75.0,ENOXAPARIN SODIUM,pulmonary embolism,1,0,0.0,MidAge,Other,0.0,2,0,18,0,0,0,0,0,0,0,2,2025,10,3,4,0.08936301793444651,0.0,0.0
25927597,US,US,1,2.0,0,0,0,0,2025-10-16,57.0,801.0,Female,75.0,JEMPERLI,chest discomfort,0,0,0.0,MidAge,US,0.0,1,0,16,0,0,0,0,0,0,0,2,2025,10,16,3,0.08073634859349145,0.0,0.0
25927759,US,US,1,1.0,0,0,1,0,2025-10-16,63.0,801.0,Female,75.0,TACROLIMUS,hypogammaglobulinaemia,1,3,0.21428571428571427,MidAge,US,0.09183673469387754,7,0,22,0,0,0,0,0,0,0,1,2025,10,16,3,0.08073634859349145,5.785714285714285,0.09183673469387754
25929636,US,Unknown,1,1.0,0,0,1,0,2025-10-15,47.0,801.0,Male,75.0,TACROLIMUS,transplant rejection,1,3,0.21428571428571427,Adult,US,0.09183673469387754,7,0,20,0,0,0,0,0,0,0,2,2025,10,15,2,0.08073634859349145,4.316326530612244,0.0
25878400,US,US,1,2.0,0,0,0,0,2025-10-03,29.0,801.0,Female,75.0,ZEPBOUND,tooth fracture,0,0,0.0,Young,US,0.0,2,0,14,0,0,0,0,0,0,0,2,2025,10,3,4,0.08073634859349145,0.0,0.0
25878439,US,US,1,2.0,0,0,0,0,2025-10-03,61.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,MidAge,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,10,3,4,0.08073634859349145,0.9463477698771816,0.015513897866839042
25878897,EU,EU,1,1.0,0,0,1,0,2025-10-03,57.0,801.0,Female,75.0,OMEPRAZOLE,cerebellar syndrome,1,3,0.21428571428571427,MidAge,EU,0.07142857142857142,3,0,19,0,0,0,0,0,0,0,2,2025,10,3,4,0.08073634859349145,4.071428571428571,0.07142857142857142
25879816,US,US,1,2.0,0,0,0,0,2025-10-03,3.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Child,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,10,3,4,0.08073634859349145,0.046541693600517124,0.015513897866839042
25880182,US,US,1,2.0,0,0,0,0,2025-10-04,57.0,801.0,Male,75.0,OTEZLA,therapeutic product effect incomplete,0,0,0.0,MidAge,US,0.0,4,0,37,0,0,0,0,0,0,0,4,2025,10,4,5,0.08073634859349145,0.0,0.0
26155011,US,US,1,2.0,0,0,0,0,2025-12-15,57.0,801.0,Male,75.0,KISUNLA,muscle spasms,0,0,0.0,MidAge,US,0.0,1,0,13,0,0,0,0,0,0,0,2,2025,12,15,0,0.08073634859349145,0.0,0.0
26155402,AU,AU,1,2.0,0,0,0,0,2025-12-15,32.0,801.0,Female,75.0,AZATHIOPRINE,parvovirus b19 infection,0,0,0.0,Young,AU,0.0,2,0,24,0,1,0,0,0,0,0,3,2025,12,15,0,0.08073634859349145,0.0,0.0
25893209,EU,EU,1,1.0,0,0,0,0,2025-10-08,55.0,801.0,Female,49.0,LETROZOLE,migraine,1,0,0.0,MidAge,EU,0.07142857142857142,3,0,8,0,0,0,0,0,0,0,1,2025,10,8,2,0.08073634859349145,3.9285714285714284,0.07142857142857142
25893276,US,US,1,2.0,0,0,0,0,2025-10-08,42.0,801.0,Female,75.0,DUPIXENT,tremor,0,0,0.0,Adult,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,10,8,2,0.08073634859349145,0.6515837104072397,0.015513897866839042
25271098,US,US,2,1.0,0,0,0,0,2025-05-06,57.0,801.0,Male,75.0,EPIDIOLEX,bipolar disorder,1,0,0.0,MidAge,US,0.14285714285714285,3,1,16,0,0,0,0,0,0,0,2,2025,5,6,1,0.08936301793444651,8.142857142857142,0.0
25273933,US,US,1,1.0,0,0,0,0,2025-05-06,57.0,801.0,Male,75.0,VONJO,foreign body in throat,1,0,0.0,MidAge,US,0.0,3,0,22,0,0,0,0,0,0,0,4,2025,5,6,1,0.08073634859349145,0.0,0.0
25283181,EU,EU,1,1.0,0,1,1,0,2025-05-08,23.0,801.0,Male,75.0,LACOSAMIDE,blood creatine phosphokinase increased,1,7,0.5,Young,EU,0.16666666666666666,3,1,38,0,0,0,0,0,0,0,4,2025,5,8,3,0.08073634859349145,3.833333333333333,0.0
25291524,US,US,1,1.0,0,0,1,0,2025-05-10,52.0,801.0,Female,94.8,DUPIXENT,sepsis,1,3,0.21428571428571427,MidAge,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,5,10,5,0.08073634859349145,0.8067226890756302,0.015513897866839042
25293979,US,US,1,2.0,0,0,0,0,2025-05-10,62.0,801.0,Male,75.0,DUPIXENT,cough,0,0,0.0,MidAge,US,0.015513897866839042,221,0,5,0,0,0,0,0,0,0,1,2025,5,10,5,0.08073634859349145,0.9618616677440206,0.0
25299878,US,US,1,1.0,0,0,1,0,2025-05-12,77.0,801.0,Female,75.0,ORENCIA,hospitalisation,1,3,0.21428571428571427,Senior,US,0.10204081632653061,14,0,15,0,0,0,0,0,0,0,1,2025,5,12,0,0.08073634859349145,7.857142857142858,0.10204081632653061
25307872,CA,CA,2,1.0,0,0,1,0,2025-05-13,58.0,801.0,Male,75.0,VEDOLIZUMAB,intestinal stenosis,1,3,0.21428571428571427,MidAge,CA,0.057692307692307696,26,0,19,0,0,0,0,0,0,0,2,2025,5,13,1,0.08936301793444651,3.3461538461538463,0.0
25321265,US,US,2,1.0,0,0,0,0,2025-05-15,52.0,801.0,Male,75.0,SKYRIZI,bladder cancer recurrent,1,0,0.0,MidAge,US,0.051587301587301584,36,0,24,0,0,0,1,0,0,0,3,2025,5,15,3,0.08936301793444651,2.6825396825396823,0.0
25326530,US,US,1,2.0,0,0,0,0,2025-05-16,16.0,801.0,Male,75.0,DUPIXENT,incorrect dose administered,0,0,0.0,Child,US,0.015513897866839042,221,0,27,0,0,0,0,0,0,0,3,2025,5,16,4,0.08073634859349145,0.24822236586942467,0.0
25344026,US,US,1,2.0,0,0,0,0,2025-05-21,29.0,801.0,Male,75.0,DUPIXENT,nasal congestion,0,0,0.0,Young,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,2,2025,5,21,2,0.08073634859349145,0.4499030381383322,0.0
25355257,US,US,1,2.0,0,0,0,0,2025-05-24,57.0,801.0,Female,75.0,RUCONEST,weight decreased,0,0,0.0,MidAge,US,0.0,1,0,16,0,0,0,0,0,0,0,2,2025,5,24,5,0.08073634859349145,0.0,0.0
25367865,EU,EU,1,1.0,0,0,0,0,2025-05-28,38.0,801.0,Female,75.0,DULOXETINE,drug abuse,1,0,0.0,Adult,EU,0.0,2,0,10,0,0,0,0,0,0,0,2,2025,5,28,2,0.08073634859349145,0.0,0.0
25382110,US,US,1,2.0,0,0,0,0,2025-05-31,57.0,801.0,Female,75.0,ZYMFENTRA,vein rupture,0,0,0.0,MidAge,US,0.0,1,0,12,0,0,0,0,0,0,0,2,2025,5,31,5,0.08073634859349145,0.0,0.0
25446449,US,Unknown,1,2.0,0,0,0,0,2025-06-17,57.0,801.0,Female,75.0,BIMZELX,acne cystic,0,0,0.0,MidAge,US,0.0,22,0,11,0,0,0,0,0,0,0,2,2025,6,17,1,0.08073634859349145,0.0,0.0
25446692,US,Unknown,1,2.0,0,0,0,0,2025-06-17,54.0,801.0,Female,75.0,BIMZELX,migraine,0,0,0.0,MidAge,US,0.0,22,0,8,0,0,0,0,0,0,0,1,2025,6,17,1,0.08073634859349145,0.0,0.0
25446759,US,Unknown,1,2.0,0,0,0,0,2025-06-17,57.0,801.0,Female,75.0,BIMZELX,candida infection,0,0,0.0,MidAge,US,0.0,22,0,17,0,1,0,0,0,0,0,2,2025,6,17,1,0.08073634859349145,0.0,0.0
25449460,US,US,1,1.0,0,0,0,0,2025-06-18,42.0,801.0,Female,74.83,PARAGARD T 380A,surgery,1,0,0.0,Adult,US,0.0,4,0,7,0,0,0,0,0,0,0,1,2025,6,18,2,0.08073634859349145,0.0,0.0
25449851,US,Unknown,1,2.0,0,0,0,0,2025-06-18,41.0,801.0,Female,75.0,BIMZELX,injection site pain,0,0,0.0,Adult,US,0.0,22,0,19,1,0,0,0,0,0,0,3,2025,6,18,2,0.08073634859349145,0.0,0.0
25465350,CA,CA,2,1.0,0,0,0,0,2025-06-22,53.0,801.0,Male,75.0,REMICADE,prostatomegaly,1,0,0.0,MidAge,CA,0.0,3,0,14,0,0,0,0,0,0,0,1,2025,6,22,6,0.08936301793444651,0.0,0.0
25485019,EU,EU,1,1.0,0,0,0,0,2025-06-26,13.0,801.0,Female,68.0,SERTRALINE,multiple acyl-coenzyme a dehydrogenase deficiency,1,0,0.0,Child,EU,0.0,1,0,49,0,0,0,0,0,0,0,5,2025,6,26,3,0.08073634859349145,0.0,0.0
25491566,US,US,2,1.0,0,0,0,0,2025-06-29,77.0,801.0,Female,75.0,SKYRIZI,mastectomy,1,0,0.0,Senior,US,0.051587301587301584,36,0,10,0,0,0,0,0,0,0,1,2025,6,29,6,0.08936301793444651,3.972222222222222,0.051587301587301584
25501814,US,US,2,1.0,0,0,0,0,2025-07-02,57.0,801.0,Male,75.0,RINVOQ,back pain,1,0,0.0,MidAge,US,0.0,3,0,9,1,0,0,0,0,0,0,2,2025,7,2,2,0.08936301793444651,0.0,0.0
25509724,JP,JP,2,1.0,1,0,0,0,2025-07-03,57.0,801.0,Female,75.0,EFGARTIGIMOD ALFA,sudden death,1,5,0.35714285714285715,MidAge,JP,0.35714285714285715,1,1,12,0,0,1,0,0,0,0,2,2025,7,3,3,0.08936301793444651,20.357142857142858,0.35714285714285715
26172708,US,US,1,1.0,0,0,0,0,2025-12-18,49.0,801.0,Male,75.0,ORENCIA,erythema,1,0,0.0,Adult,US,0.10204081632653061,14,0,8,0,0,0,0,0,0,0,1,2025,12,18,3,0.08073634859349145,5.0,0.0
26173909,CN,CN,1,1.0,0,0,1,0,2025-12-18,49.0,801.0,Female,75.0,PERJETA,myelosuppression,1,3,0.21428571428571427,Adult,CN,0.21428571428571427,2,1,16,0,0,0,0,0,0,0,1,2025,12,18,3,0.08073634859349145,10.5,0.21428571428571427
26174032,CA,CA,2,1.0,0,0,0,0,2025-12-18,80.0,801.0,Female,75.0,VEDOLIZUMAB,haematochezia,1,0,0.0,Senior,CA,0.057692307692307696,26,0,13,0,0,0,0,0,0,0,1,2025,12,18,3,0.08936301793444651,4.615384615384616,0.057692307692307696
26174423,US,US,1,2.0,0,0,0,0,2025-12-18,57.0,801.0,Male,75.0,DUPIXENT,drug ineffective,0,0,0.0,MidAge,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,2,2025,12,18,3,0.08073634859349145,0.8842921784098254,0.0
26174476,US,US,1,2.0,0,0,0,0,2025-12-18,52.0,801.0,Male,75.0,VASCEPA,hypertension,0,0,0.0,MidAge,US,0.0,2,0,12,0,0,0,0,0,0,0,1,2025,12,18,3,0.08073634859349145,0.0,0.0
25907331,JP,JP,1,1.0,0,0,1,0,2025-10-10,84.0,801.0,Female,49.9,TAVNEOS,drug-induced liver injury,1,3,0.21428571428571427,Senior,JP,0.21428571428571427,1,1,25,0,0,0,0,0,0,0,3,2025,10,10,4,0.08073634859349145,18.0,0.21428571428571427
25907803,GB,GB,1,1.0,0,0,1,0,2025-10-10,65.0,801.0,Female,99.0,DOCETAXEL,cardiotoxicity,1,3,0.21428571428571427,MidAge,GB,0.061224489795918366,7,0,14,0,0,0,0,0,0,0,1,2025,10,10,4,0.08073634859349145,3.9795918367346936,0.061224489795918366
25908895,US,US,1,2.0,0,0,0,0,2025-10-11,71.0,801.0,Female,75.0,HUMALOG,blood glucose increased,0,0,0.0,Senior,US,0.05357142857142857,4,0,23,0,0,0,0,0,0,0,3,2025,10,11,5,0.08073634859349145,3.8035714285714284,0.05357142857142857
25910557,US,US,1,2.0,0,0,0,0,2025-10-13,47.0,801.0,Female,75.0,DUPIXENT,psoriasis,0,0,0.0,Adult,US,0.015513897866839042,221,0,9,0,0,0,0,0,0,0,1,2025,10,13,0,0.08073634859349145,0.729153199741435,0.015513897866839042
25956595,GB,GB,1,1.0,0,0,0,0,2025-10-24,74.0,801.0,Male,99.0,BISOPROLOL FUMARATE,wheezing,1,0,0.0,Senior,GB,0.0,1,0,8,0,0,0,0,0,0,0,1,2025,10,24,4,0.08073634859349145,0.0,0.0
25957123,GB,GB,1,1.0,0,0,0,0,2025-10-24,57.0,801.0,Male,75.0,CLOZARIL,eosinophilia,1,0,0.0,MidAge,GB,0.10714285714285714,4,0,12,0,0,0,0,0,0,0,1,2025,10,24,4,0.08073634859349145,6.107142857142857,0.0
25958243,EU,EU,1,1.0,0,0,0,0,2025-10-24,95.0,801.0,Male,75.0,MIRTAZAPINE,wrong product administered,1,0,0.0,Senior,EU,0.19047619047619047,3,1,26,0,0,0,0,0,0,0,3,2025,10,24,4,0.08073634859349145,18.095238095238095,0.0
25958715,JP,JP,1,1.0,0,0,1,0,2025-10-24,71.0,801.0,Male,75.0,GAZYVA,pneumonia,1,3,0.21428571428571427,Senior,JP,0.21428571428571427,1,1,9,0,0,0,0,0,1,0,1,2025,10,24,4,0.08073634859349145,15.214285714285714,0.0
25531675,CA,CA,2,1.0,0,0,1,0,2025-07-09,88.0,801.0,Male,75.0,VEDOLIZUMAB,diarrhoea,1,3,0.21428571428571427,Senior,CA,0.057692307692307696,26,0,9,0,0,0,0,0,0,0,1,2025,7,9,2,0.08936301793444651,5.0769230769230775,0.0
25544406,CA,CA,2,1.0,0,0,1,0,2025-07-11,65.0,801.0,Male,75.0,ADALIMUMAB,device issue,1,3,0.21428571428571427,MidAge,CA,0.07142857142857142,3,0,12,0,0,0,0,0,0,0,2,2025,7,11,4,0.08936301793444651,4.642857142857142,0.0
25555961,US,US,1,2.0,0,0,0,0,2025-07-15,53.0,801.0,Female,75.0,DUPIXENT,asthma,0,0,0.0,MidAge,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,7,15,1,0.08073634859349145,0.8222365869424693,0.015513897866839042
25567759,US,US,2,1.0,0,0,0,0,2025-07-16,58.0,801.0,Female,75.0,VEDOLIZUMAB,colitis ulcerative,1,0,0.0,MidAge,US,0.057692307692307696,26,0,18,0,0,0,0,0,0,0,2,2025,7,16,2,0.08936301793444651,3.3461538461538463,0.057692307692307696
25574038,JP,JP,1,1.0,0,0,0,0,2025-07-17,57.0,801.0,Male,75.0,LENVIMA,hepatic function abnormal,1,0,0.0,MidAge,JP,0.07142857142857142,2,0,25,0,0,0,0,0,0,0,3,2025,7,17,3,0.08073634859349145,4.071428571428571,0.0
25581638,CN,CN,1,1.0,0,1,0,0,2025-07-19,61.0,801.0,Female,75.0,DEXAMETHASONE,neutropenia,1,4,0.2857142857142857,MidAge,CN,0.1857142857142857,5,1,11,0,0,0,0,0,0,0,1,2025,7,19,5,0.08073634859349145,11.328571428571427,0.1857142857142857
26175705,US,US,1,2.0,0,0,0,0,2025-12-18,57.0,801.0,Male,86.36,DUPIXENT,enterobiasis,0,0,0.0,MidAge,US,0.015513897866839042,221,0,12,0,0,0,0,0,0,0,1,2025,12,18,3,0.08073634859349145,0.8842921784098254,0.0
26176744,US,US,1,2.0,0,0,0,0,2025-12-18,57.0,801.0,Male,75.0,SKYRIZI,nephrolithiasis,0,0,0.0,MidAge,US,0.051587301587301584,36,0,15,0,0,0,0,0,0,0,1,2025,12,18,3,0.08073634859349145,2.9404761904761902,0.0
26176959,US,US,1,2.0,0,0,0,0,2025-12-18,57.0,801.0,Female,75.0,PLUVICTO,general physical health deterioration,0,0,0.0,MidAge,US,0.0,8,0,37,0,0,0,0,0,0,0,4,2025,12,18,3,0.08073634859349145,0.0,0.0
26177297,US,US,1,2.0,0,0,0,0,2025-12-19,57.0,801.0,Female,75.0,FLUOXETINE,depression,0,0,0.0,MidAge,US,0.0,1,0,10,0,0,0,0,0,0,0,1,2025,12,19,4,0.08073634859349145,0.0,0.0
26177783,US,US,1,1.0,0,0,0,0,2025-12-19,57.0,801.0,Male,75.0,RISPERDAL,galactorrhoea,1,0,0.0,MidAge,US,0.0,1,0,13,0,0,0,0,0,0,0,1,2025,12,19,4,0.08073634859349145,0.0,0.0
26178621,US,US,1,2.0,0,0,0,0,2025-12-19,57.0,801.0,Female,75.0,DUPIXENT,pain in extremity,0,0,0.0,MidAge,US,0.015513897866839042,221,0,17,1,0,0,0,0,0,0,3,2025,12,19,4,0.08073634859349145,0.8842921784098254,0.015513897866839042
26178836,US,US,1,2.0,0,0,0,0,2025-12-19,57.0,801.0,Female,75.0,SELINEXOR,pneumonia,0,0,0.0,MidAge,US,0.0,1,0,9,0,0,0,0,0,1,0,1,2025,12,19,4,0.08073634859349145,0.0,0.0
26178850,EU,EU,1,1.0,0,1,1,0,2025-12-19,42.0,801.0,Female,53.0,VENLAFAXINE,cardio-respiratory arrest,1,7,0.5,Adult,EU,0.25,2,1,25,0,0,0,0,0,0,0,2,2025,12,19,4,0.08073634859349145,10.5,0.25
25911691,US,US,2,1.0,0,0,0,0,2025-10-13,57.0,801.0,Female,75.0,SKYRIZI,cataract,1,0,0.0,MidAge,US,0.051587301587301584,36,0,8,0,0,0,0,0,0,0,1,2025,10,13,0,0.08936301793444651,2.9404761904761902,0.051587301587301584
25911705,US,US,1,2.0,0,0,0,0,2025-10-13,21.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Young,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,10,13,0,0.08073634859349145,0.32579185520361986,0.015513897866839042
25912205,US,US,1,2.0,0,0,0,0,2025-10-13,43.0,801.0,Female,75.0,DUPIXENT,extra dose administered,0,0,0.0,Adult,US,0.015513897866839042,221,0,23,0,0,0,0,0,0,0,3,2025,10,13,0,0.08073634859349145,0.6670976082740788,0.015513897866839042
25913244,US,US,1,2.0,0,0,0,0,2025-10-13,41.0,801.0,Female,75.0,XOLAIR,product storage error,0,0,0.0,Adult,US,0.14285714285714285,4,1,21,0,0,0,0,0,0,0,3,2025,10,13,0,0.08073634859349145,5.857142857142857,0.14285714285714285
25959888,US,US,1,2.0,0,0,0,0,2025-10-26,15.0,801.0,Male,75.0,DUPIXENT,dysphagia,0,0,0.0,Child,US,0.015513897866839042,221,0,9,0,0,0,0,0,0,0,1,2025,10,26,6,0.08073634859349145,0.23270846800258563,0.0
25959983,US,US,1,2.0,0,0,0,0,2025-10-26,57.0,801.0,Male,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,MidAge,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,10,26,6,0.08073634859349145,0.8842921784098254,0.0
25960039,US,US,1,2.0,0,0,0,0,2025-10-26,57.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,MidAge,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,10,26,6,0.08073634859349145,0.8842921784098254,0.015513897866839042
25963265,US,US,1,1.0,0,0,1,0,2025-10-27,53.0,801.0,Male,75.0,HUMALOG,renal failure,1,3,0.21428571428571427,MidAge,US,0.05357142857142857,4,0,13,0,0,0,0,1,0,0,2,2025,10,27,0,0.08073634859349145,2.839285714285714,0.0
25963980,CA,CA,1,1.0,0,0,0,0,2025-10-27,53.0,801.0,Female,75.0,GABAPENTIN,treatment failure,1,0,0.0,MidAge,CA,0.061224489795918366,7,0,17,0,0,0,0,1,0,0,2,2025,10,27,0,0.08073634859349145,3.2448979591836733,0.061224489795918366
26180336,CA,CA,2,1.0,0,0,0,0,2025-12-19,78.0,801.0,Male,58.05,METHOTREXATE SODIUM,bronchiectasis,1,0,0.0,Senior,CA,0.125,4,1,14,0,0,0,0,0,0,0,1,2025,12,19,4,0.08936301793444651,9.75,0.0
26180794,EU,EU,1,1.0,0,0,1,0,2025-12-21,84.0,801.0,Female,75.0,WELLBUTRIN XL,vertigo,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,7,0,0,0,0,0,0,0,1,2025,12,21,6,0.08073634859349145,18.0,0.21428571428571427
26180808,EU,EU,1,1.0,0,0,0,0,2025-12-21,72.0,801.0,Male,75.0,LENALIDOMIDE,diabetes mellitus,1,0,0.0,Senior,EU,0.15413533834586465,19,1,17,0,0,0,0,0,0,0,2,2025,12,21,6,0.08073634859349145,11.097744360902254,0.0
26181241,US,US,1,2.0,0,0,0,0,2025-12-21,57.0,801.0,Female,75.0,PLUVICTO,general physical health deterioration,0,0,0.0,MidAge,US,0.0,8,0,37,0,0,0,0,0,0,0,4,2025,12,21,6,0.08073634859349145,0.0,0.0
26181403,US,US,1,2.0,0,0,0,0,2025-12-21,57.0,801.0,Male,75.0,SUTAB,pain,0,0,0.0,MidAge,US,0.0,2,0,4,1,0,0,0,0,0,0,1,2025,12,21,6,0.08073634859349145,0.0,0.0
26182886,GB,GB,1,1.0,0,0,0,0,2025-12-21,30.0,801.0,Female,55.0,DYSPORT,laryngospasm,1,0,0.0,Young,GB,0.0,1,0,12,0,0,0,0,0,0,0,1,2025,12,21,6,0.08073634859349145,0.0,0.0
25915903,EU,EU,1,1.0,0,0,0,0,2025-10-13,85.0,801.0,Male,82.0,DARZALEX,pleurisy,1,0,0.0,Senior,EU,0.0,2,0,8,0,0,0,0,0,0,0,1,2025,10,13,0,0.08073634859349145,0.0,0.0
25916375,US,US,1,2.0,0,0,0,0,2025-10-14,59.0,801.0,Female,75.0,COPAXONE,treatment failure,0,0,0.0,MidAge,US,0.0,2,0,17,0,0,0,0,1,0,0,2,2025,10,14,1,0.08073634859349145,0.0,0.0
25918023,CA,CA,1,1.0,0,0,0,0,2025-10-14,57.0,801.0,Female,75.0,INFLIXIMAB,basal cell carcinoma,1,0,0.0,MidAge,CA,0.07142857142857142,9,0,20,0,0,0,0,0,0,0,3,2025,10,14,1,0.08073634859349145,4.071428571428571,0.07142857142857142
25918076,US,US,1,2.0,0,0,0,0,2025-10-14,57.0,801.0,Female,75.0,ALBUTEROL SULFATE,wrong technique in product usage process,0,0,0.0,MidAge,US,0.0,8,0,40,0,0,0,0,0,0,0,6,2025,10,14,1,0.08073634859349145,0.0,0.0
25595556,EG,EG,2,1.0,0,0,1,0,2025-07-23,65.0,801.0,Female,48.0,LONSURF,decreased immune responsiveness,1,3,0.21428571428571427,MidAge,Other,0.21428571428571427,1,1,31,0,0,0,0,0,0,0,3,2025,7,23,2,0.08936301793444651,13.928571428571427,0.21428571428571427
25596366,GB,GB,1,1.0,0,0,0,0,2025-07-23,19.0,802.0,Female,75.0,CYCLOSPORINE,adenovirus infection,1,0,0.0,Young,GB,0.0,5,0,20,0,1,0,0,0,0,0,2,2025,7,23,2,0.08073634859349145,0.0,0.0
25600148,US,US,1,1.0,0,0,0,0,2025-07-24,57.0,801.0,Female,41.723,FIRDAPSE,cholecystectomy,1,0,0.0,MidAge,US,0.0,3,0,15,0,0,0,0,0,0,0,1,2025,7,24,3,0.08073634859349145,0.0,0.0
25604575,US,US,1,2.0,0,0,0,0,2025-07-25,57.0,801.0,Female,75.0,VYLOY,face oedema,0,0,0.0,MidAge,US,0.0,1,0,11,0,0,0,0,0,0,0,2,2025,7,25,4,0.08073634859349145,0.0,0.0
25626607,US,US,1,2.0,0,0,0,0,2025-07-31,56.0,801.0,Female,75.0,HYRIMOZ,injection site haemorrhage,0,0,0.0,MidAge,US,0.0,1,0,26,0,0,0,0,0,0,0,3,2025,7,31,3,0.08073634859349145,0.0,0.0
25628847,US,US,1,1.0,0,0,1,0,2025-07-31,73.0,801.0,Male,111.11,TRULICITY,intestinal obstruction,1,3,0.21428571428571427,Senior,US,0.04285714285714286,5,0,22,0,0,0,0,0,0,0,2,2025,7,31,3,0.08073634859349145,3.1285714285714286,0.0
25633182,EU,EU,1,1.0,0,0,1,0,2025-08-01,38.0,801.0,Female,75.0,MAGNESIUM SULFATE,respiratory failure,1,3,0.21428571428571427,Adult,EU,0.21428571428571427,1,1,19,0,0,0,0,1,0,0,2,2025,8,1,4,0.08073634859349145,8.142857142857142,0.21428571428571427
25645804,US,US,1,1.0,0,0,0,0,2025-08-05,34.0,801.0,Female,158.73,PARAGARD T 380A,surgery,1,0,0.0,Young,US,0.0,4,0,7,0,0,0,0,0,0,0,1,2025,8,5,1,0.08073634859349145,0.0,0.0
25648315,JP,JP,1,1.0,0,0,1,0,2025-08-06,57.0,801.0,Female,75.0,NEMOLIZUMAB,vomiting,1,3,0.21428571428571427,MidAge,JP,0.21428571428571427,1,1,8,0,0,0,0,0,0,0,1,2025,8,6,2,0.08073634859349145,12.214285714285714,0.21428571428571427
26183467,US,US,1,1.0,0,0,0,0,2025-12-21,57.0,801.0,Female,78.005,ORENITRAM,renal function test abnormal,1,0,0.0,MidAge,US,0.0,2,0,28,0,0,0,0,0,0,0,4,2025,12,21,6,0.08073634859349145,0.0,0.0
26183953,EU,EU,3,1.0,0,0,1,0,2025-12-22,57.0,801.0,Female,75.0,DIAZEPAM,drug use disorder,1,3,0.21428571428571427,MidAge,EU,0.2619047619047619,3,1,17,0,0,0,0,0,0,0,3,2025,12,22,0,0.17857142857142855,14.928571428571429,0.2619047619047619
26185911,US,US,1,1.0,0,0,0,0,2025-12-22,54.0,801.0,Male,105.69,POMALYST,abdominal pain,1,0,0.0,MidAge,US,0.11428571428571428,5,0,14,1,0,0,0,0,0,0,2,2025,12,22,0,0.08073634859349145,6.171428571428571,0.0
26186640,US,Unknown,1,1.0,0,0,1,0,2025-12-19,84.0,801.0,Male,102.0,APIXABAN,gastrointestinal haemorrhage,1,3,0.21428571428571427,Senior,US,0.07142857142857142,3,0,28,0,0,0,0,0,0,0,2,2025,12,19,4,0.08073634859349145,6.0,0.0
26186679,US,US,1,2.0,0,0,0,0,2025-12-22,69.0,801.0,Female,75.0,DUPIXENT,sinusitis,0,0,0.0,Senior,US,0.015513897866839042,221,0,9,0,0,0,0,0,0,0,1,2025,12,22,0,0.08073634859349145,1.070458952811894,0.015513897866839042
26186802,SG,SG,1,1.0,0,0,1,0,2025-12-22,38.0,801.0,Female,106.5,FLUDARABINE,covid-19 pneumonia,1,3,0.21428571428571427,Adult,Other,0.21428571428571427,1,1,18,0,0,0,0,0,1,0,2,2025,12,22,0,0.08073634859349145,8.142857142857142,0.21428571428571427
25964804,EU,EU,1,1.0,0,0,0,0,2025-10-27,57.0,801.0,Female,75.0,NUBEQA,myocardial ischaemia,1,0,0.0,MidAge,EU,0.0,1,0,20,0,0,0,0,0,0,0,2,2025,10,27,0,0.08073634859349145,0.0,0.0
25965195,US,US,1,2.0,0,0,0,0,2025-10-27,57.0,801.0,Female,75.0,DUPIXENT,product storage error,0,0,0.0,MidAge,US,0.015513897866839042,221,0,21,0,0,0,0,0,0,0,3,2025,10,27,0,0.08073634859349145,0.8842921784098254,0.015513897866839042
25967692,EU,EU,1,1.0,0,0,1,0,2025-10-28,46.0,801.0,Male,75.0,OXALIPLATIN,acute kidney injury,1,3,0.21428571428571427,Adult,EU,0.08571428571428572,5,0,19,0,0,0,0,0,0,0,3,2025,10,28,1,0.08073634859349145,3.942857142857143,0.0
25651340,JP,JP,1,1.0,0,0,0,0,2025-08-06,57.0,801.0,Female,75.0,OPDIVO,adrenal insufficiency,1,0,0.0,MidAge,JP,0.08928571428571429,4,0,21,0,0,0,0,0,0,0,2,2025,8,6,2,0.08073634859349145,5.089285714285714,0.08928571428571429
25652460,JP,JP,1,1.0,0,0,0,0,2025-08-07,69.0,801.0,Male,75.0,LIVTENCITY,cerebral infarction,1,0,0.0,Senior,JP,0.0,1,0,19,0,0,0,0,0,0,0,2,2025,8,7,3,0.08073634859349145,0.0,0.0
25652985,US,US,2,1.0,0,0,0,0,2025-08-07,64.0,801.0,Female,75.0,SKYRIZI,rotator cuff repair,1,0,0.0,MidAge,US,0.051587301587301584,36,0,19,0,0,0,0,0,0,0,3,2025,8,7,3,0.08936301793444651,3.3015873015873014,0.051587301587301584
25668537,US,US,1,1.0,0,0,1,0,2025-08-12,57.0,801.0,Female,39.692,REVUFORJ,fungal infection,1,3,0.21428571428571427,MidAge,US,0.21428571428571427,1,1,16,0,1,0,0,0,0,0,2,2025,8,12,1,0.08073634859349145,12.214285714285714,0.21428571428571427
25676651,US,US,1,2.0,0,0,0,0,2025-08-13,57.0,801.0,Female,75.0,ESTRADIOL,device adhesion issue,0,0,0.0,MidAge,US,0.0,8,0,21,0,0,0,0,0,0,0,3,2025,8,13,2,0.08073634859349145,0.0,0.0
25678042,US,US,1,2.0,0,0,0,0,2025-08-13,23.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Young,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,8,13,2,0.08073634859349145,0.35681965093729795,0.015513897866839042
25679067,JP,JP,1,1.0,0,1,1,0,2025-08-14,41.0,801.0,Male,75.0,DAPRODUSTAT,platelet count decreased,1,7,0.5,Adult,JP,0.5,1,1,24,0,0,0,0,0,0,0,3,2025,8,14,3,0.08073634859349145,20.5,0.0
25679500,US,US,2,1.0,0,0,1,0,2025-08-14,73.0,801.0,Female,75.0,NUPLAZID,rectal ulcer haemorrhage,1,3,0.21428571428571427,Senior,US,0.09523809523809523,6,0,24,0,0,0,0,0,0,0,3,2025,8,14,3,0.08936301793444651,6.952380952380952,0.09523809523809523
25689192,EU,EU,2,1.0,0,0,1,0,2025-08-18,72.0,801.0,Female,55.0,ENHERTU,hyperpyrexia,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,12,0,0,0,0,0,0,0,1,2025,8,18,0,0.08936301793444651,15.428571428571427,0.21428571428571427
25923760,US,US,1,2.0,0,0,0,0,2025-10-15,57.0,801.0,Male,75.0,COLUMVI,product administration error,0,0,0.0,MidAge,US,0.0,1,0,28,0,0,0,0,0,0,0,3,2025,10,15,2,0.08073634859349145,0.0,0.0
25923841,US,US,1,2.0,0,0,0,0,2025-10-15,34.0,801.0,Female,75.0,ACCRUFER,maternal exposure during pregnancy,0,0,0.0,Young,US,0.07142857142857142,3,0,34,0,0,0,0,0,0,0,4,2025,10,15,2,0.08073634859349145,2.4285714285714284,0.07142857142857142
25925137,US,US,1,2.0,0,0,0,0,2025-10-15,57.0,801.0,Female,75.0,IQIRVO,product dose omission issue,0,0,0.0,MidAge,US,0.0,2,0,27,0,0,0,0,0,0,0,4,2025,10,15,2,0.08073634859349145,0.0,0.0
25925676,US,US,1,2.0,0,0,0,0,2025-10-15,51.0,801.0,Female,75.0,DUPIXENT,dry skin,0,0,0.0,MidAge,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,2,2025,10,15,2,0.08073634859349145,0.7912087912087912,0.015513897866839042
25926123,EU,EU,1,1.0,0,0,0,0,2025-10-15,58.0,801.0,Female,65.0,VALACYCLOVIR HYDROCHLORIDE,neuropathy peripheral,1,0,0.0,MidAge,EU,0.0,1,0,21,0,0,0,0,0,0,0,2,2025,10,15,2,0.08073634859349145,0.0,0.0
25969016,EU,EU,1,1.0,0,0,0,0,2025-10-28,57.0,801.0,Female,75.0,ALPRAZOLAM,hallucination,1,0,0.0,MidAge,EU,0.14285714285714285,3,1,13,0,0,0,0,0,0,0,1,2025,10,28,1,0.08073634859349145,8.142857142857142,0.14285714285714285
25970326,US,US,2,1.0,0,0,0,0,2025-10-28,76.0,801.0,Female,75.0,CREON,medical procedure,1,0,0.0,Senior,US,0.03296703296703297,13,0,17,0,0,0,0,0,0,0,2,2025,10,28,1,0.08936301793444651,2.5054945054945055,0.03296703296703297
25970474,US,US,1,2.0,0,0,0,0,2025-10-28,57.0,801.0,Male,54.431,HUMIRA,drug ineffective,0,0,0.0,MidAge,US,0.17857142857142858,2,1,16,0,0,0,0,0,0,0,2,2025,10,28,1,0.08073634859349145,10.178571428571429,0.0
25970960,US,US,1,2.0,0,0,0,0,2025-10-28,67.0,801.0,Male,75.0,METHOTREXATE SODIUM,drug ineffective,0,0,0.0,Senior,US,0.125,4,1,16,0,0,0,0,0,0,0,2,2025,10,28,1,0.08073634859349145,8.375,0.0
25928444,IN,IN,3,1.0,0,0,1,0,2025-10-16,29.0,801.0,Male,75.0,CYCLOPHOSPHAMIDE,therapeutic response unexpected,1,3,0.21428571428571427,Young,IN,0.21428571428571427,2,1,31,0,0,0,0,0,0,0,3,2025,10,16,3,0.17857142857142855,6.2142857142857135,0.0
25928754,US,US,1,1.0,0,0,0,0,2025-10-16,84.0,801.0,Male,75.0,ACCRUFER,choking,1,0,0.0,Senior,US,0.07142857142857142,3,0,7,0,0,0,0,0,0,0,1,2025,10,16,3,0.08073634859349145,6.0,0.0
25930793,EU,EU,2,1.0,1,0,0,0,2025-10-16,79.0,801.0,Female,75.0,CARBIDOPA,death,1,5,0.35714285714285715,Senior,EU,0.35714285714285715,1,1,5,0,0,1,0,0,0,0,1,2025,10,16,3,0.08936301793444651,28.214285714285715,0.35714285714285715
25931941,US,US,1,2.0,0,0,0,0,2025-10-16,58.0,801.0,Female,75.0,VUEWAY,rash,0,0,0.0,MidAge,US,0.0,1,0,4,0,0,0,0,0,0,0,1,2025,10,16,3,0.08073634859349145,0.0,0.0
26192324,US,US,1,2.0,0,0,0,0,2025-12-23,82.0,801.0,Male,75.0,DUPIXENT,injection site pain,0,0,0.0,Senior,US,0.015513897866839042,221,0,19,1,0,0,0,0,0,0,3,2025,12,23,1,0.08073634859349145,1.2721396250808015,0.0
26195307,US,US,1,1.0,0,0,1,0,2025-12-24,65.0,801.0,Female,75.0,TACROLIMUS,west nile viral infection,1,3,0.21428571428571427,MidAge,US,0.09183673469387754,7,0,25,0,1,0,0,0,0,0,4,2025,12,24,2,0.08073634859349145,5.969387755102041,0.09183673469387754
26195589,TW,TW,1,1.0,0,0,1,0,2025-12-24,23.0,801.0,Male,75.0,CELECOXIB,toxicity to various agents,1,3,0.21428571428571427,Young,Other,0.21428571428571427,1,1,26,0,0,0,0,0,0,0,4,2025,12,24,2,0.08073634859349145,4.928571428571428,0.0
25981881,EU,EU,1,1.0,0,0,0,0,2025-10-31,57.0,801.0,Female,75.0,RITUXIMAB,disease progression,1,0,0.0,MidAge,EU,0.12406015037593986,19,0,19,0,0,0,0,0,0,0,2,2025,10,31,4,0.08073634859349145,7.071428571428572,0.12406015037593986
25982800,AU,AU,1,1.0,0,0,0,0,2025-10-31,75.0,801.0,Male,75.0,CARBOPLATIN,diffuse large b-cell lymphoma,1,0,0.0,Senior,AU,0.12244897959183673,7,0,29,0,0,0,0,0,0,0,4,2025,10,31,4,0.08073634859349145,9.183673469387754,0.0
25983920,US,Unknown,1,2.0,0,0,0,0,2025-10-31,57.0,801.0,Female,75.0,WINREVAIR,adverse event,0,0,0.0,MidAge,US,0.2619047619047619,3,1,13,0,0,0,0,0,0,0,2,2025,10,31,4,0.08073634859349145,14.928571428571429,0.2619047619047619
25984325,RU,RU,1,1.0,1,0,0,0,2025-10-31,62.0,801.0,Male,75.0,POLATUZUMAB VEDOTIN,neutropenia,1,5,0.35714285714285715,MidAge,Other,0.35714285714285715,1,1,11,0,0,0,0,0,0,0,1,2025,10,31,4,0.08073634859349145,22.142857142857142,0.0
25761553,US,US,1,1.0,0,0,0,0,2025-09-04,57.0,801.0,Female,75.0,SUBOXONE,suicidal ideation,1,0,0.0,MidAge,US,0.0,1,0,17,0,0,0,0,0,0,0,2,2025,9,4,3,0.08073634859349145,0.0,0.0
25769854,JP,JP,1,1.0,0,0,0,0,2025-09-07,7.0,800.0,Female,75.0,KEYTRUDA,malignant neoplasm progression,1,0,0.0,Child,JP,0.11904761904761905,3,0,30,0,0,0,0,0,0,0,3,2025,9,7,6,0.08073634859349145,0.8333333333333334,0.11904761904761905
25773675,US,US,1,2.0,0,0,0,0,2025-09-08,57.0,801.0,Female,75.0,ESTRADIOL,circumstance or information capable of leading to device use error,0,0,0.0,MidAge,US,0.0,8,0,66,0,0,0,0,0,0,0,10,2025,9,8,0,0.08073634859349145,0.0,0.0
25942376,US,US,2,1.0,0,0,0,0,2025-10-21,42.0,801.0,Male,75.0,SPRAVATO,respiratory depression,1,0,0.0,Adult,US,0.026785714285714284,8,0,22,0,0,0,0,0,0,0,2,2025,10,21,1,0.08936301793444651,1.125,0.0
25942714,CN,CN,2,1.0,0,0,0,0,2025-10-21,57.0,801.0,Female,75.0,RITUXIMAB,infusion related reaction,1,0,0.0,MidAge,CN,0.12406015037593986,19,0,25,0,0,0,0,0,0,0,3,2025,10,21,1,0.08936301793444651,7.071428571428572,0.12406015037593986
25942943,EU,EU,1,1.0,0,0,1,0,2025-10-21,74.0,801.0,Male,72.0,RISEDRONATE SODIUM,small intestinal ulcer haemorrhage,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,34,0,0,0,0,0,0,0,4,2025,10,21,1,0.08073634859349145,15.857142857142856,0.0
25944859,US,US,1,2.0,0,0,0,0,2025-10-21,57.0,801.0,Female,75.0,VOQUEZNA,alopecia,0,0,0.0,MidAge,US,0.0,2,0,8,0,0,0,0,0,0,0,1,2025,10,21,1,0.08073634859349145,0.0,0.0
25945010,US,US,1,2.0,0,0,0,0,2025-10-21,59.0,801.0,Female,75.0,VOQUEZNA,neuralgia,0,0,0.0,MidAge,US,0.0,2,0,9,0,0,0,0,0,0,0,1,2025,10,21,1,0.08073634859349145,0.0,0.0
26202072,US,US,1,2.0,0,0,0,0,2025-12-26,20.0,801.0,Male,75.0,DUPIXENT,respiratory tract infection,0,0,0.0,Young,US,0.015513897866839042,221,0,27,0,1,0,0,0,0,0,3,2025,12,26,4,0.08073634859349145,0.3102779573367808,0.0
26202153,US,US,1,2.0,0,0,0,0,2025-12-26,20.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Young,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,12,26,4,0.08073634859349145,0.3102779573367808,0.015513897866839042
25985621,EU,EU,1,1.0,1,0,0,0,2025-10-31,32.0,801.0,Male,75.0,DIAZEPAM,high risk sexual behaviour,1,5,0.35714285714285715,Young,EU,0.2619047619047619,3,1,26,0,0,0,0,0,0,0,4,2025,10,31,4,0.08073634859349145,8.380952380952381,0.0
25987012,US,US,1,2.0,0,0,0,0,2025-11-03,87.0,801.0,Female,75.0,HUMALOG,visual impairment,0,0,0.0,Senior,US,0.05357142857142857,4,0,17,0,0,0,0,0,0,0,2,2025,11,3,0,0.08073634859349145,4.660714285714286,0.05357142857142857
25987766,EU,EU,1,1.0,0,0,0,0,2025-11-03,27.0,801.0,Female,75.0,IBUPROFEN,laryngeal oedema,1,0,0.0,Young,EU,0.11607142857142858,8,0,16,0,0,0,0,0,0,0,2,2025,11,3,0,0.08073634859349145,3.1339285714285716,0.11607142857142858
25988523,EU,EU,2,1.0,0,0,1,0,2025-11-03,6.0,800.0,Female,75.0,RITUXIMAB,rheumatoid arthritis,1,3,0.21428571428571427,Child,EU,0.12406015037593986,19,0,20,0,0,0,0,0,0,0,2,2025,11,3,0,0.08936301793444651,0.7443609022556391,0.12406015037593986
25778993,US,US,1,2.0,0,0,0,0,2025-09-09,45.0,801.0,Female,75.0,ORENCIA,arthralgia,0,0,0.0,Adult,US,0.10204081632653061,14,0,10,0,0,0,0,0,0,0,1,2025,9,9,1,0.08073634859349145,4.591836734693878,0.10204081632653061
25786015,US,US,2,1.0,0,0,0,0,2025-09-10,57.0,801.0,Female,75.0,KESIMPTA,multiple sclerosis,1,0,0.0,MidAge,US,0.0,2,0,18,0,0,0,0,0,0,0,2,2025,9,10,2,0.08936301793444651,0.0,0.0
25789146,EU,EU,1,1.0,0,0,1,0,2025-09-11,47.0,801.0,Female,75.0,FULVESTRANT,electrolyte imbalance,1,3,0.21428571428571427,Adult,EU,0.21428571428571427,1,1,21,0,0,0,0,0,0,0,2,2025,9,11,3,0.08073634859349145,10.071428571428571,0.21428571428571427
25793992,US,US,1,2.0,0,0,0,0,2025-09-12,62.0,801.0,Female,146.51,ACTEMRA,back pain,0,0,0.0,MidAge,US,0.17857142857142858,6,1,9,1,0,0,0,0,0,0,2,2025,9,12,4,0.08073634859349145,11.071428571428571,0.17857142857142858
25803310,US,US,1,1.0,0,0,0,0,2025-09-15,31.0,801.0,Female,73.016,HAEGARDA,maternal exposure during pregnancy,1,0,0.0,Young,US,0.0,1,0,34,0,0,0,0,0,0,0,4,2025,9,15,0,0.08073634859349145,0.0,0.0
25803983,EU,EU,1,1.0,0,0,1,0,2025-09-15,60.0,801.0,Female,86.0,RITUXIMAB,leukocytosis,1,3,0.21428571428571427,MidAge,EU,0.12406015037593986,19,0,12,0,0,0,0,0,0,0,1,2025,9,15,0,0.08073634859349145,7.443609022556392,0.12406015037593986
25807008,US,US,2,2.0,0,0,0,0,2025-09-16,57.0,801.0,Male,75.0,OMNITROPE,circumstance or information capable of leading to medication error,0,0,0.0,MidAge,US,0.0,5,0,66,0,0,0,0,0,0,0,9,2025,9,16,1,0.08936301793444651,0.0,0.0
26206513,GB,GB,1,1.0,0,0,1,0,2025-12-29,42.0,801.0,Male,75.0,NAPROXEN,acute kidney injury,1,3,0.21428571428571427,Adult,GB,0.2857142857142857,2,1,19,0,0,0,0,0,0,0,3,2025,12,29,0,0.08073634859349145,12.0,0.0
26206661,US,US,1,2.0,0,0,0,0,2025-12-29,40.0,801.0,Female,75.0,DUPIXENT,condition aggravated,0,0,0.0,Adult,US,0.015513897866839042,221,0,20,0,0,0,0,0,0,0,2,2025,12,29,0,0.08073634859349145,0.6205559146735616,0.015513897866839042
25989009,US,US,1,2.0,0,0,0,0,2025-11-03,49.0,801.0,Female,136.05,ALBUTEROL SULFATE,dyspnoea,0,0,0.0,Adult,US,0.0,8,0,8,0,0,0,0,0,0,0,1,2025,11,3,0,0.08073634859349145,0.0,0.0
25989467,EU,EU,1,1.0,0,0,1,0,2025-11-03,69.0,801.0,Female,68.0,LETROZOLE,dental operation,1,3,0.21428571428571427,Senior,EU,0.07142857142857142,3,0,16,0,0,0,0,0,0,0,2,2025,11,3,0,0.08073634859349145,4.928571428571428,0.07142857142857142
25989562,CN,CN,1,1.0,0,0,1,0,2025-11-03,57.0,801.0,Female,75.0,METHIMAZOLE,antithyroid arthritis syndrome,1,3,0.21428571428571427,MidAge,CN,0.21428571428571427,1,1,30,0,0,0,0,0,0,0,3,2025,11,3,0,0.08073634859349145,12.214285714285714,0.21428571428571427
25990104,EU,EU,1,1.0,0,0,1,0,2025-11-03,57.0,801.0,Female,75.0,BUPRENORPHINE,urinary retention,1,3,0.21428571428571427,MidAge,EU,0.2857142857142857,2,1,17,0,0,0,0,0,0,0,2,2025,11,3,0,0.08073634859349145,16.285714285714285,0.2857142857142857
25991277,US,US,1,2.0,0,0,0,0,2025-11-03,57.0,801.0,Female,75.0,DUPIXENT,inappropriate schedule of product administration,0,0,0.0,MidAge,US,0.015513897866839042,221,0,48,0,0,0,0,0,0,0,5,2025,11,3,0,0.08073634859349145,0.8842921784098254,0.015513897866839042
25991992,US,US,1,2.0,0,0,0,0,2025-11-03,80.0,801.0,Female,75.0,SOLIQUA 100/33,pruritus,0,0,0.0,Senior,US,0.0,1,0,8,0,0,0,0,0,0,0,1,2025,11,3,0,0.08073634859349145,0.0,0.0
25992492,US,US,1,2.0,0,0,0,0,2025-11-03,57.0,801.0,Female,75.0,DOXYLAMINE SUCCINATE,fatigue,0,0,0.0,MidAge,US,0.0,1,0,7,0,0,0,0,0,0,0,1,2025,11,3,0,0.08073634859349145,0.0,0.0
25950490,US,US,2,1.0,1,0,0,0,2025-10-23,69.0,801.0,Female,75.0,SYNTHROID,renal failure,1,5,0.35714285714285715,Senior,US,0.17857142857142858,2,1,13,0,0,0,0,1,0,0,2,2025,10,23,3,0.08936301793444651,12.321428571428571,0.17857142857142858
25950557,GB,GB,2,1.0,0,0,1,0,2025-10-23,78.0,801.0,Female,75.0,CARBIDOPA\LEVODOPA,faecaloma,1,3,0.21428571428571427,Senior,GB,0.3333333333333333,3,1,9,0,0,0,0,0,0,0,1,2025,10,23,3,0.08936301793444651,26.0,0.3333333333333333
25950571,EU,EU,1,1.0,0,0,1,0,2025-10-23,78.0,801.0,Female,68.2,RYBREVANT,mucosal inflammation,1,3,0.21428571428571427,Senior,EU,0.05357142857142857,4,0,20,0,0,0,0,0,0,0,2,2025,10,23,3,0.08073634859349145,4.178571428571428,0.05357142857142857
25950638,US,US,1,2.0,0,0,0,0,2025-10-23,57.0,801.0,Female,75.0,DUPIXENT,dry skin,0,0,0.0,MidAge,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,2,2025,10,23,3,0.08073634859349145,0.8842921784098254,0.015513897866839042
25950962,JP,JP,1,1.0,0,0,1,0,2025-10-23,57.0,801.0,Female,75.0,METHYLPHENIDATE HYDROCHLORIDE,hospitalisation,1,3,0.21428571428571427,MidAge,JP,0.10714285714285714,2,0,15,0,0,0,0,0,0,0,1,2025,10,23,3,0.08073634859349145,6.107142857142857,0.10714285714285714
25951529,GB,GB,1,1.0,0,1,0,0,2025-10-23,57.0,801.0,Female,75.0,DIMETHYL FUMARATE,leukaemia,1,4,0.2857142857142857,MidAge,GB,0.2857142857142857,1,1,9,0,0,0,0,0,0,0,1,2025,10,23,3,0.08073634859349145,16.285714285714285,0.2857142857142857
25952043,CA,CA,2,1.0,0,0,1,0,2025-10-23,53.0,801.0,Male,75.0,SKYRIZI,acute myocardial infarction,1,3,0.21428571428571427,MidAge,CA,0.051587301587301584,36,0,27,0,0,0,0,0,0,0,3,2025,10,23,3,0.08936301793444651,2.734126984126984,0.0
26209725,EU,EU,1,1.0,0,0,0,0,2025-12-29,90.0,801.0,Female,77.0,ALDACTONE,neutropenia,1,0,0.0,Senior,EU,0.0,1,0,11,0,0,0,0,0,0,0,1,2025,12,29,0,0.08073634859349145,0.0,0.0
26212493,US,US,1,1.0,0,0,0,0,2025-12-30,71.0,801.0,Female,80.726,FIRDAPSE,chondropathy,1,0,0.0,Senior,US,0.0,3,0,12,0,0,0,0,0,0,0,1,2025,12,30,1,0.08073634859349145,0.0,0.0
25809572,US,US,1,2.0,0,0,0,0,2025-09-16,62.0,801.0,Male,75.0,DUPIXENT,no adverse event,0,0,0.0,MidAge,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,3,2025,9,16,1,0.08073634859349145,0.9618616677440206,0.0
25813326,BA,BA,1,1.0,0,1,1,0,2025-09-17,50.0,801.0,Male,88.0,FRAGMIN,drug ineffective,1,7,0.5,Adult,Other,0.5,1,1,16,0,0,0,0,0,0,0,2,2025,9,17,2,0.08073634859349145,25.0,0.0
25815027,EU,EU,1,1.0,0,0,0,0,2025-09-18,58.0,801.0,Female,75.0,DOCETAXEL,infusion related reaction,1,0,0.0,MidAge,EU,0.061224489795918366,7,0,25,0,0,0,0,0,0,0,3,2025,9,18,3,0.08073634859349145,3.5510204081632653,0.061224489795918366
25820588,US,US,2,1.0,0,0,1,0,2025-09-19,57.0,801.0,Female,63.946,ISTURISA,cardiac failure,1,3,0.21428571428571427,MidAge,US,0.21428571428571427,1,1,15,0,0,0,0,1,0,0,2,2025,9,19,4,0.08936301793444651,12.214285714285714,0.21428571428571427
25824948,US,US,1,1.0,0,0,0,0,2025-09-19,68.0,801.0,Female,75.0,XELJANZ XR,neuropathy peripheral,1,0,0.0,Senior,US,0.0,9,0,21,0,0,0,0,0,0,0,2,2025,9,19,4,0.08073634859349145,0.0,0.0
25827473,CA,Unknown,2,1.0,0,0,0,0,2025-09-20,57.0,801.0,Female,75.0,CERTOLIZUMAB PEGOL,ankylosing spondylitis,1,0,0.0,MidAge,CA,0.04285714285714286,5,0,22,0,0,0,0,0,0,0,2,2025,9,20,5,0.08936301793444651,2.442857142857143,0.04285714285714286
25827554,EU,EU,1,1.0,0,0,0,0,2025-09-20,57.0,801.0,Female,75.0,PROCYSBI,endocarditis,1,0,0.0,MidAge,EU,0.0,1,0,12,0,0,0,0,0,0,0,1,2025,9,20,5,0.08073634859349145,0.0,0.0
25829336,US,US,1,2.0,0,0,0,0,2025-09-22,57.0,801.0,Female,75.0,TIOTROPIUM BROMIDE,drug ineffective,0,0,0.0,MidAge,US,0.0,1,0,16,0,0,0,0,0,0,0,2,2025,9,22,0,0.08073634859349145,0.0,0.0
25837612,US,US,1,2.0,0,0,0,0,2025-09-23,10.0,801.0,Female,75.0,OMNITROPE,circumstance or information capable of leading to medication error,0,0,0.0,Child,US,0.0,5,0,66,0,0,0,0,0,0,0,9,2025,9,23,1,0.08073634859349145,0.0,0.0
25993464,US,US,1,1.0,0,0,0,0,2025-11-04,57.0,801.0,Female,92.517,SYMBICORT,hypothyroidism,1,0,0.0,MidAge,US,0.0,2,0,14,0,0,0,0,0,0,0,1,2025,11,4,1,0.08073634859349145,0.0,0.0
25996218,US,US,1,1.0,0,0,1,0,2025-11-04,67.0,801.0,Female,75.0,CARBOPLATIN,emphysematous cystitis,1,3,0.21428571428571427,Senior,US,0.12244897959183673,7,0,22,0,0,0,0,0,0,0,2,2025,11,4,1,0.08073634859349145,8.204081632653061,0.12244897959183673
25953945,EU,EU,1,1.0,0,0,1,0,2025-10-23,69.0,801.0,Female,45.0,PEMETREXED,dermatitis bullous,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,3,1,18,0,0,0,0,0,0,0,2,2025,10,23,3,0.08073634859349145,14.785714285714285,0.21428571428571427
25955389,EU,EU,1,1.0,0,0,0,0,2025-10-24,39.0,801.0,Male,75.0,PAROXETINE,drug abuse,1,0,0.0,Adult,EU,0.0,2,0,10,0,0,0,0,0,0,0,2,2025,10,24,4,0.08073634859349145,0.0,0.0
25955970,US,US,1,2.0,0,0,0,0,2025-10-24,57.0,801.0,Female,75.0,ALBUTEROL SULFATE,wrong technique in product usage process,0,0,0.0,MidAge,US,0.0,8,0,40,0,0,0,0,0,0,0,6,2025,10,24,4,0.08073634859349145,0.0,0.0
25956632,CA,CA,1,1.0,0,0,1,0,2025-10-24,74.0,801.0,Male,102.0,AZACITIDINE,colitis,1,3,0.21428571428571427,Senior,CA,0.21428571428571427,1,1,7,0,0,0,0,0,0,0,1,2025,10,24,4,0.08073634859349145,15.857142857142856,0.0
25958252,US,US,1,2.0,0,0,0,0,2025-10-24,64.0,801.0,Male,96.0,VYEPTI,chest discomfort,0,0,0.0,MidAge,US,0.0,1,0,16,0,0,0,0,0,0,0,2,2025,10,24,4,0.08073634859349145,0.0,0.0
25958467,US,US,1,2.0,0,0,0,0,2025-10-24,67.0,801.0,Female,54.422,NICOTINE POLACRILEX,expired product administered,0,0,0.0,Senior,US,0.0,1,0,28,0,0,0,0,0,0,0,3,2025,10,24,4,0.08073634859349145,0.0,0.0
25959668,US,US,1,1.0,0,0,0,0,2025-10-26,75.0,801.0,Male,75.0,DUPIXENT,loss of consciousness,1,0,0.0,Senior,US,0.015513897866839042,221,0,21,0,0,0,0,0,0,0,3,2025,10,26,6,0.08073634859349145,1.1635423400129281,0.0
25960062,US,US,1,2.0,0,0,0,0,2025-10-26,18.0,801.0,Female,75.0,DUPIXENT,incorrect dose administered,0,0,0.0,Child,US,0.015513897866839042,221,0,27,0,0,0,0,0,0,0,3,2025,10,26,6,0.08073634859349145,0.27925016160310273,0.015513897866839042
25960453,US,US,1,2.0,0,0,0,0,2025-10-27,10.0,801.0,Male,75.0,OMNITROPE,circumstance or information capable of leading to medication error,0,0,0.0,Child,US,0.0,5,0,66,0,0,0,0,0,0,0,9,2025,10,27,0,0.08073634859349145,0.0,0.0
25960763,CN,CN,1,1.0,1,0,0,0,2025-10-27,86.0,801.0,Male,69.0,SEVOFLURANE,anaphylactic shock,1,5,0.35714285714285715,Senior,CN,0.35714285714285715,1,1,18,0,0,0,0,0,0,0,2,2025,10,27,0,0.08073634859349145,30.714285714285715,0.0
25961115,US,US,1,2.0,0,0,0,0,2025-10-27,71.0,801.0,Male,75.0,BASAGLAR,nephrolithiasis,0,0,0.0,Senior,US,0.0,2,0,15,0,0,0,0,0,0,0,1,2025,10,27,0,0.08073634859349145,0.0,0.0
25961964,EU,EU,1,1.0,0,0,1,0,2025-10-27,67.0,801.0,Male,75.0,IBUPROFEN,acute kidney injury,1,3,0.21428571428571427,Senior,EU,0.11607142857142858,8,0,19,0,0,0,0,0,0,0,3,2025,10,27,0,0.08073634859349145,7.776785714285714,0.0
25850248,GB,GB,1,1.0,0,0,1,0,2025-09-26,57.0,801.0,Female,75.0,PREGABALIN,post-traumatic stress disorder,1,3,0.21428571428571427,MidAge,GB,0.10714285714285714,6,0,30,0,0,0,0,0,0,0,3,2025,9,26,4,0.08073634859349145,6.107142857142857,0.10714285714285714
25851139,US,US,1,1.0,0,0,0,0,2025-09-26,57.0,801.0,Female,75.0,RYBREVANT,infusion related reaction,1,0,0.0,MidAge,US,0.05357142857142857,4,0,25,0,0,0,0,0,0,0,3,2025,9,26,4,0.08073634859349145,3.0535714285714284,0.05357142857142857
25851935,US,US,1,2.0,0,0,0,0,2025-09-26,57.0,801.0,Female,58.503,LEVOTHYROXINE SODIUM,thyroid disorder,0,0,0.0,MidAge,US,0.0,3,0,16,0,0,0,0,0,0,0,2,2025,9,26,4,0.08073634859349145,0.0,0.0
25852798,EU,EU,1,1.0,0,0,0,0,2025-09-26,57.0,801.0,Male,75.0,ADCETRIS,malignant neoplasm progression,1,0,0.0,MidAge,EU,0.0,2,0,30,0,0,0,0,0,0,0,3,2025,9,26,4,0.08073634859349145,0.0,0.0
25853407,CN,CN,1,1.0,0,0,0,0,2025-09-26,57.0,801.0,Female,75.0,RYBREVANT,myelosuppression,1,0,0.0,MidAge,CN,0.05357142857142857,4,0,16,0,0,0,0,0,0,0,1,2025,9,26,4,0.08073634859349145,3.0535714285714284,0.05357142857142857
25998539,US,US,1,2.0,0,0,0,0,2025-11-05,53.0,801.0,Male,75.0,ORGOVYX,abdominal discomfort,0,0,0.0,MidAge,US,0.0,4,0,20,0,0,0,0,0,0,0,2,2025,11,5,2,0.08073634859349145,0.0,0.0
25999282,US,US,1,1.0,0,0,1,0,2025-11-05,57.0,801.0,Female,68.31,DUPIXENT,haemoptysis,1,3,0.21428571428571427,MidAge,US,0.015513897866839042,221,0,11,0,0,0,0,0,0,0,1,2025,11,5,2,0.08073634859349145,0.8842921784098254,0.015513897866839042
25999497,EU,EU,1,1.0,0,0,1,0,2025-11-05,71.0,801.0,Female,46.0,LORMETAZEPAM,poisoning deliberate,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,20,0,0,0,0,0,0,0,2,2025,11,5,2,0.08073634859349145,15.214285714285714,0.21428571428571427
26000095,AU,AU,1,1.0,0,0,1,0,2025-11-05,56.0,801.0,Male,116.9,VINCRISTINE,rib fracture,1,3,0.21428571428571427,MidAge,AU,0.21428571428571427,1,1,12,0,0,0,0,0,0,0,2,2025,11,5,2,0.08073634859349145,12.0,0.0
26000567,US,Unknown,1,1.0,0,0,1,0,2025-11-04,57.0,801.0,Male,97.2,WINREVAIR,catheter site haemorrhage,1,3,0.21428571428571427,MidAge,US,0.2619047619047619,3,1,25,0,0,0,0,0,0,0,3,2025,11,4,1,0.08073634859349145,14.928571428571429,0.0
25962288,AU,AU,1,1.0,1,0,0,0,2025-10-27,57.0,801.0,Male,75.0,ALCOHOL (ALCOHOL),intentional overdose,1,5,0.35714285714285715,MidAge,AU,0.35714285714285715,1,1,20,0,0,0,0,0,0,0,2,2025,10,27,0,0.08073634859349145,20.357142857142858,0.0
25962383,EU,EU,1,1.0,0,0,1,0,2025-10-27,71.0,801.0,Male,75.0,ADRENALIN,condition aggravated,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,20,0,0,0,0,0,0,0,2,2025,10,27,0,0.08073634859349145,15.214285714285714,0.0
25964503,US,US,1,1.0,0,0,1,0,2025-10-27,13.0,801.0,Female,75.0,METHOTREXATE,neurotoxicity,1,3,0.21428571428571427,Child,US,0.17346938775510204,7,1,13,0,0,0,0,0,0,0,1,2025,10,27,0,0.08073634859349145,2.2551020408163267,0.17346938775510204
25964880,US,US,1,1.0,0,0,1,0,2025-10-27,57.0,801.0,Female,75.0,WEGOVY,intestinal obstruction,1,3,0.21428571428571427,MidAge,US,0.14285714285714285,4,1,22,0,0,0,0,0,0,0,2,2025,10,27,0,0.08073634859349145,8.142857142857142,0.14285714285714285
25965232,US,US,1,2.0,0,0,0,0,2025-10-27,57.0,801.0,Female,75.0,DUPIXENT,pruritus,0,0,0.0,MidAge,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,10,27,0,0.08073634859349145,0.8842921784098254,0.015513897866839042
25965528,US,US,1,2.0,0,0,0,0,2025-10-27,15.0,801.0,Male,75.0,DUPIXENT,fear of injection,0,0,0.0,Child,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,3,2025,10,27,0,0.08073634859349145,0.23270846800258563,0.0
25965609,US,US,1,2.0,0,0,0,0,2025-10-27,51.0,801.0,Male,75.0,DUPIXENT,eosinophilic oesophagitis,0,0,0.0,MidAge,US,0.015513897866839042,221,0,25,0,0,0,0,0,0,0,2,2025,10,27,0,0.08073634859349145,0.7912087912087912,0.0
25965919,US,US,1,2.0,0,0,0,0,2025-10-27,57.0,801.0,Female,79.55,DUPIXENT,product use in unapproved indication,0,0,0.0,MidAge,US,0.015513897866839042,221,0,36,0,0,0,0,0,0,0,5,2025,10,27,0,0.08073634859349145,0.8842921784098254,0.015513897866839042
26003335,EU,EU,1,1.0,0,0,1,0,2025-11-06,52.0,801.0,Female,75.0,CLONAZEPAM,drug abuse,1,3,0.21428571428571427,MidAge,EU,0.07142857142857142,3,0,10,0,0,0,0,0,0,0,2,2025,11,6,3,0.08073634859349145,3.714285714285714,0.07142857142857142
26003564,US,US,1,2.0,0,0,0,0,2025-11-06,1.0,801.0,Female,75.0,DUPIXENT,maternal exposure during breast feeding,0,0,0.0,Child,US,0.015513897866839042,221,0,39,0,0,0,0,0,0,0,5,2025,11,6,3,0.08073634859349145,0.015513897866839042,0.015513897866839042
26003807,US,US,1,2.0,0,0,0,0,2025-11-06,57.0,801.0,Female,60.45,DUPIXENT,pruritus,0,0,0.0,MidAge,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,11,6,3,0.08073634859349145,0.8842921784098254,0.015513897866839042
26004198,US,US,1,2.0,0,0,0,0,2025-11-06,57.0,801.0,Female,79.37,DUPIXENT,maternal exposure during pregnancy,0,0,0.0,MidAge,US,0.015513897866839042,221,0,34,0,0,0,0,0,0,0,4,2025,11,6,3,0.08073634859349145,0.8842921784098254,0.015513897866839042
26004279,US,US,1,2.0,0,0,0,0,2025-11-06,57.0,801.0,Male,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,MidAge,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,11,6,3,0.08073634859349145,0.8842921784098254,0.0
25861426,US,US,2,1.0,0,0,0,0,2025-09-29,57.0,801.0,Female,79.0,HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,mycobacterium avium complex infection,1,0,0.0,MidAge,US,0.07142857142857142,3,0,37,0,1,0,0,0,0,0,4,2025,9,29,0,0.08936301793444651,4.071428571428571,0.07142857142857142
25861479,CA,CA,2,1.0,0,0,0,0,2025-09-30,57.0,801.0,Female,75.0,SIMPONI,rheumatoid arthritis,1,0,0.0,MidAge,CA,0.0,2,0,20,0,0,0,0,0,0,0,2,2025,9,30,1,0.08936301793444651,0.0,0.0
25861574,VN,VN,2,1.0,0,0,0,0,2025-09-30,55.0,801.0,Male,75.0,DARZALEX,leukopenia,1,0,0.0,MidAge,Other,0.0,2,0,10,0,0,0,0,0,0,0,1,2025,9,30,1,0.08936301793444651,0.0,0.0
25867473,US,US,2,1.0,0,0,1,0,2025-10-01,72.0,801.0,Male,75.0,CREON,sepsis,1,3,0.21428571428571427,Senior,US,0.03296703296703297,13,0,6,0,0,0,0,0,0,0,1,2025,10,1,2,0.08936301793444651,2.3736263736263736,0.0
25868498,PR,PR,2,1.0,0,0,1,0,2025-10-01,74.0,801.0,Female,75.0,VENCLEXTA,white blood cell count decreased,1,3,0.21428571428571427,Senior,Other,0.18571428571428572,5,1,32,0,0,0,0,0,0,0,5,2025,10,1,2,0.08936301793444651,13.742857142857144,0.18571428571428572
25868889,US,US,1,1.0,0,0,0,0,2025-10-01,62.0,801.0,Male,75.0,HYDRALAZINE HYDROCHLORIDE,glomerulonephritis,1,0,0.0,MidAge,US,0.0,1,0,18,0,0,0,0,0,0,0,1,2025,10,1,2,0.08073634859349145,0.0,0.0
25868917,CA,CA,1,1.0,1,0,1,1,2025-10-01,40.0,801.0,Female,75.0,ACTEMRA,contraindicated product administered,1,10,0.7142857142857143,Adult,CA,0.17857142857142858,6,1,36,0,0,0,0,0,0,0,3,2025,10,1,2,0.08073634859349145,7.142857142857143,0.17857142857142858
25967296,US,US,2,1.0,0,0,0,0,2025-10-28,57.0,801.0,Female,75.0,SKYRIZI,nephrolithiasis,1,0,0.0,MidAge,US,0.051587301587301584,36,0,15,0,0,0,0,0,0,0,1,2025,10,28,1,0.08936301793444651,2.9404761904761902,0.051587301587301584
25969078,EU,EU,1,1.0,0,0,0,0,2025-10-28,57.0,801.0,Male,75.0,DOCETAXEL,hepatotoxicity,1,0,0.0,MidAge,EU,0.061224489795918366,7,0,14,0,0,0,0,0,0,0,1,2025,10,28,1,0.08073634859349145,3.489795918367347,0.0
25969173,CA,CA,3,1.0,0,0,0,0,2025-10-28,48.0,801.0,Male,75.0,MYCOPHENOLATE MOFETIL,lymphadenopathy,1,0,0.0,Adult,CA,0.10150375939849625,19,0,15,0,0,0,0,0,0,0,1,2025,10,28,1,0.17857142857142855,4.87218045112782,0.0
25969430,JP,JP,1,1.0,0,0,1,0,2025-10-28,78.0,801.0,Male,75.0,METHYLPREDNISOLONE,cerebral infarction,1,3,0.21428571428571427,Senior,JP,0.14285714285714285,3,1,19,0,0,0,0,0,0,0,2,2025,10,28,1,0.08073634859349145,11.142857142857142,0.0
26005494,EU,EU,1,1.0,1,0,1,0,2025-11-06,48.0,801.0,Male,75.0,DOLUTEGRAVIR,pancytopenia,1,8,0.5714285714285714,Adult,EU,0.5714285714285714,1,1,12,0,0,0,0,0,0,0,1,2025,11,6,3,0.08073634859349145,27.428571428571427,0.0
26006075,US,US,1,2.0,0,0,0,0,2025-11-06,20.0,801.0,Male,75.0,ADDERALL XR,restlessness,0,0,0.0,Young,US,0.0,2,0,12,0,0,0,0,0,0,0,1,2025,11,6,3,0.08073634859349145,0.0,0.0
26007195,US,US,2,2.0,0,0,0,0,2025-11-06,70.0,801.0,Female,75.0,ZENATANE,product use issue,0,0,0.0,Senior,US,0.0,1,0,17,0,0,0,0,0,0,0,3,2025,11,6,3,0.08936301793444651,0.0,0.0
26007924,US,Unknown,1,1.0,0,0,0,0,2025-11-05,73.0,801.0,Male,72.03,INSULIN LISPRO,device malfunction,1,0,0.0,Senior,US,0.0,1,0,18,0,0,0,0,0,0,0,2,2025,11,5,2,0.08073634859349145,0.0,0.0
26008505,US,US,1,2.0,0,0,0,0,2025-11-06,41.0,801.0,Female,75.0,DUPIXENT,eosinophilic oesophagitis,0,0,0.0,Adult,US,0.015513897866839042,221,0,25,0,0,0,0,0,0,0,2,2025,11,6,3,0.08073634859349145,0.6360698125404007,0.015513897866839042
26008572,CA,CA,1,1.0,0,0,0,0,2025-11-06,57.0,801.0,Female,75.0,VASCEPA,choking,1,0,0.0,MidAge,CA,0.0,2,0,7,0,0,0,0,0,0,0,1,2025,11,6,3,0.08073634859349145,0.0,0.0
25871308,EU,EU,1,1.0,0,0,1,0,2025-10-01,73.0,801.0,Female,64.0,GEMCITABINE,lung disorder,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,13,0,0,0,0,0,0,0,2,2025,10,1,2,0.08073634859349145,15.642857142857142,0.21428571428571427
25871403,US,US,1,2.0,0,0,0,0,2025-10-01,85.0,801.0,Female,81.633,DUPIXENT,foreign body sensation in eyes,0,0,0.0,Senior,US,0.015513897866839042,221,0,30,0,0,0,0,0,0,0,5,2025,10,1,2,0.08073634859349145,1.3186813186813187,0.015513897866839042
25872576,US,US,1,2.0,0,0,0,0,2025-10-02,45.0,801.0,Female,75.0,DUPIXENT,off label use,0,0,0.0,Adult,US,0.015513897866839042,221,0,13,0,0,0,0,0,0,0,3,2025,10,2,3,0.08073634859349145,0.6981254040077569,0.015513897866839042
25970469,EU,EU,2,1.0,0,0,1,0,2025-10-28,57.0,801.0,Female,75.0,METHOTREXATE,knee arthroplasty,1,3,0.21428571428571427,MidAge,EU,0.17346938775510204,7,1,17,0,0,0,0,0,0,0,2,2025,10,28,1,0.08936301793444651,9.887755102040817,0.17346938775510204
25971455,CA,CA,1,1.0,0,0,0,0,2025-10-28,52.0,801.0,Female,75.0,TADALAFIL,condition aggravated,1,0,0.0,MidAge,CA,0.0,2,0,20,0,0,0,0,0,0,0,2,2025,10,28,1,0.08073634859349145,0.0,0.0
25972265,EU,EU,1,1.0,0,0,0,0,2025-10-29,81.0,801.0,Female,75.0,CIPROFLOXACIN,mobility decreased,1,0,0.0,Senior,EU,0.07142857142857142,3,0,18,0,0,0,0,0,0,0,2,2025,10,29,2,0.08073634859349145,5.785714285714286,0.07142857142857142
25973695,US,US,1,2.0,0,0,0,0,2025-10-29,57.0,801.0,Female,75.0,PROGESTERONE,headache,0,0,0.0,MidAge,US,0.0,1,0,8,0,0,0,0,0,0,0,1,2025,10,29,2,0.08073634859349145,0.0,0.0
26010153,JP,JP,1,1.0,0,0,0,0,2025-11-07,57.0,801.0,Female,75.0,DENOSUMAB,carcinoembryonic antigen increased,1,0,0.0,MidAge,JP,0.0,1,0,34,0,0,0,0,0,0,0,3,2025,11,7,4,0.08073634859349145,0.0,0.0
26010759,GB,GB,1,1.0,0,0,0,0,2025-11-07,68.0,801.0,Female,80.0,ATORVASTATIN,gastrointestinal disorder,1,0,0.0,Senior,GB,0.10714285714285714,2,0,25,0,0,0,0,0,0,0,2,2025,11,7,4,0.08073634859349145,7.285714285714286,0.10714285714285714
26011435,US,US,1,2.0,0,0,0,0,2025-11-07,57.0,801.0,Female,75.0,ALBUTEROL SULFATE,circumstance or information capable of leading to medication error,0,0,0.0,MidAge,US,0.0,8,0,66,0,0,0,0,0,0,0,9,2025,11,7,4,0.08073634859349145,0.0,0.0
26012164,CA,CA,1,1.0,1,0,0,0,2025-11-07,43.0,801.0,Female,68.0,ACTEMRA,condition aggravated,1,5,0.35714285714285715,Adult,CA,0.17857142857142858,6,1,20,0,0,0,0,0,0,0,2,2025,11,7,4,0.08073634859349145,7.678571428571429,0.17857142857142858
25874196,BR,BR,2,1.0,0,0,0,0,2025-10-02,56.0,801.0,Female,69.0,VEDOLIZUMAB,colitis ulcerative,1,0,0.0,MidAge,BR,0.057692307692307696,26,0,18,0,0,0,0,0,0,0,2,2025,10,2,3,0.08936301793444651,3.230769230769231,0.057692307692307696
25874925,GB,GB,1,1.0,0,0,0,0,2025-10-02,57.0,801.0,Male,75.0,VENETOCLAX,cytopenia,1,0,0.0,MidAge,GB,0.0,1,0,9,0,0,0,0,0,0,0,1,2025,10,2,3,0.08073634859349145,0.0,0.0
25877531,CN,CN,1,1.0,0,0,0,0,2025-10-03,87.0,801.0,Female,57.0,TISLELIZUMAB,myelosuppression,1,0,0.0,Senior,CN,0.0,3,0,16,0,0,0,0,0,0,0,1,2025,10,3,4,0.08073634859349145,0.0,0.0
25878570,US,US,1,1.0,0,0,1,0,2025-10-03,70.0,801.0,Male,75.0,LENALIDOMIDE,cardiac disorder,1,3,0.21428571428571427,Senior,US,0.15413533834586465,19,1,16,0,0,0,0,0,0,0,2,2025,10,3,4,0.08073634859349145,10.789473684210526,0.0
25879151,EU,EU,1,1.0,0,0,1,0,2025-10-03,55.0,801.0,Male,72.0,CIPROFLOXACIN,dysbiosis,1,3,0.21428571428571427,MidAge,EU,0.07142857142857142,3,0,9,0,0,0,0,0,0,0,1,2025,10,3,4,0.08073634859349145,3.9285714285714284,0.0
25881042,US,US,1,2.0,0,0,0,0,2025-10-04,57.0,801.0,Male,75.0,DUPIXENT,hypersensitivity,0,0,0.0,MidAge,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,1,2025,10,4,5,0.08073634859349145,0.8842921784098254,0.0
25975653,US,Unknown,1,1.0,0,0,1,0,2025-10-29,87.0,801.0,Female,75.0,LENALIDOMIDE,intentional dose omission,1,3,0.21428571428571427,Senior,US,0.15413533834586465,19,1,25,0,0,0,0,0,0,0,3,2025,10,29,2,0.08073634859349145,13.409774436090224,0.15413533834586465
25976153,CA,CA,1,1.0,1,0,0,0,2025-10-29,43.0,801.0,Female,68.0,COSENTYX,confusional state,1,5,0.35714285714285715,Adult,CA,0.05714285714285714,10,0,17,0,0,0,0,0,0,0,2,2025,10,29,2,0.08073634859349145,2.457142857142857,0.05714285714285714
25976382,GB,GB,1,1.0,0,0,0,0,2025-10-29,57.0,801.0,Female,75.0,COSENTYX,osteonecrosis,1,0,0.0,MidAge,GB,0.05714285714285714,10,0,13,0,0,0,0,0,0,0,1,2025,10,29,2,0.08073634859349145,3.257142857142857,0.05714285714285714
25976463,US,US,1,2.0,0,0,0,0,2025-10-29,57.0,801.0,Male,75.0,TRELEGY ELLIPTA,visual impairment,0,0,0.0,MidAge,US,0.0,4,0,17,0,0,0,0,0,0,0,2,2025,10,29,2,0.08073634859349145,0.0,0.0
14520544,US,US,2,1.0,0,0,1,0,2018-02-12,78.0,801.0,Female,75.0,VEDOLIZUMAB,hip fracture,1,3,0.21428571428571427,Senior,US,0.057692307692307696,26,0,12,0,0,0,0,0,0,0,2,2018,2,12,0,0.08936301793444651,4.5,0.057692307692307696
15082980,US,US,1,2.0,0,0,0,0,2018-06-28,41.0,801.0,Female,75.0,SUBLOCADE,dysgeusia,0,0,0.0,Adult,US,0.0,1,0,9,0,0,0,0,0,0,0,1,2018,6,28,3,0.08073634859349145,0.0,0.0
17707771,US,US,2,1.0,0,0,1,0,2020-04-24,26.0,801.0,Female,56.0,HUMAN IMMUNOGLOBULIN G,covid-19 pneumonia,1,3,0.21428571428571427,Young,US,0.10714285714285714,8,0,18,0,0,0,0,0,1,0,2,2020,4,24,4,0.08936301793444651,2.7857142857142856,0.10714285714285714
17806834,CA,CA,1,1.0,0,0,0,0,2020-05-20,53.0,801.0,Female,53.0,ACTEMRA,abdominal pain,1,0,0.0,MidAge,CA,0.17857142857142858,6,1,14,1,0,0,0,0,0,0,2,2020,5,20,2,0.08073634859349145,9.464285714285715,0.17857142857142858
17966309,US,US,2,1.0,0,0,1,0,2020-06-30,64.0,801.0,Male,76.0,HUMAN IMMUNOGLOBULIN G,diverticulitis,1,3,0.21428571428571427,MidAge,US,0.10714285714285714,8,0,14,0,0,0,0,0,0,0,1,2020,6,30,1,0.08936301793444651,6.857142857142857,0.0
18512710,US,US,2,1.0,0,0,0,0,2020-11-17,67.0,801.0,Female,75.0,HUMAN IMMUNOGLOBULIN G,suspected covid-19,1,0,0.0,Senior,US,0.10714285714285714,8,0,18,0,0,0,0,0,0,0,2,2020,11,17,1,0.08936301793444651,7.178571428571428,0.10714285714285714
25883268,US,US,1,2.0,0,0,0,0,2025-10-06,23.0,801.0,Male,75.0,IBUPROFEN,drug ineffective,0,0,0.0,Young,US,0.11607142857142858,8,0,16,0,0,0,0,0,0,0,2,2025,10,6,0,0.08073634859349145,2.669642857142857,0.0
25883673,US,US,1,2.0,0,0,0,0,2025-10-06,57.0,801.0,Female,75.0,PLUVICTO,general physical health deterioration,0,0,0.0,MidAge,US,0.0,8,0,37,0,0,0,0,0,0,0,4,2025,10,6,0,0.08073634859349145,0.0,0.0
25979055,EU,EU,1,1.0,0,0,0,0,2025-10-30,79.0,801.0,Female,70.0,CAPECITABINE,chest pain,1,0,0.0,Senior,EU,0.10714285714285714,2,0,10,1,0,0,0,0,0,0,2,2025,10,30,3,0.08073634859349145,8.464285714285714,0.10714285714285714
25981270,US,US,1,2.0,0,0,0,0,2025-10-30,57.0,801.0,Female,75.0,NEMLUVIO,device malfunction,0,0,0.0,MidAge,US,0.0,1,0,18,0,0,0,0,0,0,0,2,2025,10,30,3,0.08073634859349145,0.0,0.0
25982471,US,US,1,1.0,0,0,0,0,2025-10-31,57.0,801.0,Male,75.0,TRELEGY ELLIPTA,product dose omission issue,1,0,0.0,MidAge,US,0.0,4,0,27,0,0,0,0,0,0,0,4,2025,10,31,4,0.08073634859349145,0.0,0.0
25982929,EU,EU,1,1.0,0,0,0,0,2025-10-31,43.0,801.0,Female,75.0,ASCIMINIB,blast crisis in myelogenous leukaemia,1,0,0.0,Adult,EU,0.0,1,0,37,0,0,0,0,0,0,0,5,2025,10,31,4,0.08073634859349145,0.0,0.0
26040958,US,US,1,1.0,0,0,1,0,2025-11-13,57.0,801.0,Female,75.0,DUPIXENT,road traffic accident,1,3,0.21428571428571427,MidAge,US,0.015513897866839042,221,0,21,0,0,0,0,0,0,0,3,2025,11,13,3,0.08073634859349145,0.8842921784098254,0.015513897866839042
26041849,US,US,1,2.0,0,0,0,0,2025-11-13,30.0,801.0,Male,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Young,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,11,13,3,0.08073634859349145,0.46541693600517126,0.0
20225402,CA,CA,1,1.0,0,0,0,0,2021-12-24,50.0,801.0,Female,75.0,AMLODIPINE,extrapyramidal disorder,1,0,0.0,Adult,CA,0.16964285714285715,8,1,23,0,0,0,0,0,0,0,2,2021,12,24,4,0.08073634859349145,8.482142857142858,0.16964285714285715
20582718,US,US,1,2.0,0,0,0,0,2022-03-11,65.0,801.0,Female,63.0,PREMARIN,oropharyngeal discomfort,0,0,0.0,MidAge,US,0.0,1,0,24,0,0,0,0,0,0,0,2,2022,3,11,4,0.08073634859349145,0.0,0.0
20689596,EU,EU,1,1.0,1,0,0,0,2022-04-08,7.0,801.0,Female,75.0,KYMRIAH,condition aggravated,1,5,0.35714285714285715,Child,EU,0.35714285714285715,1,1,20,0,0,0,0,0,0,0,2,2022,4,8,4,0.08073634859349145,2.5,0.35714285714285715
20711941,US,US,1,2.0,0,0,0,0,2022-04-14,57.0,801.0,Female,75.0,CRYSVITA,blood phosphorus decreased,0,0,0.0,MidAge,US,0.0,1,0,26,0,0,0,0,0,0,0,3,2022,4,14,3,0.08073634859349145,0.0,0.0
20795424,IL,IL,1,1.0,0,0,0,0,2022-05-06,42.0,801.0,Male,75.0,ELELYSO,hip arthroplasty,1,0,0.0,Adult,Other,0.0,1,0,16,0,0,0,0,0,0,0,2,2022,5,6,4,0.08073634859349145,0.0,0.0
20865961,US,US,2,1.0,0,0,1,0,2022-05-24,55.0,801.0,Female,38.0,EPIDIOLEX,cystitis,1,3,0.21428571428571427,MidAge,US,0.14285714285714285,3,1,8,0,0,0,0,0,0,0,1,2022,5,24,1,0.08936301793444651,7.857142857142857,0.14285714285714285
21022604,GB,Unknown,2,1.0,0,0,1,0,2022-06-29,57.0,801.0,Female,75.0,CERTOLIZUMAB PEGOL,otitis externa,1,3,0.21428571428571427,MidAge,GB,0.04285714285714286,5,0,14,0,0,0,0,0,0,0,2,2022,6,29,2,0.08936301793444651,2.442857142857143,0.04285714285714286
25987236,GB,GB,1,1.0,0,0,0,0,2025-11-03,43.0,801.0,Female,84.0,IBUPROFEN,rash,1,0,0.0,Adult,GB,0.11607142857142858,8,0,4,0,0,0,0,0,0,0,1,2025,11,3,0,0.08073634859349145,4.991071428571429,0.11607142857142858
25987627,GB,GB,1,1.0,0,0,0,0,2025-11-03,57.0,801.0,Male,75.0,RAMIPRIL,muscle spasms,1,0,0.0,MidAge,GB,0.0,1,0,13,0,0,0,0,0,0,0,2,2025,11,3,0,0.08073634859349145,0.0,0.0
25988518,EU,EU,3,1.0,1,0,0,0,2025-11-03,57.0,801.0,Female,75.0,ACETAMINOPHEN,drug use disorder,1,5,0.35714285714285715,MidAge,EU,0.10267857142857142,16,0,17,0,0,0,0,0,0,0,3,2025,11,3,0,0.17857142857142855,5.852678571428571,0.10267857142857142
25988666,EU,EU,1,1.0,0,0,0,0,2025-11-03,64.0,801.0,Female,75.0,MEROPENEM,linear iga disease,1,0,0.0,MidAge,EU,0.0,1,0,18,0,0,0,0,0,0,0,3,2025,11,3,0,0.08073634859349145,0.0,0.0
25989180,EU,EU,1,1.0,0,0,1,0,2025-11-03,39.0,801.0,Female,75.0,METFORMIN,maternal exposure during breast feeding,1,3,0.21428571428571427,Adult,EU,0.21428571428571427,2,1,39,0,0,0,0,0,0,0,5,2025,11,3,0,0.08073634859349145,8.357142857142856,0.21428571428571427
25989247,CR,CR,2,1.0,0,0,0,1,2025-11-03,57.0,801.0,Male,75.0,EXFORGE HCT,pollakiuria,1,2,0.14285714285714285,MidAge,Other,0.14285714285714285,1,1,11,0,0,0,0,0,0,0,1,2025,11,3,0,0.08936301793444651,8.142857142857142,0.0
25989328,EU,EU,1,1.0,0,0,0,0,2025-11-03,57.0,801.0,Female,75.0,INFLIXIMAB,colitis ulcerative,1,0,0.0,MidAge,EU,0.07142857142857142,9,0,18,0,0,0,0,0,0,0,2,2025,11,3,0,0.08073634859349145,4.071428571428571,0.07142857142857142
25989786,US,US,1,1.0,0,0,0,0,2025-11-03,58.0,801.0,Male,75.0,PREDNISONE,cystoid macular oedema,1,0,0.0,MidAge,US,0.1607142857142857,8,1,22,0,0,0,0,0,0,0,3,2025,11,3,0,0.08073634859349145,9.321428571428571,0.0
25995026,JP,JP,1,1.0,0,0,1,0,2025-11-04,17.0,801.0,Female,75.0,VENLAFAXINE HYDROCHLORIDE,altered state of consciousness,1,3,0.21428571428571427,Child,JP,0.21428571428571427,1,1,30,0,0,0,0,0,0,0,4,2025,11,4,1,0.08073634859349145,3.642857142857143,0.21428571428571427
25915682,US,US,1,2.0,0,0,0,0,2025-10-13,57.0,801.0,Female,75.0,JOENJA,chronic sinusitis,0,0,0.0,MidAge,US,0.0,3,0,17,0,0,0,0,0,0,0,2,2025,10,13,0,0.08073634859349145,0.0,0.0
25915844,US,US,1,2.0,0,0,0,0,2025-10-13,65.0,801.0,Female,75.0,DATROWAY,off label use,0,0,0.0,MidAge,US,0.0,2,0,13,0,0,0,0,0,0,0,3,2025,10,13,0,0.08073634859349145,0.0,0.0
25916249,US,US,1,2.0,0,0,0,0,2025-10-14,54.0,801.0,Male,75.0,COSENTYX,wrong technique in device usage process,0,0,0.0,MidAge,US,0.05714285714285714,10,0,39,0,0,0,0,0,0,0,6,2025,10,14,1,0.08073634859349145,3.0857142857142854,0.0
25917383,CA,CA,1,1.0,0,0,0,0,2025-10-14,57.0,801.0,Female,75.0,INFLIXIMAB,infusion site extravasation,1,0,0.0,MidAge,CA,0.07142857142857142,9,0,27,0,0,0,0,0,0,0,3,2025,10,14,1,0.08073634859349145,4.071428571428571,0.07142857142857142
21465146,CA,CA,1,1.0,0,0,1,0,2022-10-17,37.0,801.0,Female,75.0,VICTOZA,blood potassium decreased,1,3,0.21428571428571427,Adult,CA,0.21428571428571427,1,1,25,0,0,0,0,0,0,0,3,2022,10,17,0,0.08073634859349145,7.928571428571428,0.21428571428571427
21759553,EU,EU,1,1.0,0,0,0,0,2022-12-21,52.0,801.0,Female,66.0,LEVOFLOXACIN,pain in extremity,1,0,0.0,MidAge,EU,0.25,4,1,17,1,0,0,0,0,0,0,3,2022,12,21,2,0.08073634859349145,13.0,0.25
21770192,EU,EU,2,1.0,0,0,0,0,2022-12-23,66.0,801.0,Male,88.0,ENCORAFENIB,insomnia,1,0,0.0,Senior,EU,0.0,1,0,8,0,0,0,0,0,0,0,1,2022,12,23,4,0.08936301793444651,0.0,0.0
21784487,US,US,1,1.0,0,0,0,0,2022-12-27,74.0,801.0,Male,95.25,BRAFTOVI,haematemesis,1,0,0.0,Senior,US,0.0,1,0,12,0,0,0,0,0,0,0,1,2022,12,27,1,0.08073634859349145,0.0,0.0
21919609,AU,AU,2,1.0,0,0,1,0,2023-01-27,51.0,801.0,Female,75.0,TEDUGLUTIDE,duodenal polyp,1,3,0.21428571428571427,MidAge,AU,0.14285714285714285,3,1,14,0,0,0,0,0,0,0,2,2023,1,27,4,0.08936301793444651,7.285714285714286,0.14285714285714285
21995654,US,US,1,2.0,0,0,0,0,2023-02-15,35.0,801.0,Male,75.0,DUPIXENT,pain in extremity,0,0,0.0,Young,US,0.015513897866839042,221,0,17,1,0,0,0,0,0,0,3,2023,2,15,2,0.08073634859349145,0.5429864253393665,0.0
22238358,CA,CA,2,1.0,0,0,0,0,2023-04-21,57.0,801.0,Female,75.0,RITUXIMAB,pulmonary embolism,1,0,0.0,MidAge,CA,0.12406015037593986,19,0,18,0,0,0,0,0,0,0,2,2023,4,21,4,0.08936301793444651,7.071428571428572,0.12406015037593986
25920112,US,Unknown,1,1.0,0,0,0,0,2025-10-14,45.0,801.0,Female,75.0,MYCOPHENOLIC ACID,dizziness,1,0,0.0,Adult,US,0.0,1,0,9,0,0,0,0,0,0,0,1,2025,10,14,1,0.08073634859349145,0.0,0.0
25920408,US,US,1,1.0,1,0,1,0,2025-10-14,57.0,801.0,Female,75.0,YUTREPIA,pulmonary fibrosis,1,8,0.5714285714285714,MidAge,US,0.5714285714285714,1,1,18,0,0,0,0,0,0,0,2,2025,10,14,1,0.08073634859349145,32.57142857142857,0.5714285714285714
25921056,EU,EU,1,1.0,0,1,1,0,2025-10-14,59.0,801.0,Female,75.0,TUKYSA,cardiac failure,1,7,0.5,MidAge,EU,0.5,1,1,15,0,0,0,0,1,0,0,2,2025,10,14,1,0.08073634859349145,29.5,0.5
25921285,US,US,1,2.0,0,0,0,0,2025-10-14,57.0,801.0,Female,75.0,DUPIXENT,wheezing,0,0,0.0,MidAge,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,10,14,1,0.08073634859349145,0.8842921784098254,0.015513897866839042
25921542,US,US,1,2.0,0,0,0,0,2025-10-14,21.0,801.0,Female,75.0,DUPIXENT,injection site irritation,0,0,0.0,Young,US,0.015513897866839042,221,0,25,0,0,0,0,0,0,0,3,2025,10,14,1,0.08073634859349145,0.32579185520361986,0.015513897866839042
25922891,US,US,1,2.0,0,0,0,0,2025-10-15,57.0,801.0,Male,75.0,DUPIXENT,loss of personal independence in daily activities,0,0,0.0,MidAge,US,0.015513897866839042,221,0,49,0,0,0,0,0,0,0,7,2025,10,15,2,0.08073634859349145,0.8842921784098254,0.0
25923148,US,US,2,1.0,0,0,0,0,2025-10-15,57.0,801.0,Female,75.0,CREON,cerebrovascular accident,1,0,0.0,MidAge,US,0.03296703296703297,13,0,24,0,0,0,0,0,0,0,2,2025,10,15,2,0.08936301793444651,1.879120879120879,0.03296703296703297
25926550,EU,EU,1,1.0,0,0,0,0,2025-10-15,64.0,801.0,Male,75.0,AMLODIPINE,erythema,1,0,0.0,MidAge,EU,0.16964285714285715,8,1,8,0,0,0,0,0,0,0,1,2025,10,15,2,0.08073634859349145,10.857142857142858,0.0
25926684,US,US,1,2.0,0,0,0,0,2025-10-15,65.0,801.0,Male,75.0,XELJANZ XR,covid-19,0,0,0.0,MidAge,US,0.0,9,0,8,0,0,0,0,0,0,0,1,2025,10,15,2,0.08073634859349145,0.0,0.0
25927399,CN,CN,2,1.0,0,0,1,0,2025-10-15,53.0,801.0,Female,54.0,DARATUMUMAB,pyrexia,1,3,0.21428571428571427,MidAge,CN,0.14285714285714285,3,1,7,0,0,0,0,0,0,0,1,2025,10,15,2,0.08936301793444651,7.571428571428571,0.14285714285714285
25928103,US,US,1,2.0,0,0,0,0,2025-10-16,24.0,801.0,Female,75.0,DUPIXENT,urticaria,0,0,0.0,Young,US,0.015513897866839042,221,0,9,0,0,0,0,0,0,0,1,2025,10,16,3,0.08073634859349145,0.372333548804137,0.015513897866839042
25928385,US,US,1,2.0,0,0,0,0,2025-10-16,69.0,801.0,Female,75.0,TRELEGY ELLIPTA,muscle spasms,0,0,0.0,Senior,US,0.0,4,0,13,0,0,0,0,0,0,0,2,2025,10,16,3,0.08073634859349145,0.0,0.0
25929438,EU,EU,1,1.0,0,0,1,0,2025-10-16,8.0,801.0,Male,30.0,XOLAIR,scrotal oedema,1,3,0.21428571428571427,Child,EU,0.14285714285714285,4,1,14,0,0,0,0,0,0,0,2,2025,10,16,3,0.08073634859349145,1.1428571428571428,0.0
25930142,US,US,1,1.0,0,0,1,0,2025-10-16,54.0,801.0,Female,61.0,FLUOROURACIL,colitis,1,3,0.21428571428571427,MidAge,US,0.21428571428571427,1,1,7,0,0,0,0,0,0,0,1,2025,10,16,3,0.08073634859349145,11.571428571428571,0.21428571428571427
25930748,US,US,1,2.0,0,0,0,0,2025-10-16,45.0,801.0,Female,75.0,ORENCIA,loss of therapeutic response,0,0,0.0,Adult,US,0.10204081632653061,14,0,28,0,0,0,0,0,0,0,4,2025,10,16,3,0.08073634859349145,4.591836734693878,0.10204081632653061
25930829,EU,EU,1,1.0,0,0,0,0,2025-10-16,13.0,801.0,Male,75.0,DUPILUMAB,ocular surface disease,1,0,0.0,Child,EU,0.04285714285714286,5,0,22,0,0,0,0,0,0,0,3,2025,10,16,3,0.08073634859349145,0.5571428571428572,0.0
25931910,US,US,1,1.0,0,0,1,0,2025-10-16,57.0,801.0,Male,85.45,DUPIXENT,pneumonia,1,3,0.21428571428571427,MidAge,US,0.015513897866839042,221,0,9,0,0,0,0,0,1,0,1,2025,10,16,3,0.08073634859349145,0.8842921784098254,0.0
25932234,EU,EU,1,1.0,0,0,1,0,2025-10-16,68.0,801.0,Female,84.0,FUROSEMIDE,orthostatic hypotension,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,23,0,0,0,0,0,0,0,2,2025,10,16,3,0.08073634859349145,14.571428571428571,0.21428571428571427
25934784,US,Unknown,1,2.0,0,0,0,0,2025-10-17,73.0,801.0,Female,59.864,JAKAFI,pruritus,0,0,0.0,Senior,US,0.0,3,0,8,0,0,0,0,0,0,0,1,2025,10,17,4,0.08073634859349145,0.0,0.0
25934999,US,US,2,2.0,0,0,0,0,2025-10-17,14.0,801.0,Male,75.0,OMNITROPE,injection site erythema,0,0,0.0,Child,US,0.0,5,0,23,0,0,0,0,0,0,0,3,2025,10,17,4,0.08936301793444651,0.0,0.0
22969302,CA,CA,1,1.0,0,0,1,0,2023-09-22,61.0,801.0,Female,86.0,CISPLATIN,fluid intake reduced,1,3,0.21428571428571427,MidAge,CA,0.10714285714285714,2,0,20,0,0,0,0,0,0,0,3,2023,9,22,4,0.08073634859349145,6.535714285714286,0.10714285714285714
23150136,US,US,2,1.0,0,0,1,0,2023-11-06,64.0,801.0,Female,86.168,LANADELUMAB,faecaloma,1,3,0.21428571428571427,MidAge,US,0.12857142857142856,5,1,9,0,0,0,0,0,0,0,1,2023,11,6,0,0.08936301793444651,8.228571428571428,0.12857142857142856
23244501,CA,Unknown,2,1.0,0,0,0,0,2023-11-30,66.0,801.0,Female,75.0,CERTOLIZUMAB PEGOL,bladder operation,1,0,0.0,Senior,CA,0.04285714285714286,5,0,17,0,0,0,0,0,0,0,2,2023,11,30,3,0.08936301793444651,2.8285714285714287,0.04285714285714286
23245445,US,US,1,2.0,0,0,0,0,2023-11-30,57.0,801.0,Female,75.0,TERIPARATIDE,device use error,0,0,0.0,MidAge,US,0.0,1,0,16,0,0,0,0,0,0,0,3,2023,11,30,3,0.08073634859349145,0.0,0.0
23318507,JP,JP,1,1.0,1,0,0,0,2023-12-20,57.0,801.0,Female,75.0,VENCLEXTA,death,1,5,0.35714285714285715,MidAge,JP,0.18571428571428572,5,1,5,0,0,1,0,0,0,0,1,2023,12,20,2,0.08073634859349145,10.585714285714285,0.18571428571428572
23662905,EU,EU,1,1.0,0,0,0,0,2024-03-22,41.0,801.0,Male,75.0,PREGABALIN,condition aggravated,1,0,0.0,Adult,EU,0.10714285714285714,6,0,20,0,0,0,0,0,0,0,2,2024,3,22,4,0.08073634859349145,4.392857142857142,0.0
23763116,CA,CA,1,1.0,0,0,0,0,2024-04-19,69.0,801.0,Female,75.0,PANTOPRAZOLE,blood magnesium decreased,1,0,0.0,Senior,CA,0.0,1,0,25,0,0,0,0,0,0,0,3,2024,4,19,4,0.08073634859349145,0.0,0.0
26007676,US,US,1,1.0,0,0,1,0,2025-11-06,57.0,801.0,Female,75.0,DUPIXENT,hospitalisation,1,3,0.21428571428571427,MidAge,US,0.015513897866839042,221,0,15,0,0,0,0,0,0,0,1,2025,11,6,3,0.08073634859349145,0.8842921784098254,0.015513897866839042
26008271,US,US,1,2.0,0,0,0,0,2025-11-06,54.0,801.0,Female,75.0,DUPIXENT,injection site pain,0,0,0.0,MidAge,US,0.015513897866839042,221,0,19,1,0,0,0,0,0,0,3,2025,11,6,3,0.08073634859349145,0.8377504848093082,0.015513897866839042
26009067,US,US,1,2.0,0,0,0,0,2025-11-07,35.0,801.0,Male,75.0,DUPIXENT,wisdom teeth removal,0,0,0.0,Young,US,0.015513897866839042,221,0,20,0,0,0,0,0,0,0,3,2025,11,7,4,0.08073634859349145,0.5429864253393665,0.0
26009081,US,US,1,2.0,0,0,0,0,2025-11-07,33.0,801.0,Female,75.0,DUPIXENT,injection site pain,0,0,0.0,Young,US,0.015513897866839042,221,0,19,1,0,0,0,0,0,0,3,2025,11,7,4,0.08073634859349145,0.5119586296056884,0.015513897866839042
26010997,US,US,2,1.0,0,0,0,0,2025-11-07,63.0,801.0,Male,75.0,SKYRIZI,surgery,1,0,0.0,MidAge,US,0.051587301587301584,36,0,7,0,0,0,0,0,0,0,1,2025,11,7,4,0.08936301793444651,3.25,0.0
26057644,US,Unknown,1,2.0,0,0,0,0,2025-11-18,57.0,801.0,Female,75.0,LACOSAMIDE,hypersensitivity,0,0,0.0,MidAge,US,0.16666666666666666,3,1,16,0,0,0,0,0,0,0,1,2025,11,18,1,0.08073634859349145,9.5,0.16666666666666666
26058049,US,US,1,2.0,0,0,0,0,2025-11-18,57.0,801.0,Male,75.0,OTEZLA,dry skin,0,0,0.0,MidAge,US,0.0,4,0,8,0,0,0,0,0,0,0,2,2025,11,18,1,0.08073634859349145,0.0,0.0
26058454,EU,EU,1,1.0,0,0,1,0,2025-11-18,52.0,801.0,Female,75.0,GABAPENTIN,hepatic cytolysis,1,3,0.21428571428571427,MidAge,EU,0.061224489795918366,7,0,17,0,0,0,0,0,0,0,2,2025,11,18,1,0.08073634859349145,3.183673469387755,0.061224489795918366
26059507,JP,JP,1,1.0,0,0,0,0,2025-11-18,35.0,801.0,Male,75.0,MOUNJARO,retinal haemorrhage,1,0,0.0,Young,JP,0.2142857142857143,4,1,19,0,0,0,0,0,0,0,2,2025,11,18,1,0.08073634859349145,7.500000000000001,0.0
26011835,CA,CA,3,1.0,0,0,1,0,2025-11-07,57.0,801.0,Female,75.0,DOXORUBICIN HYDROCHLORIDE,acute hepatic failure,1,3,0.21428571428571427,MidAge,CA,0.21428571428571427,1,1,21,0,0,0,0,1,0,0,3,2025,11,7,4,0.17857142857142855,12.214285714285714,0.21428571428571427
26014980,US,US,1,2.0,0,0,0,0,2025-11-09,69.0,801.0,Male,75.0,DUPIXENT,vision blurred,0,0,0.0,Senior,US,0.015513897866839042,221,0,14,0,0,0,0,0,0,0,2,2025,11,9,6,0.08073634859349145,1.070458952811894,0.0
26015075,US,US,1,2.0,0,0,0,0,2025-11-09,42.0,801.0,Female,75.0,DUPIXENT,injection site pain,0,0,0.0,Adult,US,0.015513897866839042,221,0,19,1,0,0,0,0,0,0,3,2025,11,9,6,0.08073634859349145,0.6515837104072397,0.015513897866839042
26015251,US,US,1,2.0,0,0,0,0,2025-11-09,7.0,801.0,Female,75.0,DUPIXENT,injection site erythema,0,0,0.0,Child,US,0.015513897866839042,221,0,23,0,0,0,0,0,0,0,3,2025,11,9,6,0.08073634859349145,0.10859728506787329,0.015513897866839042
26062127,US,US,2,1.0,0,0,0,0,2025-11-19,52.0,801.0,Female,75.0,NUPLAZID,mental impairment,1,0,0.0,MidAge,US,0.09523809523809523,6,0,17,0,0,0,0,0,0,0,2,2025,11,19,2,0.08936301793444651,4.9523809523809526,0.09523809523809523
26063328,BR,BR,1,1.0,0,0,0,0,2025-11-19,57.0,801.0,Female,56.0,CLONAZEPAM,diabetes mellitus,1,0,0.0,MidAge,BR,0.07142857142857142,3,0,17,0,0,0,0,0,0,0,2,2025,11,19,2,0.08073634859349145,4.071428571428571,0.07142857142857142
26019178,US,US,1,2.0,0,0,0,0,2025-11-10,57.0,801.0,Female,75.0,LENALIDOMIDE,product dose omission issue,0,0,0.0,MidAge,US,0.15413533834586465,19,1,27,0,0,0,0,0,0,0,4,2025,11,10,0,0.08073634859349145,8.785714285714285,0.15413533834586465
26020125,US,US,1,2.0,0,0,0,0,2025-11-10,57.0,801.0,Female,75.0,POLYETHYLENE GLYCOL 3350,therapeutic product effect delayed,0,0,0.0,MidAge,US,0.0,4,0,34,0,0,0,0,0,0,0,4,2025,11,10,0,0.08073634859349145,0.0,0.0
26020435,US,US,1,2.0,0,0,0,0,2025-11-10,57.0,801.0,Female,75.0,POLYETHYLENE GLYCOL 3350,drug ineffective,0,0,0.0,MidAge,US,0.0,4,0,16,0,0,0,0,0,0,0,2,2025,11,10,0,0.08073634859349145,0.0,0.0
25936027,US,US,2,1.0,0,0,0,0,2025-10-17,67.0,801.0,Male,75.0,AUSTEDO XR,aspiration,1,0,0.0,Senior,US,0.0,1,0,10,0,0,0,0,0,0,0,1,2025,10,17,4,0.08936301793444651,0.0,0.0
25936351,CA,CA,2,1.0,0,0,0,0,2025-10-17,32.0,801.0,Female,75.0,VEDOLIZUMAB,rectal haemorrhage,1,0,0.0,Young,CA,0.057692307692307696,26,0,18,0,0,0,0,0,0,0,2,2025,10,17,4,0.08936301793444651,1.8461538461538463,0.057692307692307696
25936823,JP,JP,1,1.0,0,0,1,0,2025-10-17,73.0,801.0,Male,75.0,VYXEOS,pneumonia,1,3,0.21428571428571427,Senior,JP,0.21428571428571427,1,1,9,0,0,0,0,0,1,0,1,2025,10,17,4,0.08073634859349145,15.642857142857142,0.0
25937309,US,US,2,1.0,0,0,0,0,2025-10-17,55.0,801.0,Female,75.0,SKYRIZI,drug-induced liver injury,1,0,0.0,MidAge,US,0.051587301587301584,36,0,25,0,0,0,0,0,0,0,3,2025,10,17,4,0.08936301793444651,2.837301587301587,0.051587301587301584
25937457,US,US,2,2.0,0,0,0,0,2025-10-18,66.0,801.0,Male,75.0,SKYRIZI,cough,0,0,0.0,Senior,US,0.051587301587301584,36,0,5,0,0,0,0,0,0,0,1,2025,10,18,5,0.08936301793444651,3.4047619047619047,0.0
25937714,CN,CN,1,1.0,0,0,0,0,2025-10-18,67.0,801.0,Male,75.0,TADALAFIL,drug ineffective,1,0,0.0,Senior,CN,0.0,2,0,16,0,0,0,0,0,0,0,2,2025,10,18,5,0.08073634859349145,0.0,0.0
26021326,US,US,1,1.0,0,0,0,0,2025-11-10,31.0,801.0,Female,75.0,METHOTREXATE,drug ineffective,1,0,0.0,Young,US,0.17346938775510204,7,1,16,0,0,0,0,0,0,0,2,2025,11,10,0,0.08073634859349145,5.377551020408164,0.17346938775510204
26022499,US,US,1,1.0,0,0,1,0,2025-11-10,79.0,801.0,Female,82.55,REVLIMID,blood calcium abnormal,1,3,0.21428571428571427,Senior,US,0.05357142857142857,4,0,22,0,0,0,0,0,0,0,3,2025,11,10,0,0.08073634859349145,4.232142857142857,0.05357142857142857
26022703,US,US,1,2.0,0,0,0,0,2025-11-10,57.0,801.0,Female,75.0,LEVOTHYROXINE SODIUM,alopecia,0,0,0.0,MidAge,US,0.0,3,0,8,0,0,0,0,0,0,0,1,2025,11,10,0,0.08073634859349145,0.0,0.0
26064596,US,US,1,2.0,0,0,0,0,2025-11-19,4.0,801.0,Male,75.0,DUPIXENT,eczema,0,0,0.0,Child,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,11,19,2,0.08073634859349145,0.06205559146735617,0.0
26064624,US,US,1,2.0,0,0,0,0,2025-11-19,23.0,801.0,Male,75.0,DUPIXENT,feeling abnormal,0,0,0.0,Young,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,2,2025,11,19,2,0.08073634859349145,0.35681965093729795,0.0
26064691,US,US,1,2.0,0,0,0,0,2025-11-19,57.0,801.0,Female,75.0,DUPIXENT,illness,0,0,0.0,MidAge,US,0.015513897866839042,221,0,7,0,0,0,0,0,0,0,1,2025,11,19,2,0.08073634859349145,0.8842921784098254,0.015513897866839042
26065649,US,Unknown,1,1.0,0,0,1,0,2025-11-19,56.0,801.0,Female,75.0,AMJEVITA,abdominal operation,1,3,0.21428571428571427,MidAge,US,0.21428571428571427,1,1,19,0,0,0,0,0,0,0,2,2025,11,19,2,0.08073634859349145,12.0,0.21428571428571427
26066811,CA,CA,1,1.0,0,0,0,0,2025-11-19,57.0,801.0,Female,75.0,TRIAMCINOLONE ACETONIDE,irritable bowel syndrome,1,0,0.0,MidAge,CA,0.19047619047619047,3,1,24,0,0,0,0,0,0,0,3,2025,11,19,2,0.08073634859349145,10.857142857142856,0.19047619047619047
26067188,US,US,2,1.0,0,0,0,0,2025-11-19,61.0,801.0,Female,75.0,SKYRIZI,rotator cuff syndrome,1,0,0.0,MidAge,US,0.051587301587301584,36,0,21,0,0,0,0,0,0,0,3,2025,11,19,2,0.08936301793444651,3.1468253968253967,0.051587301587301584
26067889,EU,EU,1,1.0,0,0,1,0,2025-11-20,57.0,801.0,Male,75.0,PEMETREXED,acute kidney injury,1,3,0.21428571428571427,MidAge,EU,0.21428571428571427,3,1,19,0,0,0,0,0,0,0,3,2025,11,20,3,0.08073634859349145,12.214285714285714,0.0
26068202,US,US,1,2.0,0,0,0,0,2025-11-20,43.0,801.0,Female,109.0,NEULASTA,device malfunction,0,0,0.0,Adult,US,0.0,5,0,18,0,0,0,0,0,0,0,2,2025,11,20,3,0.08073634859349145,0.0,0.0
25939859,GB,Unknown,1,1.0,0,0,0,1,2025-10-20,57.0,801.0,Female,66.0,EZETIMIBE AND SIMVASTATIN,dizziness postural,1,2,0.14285714285714285,MidAge,GB,0.14285714285714285,1,1,18,0,0,0,0,0,0,0,2,2025,10,20,0,0.08073634859349145,8.142857142857142,0.14285714285714285
25940334,US,US,1,1.0,0,0,0,0,2025-10-20,57.0,801.0,Female,75.0,JAYPIRCA,malignant neoplasm progression,1,0,0.0,MidAge,US,0.0,1,0,30,0,0,0,0,0,0,0,3,2025,10,20,0,0.08073634859349145,0.0,0.0
25941010,US,US,2,2.0,0,0,0,0,2025-10-20,57.0,801.0,Male,75.0,CORTICOTROPIN,skin irritation,0,0,0.0,MidAge,US,0.0,3,0,15,0,0,0,0,0,0,0,2,2025,10,20,0,0.08936301793444651,0.0,0.0
25942884,US,US,1,2.0,0,0,0,0,2025-10-21,57.0,801.0,Female,75.0,DUPIXENT,weight increased,0,0,0.0,MidAge,US,0.015513897866839042,221,0,16,0,0,0,0,0,0,0,2,2025,10,21,1,0.08073634859349145,0.8842921784098254,0.015513897866839042
26026387,US,US,1,2.0,0,0,0,0,2025-11-11,57.0,801.0,Female,75.0,DUPIXENT,injection site scar,0,0,0.0,MidAge,US,0.015513897866839042,221,0,19,0,0,0,0,0,0,0,3,2025,11,11,1,0.08073634859349145,0.8842921784098254,0.015513897866839042
26026644,US,US,1,2.0,0,0,0,0,2025-11-11,81.0,801.0,Female,75.0,DUPIXENT,urticaria,0,0,0.0,Senior,US,0.015513897866839042,221,0,9,0,0,0,0,0,0,0,1,2025,11,11,1,0.08073634859349145,1.2566257272139625,0.015513897866839042
26026725,US,US,1,2.0,0,0,0,0,2025-11-11,72.0,801.0,Male,75.0,DUPIXENT,incorrect dose administered,0,0,0.0,Senior,US,0.015513897866839042,221,0,27,0,0,0,0,0,0,0,3,2025,11,11,1,0.08073634859349145,1.117000646412411,0.0
26069713,CA,CA,1,1.0,0,0,0,0,2025-11-20,34.0,801.0,Male,75.0,GABAPENTIN,crohn^s disease,1,0,0.0,Young,CA,0.061224489795918366,7,0,15,0,0,0,0,0,0,0,2,2025,11,20,3,0.08073634859349145,2.0816326530612246,0.0
26069766,US,US,2,1.0,0,0,0,0,2025-11-20,53.0,801.0,Male,75.0,CREON,gallbladder operation,1,0,0.0,MidAge,US,0.03296703296703297,13,0,21,0,0,0,0,0,0,0,2,2025,11,20,3,0.08936301793444651,1.7472527472527473,0.0
26070065,CA,CA,2,1.0,0,0,0,0,2025-11-20,57.0,801.0,Female,75.0,RITUXIMAB,abdominal operation,1,0,0.0,MidAge,CA,0.12406015037593986,19,0,19,0,0,0,0,0,0,0,2,2025,11,20,3,0.08936301793444651,7.071428571428572,0.12406015037593986
26070146,US,US,1,1.0,0,0,1,0,2025-11-20,15.0,801.0,Female,75.0,PREDNISONE,immune-mediated myositis,1,3,0.21428571428571427,Child,US,0.1607142857142857,8,1,24,0,0,0,0,0,0,0,2,2025,11,20,3,0.08073634859349145,2.4107142857142856,0.1607142857142857
26070470,US,US,1,1.0,0,0,0,0,2025-11-20,57.0,801.0,Female,75.0,DUPIXENT,crohn^s disease,1,0,0.0,MidAge,US,0.015513897866839042,221,0,15,0,0,0,0,0,0,0,2,2025,11,20,3,0.08073634859349145,0.8842921784098254,0.015513897866839042
26070995,US,US,1,2.0,0,0,0,0,2025-11-20,15.0,801.0,Female,75.0,DUPIXENT,injection site pain,0,0,0.0,Child,US,0.015513897866839042,221,0,19,1,0,0,0,0,0,0,3,2025,11,20,3,0.08073634859349145,0.23270846800258563,0.015513897866839042
26033677,EU,EU,1,1.0,1,0,1,0,2025-11-12,73.0,801.0,Male,75.0,CARBIDOPA\LEVODOPA,pneumonia,1,8,0.5714285714285714,Senior,EU,0.3333333333333333,3,1,9,0,0,0,0,0,1,0,1,2025,11,12,2,0.08073634859349145,24.333333333333332,0.0
26034663,US,US,1,1.0,0,0,1,0,2025-11-12,15.0,801.0,Female,75.0,MYCOPHENOLATE MOFETIL,gastrointestinal disorder,1,3,0.21428571428571427,Child,US,0.10150375939849625,19,0,25,0,0,0,0,0,0,0,2,2025,11,12,2,0.08073634859349145,1.5225563909774438,0.10150375939849625
26035068,US,US,1,2.0,0,0,0,0,2025-11-12,16.0,801.0,Female,75.0,DUPIXENT,injection site swelling,0,0,0.0,Child,US,0.015513897866839042,221,0,23,0,0,0,0,0,0,0,3,2025,11,12,2,0.08073634859349145,0.24822236586942467,0.015513897866839042
26035730,US,US,1,1.0,0,0,0,0,2025-11-12,57.0,801.0,Male,75.0,CARVYKTI,immunodeficiency,1,0,0.0,MidAge,US,0.0,1,0,16,0,0,0,0,0,0,0,1,2025,11,12,2,0.08073634859349145,0.0,0.0
26036311,EU,EU,1,1.0,0,0,0,0,2025-11-12,59.0,801.0,Male,75.0,BINIMETINIB,autoimmune colitis,1,0,0.0,MidAge,EU,0.0,1,0,18,0,0,0,0,0,0,0,2,2025,11,12,2,0.08073634859349145,0.0,0.0
26037107,EU,EU,1,1.0,0,0,0,0,2025-11-12,57.0,801.0,Female,75.0,METHOTREXATE,cerebral infarction,1,0,0.0,MidAge,EU,0.17346938775510204,7,1,19,0,0,0,0,0,0,0,2,2025,11,12,2,0.08073634859349145,9.887755102040817,0.17346938775510204
25945180,US,US,1,2.0,0,0,0,0,2025-10-21,57.0,801.0,Female,75.0,XEOMIN,urticaria,0,0,0.0,MidAge,US,0.08928571428571429,4,0,9,0,0,0,0,0,0,0,1,2025,10,21,1,0.08073634859349145,5.089285714285714,0.08928571428571429
25946758,US,US,1,1.0,0,0,0,0,2025-10-22,57.0,801.0,Female,75.0,COBENFY,serotonin syndrome,1,0,0.0,MidAge,US,0.0,1,0,18,0,0,0,0,0,0,0,2,2025,10,22,2,0.08073634859349145,0.0,0.0
25946987,GB,GB,1,1.0,0,0,0,0,2025-10-22,57.0,801.0,Female,75.0,PREGABALIN,decreased appetite,1,0,0.0,MidAge,GB,0.10714285714285714,6,0,18,0,0,0,0,0,0,0,2,2025,10,22,2,0.08073634859349145,6.107142857142857,0.10714285714285714
25947177,EU,EU,1,1.0,0,0,1,0,2025-10-22,37.0,801.0,Male,75.0,OLANZAPINE,intentional overdose,1,3,0.21428571428571427,Adult,EU,0.11904761904761905,6,0,20,0,0,0,0,0,0,0,2,2025,10,22,2,0.08073634859349145,4.404761904761905,0.0
26037822,US,US,1,1.0,0,0,0,0,2025-11-12,57.0,801.0,Male,75.0,LUMASON,hypersensitivity,1,0,0.0,MidAge,US,0.25,2,1,16,0,0,0,0,0,0,0,1,2025,11,12,2,0.08073634859349145,14.25,0.0
26038199,US,US,1,1.0,0,0,1,0,2025-11-13,63.0,801.0,Female,69.85,OPSUMIT,dyspnoea,1,3,0.21428571428571427,MidAge,US,0.10714285714285714,2,0,8,0,0,0,0,0,0,0,1,2025,11,13,3,0.08073634859349145,6.75,0.10714285714285714
26038847,GB,GB,1,1.0,0,0,0,0,2025-11-13,49.0,801.0,Female,70.0,LEVETIRACETAM,dyspnoea,1,0,0.0,Adult,GB,0.05714285714285714,5,0,8,0,0,0,0,0,0,0,1,2025,11,13,3,0.08073634859349145,2.8,0.05714285714285714
26039442,US,US,1,2.0,0,0,0,0,2025-11-13,20.0,801.0,Female,75.0,AMOXICILLIN,maternal exposure during pregnancy,0,0,0.0,Young,US,0.0,1,0,34,0,0,0,0,0,0,0,4,2025,11,13,3,0.08073634859349145,0.0,0.0
26039914,EU,EU,2,1.0,0,0,0,0,2025-11-13,57.0,801.0,Male,94.0,UPTRAVI,renal impairment,1,0,0.0,MidAge,EU,0.0,1,0,16,0,0,0,0,0,0,0,2,2025,11,13,3,0.08936301793444651,0.0,0.0
26040833,US,Unknown,1,1.0,0,0,1,0,2025-11-13,22.0,801.0,Male,70.3,DEXAMETHASONE,pancreatitis,1,3,0.21428571428571427,Young,US,0.1857142857142857,5,1,12,0,0,0,0,0,0,0,1,2025,11,13,3,0.08073634859349145,4.085714285714285,0.0
26041333,US,US,1,1.0,0,0,0,0,2025-11-13,53.0,801.0,Female,75.0,AYVAKIT,toe operation,1,0,0.0,MidAge,US,0.0,2,0,13,0,0,0,0,0,0,0,2,2025,11,13,3,0.08073634859349145,0.0,0.0
24422928,JP,JP,1,2.0,0,0,0,0,2024-10-10,57.0,801.0,Male,75.0,NGENLA,patient-device incompatibility,0,0,0.0,MidAge,JP,0.0,1,0,30,0,0,0,0,0,0,0,2,2024,10,10,3,0.08073634859349145,0.0,0.0
24533750,US,US,1,2.0,0,0,0,0,2024-10-22,57.0,801.0,Female,75.0,ILUVIEN,device difficult to use,0,0,0.0,MidAge,US,0.0,3,0,23,0,0,0,0,0,0,0,4,2024,10,22,1,0.08073634859349145,0.0,0.0
24533789,US,US,1,2.0,0,0,0,0,2024-10-22,69.0,801.0,Female,75.0,ILUVIEN,device malfunction,0,0,0.0,Senior,US,0.0,3,0,18,0,0,0,0,0,0,0,2,2024,10,22,1,0.08073634859349145,0.0,0.0
24598913,US,US,1,1.0,0,0,1,0,2024-11-10,71.0,801.0,Female,75.0,DUPIXENT,infection,1,3,0.21428571428571427,Senior,US,0.015513897866839042,221,0,9,0,1,0,0,0,0,0,1,2024,11,10,6,0.08073634859349145,1.101486748545572,0.015513897866839042
24607675,EU,EU,1,1.0,0,0,1,0,2024-11-12,50.0,801.0,Female,75.0,LORAZEPAM,suicide attempt,1,3,0.21428571428571427,Adult,EU,0.21428571428571427,1,1,15,0,0,0,0,0,0,0,2,2024,11,12,1,0.08073634859349145,10.714285714285714,0.21428571428571427
24610147,US,US,1,2.0,0,0,0,0,2024-11-12,52.0,801.0,Male,75.0,DUPIXENT,bone pain,0,0,0.0,MidAge,US,0.015513897866839042,221,0,9,1,0,0,0,0,0,0,2,2024,11,12,1,0.08073634859349145,0.8067226890756302,0.0
24632299,US,Unknown,1,2.0,0,0,0,0,2024-11-18,23.0,801.0,Female,83.9,REVCOVI,weight increased,0,0,0.0,Young,US,0.0,1,0,16,0,0,0,0,0,0,0,2,2024,11,18,0,0.08073634859349145,0.0,0.0
24645921,US,US,1,2.0,0,0,0,0,2024-11-21,48.0,801.0,Female,75.0,VERZENIO,taste disorder,0,0,0.0,Adult,US,0.0,1,0,14,0,0,0,0,0,0,0,2,2024,11,21,3,0.08073634859349145,0.0,0.0
25952456,CN,CN,1,1.0,0,0,0,0,2025-10-23,57.0,801.0,Female,75.0,CARBOPLATIN,neoplasm progression,1,0,0.0,MidAge,CN,0.12244897959183673,7,0,20,0,0,0,0,0,0,0,2,2025,10,23,3,0.08073634859349145,6.979591836734694,0.12244897959183673
25953347,US,Unknown,1,1.0,1,0,0,0,2025-10-23,84.0,801.0,Male,75.0,LENALIDOMIDE,death,1,5,0.35714285714285715,Senior,US,0.15413533834586465,19,1,5,0,0,1,0,0,0,0,1,2025,10,23,3,0.08073634859349145,12.94736842105263,0.0
25955224,US,US,1,2.0,0,0,0,0,2025-10-24,57.0,801.0,Female,75.0,SPRAVATO,drug monitoring procedure incorrectly performed,0,0,0.0,MidAge,US,0.026785714285714284,8,0,47,0,0,0,0,0,0,0,5,2025,10,24,4,0.08073634859349145,1.5267857142857142,0.026785714285714284
25955534,US,US,2,1.0,0,0,0,0,2025-10-24,66.0,801.0,Male,75.0,IXAZOMIB,plasma cell myeloma,1,0,0.0,Senior,US,0.0,2,0,19,0,0,0,0,0,0,0,3,2025,10,24,4,0.08936301793444651,0.0,0.0
26078137,EU,EU,3,1.0,0,0,1,0,2025-11-22,57.0,801.0,Female,75.0,ACETAMINOPHEN,depressed level of consciousness,1,3,0.21428571428571427,MidAge,EU,0.10267857142857142,16,0,32,0,0,0,0,0,0,0,4,2025,11,22,5,0.17857142857142855,5.852678571428571,0.10267857142857142
26078313,US,US,1,2.0,0,0,0,0,2025-11-22,8.0,801.0,Male,75.0,DUPIXENT,eczema,0,0,0.0,Child,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,11,22,5,0.08073634859349145,0.12411118293471234,0.0
26046651,EU,EU,1,1.0,0,0,1,0,2025-11-14,72.0,801.0,Male,65.0,NINTEDANIB,large granular lymphocytosis,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,1,1,28,0,0,0,0,0,0,0,3,2025,11,14,4,0.08073634859349145,15.428571428571427,0.0
26048905,EU,EU,1,1.0,1,0,0,0,2025-11-15,57.0,801.0,Female,75.0,RITUXIMAB,multiple organ dysfunction syndrome,1,5,0.35714285714285715,MidAge,EU,0.12406015037593986,19,0,35,0,0,0,0,0,0,0,4,2025,11,15,5,0.08073634859349145,7.071428571428572,0.12406015037593986
26048972,US,US,1,1.0,0,0,0,0,2025-11-15,57.0,801.0,Male,90.703,TYVASO DPI,pneumonia,1,0,0.0,MidAge,US,0.0,4,0,9,0,0,0,0,0,1,0,1,2025,11,15,5,0.08073634859349145,0.0,0.0
26049500,US,US,1,2.0,0,0,0,0,2025-11-15,52.0,801.0,Male,75.0,TRULICITY,tremor,0,0,0.0,MidAge,US,0.04285714285714286,5,0,6,0,0,0,0,0,0,0,1,2025,11,15,5,0.08073634859349145,2.2285714285714286,0.0
25957936,EU,EU,1,1.0,0,0,1,0,2025-10-24,41.0,801.0,Male,163.0,INFLIXIMAB,drug-induced liver injury,1,3,0.21428571428571427,Adult,EU,0.07142857142857142,9,0,25,0,0,0,0,0,0,0,3,2025,10,24,4,0.08073634859349145,2.9285714285714284,0.0
25958665,CA,CA,1,1.0,0,0,1,0,2025-10-24,93.0,801.0,Male,75.0,SEMAGLUTIDE,incontinence,1,3,0.21428571428571427,Senior,CA,0.14285714285714285,3,1,12,0,0,0,0,0,0,0,1,2025,10,24,4,0.08073634859349145,13.285714285714285,0.0
26049768,US,US,1,2.0,0,0,0,0,2025-11-15,10.0,801.0,Male,75.0,DUPIXENT,dry eye,0,0,0.0,Child,US,0.015513897866839042,221,0,7,0,0,0,0,0,0,0,2,2025,11,15,5,0.08073634859349145,0.1551389786683904,0.0
26050148,US,US,3,2.0,0,0,0,0,2025-11-16,57.0,801.0,Male,75.0,FILSPARI,fatigue,0,0,0.0,MidAge,US,0.0,4,0,7,0,0,0,0,0,0,0,1,2025,11,16,6,0.17857142857142855,0.0,0.0
26050324,US,US,1,2.0,0,0,0,0,2025-11-16,57.0,801.0,Female,53.64,DUPIXENT,injection site pain,0,0,0.0,MidAge,US,0.015513897866839042,221,0,19,1,0,0,0,0,0,0,3,2025,11,16,6,0.08073634859349145,0.8842921784098254,0.015513897866839042
26051620,US,US,1,2.0,0,0,0,0,2025-11-17,43.0,801.0,Male,75.0,DUPIXENT,injection site bruising,0,0,0.0,Adult,US,0.015513897866839042,221,0,23,0,0,0,0,0,0,0,3,2025,11,17,0,0.08073634859349145,0.6670976082740788,0.0
26052254,US,US,1,2.0,0,0,0,0,2025-11-17,76.0,801.0,Female,75.0,COSENTYX,injection site pain,0,0,0.0,Senior,US,0.05714285714285714,10,0,19,1,0,0,0,0,0,0,3,2025,11,17,0,0.08073634859349145,4.3428571428571425,0.05714285714285714
26052807,US,Unknown,1,1.0,0,0,1,0,2025-11-14,79.0,801.0,Female,62.1,CABOMETYX,coronary arterial stent insertion,1,3,0.21428571428571427,Senior,US,0.10714285714285714,4,0,33,0,0,0,0,0,0,0,4,2025,11,14,4,0.08073634859349145,8.464285714285714,0.10714285714285714
26053226,TH,TH,2,1.0,0,0,0,0,2025-11-17,57.0,801.0,Female,75.0,BEVACIZUMAB,sepsis,1,0,0.0,MidAge,Other,0.17857142857142858,2,1,6,0,0,0,0,0,0,0,1,2025,11,17,0,0.08936301793444651,10.178571428571429,0.17857142857142858
26081458,AU,AU,1,1.0,0,0,0,0,2025-11-24,57.0,801.0,Female,75.0,LACOSAMIDE,cardiac septal defect,1,0,0.0,MidAge,AU,0.16666666666666666,3,1,21,0,0,0,0,0,0,0,3,2025,11,24,0,0.08073634859349145,9.5,0.16666666666666666
26081500,US,US,1,2.0,0,0,0,0,2025-11-24,57.0,801.0,Female,79.09,DUPIXENT,injection site pain,0,0,0.0,MidAge,US,0.015513897866839042,221,0,19,1,0,0,0,0,0,0,3,2025,11,24,0,0.08073634859349145,0.8842921784098254,0.015513897866839042
26082349,US,US,1,2.0,0,0,0,0,2025-11-24,57.0,801.0,Male,75.0,METHYLPHENIDATE HYDROCHLORIDE,drug ineffective,0,0,0.0,MidAge,US,0.10714285714285714,2,0,16,0,0,0,0,0,0,0,2,2025,11,24,0,0.08073634859349145,6.107142857142857,0.0
26082363,US,Unknown,1,1.0,0,0,0,1,2025-11-23,36.0,801.0,Female,49.05,CIPROFLOXACIN HYDROCHLORIDE,tendonitis,1,2,0.14285714285714285,Adult,US,0.14285714285714285,1,1,10,0,0,0,0,0,0,0,1,2025,11,23,6,0.08073634859349145,5.142857142857142,0.14285714285714285
26082659,US,US,1,2.0,0,0,0,0,2025-11-24,57.0,801.0,Female,75.0,ESTRADIOL,device adhesion issue,0,0,0.0,MidAge,US,0.0,8,0,21,0,0,0,0,0,0,0,3,2025,11,24,0,0.08073634859349145,0.0,0.0
26082673,US,Unknown,1,1.0,0,0,1,0,2025-11-22,57.0,801.0,Male,75.0,LENALIDOMIDE,pneumonia bacterial,1,3,0.21428571428571427,MidAge,US,0.15413533834586465,19,1,19,0,0,0,0,0,1,0,2,2025,11,22,5,0.08073634859349145,8.785714285714285,0.0
26083511,US,Unknown,1,2.0,0,0,0,0,2025-11-24,57.0,801.0,Female,75.0,ADDERALL XR,heart rate increased,0,0,0.0,MidAge,US,0.0,2,0,20,0,0,0,0,0,0,0,3,2025,11,24,0,0.08073634859349145,0.0,0.0
26053765,US,US,1,2.0,0,0,0,0,2025-11-17,65.0,801.0,Male,75.0,DUPIXENT,pyrexia,0,0,0.0,MidAge,US,0.015513897866839042,221,0,7,0,0,0,0,0,0,0,1,2025,11,17,0,0.08073634859349145,1.0084033613445378,0.0
26054117,US,US,2,2.0,0,0,0,0,2025-11-17,48.0,801.0,Female,130.0,NEULASTA,device adhesion issue,0,0,0.0,Adult,US,0.0,5,0,21,0,0,0,0,0,0,0,3,2025,11,17,0,0.08936301793444651,0.0,0.0
26055480,GB,GB,1,1.0,0,0,0,0,2025-11-17,86.0,801.0,Female,99.0,XARELTO,ageusia,1,0,0.0,Senior,GB,0.0,1,0,7,0,0,0,0,0,0,0,1,2025,11,17,0,0.08073634859349145,0.0,0.0
26056209,EU,EU,1,1.0,0,0,1,0,2025-11-18,55.0,801.0,Male,74.0,BACTRIM,rash morbilliform,1,3,0.21428571428571427,MidAge,EU,0.21428571428571427,1,1,17,0,0,0,0,0,0,0,2,2025,11,18,1,0.08073634859349145,11.785714285714285,0.0
26057114,US,US,1,2.0,0,0,0,0,2025-11-18,57.0,801.0,Female,75.0,ISOTRETINOIN,adverse drug reaction,0,0,0.0,MidAge,US,0.023809523809523808,9,0,21,0,0,0,0,0,0,0,3,2025,11,18,1,0.08073634859349145,1.357142857142857,0.023809523809523808
25959785,US,US,1,2.0,0,0,0,0,2025-10-26,2.0,801.0,Female,75.0,DUPIXENT,dry skin,0,0,0.0,Child,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,2,2025,10,26,6,0.08073634859349145,0.031027795733678084,0.015513897866839042
25961704,CA,CA,2,1.0,0,0,0,0,2025-10-27,57.0,801.0,Female,75.0,TEZEPELUMAB,swollen tongue,1,0,0.0,MidAge,CA,0.10714285714285714,2,0,14,0,0,0,0,0,0,0,2,2025,10,27,0,0.08936301793444651,6.107142857142857,0.10714285714285714
25961919,CN,CN,1,1.0,0,0,0,0,2025-10-27,35.0,801.0,Female,75.0,ETANERCEPT,carotid artery stenosis,1,0,0.0,Young,CN,0.0,1,0,23,0,0,0,0,0,0,0,3,2025,10,27,0,0.08073634859349145,0.0,0.0
25962514,US,Unknown,1,1.0,1,0,0,0,2025-10-24,53.0,801.0,Male,75.0,CABENUVA,sepsis,1,5,0.35714285714285715,MidAge,US,0.35714285714285715,1,1,6,0,0,0,0,0,0,0,1,2025,10,24,4,0.08073634859349145,18.92857142857143,0.0
25963229,US,US,1,2.0,0,0,0,0,2025-10-27,57.0,801.0,Female,75.0,ATENOLOL,heart rate decreased,0,0,0.0,MidAge,US,0.0,1,0,20,0,0,0,0,0,0,0,3,2025,10,27,0,0.08073634859349145,0.0,0.0
26084617,US,US,1,2.0,0,0,0,0,2025-11-24,66.0,801.0,Female,75.0,DUPIXENT,pruritus,0,0,0.0,Senior,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,11,24,0,0.08073634859349145,1.0239172592113768,0.015513897866839042
26085913,EU,EU,1,2.0,0,0,0,0,2025-11-25,68.0,801.0,Female,75.0,METFORMIN HYDROCHLORIDE,potentiating drug interaction,0,0,0.0,Senior,EU,0.0,1,0,29,0,0,0,0,0,0,0,3,2025,11,25,1,0.08073634859349145,0.0,0.0
26086466,EU,EU,1,1.0,0,0,0,0,2025-11-25,77.0,801.0,Female,75.0,PACLITAXEL,pneumonitis,1,0,0.0,Senior,EU,0.07142857142857142,3,0,11,0,0,0,0,0,0,0,1,2025,11,25,1,0.08073634859349145,5.5,0.07142857142857142
24700004,US,US,1,2.0,0,0,0,0,2024-12-05,57.0,801.0,Female,75.0,YUTIQ,circumstance or information capable of leading to medication error,0,0,0.0,MidAge,US,0.0,1,0,66,0,0,0,0,0,0,0,9,2024,12,5,3,0.08073634859349145,0.0,0.0
24701744,US,US,1,2.0,0,0,0,0,2024-12-05,40.0,801.0,Female,75.0,DUPIXENT,stress,0,0,0.0,Adult,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2024,12,5,3,0.08073634859349145,0.6205559146735616,0.015513897866839042
24757888,US,Unknown,1,2.0,0,0,0,0,2024-12-20,57.0,801.0,Female,75.0,BIMZELX,pain,0,0,0.0,MidAge,US,0.0,22,0,4,1,0,0,0,0,0,0,1,2024,12,20,4,0.08073634859349145,0.0,0.0
24798092,JP,JP,1,1.0,0,0,0,0,2025-01-02,57.0,801.0,Male,56.9,ACTEMRA,blood immunoglobulin e abnormal,1,0,0.0,MidAge,JP,0.17857142857142858,6,1,31,0,0,0,0,0,0,0,4,2025,1,2,3,0.08073634859349145,10.178571428571429,0.0
24836905,US,US,2,1.0,0,0,0,0,2025-01-13,36.0,801.0,Female,75.0,VEDOLIZUMAB,colitis ulcerative,1,0,0.0,Adult,US,0.057692307692307696,26,0,18,0,0,0,0,0,0,0,2,2025,1,13,0,0.08936301793444651,2.076923076923077,0.057692307692307696
24839201,US,US,2,1.0,0,0,0,0,2025-01-14,53.0,801.0,Female,93.44,LANADELUMAB,spinal fracture,1,0,0.0,MidAge,US,0.12857142857142856,5,1,15,0,0,0,0,0,0,0,2,2025,1,14,1,0.08936301793444651,6.814285714285713,0.12857142857142856
24855454,GB,GB,1,1.0,0,0,0,1,2025-01-17,59.0,801.0,Male,100.0,LOSARTAN,pain in extremity,1,2,0.14285714285714285,MidAge,GB,0.2857142857142857,2,1,17,1,0,0,0,0,0,0,3,2025,1,17,4,0.08073634859349145,16.857142857142858,0.0
26089368,US,US,1,2.0,0,0,0,0,2025-11-25,64.0,801.0,Female,75.0,DUPIXENT,rhinorrhoea,0,0,0.0,MidAge,US,0.015513897866839042,221,0,11,0,0,0,0,0,0,0,1,2025,11,25,1,0.08073634859349145,0.9928894634776987,0.015513897866839042
26089463,US,US,1,2.0,0,0,0,0,2025-11-25,66.0,801.0,Male,75.0,DUPIXENT,arthralgia,0,0,0.0,Senior,US,0.015513897866839042,221,0,10,0,0,0,0,0,0,0,1,2025,11,25,1,0.08073634859349145,1.0239172592113768,0.0
26090100,US,US,1,2.0,0,0,0,0,2025-11-26,35.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Young,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,11,26,2,0.08073634859349145,0.5429864253393665,0.015513897866839042
26090382,GB,GB,1,1.0,0,0,0,0,2025-11-26,67.0,801.0,Female,75.0,CYPROTERONE ACETATE,meningioma,1,0,0.0,Senior,GB,0.0,1,0,10,0,0,0,0,0,0,0,1,2025,11,26,2,0.08073634859349145,0.0,0.0
26090706,US,US,2,1.0,0,0,1,0,2025-11-26,54.0,801.0,Female,89.811,CREON,trigeminal neuralgia,1,3,0.21428571428571427,MidAge,US,0.03296703296703297,13,0,20,0,0,0,0,0,0,0,2,2025,11,26,2,0.08936301793444651,1.7802197802197803,0.03296703296703297
26091893,CN,CN,1,1.0,0,1,0,0,2025-11-26,57.0,801.0,Female,75.0,PREDNISONE,febrile neutropenia,1,4,0.2857142857142857,MidAge,CN,0.1607142857142857,8,1,19,0,0,0,0,0,0,0,2,2025,11,26,2,0.08073634859349145,9.160714285714285,0.1607142857142857
26091907,US,Unknown,1,1.0,0,0,1,0,2025-11-25,57.0,801.0,Female,75.0,MYCOPHENOLATE MOFETIL,pneumonia aspiration,1,3,0.21428571428571427,MidAge,US,0.10150375939849625,19,0,20,0,0,0,0,0,1,0,2,2025,11,25,1,0.08073634859349145,5.7857142857142865,0.10150375939849625
26093284,US,US,1,2.0,0,0,0,0,2025-11-26,42.0,801.0,Female,75.0,DUPIXENT,arthralgia,0,0,0.0,Adult,US,0.015513897866839042,221,0,10,0,0,0,0,0,0,0,1,2025,11,26,2,0.08073634859349145,0.6515837104072397,0.015513897866839042
26093756,US,US,1,2.0,0,0,0,0,2025-11-26,45.0,801.0,Female,148.0,NEULASTA,unintentional medical device removal,0,0,0.0,Adult,US,0.0,5,0,36,0,0,0,0,0,0,0,4,2025,11,26,2,0.08073634859349145,0.0,0.0
26093985,JP,JP,2,1.0,0,0,0,0,2025-11-26,51.0,801.0,Male,60.0,LEUPROLIDE ACETATE,erectile dysfunction,1,0,0.0,MidAge,JP,0.38095238095238093,3,1,20,0,0,0,0,0,0,0,2,2025,11,26,2,0.08936301793444651,19.428571428571427,0.0
26094108,GB,GB,1,1.0,0,0,0,0,2025-11-26,68.0,801.0,Female,75.0,MYCOPHENOLATE MOFETIL,diffuse large b-cell lymphoma,1,0,0.0,Senior,GB,0.10150375939849625,19,0,29,0,0,0,0,0,0,0,4,2025,11,26,2,0.08073634859349145,6.902255639097745,0.10150375939849625
26095686,US,US,1,1.0,0,0,0,0,2025-11-27,58.0,801.0,Female,75.0,TACROLIMUS,delirium,1,0,0.0,MidAge,US,0.09183673469387754,7,0,8,0,0,0,0,0,0,0,1,2025,11,27,3,0.08073634859349145,5.326530612244897,0.09183673469387754
26096281,US,US,1,1.0,0,0,0,0,2025-11-27,57.0,801.0,Male,97.506,TYVASO DPI,insomnia,1,0,0.0,MidAge,US,0.0,4,0,8,0,0,0,0,0,0,0,1,2025,11,27,3,0.08073634859349145,0.0,0.0
26096524,EU,EU,1,1.0,0,0,1,0,2025-11-27,72.0,801.0,Male,75.0,RIVAROXABAN,haematoma,1,3,0.21428571428571427,Senior,EU,0.21428571428571427,2,1,9,0,0,0,0,0,0,0,1,2025,11,27,3,0.08073634859349145,15.428571428571427,0.0
24911143,KR,KR,2,1.0,0,0,0,0,2025-01-31,75.0,801.0,Female,60.0,LAZERTINIB,embolism,1,0,0.0,Senior,Other,0.0,1,0,8,0,0,0,0,0,0,0,1,2025,1,31,4,0.08936301793444651,0.0,0.0
24942367,US,Unknown,1,1.0,0,0,0,0,2025-02-07,61.0,801.0,Female,75.0,JAKAFI,bone pain,1,0,0.0,MidAge,US,0.0,3,0,9,1,0,0,0,0,0,0,2,2025,2,7,4,0.08073634859349145,0.0,0.0
24966491,US,US,2,1.0,0,0,0,0,2025-02-13,72.0,801.0,Female,76.0,.ALPHA.1-PROTEINASE INHIBITOR HUMAN,diabetes mellitus,1,0,0.0,Senior,US,0.0,1,0,17,0,0,0,0,0,0,0,2,2025,2,13,3,0.08936301793444651,0.0,0.0
24979923,US,US,2,1.0,0,0,0,0,2025-02-18,57.0,801.0,Male,75.0,RAVULIZUMAB,diabetes mellitus,1,0,0.0,MidAge,US,0.0,1,0,17,0,0,0,0,0,0,0,2,2025,2,18,1,0.08936301793444651,0.0,0.0
24987065,JP,JP,2,1.0,1,1,1,0,2025-02-19,73.0,801.0,Female,45.6,ELRANATAMAB,plasma cell myeloma,1,12,0.8571428571428571,Senior,JP,0.8571428571428571,1,1,19,0,0,0,0,0,0,0,3,2025,2,19,2,0.08936301793444651,62.57142857142857,0.8571428571428571
25967441,US,US,1,1.0,1,0,1,0,2025-10-28,57.0,801.0,Female,75.0,WINREVAIR,death,1,8,0.5714285714285714,MidAge,US,0.2619047619047619,3,1,5,0,0,1,0,0,0,0,1,2025,10,28,1,0.08073634859349145,14.928571428571429,0.2619047619047619
25967670,GB,GB,1,1.0,0,0,1,0,2025-10-28,74.0,801.0,Female,75.0,AMLODIPINE,gastroenteritis salmonella,1,3,0.21428571428571427,Senior,GB,0.16964285714285715,8,1,26,0,0,0,0,0,0,0,2,2025,10,28,1,0.08073634859349145,12.553571428571429,0.16964285714285715
25002592,US,US,1,2.0,0,0,0,0,2025-02-24,57.0,801.0,Female,85.714,TYVASO,flushing,0,0,0.0,MidAge,US,0.0,2,0,8,0,0,0,0,0,0,0,1,2025,2,24,0,0.08073634859349145,0.0,0.0
25046871,GB,GB,2,1.0,0,0,0,0,2025-03-06,36.0,801.0,Male,75.0,COPAXONE,confusional state,1,0,0.0,Adult,GB,0.0,2,0,17,0,0,0,0,0,0,0,2,2025,3,6,3,0.08936301793444651,0.0,0.0
25048167,US,US,2,2.0,0,0,0,0,2025-03-06,66.0,801.0,Female,75.0,RINVOQ,aphonia,0,0,0.0,Senior,US,0.0,3,0,7,0,0,0,0,0,0,0,1,2025,3,6,3,0.08936301793444651,0.0,0.0
25068970,US,US,1,2.0,0,0,0,0,2025-03-12,34.0,801.0,Female,75.0,DUPIXENT,rash erythematous,0,0,0.0,Young,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,3,12,2,0.08073634859349145,0.5274725274725274,0.015513897866839042
25070241,US,US,1,2.0,0,0,0,0,2025-03-12,61.0,801.0,Female,75.0,OPZELURA,product dose omission issue,0,0,0.0,MidAge,US,0.0,2,0,27,0,0,0,0,0,0,0,4,2025,3,12,2,0.08073634859349145,0.0,0.0
25071886,EU,EU,1,1.0,0,0,0,0,2025-03-13,11.0,801.0,Male,23.0,TACROLIMUS,hypogammaglobulinaemia,1,0,0.0,Child,EU,0.09183673469387754,7,0,22,0,0,0,0,0,0,0,1,2025,3,13,3,0.08073634859349145,1.010204081632653,0.0
25074249,EU,EU,1,1.0,0,0,0,0,2025-03-13,8.0,801.0,Female,75.0,DORZOLAMIDE\TIMOLOL,dry eye,1,0,0.0,Child,EU,0.0,1,0,7,0,0,0,0,0,0,0,2,2025,3,13,3,0.08073634859349145,0.0,0.0
26097105,EU,EU,1,1.0,0,0,0,0,2025-11-27,27.0,801.0,Male,75.0,DASATINIB,pulmonary hypertension,1,0,0.0,Young,EU,0.0,2,0,22,0,0,0,0,0,0,0,2,2025,11,27,3,0.08073634859349145,0.0,0.0
26097334,US,US,1,2.0,0,0,0,0,2025-11-27,74.0,801.0,Female,75.0,DATROWAY,off label use,0,0,0.0,Senior,US,0.0,2,0,13,0,0,0,0,0,0,0,3,2025,11,27,3,0.08073634859349145,0.0,0.0
26097873,US,US,1,2.0,0,0,0,0,2025-11-27,28.0,801.0,Female,75.0,DUPIXENT,eczema,0,0,0.0,Young,US,0.015513897866839042,221,0,6,0,0,0,0,0,0,0,1,2025,11,27,3,0.08073634859349145,0.43438914027149317,0.015513897866839042
26098401,US,US,1,2.0,0,0,0,0,2025-11-27,29.0,801.0,Female,75.0,XELJANZ,drug ineffective,0,0,0.0,Young,US,0.0,3,0,16,0,0,0,0,0,0,0,2,2025,11,27,3,0.08073634859349145,0.0,0.0
26099183,US,US,1,2.0,0,0,0,0,2025-11-28,13.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Child,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,11,28,4,0.08073634859349145,0.20168067226890754,0.015513897866839042
26099345,US,US,1,2.0,0,0,0,0,2025-11-28,57.0,801.0,Female,75.0,AMLODIPINE,adverse drug reaction,0,0,0.0,MidAge,US,0.16964285714285715,8,1,21,0,0,0,0,0,0,0,3,2025,11,28,4,0.08073634859349145,9.669642857142858,0.16964285714285715
25968385,CN,CN,1,1.0,0,0,0,0,2025-10-28,9.0,801.0,Male,75.0,DEXAMETHASONE,gene mutation,1,0,0.0,Child,CN,0.1857142857142857,5,1,13,0,0,0,0,0,0,0,2,2025,10,28,1,0.08073634859349145,1.6714285714285713,0.0
25968466,GB,GB,2,1.0,0,0,0,0,2025-10-28,57.0,801.0,Female,75.0,COSENTYX,crohn^s disease,1,0,0.0,MidAge,GB,0.05714285714285714,10,0,15,0,0,0,0,0,0,0,2,2025,10,28,1,0.08936301793444651,3.257142857142857,0.05714285714285714
25971963,CA,CA,1,1.0,1,0,0,0,2025-10-29,57.0,801.0,Female,75.0,TUMS ULTRA,hip arthroplasty,1,5,0.35714285714285715,MidAge,CA,0.35714285714285715,1,1,16,0,0,0,0,0,0,0,2,2025,10,29,2,0.08073634859349145,20.357142857142858,0.35714285714285715
25102021,US,US,1,1.0,0,0,0,0,2025-03-20,27.0,801.0,Male,75.0,ALTUVIIIO,ankle operation,1,0,0.0,Young,US,0.0,1,0,15,0,0,0,0,0,0,0,2,2025,3,20,3,0.08073634859349145,0.0,0.0
25110174,AU,AU,2,1.0,0,0,0,0,2025-03-24,38.0,801.0,Female,75.0,VEDOLIZUMAB,uveitis,1,0,0.0,Adult,AU,0.057692307692307696,26,0,7,0,0,0,0,0,0,0,1,2025,3,24,0,0.08936301793444651,2.1923076923076925,0.057692307692307696
25112657,US,Unknown,1,2.0,0,0,0,0,2025-03-24,66.0,801.0,Female,75.0,BIMZELX,diarrhoea,0,0,0.0,Senior,US,0.0,22,0,9,0,0,0,0,0,0,0,1,2025,3,24,0,0.08073634859349145,0.0,0.0
25112981,US,Unknown,1,2.0,0,0,0,0,2025-03-24,42.0,801.0,Female,75.0,BIMZELX,anxiety,0,0,0.0,Adult,US,0.0,22,0,7,0,0,0,0,0,0,0,1,2025,3,24,0,0.08073634859349145,0.0,0.0
25114615,US,US,1,2.0,0,0,0,0,2025-03-24,23.0,801.0,Male,75.0,DUPIXENT,illness,0,0,0.0,Young,US,0.015513897866839042,221,0,7,0,0,0,0,0,0,0,1,2025,3,24,0,0.08073634859349145,0.35681965093729795,0.0
25118165,US,US,1,1.0,0,0,0,0,2025-03-25,82.0,801.0,Female,54.0,REFRESH OPTIVE GEL DROPS,corneal scar,1,0,0.0,Senior,US,0.0,1,0,12,0,0,0,0,0,0,0,2,2025,3,25,1,0.08073634859349145,0.0,0.0
25124335,US,US,1,2.0,0,0,0,0,2025-03-26,85.0,801.0,Female,75.0,IBRANCE,fatigue,0,0,0.0,Senior,US,0.07142857142857142,3,0,7,0,0,0,0,0,0,0,1,2025,3,26,2,0.08073634859349145,6.071428571428571,0.07142857142857142
25138387,US,US,1,1.0,0,0,1,0,2025-03-30,72.0,801.0,Female,75.0,TYMLOS,depression suicidal,1,3,0.21428571428571427,Senior,US,0.21428571428571427,1,1,19,0,0,0,0,0,0,0,2,2025,3,30,6,0.08073634859349145,15.428571428571427,0.21428571428571427
25138482,US,US,1,1.0,0,0,0,0,2025-03-30,4.0,801.0,Male,75.0,IDELVION,haemorrhage,1,0,0.0,Child,US,0.10714285714285714,2,0,11,0,0,0,0,0,0,0,1,2025,3,30,6,0.08073634859349145,0.42857142857142855,0.0
25142074,EU,EU,1,1.0,0,0,0,0,2025-03-31,39.0,801.0,Female,75.0,CEFIDEROCOL,encephalitis,1,0,0.0,Adult,EU,0.0,1,0,12,0,0,0,0,0,0,0,1,2025,3,31,0,0.08073634859349145,0.0,0.0
25144328,BR,BR,2,1.0,0,0,1,0,2025-04-01,15.0,801.0,Male,45.0,INFLIXIMAB,disseminated tuberculosis,1,3,0.21428571428571427,Child,BR,0.07142857142857142,9,0,25,0,0,0,0,0,0,0,2,2025,4,1,1,0.08936301793444651,1.0714285714285714,0.0
25148850,US,US,2,2.0,0,0,0,0,2025-04-02,71.0,801.0,Male,75.0,ORGOVYX,hypersomnia,0,0,0.0,Senior,US,0.0,4,0,11,0,0,0,0,0,0,0,1,2025,4,2,2,0.08936301793444651,0.0,0.0
25152132,US,US,2,1.0,0,0,0,0,2025-04-02,68.0,801.0,Female,75.0,TREMFYA,liver function test increased,1,0,0.0,Senior,US,0.10714285714285714,2,0,29,0,0,0,0,0,0,0,4,2025,4,2,2,0.08936301793444651,7.285714285714286,0.10714285714285714
25170949,EU,EU,1,1.0,0,0,0,0,2025-04-08,44.0,801.0,Female,65.0,LYNPARZA,haemoglobin decreased,1,0,0.0,Adult,EU,0.0,1,0,21,0,0,0,0,0,0,0,2,2025,4,8,1,0.08073634859349145,0.0,0.0
26101211,US,US,2,1.0,0,0,0,0,2025-11-28,57.0,801.0,Male,75.0,SKYRIZI,skin cancer,1,0,0.0,MidAge,US,0.051587301587301584,36,0,11,0,0,0,1,0,0,0,2,2025,11,28,4,0.08936301793444651,2.9404761904761902,0.0
26101493,CN,CN,1,1.0,0,0,0,0,2025-11-28,35.0,801.0,Female,70.0,PALIPERIDONE,blood prolactin increased,1,0,0.0,Young,CN,0.0,1,0,25,0,0,0,0,0,0,0,3,2025,11,28,4,0.08073634859349145,0.0,0.0
26101912,US,US,2,1.0,0,0,0,0,2025-11-28,57.0,801.0,Female,75.0,SKYRIZI,skin disorder,1,0,0.0,MidAge,US,0.051587301587301584,36,0,13,0,0,0,0,0,0,0,2,2025,11,28,4,0.08936301793444651,2.9404761904761902,0.051587301587301584
26102102,CA,CA,1,1.0,0,0,0,0,2025-11-28,58.0,801.0,Female,75.0,APIXABAN,deep vein thrombosis,1,0,0.0,MidAge,CA,0.07142857142857142,3,0,20,0,0,0,0,0,0,0,3,2025,11,28,4,0.08073634859349145,4.142857142857142,0.07142857142857142
26102627,US,US,1,2.0,0,0,0,0,2025-11-28,57.0,801.0,Female,75.0,DUPIXENT,injection site exfoliation,0,0,0.0,MidAge,US,0.015513897866839042,221,0,26,0,0,0,0,0,0,0,3,2025,11,28,4,0.08073634859349145,0.8842921784098254,0.015513897866839042
26102722,GB,GB,1,1.0,0,0,0,0,2025-11-28,57.0,801.0,Female,75.0,DOXYCYCLINE,depression,1,0,0.0,MidAge,GB,0.19642857142857142,4,1,10,0,0,0,0,0,0,0,1,2025,11,28,4,0.08073634859349145,11.196428571428571,0.19642857142857142
26103127,US,US,1,2.0,0,0,0,0,2025-11-29,57.0,801.0,Female,75.0,LEVOTHYROXINE SODIUM,abdominal discomfort,0,0,0.0,MidAge,US,0.0,3,0,20,0,0,0,0,0,0,0,2,2025,11,29,5,0.08073634859349145,0.0,0.0
26104652,JP,JP,1,1.0,0,0,0,0,2025-11-30,57.0,801.0,Female,75.0,DUPIXENT,breast cancer,1,0,0.0,MidAge,JP,0.015513897866839042,221,0,13,0,0,0,1,0,0,0,2,2025,11,30,6,0.08073634859349145,0.8842921784098254,0.015513897866839042
25973192,JP,JP,1,1.0,0,0,1,0,2025-10-29,62.0,801.0,Female,75.0,DOCETAXEL,hemiparesis,1,3,0.21428571428571427,MidAge,JP,0.061224489795918366,7,0,11,0,0,0,0,0,0,0,1,2025,10,29,2,0.08073634859349145,3.7959183673469385,0.061224489795918366
25975499,EU,EU,1,1.0,0,0,0,0,2025-10-29,62.0,801.0,Male,54.0,MYCOPHENOLATE MOFETIL,deep vein thrombosis,1,0,0.0,MidAge,EU,0.10150375939849625,19,0,20,0,0,0,0,0,0,0,3,2025,10,29,2,0.08073634859349145,6.2932330827067675,0.0
25176848,US,US,1,1.0,0,0,0,0,2025-04-09,57.0,801.0,Female,75.0,CREXONT,cholelithiasis,1,0,0.0,MidAge,US,0.0,1,0,14,0,0,0,0,0,0,0,1,2025,4,9,2,0.08073634859349145,0.0,0.0
25179010,US,US,1,2.0,0,0,0,0,2025-04-09,13.0,801.0,Male,75.0,DUPIXENT,rash,0,0,0.0,Child,US,0.015513897866839042,221,0,4,0,0,0,0,0,0,0,1,2025,4,9,2,0.08073634859349145,0.20168067226890754,0.0
25183842,US,US,1,2.0,0,0,0,0,2025-04-10,33.0,801.0,Female,75.0,DUPIXENT,dermatitis atopic,0,0,0.0,Young,US,0.015513897866839042,221,0,17,0,0,0,0,0,0,0,2,2025,4,10,3,0.08073634859349145,0.5119586296056884,0.015513897866839042
25199838,CL,CL,2,1.0,0,0,0,0,2025-04-15,35.0,801.0,Female,75.0,SIMPONI,pneumonia,1,0,0.0,Young,Other,0.0,2,0,9,0,0,0,0,0,1,0,1,2025,4,15,1,0.08936301793444651,0.0,0.0
25203687,US,US,1,2.0,0,0,0,0,2025-04-16,77.0,801.0,Male,75.0,DUPIXENT,erythema,0,0,0.0,Senior,US,0.015513897866839042,221,0,8,0,0,0,0,0,0,0,1,2025,4,16,2,0.08073634859349145,1.1945701357466063,0.0
25210748,US,US,1,2.0,0,0,0,0,2025-04-17,80.0,801.0,Female,75.0,OLANZAPINE,sedation,0,0,0.0,Senior,US,0.11904761904761905,6,0,8,0,0,0,0,0,0,0,1,2025,4,17,3,0.08073634859349145,9.523809523809524,0.11904761904761905
25211653,US,US,2,1.0,0,0,1,0,2025-04-18,57.0,801.0,Male,75.0,EPIDIOLEX,hospitalisation,1,3,0.21428571428571427,MidAge,US,0.14285714285714285,3,1,15,0,0,0,0,0,0,0,1,2025,4,18,4,0.08936301793444651,8.142857142857142,0.0
25213301,CA,CA,1,1.0,0,0,0,0,2025-04-18,3.0,801.0,Male,75.0,RITUXIMAB,abdominal discomfort,1,0,0.0,Child,CA,0.12406015037593986,19,0,20,0,0,0,0,0,0,0,2,2025,4,18,4,0.08073634859349145,0.37218045112781956,0.0
25226934,EU,EU,1,1.0,0,0,0,1,2025-04-22,21.0,801.0,Male,75.0,CLOZAPINE,general physical health deterioration,1,2,0.14285714285714285,Young,EU,0.23214285714285715,4,1,37,0,0,0,0,0,0,0,4,2025,4,22,1,0.08073634859349145,4.875,0.0
25237383,EU,EU,1,1.0,0,0,0,0,2025-04-25,57.0,801.0,Male,2.49,GENTAMICIN,neonatal respiratory distress syndrome,1,0,0.0,MidAge,EU,0.0,1,0,38,0,0,0,0,0,0,0,4,2025,4,25,4,0.08073634859349145,0.0,0.0